data_1d8j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1d8j _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HB3' ' CH2' ' A' ' 53' ' ' TRP . 17.7 mtmt . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 120.486 0.184 . . . . 0.0 110.716 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -56.38 -51.85 66.77 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.775 -173.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.38 -49.77 74.92 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.465 HG13 ' CD2' ' A' ' 43' ' ' HIS . 3.3 t -58.81 -45.73 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.28 -45.5 94.23 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -38.0 82.58 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -69.4 -38.34 77.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.21 -48.85 85.62 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.59 -48.35 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -60.66 -43.71 97.3 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -60.73 -57.48 12.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 95.4 mtp -55.86 -40.84 73.48 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -59.35 -48.3 82.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.6 m -66.45 -51.18 59.61 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.124 0.17 . . . . 0.0 110.771 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -59.18 -36.7 75.78 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -68.56 -41.81 79.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -58.26 -48.34 80.73 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.871 0.468 . . . . 0.0 111.386 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -65.25 -33.38 75.84 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.73 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.25 -31.05 0.48 Allowed Glycine 0 C--N 1.346 1.085 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.627 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.95 70.2 2.65 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 117.95 0.875 . . . . 0.0 109.956 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.2 p -79.58 -4.16 50.25 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -61.89 155.71 60.99 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 122.662 0.385 . . . . 0.0 110.793 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -67.4 158.51 56.7 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.613 2.208 . . . . 0.0 110.622 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.1 mt -137.06 140.34 41.95 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.6 p -64.72 167.59 7.2 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.51 -48.92 79.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.68 -49.76 74.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.534 0.334 . . . . 0.0 110.924 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -52.58 -36.11 55.43 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.62 -45.29 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.2 mt -47.97 -57.84 5.21 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 117.852 0.296 . . . . 0.0 110.669 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.99 -63.86 0.88 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.934 0.494 . . . . 0.0 111.577 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -59.95 -27.17 66.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.494 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 67.4 p -93.32 -0.99 56.47 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.491 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 66.6 41.15 3.16 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.846 0.458 . . . . 0.0 109.961 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.494 ' CE1' ' O ' ' A' ' 41' ' ' THR . 7.9 m-70 -129.72 44.13 3.02 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.74 -51.28 11.71 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.07 -39.85 91.46 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.604 ' CG2' ' H ' ' A' ' 47' ' ' GLY . 18.5 tt 26.28 -105.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.866 1.266 . . . . 0.0 112.325 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.604 ' H ' ' CG2' ' A' ' 46' ' ' ILE . . . 157.34 148.84 5.24 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 108.04 -2.024 . . . . 0.0 108.04 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.4 tp -53.9 -39.97 66.23 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 117.397 0.599 . . . . 0.0 110.676 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -55.86 -58.92 5.82 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.227 0.211 . . . . 0.0 110.553 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.11 -50.14 62.53 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-O 119.513 -0.279 . . . . 0.0 110.395 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -46.01 -51.12 14.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.556 0.342 . . . . 0.0 110.47 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -64.53 -47.44 78.79 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.428 ' CH2' ' HB3' ' A' ' 9' ' ' LYS . 39.6 t90 -56.6 -41.53 77.17 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.381 0.272 . . . . 0.0 110.67 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.07 -45.53 94.35 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 5.0 mmt -66.83 -47.18 72.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.729 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.3 p -110.91 33.39 4.61 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -173.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.45 -67.39 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.821 0.737 . . . . 0.0 111.092 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.58 -62.33 1.73 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.3 mt -79.71 27.93 0.28 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.88 -38.8 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -88.21 -30.54 19.64 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -60.8 120.71 55.81 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.22 -36.89 54.63 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.661 2.241 . . . . 0.0 112.183 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -66.77 -20.51 65.96 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 119.678 -0.201 . . . . 0.0 110.921 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.8 mm -92.5 117.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -106.59 122.57 46.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.7 t -83.56 121.36 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.1 mt -115.96 -98.66 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 71' ' ' LYS . 21.0 t0 -82.47 52.81 2.15 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.76 -33.01 1.43 Allowed Glycine 0 CA--C 1.534 1.265 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 69' ' ' ASP . 48.1 mttp -77.8 176.51 8.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.228 0.611 . . . . 0.0 109.542 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -109.1 129.25 55.47 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.489 0.185 . . . . 0.0 110.729 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.15 172.32 8.34 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -97.11 148.14 23.33 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -104.02 106.96 55.52 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.778 0.431 . . . . 0.0 111.799 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 N--CA 1.449 -1.144 0 C-N-CA 122.75 2.3 . . . . 0.0 110.644 177.674 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HG3' ' CH2' ' A' ' 53' ' ' TRP . 1.5 ptmt . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -69.32 -46.34 67.33 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.73 -49.86 67.45 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.24 -45.4 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 117.015 0.407 . . . . 0.0 110.224 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.63 -37.87 76.85 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.27 74.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -61.98 -50.21 73.01 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 96.1 mt -57.76 -55.83 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.228 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 t -56.6 -44.4 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.144 0.178 . . . . 0.0 110.98 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -65.86 -52.19 52.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.57 0.168 . . . . 0.0 111.152 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -46.81 88.4 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 66.9 mmm -53.6 -48.79 68.94 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.92 -66.62 0.37 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 122.51 0.324 . . . . 0.0 110.71 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 m -52.55 -45.61 66.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.661 0.384 . . . . 0.0 111.999 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -24.36 60.43 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 122.253 -0.279 . . . . 0.0 111.06 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -78.33 -39.13 40.5 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -62.04 -40.37 95.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -52.64 -54.14 37.41 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 122.497 0.319 . . . . 0.0 110.341 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.4 -22.31 0.25 Allowed Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -82.06 46.38 1.01 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 117.621 0.711 . . . . 0.0 110.006 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -5.13 7.81 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.65 0.78 . . . . 0.0 111.291 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -54.88 153.42 11.41 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 122.446 0.298 . . . . 0.0 111.042 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.23 153.6 58.09 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.764 2.309 . . . . 0.0 111.08 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.2 mt -132.16 142.84 49.61 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.0 p -71.9 172.14 10.46 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -48.83 78.61 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.09 -52.39 61.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.89 0.476 . . . . 0.0 110.996 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -51.83 -42.32 62.46 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 122.468 0.307 . . . . 0.0 110.832 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.45 -57.75 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.5 mt -51.87 -39.95 59.79 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.255 0.222 . . . . 0.0 111.43 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -55.39 -52.84 62.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.722 -0.103 . . . . 0.0 110.722 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -75.44 -37.48 60.35 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.127 0.171 . . . . 0.0 110.967 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 43' ' ' HIS . 71.0 p -87.26 91.95 8.9 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -26.47 72.71 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.554 1.941 . . . . 0.0 115.592 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 41' ' ' THR . 1.3 p80 -178.58 58.12 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.89 56.68 4.08 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -162.21 -45.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.88 -89.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.597 0 C-N-CA 124.821 1.248 . . . . 0.0 112.3 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 140.11 168.95 11.51 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 107.166 -2.373 . . . . 0.0 107.166 -175.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.28 -49.37 77.38 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.65 0.725 . . . . 0.0 110.151 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -52.36 -55.7 19.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.312 0.245 . . . . 0.0 111.117 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -66.96 -58.58 4.68 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.282 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -48.94 -42.91 38.98 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 118.033 0.379 . . . . 0.0 110.7 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -68.15 -56.78 7.54 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.412 ' CH2' ' HG3' ' A' ' 9' ' ' LYS . 23.3 t90 -52.58 -52.6 54.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 123.151 0.282 . . . . 0.0 110.625 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.07 -49.93 74.32 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.19 0.196 . . . . 0.0 110.762 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 59.2 ttm -62.09 -57.66 10.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -174.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -109.78 16.86 21.77 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -138.84 -54.21 0.59 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.432 1.015 . . . . 0.0 111.295 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.68 -64.76 1.01 Allowed 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.03 -29.64 70.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.3 m -67.95 -18.71 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.144 -0.455 . . . . 0.0 111.998 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.3 p30 -136.57 15.14 3.17 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 118.67 0.668 . . . . 0.0 111.783 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -69.38 132.78 89.47 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -53.37 -27.18 38.15 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.818 2.345 . . . . 0.0 113.249 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -112.36 30.25 7.24 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.242 0.474 . . . . 0.0 111.675 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.7 mm -135.3 150.51 29.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -142.69 148.3 37.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.78 110.96 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.5 mt -129.52 126.47 63.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.5 t70 58.03 27.11 14.38 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.705 0.402 . . . . 0.0 109.984 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.15 -13.38 26.61 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -91.57 174.12 7.53 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -105.26 118.28 36.16 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.43 148.64 32.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -75.32 121.56 22.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -88.02 116.39 66.05 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo . . . . . 0 N--CA 1.447 -1.213 0 C-N-CA 122.123 1.882 . . . . 0.0 110.094 -179.936 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.442 ' HB2' ' CZ3' ' A' ' 53' ' ' TRP . 20.5 ptmt . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -68.58 -42.48 78.19 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.95 72.89 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.87 -45.58 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.4 tp -58.53 -46.14 87.41 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.13 99.35 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -62.55 -44.17 97.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.9 mt -60.85 -51.03 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 t -55.04 -47.74 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.2 -48.52 81.38 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 110.561 -0.162 . . . . 0.0 110.561 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -55.9 28.49 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -39.34 72.16 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -44.25 97.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.1 m -66.0 -45.49 81.37 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.135 0.174 . . . . 0.0 110.594 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -67.15 -40.59 86.72 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -61.25 -45.2 95.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -79.3 59.98 2.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.87 -51.71 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 177.48 -47.68 0.1 OUTLIER Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -76.61 73.25 3.31 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 116.97 0.385 . . . . 0.0 110.288 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.4 p -81.88 -12.18 58.57 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -63.64 154.24 80.73 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.577 0.351 . . . . 0.0 110.51 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.68 158.15 58.07 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.56 2.173 . . . . 0.0 111.386 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.4 mt -133.04 149.7 52.17 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -61.99 166.54 4.54 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tt -59.05 -52.45 65.68 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.02 -40.58 89.79 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.06 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -58.04 -43.51 86.87 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.4 mt -64.29 -43.97 97.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.36 -52.41 65.49 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -45.38 -56.89 4.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.575 0.35 . . . . 0.0 111.224 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -60.42 -34.75 74.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.549 0.34 . . . . 0.0 111.77 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.495 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 17.7 p -83.35 9.01 11.92 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 119.644 -0.217 . . . . 0.0 111.092 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 69.38 38.61 1.79 Allowed 'General case' 0 C--N 1.344 0.347 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.495 ' CE1' ' O ' ' A' ' 41' ' ' THR . 5.8 m-70 -132.37 167.05 20.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mt 166.26 -52.59 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.06 7.91 9.81 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 tt -48.48 147.21 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.469 0 C-N-CA 123.596 0.759 . . . . 0.0 110.237 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.35 133.43 19.9 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.3 tp -56.49 -31.05 63.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -58.02 -45.69 86.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -68.56 -47.8 65.9 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -55.69 -43.92 76.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -66.53 -50.7 62.3 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 9' ' ' LYS . 31.5 t90 -55.16 -45.66 75.71 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.457 0.303 . . . . 0.0 110.442 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.2 mt -56.08 -43.25 77.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.2 ttm -71.73 -50.37 30.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.5 p -104.94 23.49 13.47 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.421 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 36.0 tt0 -160.32 -68.89 0.07 Allowed 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 119.241 0.928 . . . . 0.0 111.567 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.55 -66.71 0.37 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.09 -41.52 99.41 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -65.27 -37.92 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 117.834 0.288 . . . . 0.0 110.591 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -101.78 58.35 0.84 Allowed 'General case' 0 C--N 1.342 0.279 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -148.1 112.66 3.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.29 -27.61 81.59 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.515 2.143 . . . . 0.0 111.812 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -74.92 -5.14 42.15 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.944 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.1 mm -120.5 138.21 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -126.6 119.66 27.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.29 139.06 18.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.6 mt -131.79 -96.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.316 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 71' ' ' LYS . 21.8 t0 -83.64 55.25 3.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.53 -39.05 1.47 Allowed Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 69' ' ' ASP . 8.1 mtmp? -72.27 161.42 30.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -108.52 128.55 54.9 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.866 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.2 163.01 15.81 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -92.87 125.47 37.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -78.8 122.46 84.73 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 C--N 1.357 0.974 0 C-N-CA 122.835 2.357 . . . . 0.0 110.955 179.573 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt . . . . . 0 CA--C 1.515 -0.392 0 CA-C-O 121.051 0.453 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -60.78 -37.05 80.56 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.979 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.15 -49.68 69.38 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 t -60.12 -41.99 88.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.36 -43.5 98.76 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.07 -48.8 80.28 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.021 0.128 . . . . 0.0 111.084 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.11 -30.52 67.73 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 120.643 -0.423 . . . . 0.0 109.993 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.8 mt -64.64 -46.05 93.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.89 -41.75 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.67 -47.81 77.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -44.29 95.05 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 89.2 mmm -62.51 -37.24 85.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -69.28 -53.54 19.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 m -54.1 -48.92 70.21 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.413 0.285 . . . . 0.0 111.011 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 ptm85 -64.44 -40.02 94.94 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -64.96 -19.62 66.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -88.36 -39.53 14.26 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.663 0.385 . . . . 0.0 110.68 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -69.88 -37.32 76.0 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 117.593 0.179 . . . . 0.0 110.588 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.7 48.45 0.06 OUTLIER Glycine 0 C--N 1.342 0.88 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -140.46 53.96 1.62 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.7 p -78.89 -10.09 59.7 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.679 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -61.89 147.58 89.45 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.8 151.72 68.85 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.863 2.376 . . . . 0.0 111.647 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.3 mt -131.28 142.38 50.12 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.7 p -70.53 170.85 11.26 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -46.41 90.41 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.55 -54.65 38.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.604 0.362 . . . . 0.0 110.444 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -52.28 -35.8 51.12 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.595 0.358 . . . . 0.0 111.108 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.6 mt -67.4 -48.85 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.4 mt -59.54 -43.78 93.39 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.11 -62.21 1.78 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.524 0.329 . . . . 0.0 111.164 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.07 -50.58 70.6 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.5 p -76.64 -1.29 26.97 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.588 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 56.68 60.2 3.19 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -129.35 31.37 4.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 mt -77.18 67.73 3.2 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -163.54 -40.65 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.516 ' CD1' ' H ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 18.18 -88.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.928 0 C-N-CA 125.441 1.496 . . . . 0.0 112.759 178.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.516 ' H ' ' CD1' ' A' ' 46' ' ' ILE . . . 132.77 160.48 9.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 107.351 -2.299 . . . . 0.0 107.351 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 tp -55.34 -43.81 75.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.756 0.778 . . . . 0.0 109.641 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -59.37 -53.37 58.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.522 0.329 . . . . 0.0 110.635 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -64.99 -57.66 8.12 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 119.669 -0.205 . . . . 0.0 111.083 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -48.71 -48.83 40.04 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 120.636 0.255 . . . . 0.0 110.392 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -62.5 -52.92 61.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.255 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -54.65 -49.22 71.1 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 122.286 0.235 . . . . 0.0 110.657 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.3 mt -56.22 -52.32 64.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 45.8 ttp -63.15 -40.78 98.55 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.2 p -114.48 27.49 9.42 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.29 -66.86 0.05 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.811 0.732 . . . . 0.0 110.749 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.35 -20.06 65.86 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.8 mt -121.23 21.84 11.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.201 0.455 . . . . 0.0 111.312 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.22 -41.78 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.22 -30.7 23.65 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -57.41 114.91 9.19 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.999 0.52 . . . . 0.0 109.962 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.83 -21.52 73.15 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.524 2.149 . . . . 0.0 111.786 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -80.96 0.68 34.42 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.543 -0.265 . . . . 0.0 110.714 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 mm -127.76 147.89 32.44 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -136.54 149.71 48.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.0 t -102.79 116.81 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.17 132.46 65.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 57.24 26.95 12.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.708 0.403 . . . . 0.0 110.136 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 -17.57 10.3 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -86.91 -179.63 6.55 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -116.05 137.6 51.98 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.657 0.265 . . . . 0.0 110.54 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.48 151.44 48.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -71.7 126.48 29.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -77.7 117.33 64.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.447 -1.223 0 C-N-CA 122.227 1.951 . . . . 0.0 111.426 -178.6 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -55.04 -40.57 70.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.638 0.375 . . . . 0.0 110.96 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.25 -45.06 96.04 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.72 -45.1 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.26 -42.61 98.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.049 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.96 86.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -67.96 -41.56 82.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.2 mt -62.14 -45.83 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.54 -50.12 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -58.71 -43.54 90.12 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -58.56 8.02 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.9 mmm -54.36 -42.42 70.25 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -50.49 72.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 122.466 0.306 . . . . 0.0 110.505 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.7 m -61.83 -49.13 77.52 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -58.16 -45.13 88.01 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -62.14 -34.3 76.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -73.11 -16.98 61.45 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.506 0.322 . . . . 0.0 110.553 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.05 -52.15 4.85 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 122.49 0.316 . . . . 0.0 110.171 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.54 -30.73 0.11 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -75.35 78.28 2.43 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.2 p -93.92 -17.03 23.43 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.196 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -66.06 154.46 89.65 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 117.6 0.182 . . . . 0.0 111.012 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.8 156.6 63.3 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.075 2.517 . . . . 0.0 111.76 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -137.96 147.7 44.54 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 122.906 0.482 . . . . 0.0 109.772 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.0 p -63.64 170.99 2.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 109.923 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -55.85 29.56 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.81 -42.3 79.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.286 0.234 . . . . 0.0 111.25 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.81 -35.07 70.35 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.2 mt -69.76 -40.98 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.63 -41.92 82.32 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -50.28 -62.51 1.54 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.199 0.2 . . . . 0.0 111.011 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.4 -46.32 86.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.84 0.456 . . . . 0.0 111.671 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.42 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 48.1 p -75.65 -6.69 51.7 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 119.243 -0.408 . . . . 0.0 111.653 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 61.0 52.95 3.85 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.42 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.0 m-70 -129.16 36.32 4.18 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.387 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.0 mp -69.35 -45.84 68.45 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -83.13 62.18 6.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.8 tt -101.75 146.69 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.831 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.95 136.06 48.78 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.6 tp -52.1 -39.32 59.62 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.944 0.372 . . . . 0.0 110.64 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -62.96 -40.03 96.45 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -70.02 -50.39 41.88 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -51.39 -47.15 62.99 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -60.65 -56.52 20.27 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.669 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -50.48 -46.88 57.22 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 122.795 0.438 . . . . 0.0 111.202 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 68.3 mt -56.99 -44.92 83.2 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 21.5 ttt -76.89 -34.36 57.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.2 p -101.34 -4.47 26.94 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -138.77 -74.43 0.38 Allowed 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.028 0.831 . . . . 0.0 111.567 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.83 -63.43 1.11 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.4 mt -73.07 4.04 4.8 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.4 m -116.86 6.3 7.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 CA-C-N 118.826 0.739 . . . . 0.0 110.679 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -145.81 -15.78 0.47 Allowed 'General case' 0 C--N 1.348 0.51 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.483 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -63.9 117.88 40.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.34 -25.27 77.8 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.558 2.172 . . . . 0.0 112.346 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.66 -12.51 60.01 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 119.357 -0.354 . . . . 0.0 110.993 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.33 144.68 22.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.38 130.14 51.96 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -89.15 125.73 42.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.3 mm -116.94 -108.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -82.52 55.88 3.1 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.75 -34.47 2.09 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -77.05 166.36 23.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.87 125.17 52.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.239 0.216 . . . . 0.0 110.796 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.8 172.51 6.89 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -94.79 122.71 37.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -73.95 114.94 37.55 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.447 -1.239 0 C-N-CA 122.309 2.006 . . . . 0.0 110.922 -178.191 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HB2' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -67.35 -49.7 62.96 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.327 0.251 . . . . 0.0 110.748 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.91 -47.59 87.92 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.9 -49.53 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 tp -56.91 -47.95 79.36 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.67 99.22 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.172 0.189 . . . . 0.0 110.711 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.91 -42.12 95.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.9 mt -60.3 -50.04 81.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 t -54.56 -44.77 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 122.411 0.285 . . . . 0.0 110.269 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -70.77 -39.0 73.47 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.321 0.105 . . . . 0.0 110.859 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.429 ' CE1' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -64.05 -52.98 56.83 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 96.0 mtp -61.63 -31.55 71.65 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -55.92 14.65 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.2 m -57.44 -40.33 78.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.429 ' HG3' ' CE1' ' A' ' 19' ' ' TYR . 42.4 mmt-85 -60.87 -50.82 71.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.94 0.496 . . . . 0.0 110.29 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -62.37 -22.07 65.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.447 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -88.9 16.18 7.34 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.654 0.382 . . . . 0.0 110.489 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -136.81 -47.09 0.6 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 117.611 0.187 . . . . 0.0 110.721 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 178.21 -38.64 0.08 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -73.44 76.86 1.41 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.5 p -100.77 -30.26 11.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.141 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.6 161.97 7.27 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 123.627 0.771 . . . . 0.0 111.288 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -68.81 124.6 11.65 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.201 1.934 . . . . 0.0 110.839 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 mt -101.24 153.86 19.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 p -69.79 167.36 17.37 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.68 -56.16 25.72 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -57.64 -40.23 78.77 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.516 -0.278 . . . . 0.0 111.621 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.0 -37.61 71.9 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 118.084 0.402 . . . . 0.0 109.982 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.3 mt -71.62 -40.62 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.69 -57.24 11.7 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.454 0.115 . . . . 0.0 111.195 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -40.83 67.83 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.189 0.196 . . . . 0.0 111.349 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.9 -3.17 37.28 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.57 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 16.7 p -120.6 0.78 10.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.105 0.412 . . . . 0.0 110.289 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.434 ' N ' ' NE2' ' A' ' 42' ' ' GLN . 10.4 mm-40 73.04 26.1 2.24 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.445 0.698 . . . . 0.0 109.132 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.57 ' CE1' ' HB ' ' A' ' 41' ' ' THR . 26.6 m170 -106.56 38.45 2.06 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.62 -38.75 21.17 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.51 -44.79 95.62 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.62 ' CG2' ' H ' ' A' ' 47' ' ' GLY . 16.3 tt 22.47 -102.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.26 1.424 . . . . 0.0 112.787 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.62 ' H ' ' CG2' ' A' ' 46' ' ' ILE . . . 153.05 148.94 5.02 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.3 tt -54.95 -42.15 71.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.515 0.658 . . . . 0.0 110.253 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -59.24 -51.02 71.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.416 0.286 . . . . 0.0 110.644 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -65.77 -51.32 60.08 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.273 0.229 . . . . 0.0 110.533 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -53.33 -50.48 64.9 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -58.53 -49.15 78.45 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.401 ' CH2' ' HB2' ' A' ' 9' ' ' LYS . 22.8 t90 -54.44 -50.93 66.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.1 mt -57.46 -47.87 80.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.3 ttt -60.17 -49.75 76.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.324 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.8 t -123.69 52.19 1.45 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.31 0.505 . . . . 0.0 112.221 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -167.58 -55.16 0.02 OUTLIER 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.255 -0.278 . . . . 0.0 110.284 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.92 -62.12 1.72 Allowed 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.3 mt -71.87 2.0 6.21 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.55 0.34 . . . . 0.0 111.882 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.5 t -82.5 -49.51 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -120.15 37.43 4.24 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.738 0.415 . . . . 0.0 110.14 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -74.98 133.3 75.91 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.13 -21.39 62.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.342 2.028 . . . . 0.0 111.993 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.89 10.15 13.09 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-O 119.391 -0.338 . . . . 0.0 111.851 -177.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.2 151.34 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -141.8 152.44 43.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 t -97.37 121.2 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -138.92 136.46 42.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.1 t70 56.68 26.91 11.84 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.872 0.469 . . . . 0.0 110.477 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 -20.42 6.14 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm -86.47 -167.12 1.76 Allowed 'General case' 0 C--N 1.345 0.382 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -132.42 126.91 34.23 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-O 120.918 0.39 . . . . 0.0 110.933 -176.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.71 166.8 11.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.678 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -92.96 127.93 38.65 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -83.95 118.91 72.58 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.449 -1.106 0 C-N-CA 122.282 1.988 . . . . 0.0 110.565 -179.487 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt . . . . . 0 CA--C 1.505 -0.781 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -63.29 -46.44 86.73 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.049 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.83 -49.62 76.05 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 t -59.66 -47.81 89.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.8 tp -59.39 -45.19 92.15 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.91 96.69 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -64.91 -44.03 90.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.2 mt -60.86 -46.94 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.13 -48.03 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 122.595 0.358 . . . . 0.0 110.048 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -61.48 -44.82 96.4 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -58.99 6.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.6 mmm -54.94 -37.69 66.76 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -45.8 92.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.2 m -60.06 -44.84 94.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -56.96 -53.18 60.9 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -61.92 -34.9 76.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.587 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -67.03 -46.78 73.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.686 -0.197 . . . . 0.0 111.05 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -71.04 -29.58 65.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 119.395 -0.335 . . . . 0.0 111.292 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.98 -20.0 0.97 Allowed Glycine 0 C--N 1.346 1.111 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.205 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -79.65 65.3 4.77 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.732 0.766 . . . . 0.0 109.747 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.0 p -78.19 -4.44 47.61 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.392 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -64.94 155.52 83.21 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 122.427 0.291 . . . . 0.0 110.725 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -69.29 155.71 66.69 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.75 2.3 . . . . 0.0 110.986 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.7 mt -136.6 143.45 43.58 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.4 p -70.99 167.32 19.41 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -47.8 81.3 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -55.88 -52.52 63.78 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.25 0.22 . . . . 0.0 110.466 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -55.13 -37.07 66.46 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 122.433 0.293 . . . . 0.0 110.496 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -69.42 -51.92 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.5 mt -57.4 -44.84 84.89 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -52.03 -56.81 12.02 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.465 0.306 . . . . 0.0 110.916 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.33 -41.26 88.7 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.689 -0.115 . . . . 0.0 110.689 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.416 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 40.9 p -82.36 7.29 14.45 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.121 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? 68.83 -11.95 0.4 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.358 0.663 . . . . 0.0 111.621 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.416 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.2 m-70 -77.35 35.51 0.18 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.745 -0.597 . . . . 0.0 111.701 -177.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -48.04 67.6 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.525 -0.734 . . . . 0.0 109.552 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -86.3 37.82 0.75 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.7 tt -72.77 147.3 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.09 137.54 46.75 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -55.46 -32.21 62.6 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.695 0.247 . . . . 0.0 110.471 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -54.02 -38.74 65.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -86.53 -43.83 12.41 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -51.22 -48.72 62.0 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 122.39 0.276 . . . . 0.0 110.344 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -66.22 -49.43 67.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.457 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 34.8 t90 -51.36 -44.84 62.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.547 0.339 . . . . 0.0 110.615 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.3 mt -56.95 -40.99 77.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.7 mtp -85.61 -9.36 57.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.731 -0.652 . . . . 0.0 112.643 -176.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 74.5 p -136.28 20.6 3.18 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.177 0.899 . . . . 0.0 112.931 -175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 30.7 tt0 -160.93 -49.89 0.05 OUTLIER 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.973 0.806 . . . . 0.0 111.725 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.93 -76.82 0.24 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.8 mt -56.69 -31.19 64.22 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.553 0.341 . . . . 0.0 111.694 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.7 m -58.28 -21.62 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 119.58 -0.248 . . . . 0.0 111.577 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -147.5 26.57 1.04 Allowed 'General case' 0 C--N 1.346 0.423 0 CA-C-N 118.148 0.431 . . . . 0.0 110.889 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.54 126.52 92.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.01 -24.14 78.95 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.403 2.069 . . . . 0.0 112.203 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.78 5.44 28.63 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-O 119.063 -0.494 . . . . 0.0 111.677 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.9 mt -145.2 112.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.453 0 CA-C-N 118.671 0.669 . . . . 0.0 109.573 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -96.16 156.8 16.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.257 0.623 . . . . 0.0 109.456 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -103.46 140.32 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.1 mt -127.71 -112.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 71' ' ' LYS . 25.8 t70 -80.08 61.15 3.84 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.29 -35.81 1.75 Allowed Glycine 0 CA--C 1.532 1.102 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 69' ' ' ASP . 15.4 mttp -76.38 179.17 6.0 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -123.74 134.08 53.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.13 135.8 53.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -62.4 125.4 23.79 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -86.27 128.93 55.51 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 N--CA 1.449 -1.128 0 C-N-CA 122.201 1.934 . . . . 0.0 110.583 179.608 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 17.2 mtmm . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 120.754 0.311 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -57.31 -44.92 84.56 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.645 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.41 -49.77 73.82 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.0 -47.83 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.5 -46.19 89.54 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.502 0.321 . . . . 0.0 110.506 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.19 93.76 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HZ1' ' CE1' ' A' ' 43' ' ' HIS . 15.6 ttpp -65.98 -39.27 90.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 mt -62.22 -46.88 95.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.38 -48.69 84.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -63.33 -38.22 90.32 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.15 -56.6 17.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.3 mtp -59.93 -35.41 74.85 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -46.14 91.86 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 m -67.59 -44.67 77.58 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 122.318 0.247 . . . . 0.0 110.397 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 47.4 ttt85 -60.02 -45.94 91.14 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -63.28 -39.66 95.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -79.42 54.8 1.79 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -165.53 -59.29 0.03 OUTLIER 'General case' 0 C--N 1.343 0.292 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.69 -44.07 0.08 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.79 74.64 2.1 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.6 p -83.71 -8.01 59.36 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -67.76 155.28 91.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -73.6 160.76 43.55 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.791 2.328 . . . . 0.0 111.617 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.5 mt -134.38 140.51 46.36 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.5 p -61.89 169.21 2.69 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.03 -50.34 74.45 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -61.6 -41.29 97.22 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.696 -0.193 . . . . 0.0 111.001 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -55.5 -34.82 64.95 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -70.15 -44.05 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 mt -52.18 -36.57 52.18 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.647 0.203 . . . . 0.0 110.531 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.86 -59.99 4.4 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.615 -0.142 . . . . 0.0 110.615 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -61.94 -66.16 0.58 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.53 80.44 4.01 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -32.6 86.41 0.0 OUTLIER 'General case' 0 C--N 1.352 0.717 0 C-N-CA 125.091 1.356 . . . . 0.0 112.555 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.416 ' CE1' ' HZ1' ' A' ' 15' ' ' LYS . 18.8 m-70 -140.6 29.27 1.95 Allowed 'General case' 0 C--O 1.213 -0.823 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.32 -38.69 80.92 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -91.04 69.18 6.23 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.443 ' CG1' ' HB2' ' A' ' 50' ' ' GLN . 1.3 tt -94.55 -46.67 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.029 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.73 131.3 6.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.859 -1.697 . . . . 0.0 108.859 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.1 tt -51.23 -40.42 58.74 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.86 0.33 . . . . 0.0 111.207 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -56.94 -33.85 67.43 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 119.828 -0.129 . . . . 0.0 111.071 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.443 ' HB2' ' CG1' ' A' ' 46' ' ' ILE . 25.6 mt-30 -89.9 -47.45 7.87 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -50.43 -52.77 34.82 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -58.87 -45.37 90.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.453 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 28.8 t90 -57.02 -54.24 48.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.7 mt -51.32 -45.89 62.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -60.75 -52.82 63.46 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.13 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 t -120.26 51.33 1.22 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.358 0.527 . . . . 0.0 112.137 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -166.95 -67.29 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.75 -60.48 2.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.16 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.5 mt -80.27 37.45 0.39 Allowed 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 122.367 0.267 . . . . 0.0 110.599 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.33 -45.84 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -112.23 -7.29 14.03 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.42 124.54 81.29 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.06 -34.84 99.02 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.745 2.297 . . . . 0.0 112.394 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -86.86 21.49 2.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 119.695 -0.193 . . . . 0.0 111.168 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.4 mm -135.64 144.29 34.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -145.92 141.48 27.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.56 136.0 29.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp -104.92 -59.01 3.59 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -160.32 77.6 0.63 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.29 -40.67 2.58 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -83.25 145.81 28.92 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -104.62 126.57 51.84 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 122.675 0.39 . . . . 0.0 110.617 -176.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.61 150.55 29.91 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -79.23 121.56 25.21 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -74.09 121.21 84.67 Favored Pre-proline 0 N--CA 1.448 -0.574 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.448 -1.154 0 C-N-CA 122.32 2.013 . . . . 0.0 110.403 -179.37 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -65.69 -42.78 90.81 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.106 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.74 -46.5 91.77 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -60.87 -46.03 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.75 -45.87 90.89 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.17 86.26 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -62.77 -42.57 99.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.96 -51.67 66.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.2 t -55.91 -45.35 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -64.14 -45.16 89.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -57.35 12.84 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 96.4 mtp -55.39 -39.88 70.68 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -61.09 -50.23 74.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.5 m -59.47 -46.68 88.08 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 ttm-85 -60.65 -44.31 96.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -60.8 -35.81 77.42 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -79.95 12.75 2.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.485 0.314 . . . . 0.0 110.952 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -127.86 29.95 5.35 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 117.949 0.341 . . . . 0.0 110.478 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.29 -34.53 3.61 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -74.92 77.4 2.16 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.9 p -97.2 -3.56 40.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.799 0.44 . . . . 0.0 110.993 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -70.91 156.71 91.65 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 117.739 0.245 . . . . 0.0 110.584 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.48 156.18 64.9 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.979 2.453 . . . . 0.0 111.717 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -137.69 141.88 41.09 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 122.973 0.509 . . . . 0.0 109.643 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.8 p -63.62 168.55 4.67 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.007 0.432 . . . . 0.0 110.408 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 tt -58.28 -51.83 68.12 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -54.86 -48.45 72.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.878 0.471 . . . . 0.0 111.106 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -56.25 -34.88 66.78 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.8 mt -73.5 -46.21 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.6 mt -46.31 -58.62 3.53 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.324 0.25 . . . . 0.0 111.048 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -46.27 -56.68 5.43 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.82 0.448 . . . . 0.0 111.913 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.79 -26.36 68.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.165 0.186 . . . . 0.0 111.445 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 28.3 p -99.12 16.94 21.11 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? 73.68 -88.84 0.02 OUTLIER 'General case' 0 C--N 1.35 0.597 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 41' ' ' THR . 23.7 m170 31.82 -109.6 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.762 0.825 . . . . 0.0 111.649 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 mt 69.36 -64.71 0.33 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.901 1.28 . . . . 0.0 110.443 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.52 -68.78 0.27 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.7 tt 47.51 137.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.143 1.777 . . . . 0.0 114.305 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.21 137.59 40.66 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.9 tp -52.16 -41.85 62.94 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.217 0.508 . . . . 0.0 109.867 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -60.06 -40.58 89.99 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -66.62 -57.99 6.08 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -49.84 -48.38 51.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.919 0.488 . . . . 0.0 110.668 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -64.25 -47.34 79.97 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 38.6 t90 -57.44 -45.94 84.13 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.7 mt -56.22 -51.49 67.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 40.6 ttm -56.86 -54.69 43.58 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.792 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -121.15 50.3 1.39 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.227 0.467 . . . . 0.0 111.937 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -170.5 -65.65 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.098 -0.376 . . . . 0.0 110.497 176.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.27 -50.02 69.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.392 0.277 . . . . 0.0 111.367 -176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.2 mt -79.29 -29.58 42.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.599 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.69 139.1 19.95 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 69.17 -9.34 0.61 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.328 0.651 . . . . 0.0 111.579 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.56 125.11 78.71 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.42 -12.29 30.0 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.339 2.026 . . . . 0.0 112.05 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.01 7.45 21.55 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 118.029 0.377 . . . . 0.0 111.534 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 mm -136.23 157.34 37.6 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -147.95 144.19 27.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.06 106.59 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.4 mm -121.1 126.13 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.0 t0 59.16 19.9 7.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.815 0.446 . . . . 0.0 110.462 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.41 -29.2 7.95 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 168.86 18.79 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -104.59 124.89 50.12 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.543 0.211 . . . . 0.0 110.523 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.05 137.48 52.88 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.308 0.643 . . . . 0.0 109.334 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -66.99 126.86 30.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.44 117.91 69.63 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo . . . . . 0 N--CA 1.447 -1.225 0 C-N-CA 122.201 1.934 . . . . 0.0 109.731 178.935 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -60.27 -45.41 93.41 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 122.901 0.48 . . . . 0.0 110.205 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.44 -47.52 90.7 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.02 -45.91 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.27 -44.64 96.91 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.24 99.4 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -61.86 -48.38 80.81 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 52.2 mt -58.26 -52.16 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.293 0.371 . . . . 0.0 110.114 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -55.73 -50.8 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.72 -43.29 94.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.249 0.22 . . . . 0.0 110.751 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -59.67 4.66 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -33.43 69.45 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -60.57 -46.65 89.44 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 m -73.23 -40.26 64.83 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.543 0.337 . . . . 0.0 110.164 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.434 HH21 ' CD ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -64.41 -33.71 76.49 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.576 0.75 . . . . 0.0 109.168 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -72.71 -49.77 29.09 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -38.14 65.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.897 0.479 . . . . 0.0 110.24 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -54.13 -42.51 69.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.139 0.576 . . . . 0.0 110.884 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.72 -27.73 1.77 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.75 59.68 2.59 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.7 p -66.63 -9.09 32.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.143 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -57.43 152.04 35.38 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 122.467 0.307 . . . . 0.0 110.839 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.89 155.53 54.32 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.719 2.279 . . . . 0.0 111.331 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 mt -135.19 144.01 46.75 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.4 p -73.38 175.25 7.11 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -54.0 50.77 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.6 -48.25 72.4 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.292 0.237 . . . . 0.0 110.584 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -54.34 -44.0 71.74 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.9 mt -63.61 -47.32 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.8 mt -56.99 -48.99 77.12 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -51.52 -56.93 10.68 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 123.187 0.304 . . . . 0.0 111.1 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.434 ' CD ' HH21 ' A' ' 23' ' ' ARG . 3.0 mt-10 -58.94 -37.19 76.17 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.047 0.139 . . . . 0.0 111.144 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.425 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 47.7 p -86.37 6.22 31.12 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.122 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? 69.04 -10.52 0.51 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.313 0.645 . . . . 0.0 111.34 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.425 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.0 m-70 -78.06 39.15 0.3 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.65 -0.656 . . . . 0.0 111.395 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.81 -45.48 61.36 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -84.23 51.71 2.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.9 tt -90.81 148.84 4.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.22 137.16 50.45 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.7 tp -54.72 -35.76 64.01 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.322 0.249 . . . . 0.0 110.631 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -58.11 -48.88 78.85 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -68.34 -44.26 75.69 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -52.54 -49.99 63.79 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.0 -52.17 66.91 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -53.74 -50.04 66.85 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.3 mt -57.33 -43.25 83.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.4 ttt -66.91 -53.03 36.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -120.41 47.14 1.83 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -167.75 -56.19 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.67 -60.18 2.46 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.179 -0.325 . . . . 0.0 111.569 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -80.61 27.74 0.35 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.9 m -124.73 -17.28 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 117.782 0.264 . . . . 0.0 110.36 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -130.12 6.6 4.98 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 117.718 0.235 . . . . 0.0 110.692 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -70.11 127.57 92.22 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.83 -29.96 87.8 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.443 2.095 . . . . 0.0 112.224 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -94.23 21.13 7.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 119.707 -0.187 . . . . 0.0 111.484 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.81 156.48 12.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -154.2 148.76 26.29 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.19 130.76 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.9 mt -120.87 -95.9 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 71' ' ' LYS . 30.4 t70 -83.72 51.59 2.06 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.65 -36.27 1.84 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 69' ' ' ASP . 28.9 mttp -74.07 179.13 4.56 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -114.14 126.36 54.99 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.2 138.82 50.95 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -70.06 127.32 32.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.02 120.51 81.51 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 N--CA 1.452 -0.959 0 C-N-CA 122.521 2.147 . . . . 0.0 110.775 179.226 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.402 ' HB2' ' CZ3' ' A' ' 53' ' ' TRP . 19.9 ptmt . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -68.89 -43.35 75.45 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.45 93.83 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.0 -47.92 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.27 -43.92 92.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.9 97.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -59.43 -46.53 88.47 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.8 mt -61.48 -49.11 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -57.61 -46.85 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -65.68 -42.22 91.53 Favored 'General case' 0 CA--C 1.527 0.063 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -60.22 -58.41 8.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtp -55.67 -44.51 77.36 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -55.34 -45.17 76.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.534 0.334 . . . . 0.0 110.308 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.7 m -62.98 -53.93 46.32 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 119.541 -0.266 . . . . 0.0 111.134 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -64.62 -30.87 71.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.61 0.641 . . . . 0.0 109.984 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -66.41 -40.34 89.54 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -65.35 -41.97 93.33 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.63 -55.51 29.81 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 122.179 0.192 . . . . 0.0 110.507 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.3 -30.35 0.12 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -75.89 71.31 2.7 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 117.338 0.569 . . . . 0.0 109.669 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.6 p -76.51 -9.6 58.78 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -62.98 156.32 67.9 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.85 161.88 29.95 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.682 2.255 . . . . 0.0 111.019 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.3 mt -132.74 144.86 50.56 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.9 p -60.75 167.19 2.87 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.98 -50.03 71.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.64 -49.08 79.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.863 0.465 . . . . 0.0 110.861 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -55.32 -34.08 63.88 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 58.5 mt -75.64 -50.53 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.417 ' CD1' HD13 ' A' ' 46' ' ' ILE . 8.8 mt -45.29 -54.16 7.47 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 122.691 0.397 . . . . 0.0 111.104 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -47.87 -59.34 3.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.699 0.399 . . . . 0.0 111.311 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -60.0 -37.7 80.48 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.221 0.208 . . . . 0.0 111.009 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.7 p -81.7 10.53 5.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.042 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 75.63 -61.0 0.48 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.74 0.816 . . . . 0.0 111.001 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 113.1 1.19 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.0 -34.09 3.8 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 122.45 0.3 . . . . 0.0 110.964 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -94.54 -40.88 9.63 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 38' ' ' LEU . 3.1 mt 55.63 -134.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.934 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.19 143.57 15.06 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 105.275 -3.13 . . . . 0.0 105.275 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -49.74 -45.36 49.26 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.23 1.015 . . . . 0.0 110.527 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -58.24 -46.57 85.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -64.3 -63.07 1.24 Allowed 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -42.77 -49.63 5.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.012 0.525 . . . . 0.0 110.966 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -65.31 -52.24 55.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 37.1 t90 -52.77 -46.03 67.38 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.822 0.449 . . . . 0.0 110.81 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.0 mt -57.1 -47.23 81.58 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.2 ttt -65.31 -47.2 77.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t -120.81 40.48 3.53 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.425 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 34.4 tt0 -165.72 -66.77 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.937 -0.477 . . . . 0.0 110.115 174.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.47 -61.07 2.86 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 -177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.1 mt -81.46 31.7 0.34 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.338 0.255 . . . . 0.0 110.373 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.41 -40.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.41 -30.48 16.48 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.386 0.274 . . . . 0.0 110.423 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -56.1 118.98 23.64 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.88 -30.99 91.14 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.534 2.156 . . . . 0.0 112.075 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -82.22 10.77 6.23 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.234 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 mm -129.65 143.65 40.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -146.67 135.68 22.47 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 t -89.52 131.92 35.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.1 mm -104.06 -60.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -152.45 76.23 1.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.8 -40.01 2.44 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -85.71 154.31 21.72 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -107.73 132.17 53.65 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.913 0.485 . . . . 0.0 109.997 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.32 151.82 39.66 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 122.54 0.336 . . . . 0.0 110.196 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -75.27 120.64 21.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -80.39 123.26 83.08 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 N--CA 1.447 -1.232 0 C-N-CA 122.342 2.028 . . . . 0.0 110.512 -179.412 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 7.7 mtmm . . . . . 0 N--CA 1.461 0.115 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -62.06 -42.57 99.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.622 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.91 -51.93 53.79 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.6 t -60.64 -45.89 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.63 -51.54 69.37 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.235 0.214 . . . . 0.0 110.43 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.69 -43.9 85.44 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -50.34 74.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.1 mt -59.33 -47.8 89.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 122.544 0.338 . . . . 0.0 110.285 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.5 t -58.42 -50.11 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -59.34 -47.16 86.44 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.81 -57.32 13.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 87.9 mtp -52.93 -41.21 64.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -60.66 -63.19 1.38 Allowed 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -45.95 -45.89 15.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 122.432 0.293 . . . . 0.0 110.793 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -63.45 -41.37 98.64 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -66.81 -34.12 77.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.236 0.614 . . . . 0.0 110.094 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -69.01 -36.47 77.83 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -62.78 -56.71 15.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.169 0.188 . . . . 0.0 110.725 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.35 -35.52 0.14 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -71.11 79.73 0.68 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.0 p -91.26 -19.07 23.39 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.443 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -61.78 151.71 78.25 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 117.936 0.335 . . . . 0.0 110.21 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -71.86 157.11 55.75 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.771 2.314 . . . . 0.0 111.589 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.9 mt -125.19 148.32 48.67 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.5 p -59.75 168.42 1.73 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -57.7 11.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.2 -43.3 70.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.481 0.312 . . . . 0.0 111.205 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -53.02 -49.94 65.24 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.6 mt -58.34 -40.17 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 122.127 0.171 . . . . 0.0 110.666 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.52 -28.97 69.7 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 117.82 0.282 . . . . 0.0 110.434 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.48 -59.32 4.11 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -55.86 -68.57 0.19 Allowed 'General case' 0 C--N 1.347 0.47 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -78.65 85.39 4.69 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -36.92 84.4 0.0 OUTLIER 'General case' 0 C--N 1.351 0.669 0 C-N-CA 125.003 1.321 . . . . 0.0 112.735 -176.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -140.04 45.1 1.89 Allowed 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.0 mt -79.77 -37.59 35.05 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.76 -43.22 99.37 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.588 ' CG2' ' H ' ' A' ' 47' ' ' GLY . 13.5 tt 22.85 -98.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.232 1.413 . . . . 0.0 113.022 177.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.588 ' H ' ' CG2' ' A' ' 46' ' ' ILE . . . 150.59 148.24 4.74 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.1 tp -54.43 -47.56 72.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.462 0.631 . . . . 0.0 110.712 -177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -57.35 -50.95 71.32 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.166 0.186 . . . . 0.0 110.742 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -62.79 -56.51 16.85 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -48.88 -50.04 36.83 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 122.577 0.351 . . . . 0.0 110.763 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -61.77 -45.23 94.78 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.453 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 49.7 t90 -61.29 -38.05 85.38 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.6 mt -62.57 -46.44 88.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.4 -50.64 69.07 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.898 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.2 p -89.1 -42.14 11.88 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -102.0 -72.68 0.68 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.42 -64.52 0.74 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -173.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.6 mt -80.39 31.9 0.29 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.128 0.171 . . . . 0.0 111.37 -175.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.47 -47.68 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -81.42 -28.17 34.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.603 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -57.47 121.67 49.84 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.46 -18.41 62.87 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.726 2.284 . . . . 0.0 112.557 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -97.98 20.0 12.98 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.049 0.386 . . . . 0.0 110.907 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 mm -131.05 146.89 33.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 117.936 0.334 . . . . 0.0 110.115 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -137.86 136.06 36.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.14 130.47 49.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.4 mt -142.94 123.45 10.43 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.3 t70 53.79 34.54 19.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.92 0.488 . . . . 0.0 111.073 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.09 -36.31 3.32 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -72.0 163.27 28.16 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -119.25 134.01 55.44 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.375 0.27 . . . . 0.0 110.455 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -125.03 152.17 44.62 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -76.17 121.84 23.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -69.19 119.34 69.51 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo . . . . . 0 N--CA 1.448 -1.181 0 C-N-CA 122.122 1.881 . . . . 0.0 109.695 -179.708 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.4 mttm . . . . . 0 N--CA 1.472 0.662 0 CA-C-O 120.58 0.229 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -57.99 -47.6 82.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.759 0.823 . . . . 0.0 111.821 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.21 -45.25 94.11 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.9 t -59.74 -46.57 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.17 -42.82 99.47 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.14 89.59 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -66.23 -41.56 89.86 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.7 mt -62.68 -47.82 91.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.25 -47.82 89.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -59.63 -47.21 86.47 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -48.22 80.88 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.634 0.373 . . . . 0.0 110.387 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 80.8 mmm -57.22 -33.12 67.21 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 122.498 0.319 . . . . 0.0 110.256 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . 20.6 ttpp -73.66 -62.58 1.44 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -44.98 -50.22 10.75 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.087 0.555 . . . . 0.0 111.546 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -63.13 -42.39 99.51 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.26 0.482 . . . . 0.0 109.872 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -64.55 -27.28 68.85 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.778 0.431 . . . . 0.0 109.956 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -74.44 -34.7 63.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.652 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -95.17 38.99 1.12 Allowed 'General case' 0 C--N 1.35 0.623 0 CA-C-N 118.13 0.423 . . . . 0.0 111.59 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.46 -16.5 48.99 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.185 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.3 41.76 0.71 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.489 1.145 . . . . 0.0 109.889 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.58 66.65 6.17 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -142.53 152.27 59.66 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.05 151.0 84.32 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.053 2.502 . . . . 0.0 111.91 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.3 mt -140.42 143.15 35.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.4 p -62.47 171.28 2.01 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -55.29 34.05 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -58.16 -41.88 84.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.242 0.217 . . . . 0.0 111.31 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.57 -40.78 75.79 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.0 mt -64.82 -45.73 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.5 mt -55.38 -49.04 73.34 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -49.2 -58.79 4.4 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.199 0.2 . . . . 0.0 111.081 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -61.25 -42.51 98.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.24 0.216 . . . . 0.0 111.56 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.47 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 35.5 p -75.7 -8.06 55.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 119.344 -0.36 . . . . 0.0 111.228 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 64.96 49.24 2.14 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.47 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 6.5 m-70 -130.46 39.2 3.66 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.462 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mt -73.82 -44.36 55.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.9 41.22 0.79 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 tt -79.32 -31.38 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 122.793 0.437 . . . . 0.0 110.297 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.16 138.43 10.28 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.25 -25.74 65.91 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 117.079 0.44 . . . . 0.0 111.2 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -61.11 -34.08 74.39 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -89.51 -43.85 10.54 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.693 0.397 . . . . 0.0 109.947 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -55.58 -47.74 75.95 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -57.24 -48.34 79.07 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -57.16 -54.83 42.28 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.0 mt -53.46 -43.13 67.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.3 ttt -70.85 -38.88 73.2 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.0 p -118.11 36.46 4.34 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -168.38 -70.33 0.02 OUTLIER 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.291 0.496 . . . . 0.0 110.539 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.76 -63.97 1.12 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -175.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.6 mt -79.1 28.59 0.22 Allowed 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.516 -0.115 . . . . 0.0 111.192 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.49 -40.75 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -116.16 4.86 13.65 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.37 0.268 . . . . 0.0 111.403 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.42 127.5 91.3 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.78 -30.05 91.54 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.593 2.195 . . . . 0.0 112.107 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.0 36.52 1.68 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.594 0.179 . . . . 0.0 110.733 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 tp -150.85 156.99 5.89 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -157.75 138.8 13.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.9 t -87.81 108.3 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.96 122.53 69.26 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 53.08 36.93 23.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.693 0.397 . . . . 0.0 110.489 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.71 -32.91 3.34 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -78.61 162.01 26.56 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 117.804 0.802 . . . . 0.0 108.98 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.63 123.24 44.56 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.4 153.42 28.62 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 21' ' ' LYS . 76.2 t80 -80.35 114.49 19.29 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.182 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -73.95 122.52 87.76 Favored Pre-proline 0 N--CA 1.446 -0.646 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo . . . . . 0 N--CA 1.446 -1.304 0 C-N-CA 122.246 1.964 . . . . 0.0 111.643 -177.372 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HB3' ' CH2' ' A' ' 53' ' ' TRP . 13.7 mttp . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 120.649 0.262 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -53.88 -39.4 65.69 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.804 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.45 -50.23 60.64 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.7 t -64.21 -46.63 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.18 -46.26 91.22 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.77 -42.45 93.33 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -58.72 -51.65 69.05 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.2 mt -55.42 -49.24 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 t -58.02 -46.14 87.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.17 -50.56 69.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.559 0.344 . . . . 0.0 110.747 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CE1' ' CD ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -60.81 -46.16 91.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.725 0.41 . . . . 0.0 110.323 -177.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.3 mmm -63.04 -47.37 83.3 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -56.73 -52.07 66.42 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.758 0.423 . . . . 0.0 110.906 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.5 m -57.5 -42.13 82.11 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.449 ' CD ' ' CE1' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -68.15 -40.51 82.37 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -62.2 -34.55 76.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -67.44 -47.18 70.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.443 0.297 . . . . 0.0 111.406 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -70.37 -35.44 73.54 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 119.143 -0.456 . . . . 0.0 111.756 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.74 -30.14 0.34 Allowed Glycine 0 C--N 1.345 1.04 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.195 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -74.52 77.58 1.95 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p -93.23 -14.23 27.33 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.826 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -61.94 149.71 85.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 117.447 0.112 . . . . 0.0 110.729 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -62.98 158.42 43.47 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.932 2.421 . . . . 0.0 111.225 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 mt -138.04 142.33 40.34 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.8 p -62.11 167.83 3.71 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -50.29 74.08 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.56 -51.9 63.8 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.785 0.434 . . . . 0.0 110.826 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.09 -45.52 79.38 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.3 mt -59.39 -46.95 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.41 ' CD2' HD13 ' A' ' 46' ' ' ILE . 24.2 mt -59.62 -63.75 1.19 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -40.19 -58.15 1.54 Allowed 'General case' 0 C--N 1.343 0.301 0 C-N-CA 123.674 0.79 . . . . 0.0 112.452 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -57.23 -34.56 68.7 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 117.411 0.096 . . . . 0.0 111.063 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.505 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -99.3 28.77 4.3 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 67.54 -111.27 0.14 Allowed 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.505 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 3.6 m-70 46.71 -116.3 0.66 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.513 0.325 . . . . 0.0 110.536 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 78.44 -55.4 0.48 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.582 1.153 . . . . 0.0 111.029 175.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.57 -62.04 1.6 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.41 HD13 ' CD2' ' A' ' 38' ' ' LEU . 30.3 mt 66.39 -74.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 O-C-N 124.592 1.183 . . . . 0.0 111.594 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.52 124.77 1.42 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 105.166 -3.174 . . . . 0.0 105.166 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.3 tp -43.84 -42.39 5.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.536 0.668 . . . . 0.0 111.798 -175.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -51.37 -52.61 44.23 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.372 0.269 . . . . 0.0 110.333 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -69.08 -61.69 1.69 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 122.519 0.328 . . . . 0.0 110.628 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -42.13 -42.89 3.11 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.757 0.423 . . . . 0.0 110.895 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -69.45 -53.81 17.41 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' A' ' 9' ' ' LYS . 34.1 t90 -51.94 -44.78 64.06 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 122.507 0.323 . . . . 0.0 110.712 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.3 mt -57.07 -45.75 83.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 47.8 ttm -74.68 -37.45 62.66 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -176.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 t -106.56 6.73 30.3 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -173.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -152.46 -67.91 0.16 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.282 0.946 . . . . 0.0 111.917 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.01 -65.4 0.57 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.63 -48.77 71.06 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.4 m -55.74 -35.37 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 119.534 -0.27 . . . . 0.0 110.883 -177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -109.76 36.23 3.06 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -94.15 127.64 44.01 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.86 -22.86 62.9 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.32 2.013 . . . . 0.0 112.021 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -111.75 6.06 19.53 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -176.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 mt -140.81 129.21 24.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -122.98 168.96 11.66 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.4 t -98.68 131.86 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.9 mt -139.21 121.07 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.8 t70 58.46 29.94 19.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.625 0.37 . . . . 0.0 110.252 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.47 -36.54 3.22 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 168.79 15.01 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -109.12 141.98 40.53 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.5 137.51 38.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.545 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -71.59 125.96 28.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -80.17 122.07 82.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 N--CA 1.451 -1.023 0 C-N-CA 122.435 2.09 . . . . 0.0 110.766 179.501 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.403 ' HB2' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -59.62 -48.99 79.5 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.258 0.223 . . . . 0.0 110.696 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.7 -50.22 69.49 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.5 t -59.69 -49.7 82.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.53 -46.35 86.96 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.46 98.18 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -63.63 -45.68 89.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.08 -48.1 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 t -57.5 -42.81 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -73.24 -42.7 62.25 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.484 -0.135 . . . . 0.0 111.087 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -49.0 77.52 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.1 mmm -55.88 -48.49 75.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -52.39 -61.1 2.49 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 123.349 0.405 . . . . 0.0 110.6 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -54.99 -51.59 65.74 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -62.1 -38.72 89.94 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.182 0.447 . . . . 0.0 110.251 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -64.46 -37.02 86.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -82.41 43.37 0.81 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.559 0.744 . . . . 0.0 109.012 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 ttp-105 -158.6 -51.43 0.06 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.22 -38.17 0.07 OUTLIER Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.8 59.66 3.77 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.315 0.557 . . . . 0.0 110.012 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.62 -3.53 59.05 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.15 154.37 92.8 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 122.651 0.38 . . . . 0.0 110.635 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.99 120.67 7.95 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.104 1.869 . . . . 0.0 110.121 176.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 mt -100.76 149.44 23.81 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.0 p -76.59 170.87 15.62 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -53.32 59.63 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -58.14 -43.56 87.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.22 0.208 . . . . 0.0 111.057 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -56.62 -41.77 77.68 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.2 mt -63.97 -49.68 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.9 mt -53.76 -55.73 23.7 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -45.79 -59.11 2.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.787 0.435 . . . . 0.0 111.442 -177.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.38 -38.74 84.86 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.3 p -81.41 -1.33 45.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.072 0.396 . . . . 0.0 111.159 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 65.54 44.91 2.89 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -127.6 28.8 5.59 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.22 -44.33 75.98 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.93 55.88 2.91 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.0 tt -99.89 148.17 6.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 122.711 0.404 . . . . 0.0 110.001 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.62 141.99 41.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -57.29 -24.95 58.23 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 117.064 0.432 . . . . 0.0 111.289 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -64.87 -50.97 64.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -69.49 -43.68 72.64 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -53.68 -50.57 65.54 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 -62.45 -48.13 81.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.98 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.403 ' CH2' ' HB2' ' A' ' 9' ' ' LYS . 28.8 t90 -54.38 -50.89 66.44 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.1 mt -55.16 -49.34 72.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.7 ttt -63.69 -48.07 78.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -124.96 50.24 1.77 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.726 0.694 . . . . 0.0 112.554 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -172.77 -61.88 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.61 -67.02 0.47 Allowed 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.463 -0.148 . . . . 0.0 111.155 -177.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.85 -48.35 82.21 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.351 0.26 . . . . 0.0 111.523 -175.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 m -53.74 -38.75 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -89.12 -25.11 22.04 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 117.797 0.271 . . . . 0.0 110.916 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.45 117.58 28.81 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -63.81 -35.4 56.91 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.633 2.222 . . . . 0.0 111.882 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.83 -26.61 64.31 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.902 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.09 95.2 3.62 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -91.97 157.95 16.53 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.7 t -96.21 136.53 26.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.1 mm -115.8 -114.07 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.19 62.47 6.66 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.87 1.96 60.24 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -117.72 -179.98 3.9 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -114.67 129.58 56.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.654 0.264 . . . . 0.0 110.51 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.5 146.09 48.34 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.45 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -87.66 125.23 34.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -81.3 121.32 80.14 Favored Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo . . . . . 0 N--CA 1.449 -1.101 0 C-N-CA 122.398 2.065 . . . . 0.0 111.124 -179.056 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.448 ' HB2' ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.73 -39.92 95.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.353 0.261 . . . . 0.0 110.505 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.23 -50.42 65.23 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.9 t -62.78 -44.09 99.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.67 -49.42 77.63 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.95 86.09 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.34 -44.53 96.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.21 -49.29 84.71 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.1 t -53.45 -45.47 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.63 -45.63 82.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.232 0.213 . . . . 0.0 111.228 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -40.26 94.17 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -41.74 87.58 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -58.31 8.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -63.4 -48.44 77.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.847 0.459 . . . . 0.0 112.029 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -35.04 79.3 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.309 0.504 . . . . 0.0 110.272 -177.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -66.29 -39.3 89.27 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -78.52 53.19 1.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.45 -50.13 0.09 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.76 -29.59 0.17 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -75.39 60.2 1.13 Allowed 'General case' 0 C--N 1.343 0.314 0 C-N-CA 122.966 0.506 . . . . 0.0 110.125 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.5 p -87.87 57.5 4.37 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -137.58 154.77 75.3 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.56 150.76 83.87 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.927 2.418 . . . . 0.0 112.32 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.1 mt -138.37 142.92 39.64 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.3 p -63.25 169.44 3.58 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.2 tt -60.88 -51.88 67.43 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -59.92 -41.34 91.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 119.675 -0.202 . . . . 0.0 110.655 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -56.93 -39.3 74.25 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 mt -67.0 -47.69 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.8 mt -52.0 -47.41 64.93 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -50.58 -56.77 10.22 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.33 0.252 . . . . 0.0 111.331 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -66.71 -45.06 79.97 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.13 -4.82 40.93 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.93 0.332 . . . . 0.0 110.934 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 63.2 50.22 3.08 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -130.9 45.77 2.77 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -77.59 -42.35 35.41 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -84.74 27.72 0.72 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 tt -63.26 -32.88 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 122.766 0.427 . . . . 0.0 110.456 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.76 137.73 9.93 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -59.11 -26.4 64.65 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.996 0.398 . . . . 0.0 110.99 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -61.17 -34.11 74.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -89.41 -47.42 8.03 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -57.41 -45.03 85.0 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.77 -49.17 76.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.448 ' CZ3' ' HB2' ' A' ' 9' ' ' LYS . 27.6 t90 -58.92 -50.84 72.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.8 mt -54.29 -42.25 69.82 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 122.104 -0.373 . . . . 0.0 110.237 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 21.7 ttt -64.12 -60.46 3.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -174.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 t -105.55 -3.34 22.49 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -117.74 -67.46 0.99 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.051 0.841 . . . . 0.0 111.214 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.01 -69.08 0.25 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.3 mt -57.94 -33.64 69.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.45 0.3 . . . . 0.0 111.077 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.0 t -63.58 -36.55 76.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -111.75 46.85 1.08 Allowed 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -118.23 115.91 35.91 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -66.78 -4.75 11.73 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.734 2.289 . . . . 0.0 112.853 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 4.51 17.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.404 0.547 . . . . 0.0 111.182 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.23 142.16 39.42 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.87 137.58 48.1 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.91 125.96 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.6 mt -137.54 116.6 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t0 54.31 45.49 27.13 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.687 0.395 . . . . 0.0 110.082 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.03 -41.72 2.24 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -69.5 169.99 11.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.106 0.453 . . . . 0.0 109.989 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.85 125.54 54.12 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 122.524 0.33 . . . . 0.0 110.129 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.84 127.93 56.2 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.061 0.545 . . . . 0.0 110.208 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -63.4 121.02 12.77 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -77.65 115.69 51.93 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 N--CA 1.449 -1.143 0 C-N-CA 122.264 1.976 . . . . 0.0 110.956 -178.066 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -75.52 -47.8 25.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 119.015 0.825 . . . . 0.0 109.637 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.93 -44.46 97.79 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.3 -43.92 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.1 tp -59.07 -47.22 86.01 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.31 -43.19 92.68 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -61.31 -43.48 98.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.7 mt -61.3 -45.65 98.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 t -58.15 -48.09 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -61.79 -42.44 99.0 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -58.32 9.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.8 ttm -55.61 -37.68 68.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 122.615 0.366 . . . . 0.0 110.442 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -60.99 -48.77 80.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.2 m -62.39 -44.68 95.86 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.425 ' HE ' ' CB ' ' A' ' 28' ' ' ASP . 3.1 ttt85 -61.48 -47.49 85.42 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.784 0.326 . . . . 0.0 110.273 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -63.18 -54.29 39.88 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.044 0.538 . . . . 0.0 109.834 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -58.63 -32.98 69.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.979 0.512 . . . . 0.0 110.447 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -66.63 -52.55 43.9 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.75 -34.31 0.1 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.775 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.425 ' CB ' ' HE ' ' A' ' 23' ' ' ARG . 5.4 m-20 -76.14 69.67 2.72 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 117.583 0.692 . . . . 0.0 109.825 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.1 p -77.32 -14.89 59.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.644 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -61.62 154.34 66.11 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 122.402 0.281 . . . . 0.0 110.711 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.24 157.62 52.99 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.598 2.198 . . . . 0.0 110.84 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 mt -135.91 147.63 48.21 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.0 p -70.77 171.23 10.9 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.2 -54.93 39.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.69 -52.07 57.58 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.354 0.262 . . . . 0.0 110.641 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -51.68 -37.49 50.86 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 122.165 0.186 . . . . 0.0 110.545 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.0 mt -69.41 -48.51 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.5 mt -53.62 -52.03 61.18 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 117.537 0.153 . . . . 0.0 110.798 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.64 -65.12 0.51 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 122.934 0.494 . . . . 0.0 111.679 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.64 -46.15 81.16 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.34 0.256 . . . . 0.0 111.426 -177.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.408 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -71.98 -6.19 40.34 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.002 -178.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 67.94 41.55 2.07 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 122.899 0.48 . . . . 0.0 109.99 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.408 ' CE1' ' O ' ' A' ' 41' ' ' THR . 7.2 m-70 -127.68 33.87 4.74 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -49.18 73.65 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.22 38.72 0.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 tt -72.1 149.62 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.11 133.41 37.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.7 tp -54.29 -35.3 62.45 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.363 0.265 . . . . 0.0 110.409 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -54.56 -46.29 73.63 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -70.2 -48.66 56.15 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -49.99 -44.13 50.8 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -69.24 -54.59 13.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 15.1 t90 -50.85 -40.14 55.34 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.709 0.404 . . . . 0.0 110.881 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.3 -39.8 88.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 73.0 mtm -89.96 -0.87 57.82 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.239 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.5 p -132.4 17.23 4.44 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.765 0.711 . . . . 0.0 111.888 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -166.79 -70.77 0.03 OUTLIER 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.447 0.567 . . . . 0.0 111.038 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.45 -80.09 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -174.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 mt -59.29 -20.99 58.96 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 122.564 -0.085 . . . . 0.0 111.001 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 96.8 t -68.0 -40.74 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.575 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.66 54.57 1.18 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 117.844 0.293 . . . . 0.0 111.607 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -101.9 135.18 19.76 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -51.2 -44.99 39.53 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.655 2.237 . . . . 0.0 112.682 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -83.3 8.81 12.37 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -176.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.4 mm -123.88 150.85 28.45 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 118.091 0.405 . . . . 0.0 109.926 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -134.69 138.55 44.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.2 t -96.93 121.25 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -134.39 130.67 54.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 52.43 31.82 10.31 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 123.464 0.478 . . . . 0.0 111.196 176.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.42 -17.25 20.08 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -87.66 -173.25 4.24 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -127.49 137.36 52.64 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.19 154.18 51.4 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -77.3 125.68 29.71 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -73.94 116.97 57.36 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 N--CA 1.448 -1.198 0 C-N-CA 122.427 2.085 . . . . 0.0 110.94 179.821 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.1 tttp . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.8 -48.73 65.48 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.033 0.533 . . . . 0.0 110.68 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.63 -43.28 99.16 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.84 -50.35 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.51 -45.29 94.36 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.59 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.68 96.29 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -57.43 -48.82 78.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.8 mt -59.7 -50.24 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.392 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 t -55.9 -48.69 78.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -62.15 -45.17 94.6 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.074 0.15 . . . . 0.0 110.66 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -59.04 -55.27 37.22 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 ttt -62.86 -35.83 81.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -60.86 -55.14 36.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 m -62.02 -43.01 99.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.423 ' HG3' ' CE1' ' A' ' 19' ' ' TYR . 14.3 mmt180 -56.26 -50.2 72.01 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.824 0.45 . . . . 0.0 109.905 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -63.81 -38.76 92.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -83.82 48.74 1.49 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -162.79 -50.14 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.1 -31.95 0.12 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -81.19 60.29 4.25 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.069 0.434 . . . . 0.0 110.175 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -6.32 59.13 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -70.12 155.13 93.96 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -70.02 147.11 60.46 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.73 2.287 . . . . 0.0 111.957 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.3 mt -134.55 144.91 48.26 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.477 0.711 . . . . 0.0 109.447 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -64.52 173.65 2.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.013 0.435 . . . . 0.0 110.027 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -58.3 9.15 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.644 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -59.06 -38.5 79.55 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 119.599 -0.238 . . . . 0.0 111.411 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.25 -39.53 79.41 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.2 mt -68.43 -42.58 84.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.423 ' CD1' ' HZ1' ' A' ' 51' ' ' LYS . 66.3 mt -59.8 -46.66 88.5 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.676 -0.12 . . . . 0.0 110.676 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -48.52 -59.48 3.46 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.645 0.378 . . . . 0.0 111.059 -177.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -56.84 -42.37 79.52 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.386 0.274 . . . . 0.0 111.077 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.0 p -80.19 4.69 16.69 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.876 -0.583 . . . . 0.0 111.213 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? 72.45 -15.37 0.49 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.846 0.858 . . . . 0.0 111.618 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -78.18 42.73 0.42 Allowed 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 118.409 0.55 . . . . 0.0 111.285 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.38 -45.59 54.0 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.67 -0.644 . . . . 0.0 109.421 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.11 -55.14 31.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.45 HG23 ' H ' ' A' ' 47' ' ' GLY . 4.0 tt 34.74 -132.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.095 0.958 . . . . 0.0 110.533 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.45 ' H ' HG23 ' A' ' 46' ' ' ILE . . . -154.35 151.21 22.92 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tt -56.17 -44.55 79.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.542 0.671 . . . . 0.0 110.493 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -59.73 -45.77 91.17 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.163 0.185 . . . . 0.0 110.628 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.1 -48.8 61.6 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HZ1' ' CD1' ' A' ' 38' ' ' LEU . 20.7 ttmm -52.37 -48.51 65.55 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -63.19 -48.03 80.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.407 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 26.5 t90 -53.78 -46.03 70.89 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.459 0.304 . . . . 0.0 110.405 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.8 mt -61.86 -40.72 96.35 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 40.0 ttm -76.13 -26.86 56.74 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.2 t -118.81 -8.05 10.38 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -174.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 26.8 tt0 -132.9 -49.09 0.87 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.152 0.887 . . . . 0.0 112.404 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.2 -63.52 1.4 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.0 mt -80.36 2.49 24.65 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -173.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.83 -93.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.773 0.715 . . . . 0.0 109.422 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -83.96 51.61 2.09 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -80.85 135.01 52.43 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.113 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -64.82 -25.02 60.75 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.112 1.875 . . . . 0.0 111.266 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -108.8 1.34 20.91 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 119.011 -0.518 . . . . 0.0 112.037 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.36 134.5 22.93 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 118.776 0.716 . . . . 0.0 110.014 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -115.89 157.38 24.57 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.7 t -100.62 126.79 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.42 121.43 31.52 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t0 51.53 46.96 25.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.823 0.449 . . . . 0.0 110.455 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.81 -39.49 2.0 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -73.16 176.29 6.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -117.49 153.0 33.9 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.19 139.07 28.53 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -64.82 133.86 52.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -90.14 115.92 65.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.112 0.565 . . . . 0.0 110.187 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.447 -1.226 0 C-N-CA 122.338 2.025 . . . . 0.0 110.135 179.26 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.449 ' HG3' ' CH2' ' A' ' 53' ' ' TRP . 5.6 pttt . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 119.744 -0.169 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -68.59 -47.4 66.84 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.103 0.41 . . . . 0.0 110.543 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.73 -36.11 88.63 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -72.69 -49.81 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.3 tp -57.69 -40.91 80.52 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.77 0.428 . . . . 0.0 110.775 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.14 -49.49 77.66 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -62.55 -38.94 92.0 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.1 mt -60.84 -49.0 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.53 -47.92 86.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -65.77 -40.32 91.91 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.434 ' CE1' ' HG2' ' A' ' 40' ' ' GLU . 1.8 t80 -60.17 -56.65 18.96 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.524 0.33 . . . . 0.0 110.27 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -40.66 86.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -55.84 -47.39 77.33 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -63.37 -47.61 81.39 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.395 0.278 . . . . 0.0 110.921 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.402 HH21 ' CG ' ' A' ' 28' ' ' ASP . 2.2 mtp180 -58.55 -48.72 79.95 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -60.2 -40.26 89.48 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -61.85 -42.74 99.42 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -65.82 -45.65 81.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.461 0.304 . . . . 0.0 110.311 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.91 -20.83 0.3 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.402 ' CG ' HH21 ' A' ' 23' ' ' ARG . 14.9 t70 -79.83 68.78 6.02 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.53 -5.69 58.67 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.979 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -64.22 148.46 95.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 O-C-N 122.329 -0.232 . . . . 0.0 110.436 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.08 146.67 86.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.038 2.492 . . . . 0.0 112.251 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.2 mt -134.78 136.53 42.65 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.6 p -63.12 169.91 3.16 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.059 0.457 . . . . 0.0 110.049 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tt -58.35 -51.44 69.79 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -58.14 -44.75 87.99 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.59 0.356 . . . . 0.0 110.99 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -56.59 -30.43 63.19 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.4 mt -78.3 -42.99 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.3 mt -55.26 -43.58 74.78 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -49.47 -50.08 42.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.381 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.434 ' HG2' ' CE1' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -77.28 -49.8 14.25 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.204 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.5 p -69.08 -3.49 13.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.251 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 65.47 45.95 2.65 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -125.57 42.29 3.32 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.57 -49.7 20.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.59 42.53 0.91 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.4 tt -72.82 -36.13 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 122.816 0.446 . . . . 0.0 110.309 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.69 132.19 6.78 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.9 -36.21 62.45 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.821 0.311 . . . . 0.0 110.368 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -50.13 -44.09 52.16 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -78.25 -46.9 19.11 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.484 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -50.61 -49.67 55.99 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -48.95 78.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.449 ' CH2' ' HG3' ' A' ' 9' ' ' LYS . 12.8 t90 -55.76 -53.27 58.74 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.0 mt -54.95 -44.02 73.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -53.09 61.82 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.303 -175.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 t -120.15 48.18 1.62 Allowed 'General case' 0 C--N 1.348 0.541 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -175.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -165.75 -66.11 0.03 OUTLIER 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.5 -69.39 0.29 Allowed 'General case' 0 C--O 1.224 -0.267 0 O-C-N 122.904 0.127 . . . . 0.0 111.168 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.7 mt -59.72 -25.28 64.7 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.416 0.286 . . . . 0.0 111.088 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.5 t -75.2 -47.89 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -102.26 66.02 0.98 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -143.89 118.55 6.07 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.36 -23.3 74.25 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.602 2.202 . . . . 0.0 112.285 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -93.87 12.35 26.22 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 117.793 0.27 . . . . 0.0 110.95 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mm -135.68 152.02 30.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -144.8 142.37 29.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.7 t -96.06 127.5 48.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.049 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.7 mm -112.59 -120.97 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -81.02 67.51 6.95 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.19 -36.86 1.96 Allowed Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -75.25 169.25 18.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 117.111 0.455 . . . . 0.0 109.999 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -112.47 120.81 42.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.48 134.59 51.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -64.47 135.03 55.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -97.23 118.27 64.77 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo . . . . . 0 N--CA 1.448 -1.203 0 C-N-CA 122.311 2.007 . . . . 0.0 110.24 179.619 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 120.597 0.236 . . . . 0.0 110.502 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -58.11 -37.45 74.58 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 122.868 0.467 . . . . 0.0 111.383 -175.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.48 -48.17 76.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.06 -41.97 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.82 -47.55 85.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.91 -44.14 91.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -60.7 -47.33 86.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.32 -49.66 82.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.8 t -55.68 -43.8 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 122.663 0.385 . . . . 0.0 110.152 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -65.11 -48.22 74.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -50.25 73.03 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.3 mmm -55.73 -45.54 77.94 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -43.02 87.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.6 m -61.27 -51.36 69.24 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 119.422 -0.323 . . . . 0.0 111.285 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.65 -34.4 78.13 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.857 0.753 . . . . 0.0 109.691 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -65.37 -35.37 80.75 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -69.74 -42.35 74.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.078 0.551 . . . . 0.0 110.436 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -65.75 -36.19 82.85 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.69 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.99 -23.37 0.6 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-O 119.695 -0.503 . . . . 0.0 111.935 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.74 66.68 2.71 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.651 0.726 . . . . 0.0 109.658 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.2 p -76.42 -4.16 40.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.079 0.152 . . . . 0.0 110.676 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -66.03 156.14 85.06 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -70.32 162.46 42.26 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.708 2.272 . . . . 0.0 110.881 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.2 mt -138.65 150.28 46.06 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 177.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.3 p -77.88 167.94 20.71 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -44.83 92.5 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.0 -54.45 46.63 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -54.58 -43.03 71.74 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 122.582 0.353 . . . . 0.0 110.339 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.2 mt -59.13 -62.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.2 mt -54.81 -42.34 71.72 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.162 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -52.1 -54.91 24.63 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -64.05 -31.99 73.38 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.02 13.79 5.68 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 74.44 -58.51 0.58 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 124.312 1.045 . . . . 0.0 112.592 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.76 77.75 0.45 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.615 0.366 . . . . 0.0 111.944 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.94 -33.98 51.37 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 47' ' ' GLY . 19.4 t70 -68.98 -55.37 11.1 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 tt 50.26 -70.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.675 1.59 . . . . 0.0 112.693 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 45' ' ' ASP . . . 142.46 126.34 2.09 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.5 tp -46.81 -44.96 19.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.261 0.53 . . . . 0.0 111.238 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.6 -39.21 61.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.196 0.198 . . . . 0.0 111.244 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -87.97 -48.05 8.08 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -48.11 -48.84 33.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.118 0.567 . . . . 0.0 110.495 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.39 -47.43 76.33 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.433 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 31.2 t90 -55.8 -40.27 72.46 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 122.376 0.27 . . . . 0.0 110.425 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.5 mt -58.66 -49.0 79.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 83.1 mtp -64.84 -47.98 75.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.279 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.5 p -110.32 34.35 3.97 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -173.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.17 -75.17 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.738 0.699 . . . . 0.0 110.681 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.49 -53.78 41.24 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.7 mt -79.92 -20.1 46.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.756 -0.164 . . . . 0.0 111.041 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.89 -69.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.95 60.13 5.7 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -107.44 122.81 40.05 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.128 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -63.48 -19.6 68.15 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.247 1.964 . . . . 0.0 111.845 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -125.86 19.69 7.8 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.1 mt -146.0 129.69 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -111.46 154.12 25.15 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.3 t -105.93 144.29 15.58 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.0 mt -126.52 -125.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.51 65.04 3.71 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.29 -37.34 2.57 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 171.31 14.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -122.99 147.69 46.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.94 136.51 33.9 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -66.71 130.23 42.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -77.42 129.84 76.23 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.452 -0.937 0 C-N-CA 122.651 2.234 . . . . 0.0 112.188 -177.644 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.18 57.71 3.69 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.3 p -81.08 -35.87 31.16 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.118 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.58 -62.09 5.37 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.5 t -165.18 -170.18 1.84 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.7 m -152.77 97.0 2.18 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.05 -47.68 0.02 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -53.8 123.62 12.92 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.428 ' HB3' ' CH2' ' A' ' 53' ' ' TRP . 17.7 mtmt 74.93 -59.9 0.53 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.066 0.947 . . . . 0.0 110.716 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -56.38 -51.85 66.77 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.775 -173.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.38 -49.77 74.92 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.465 HG13 ' CD2' ' A' ' 43' ' ' HIS . 3.3 t -58.81 -45.73 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.28 -45.5 94.23 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -38.0 82.58 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -69.4 -38.34 77.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.21 -48.85 85.62 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.59 -48.35 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -60.66 -43.71 97.3 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -60.73 -57.48 12.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 95.4 mtp -55.86 -40.84 73.48 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -59.35 -48.3 82.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.6 m -66.45 -51.18 59.61 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.124 0.17 . . . . 0.0 110.771 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -59.18 -36.7 75.78 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -68.56 -41.81 79.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -58.26 -48.34 80.73 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.871 0.468 . . . . 0.0 111.386 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -65.25 -33.38 75.84 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.73 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.25 -31.05 0.48 Allowed Glycine 0 C--N 1.346 1.085 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.627 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.95 70.2 2.65 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 117.95 0.875 . . . . 0.0 109.956 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.2 p -79.58 -4.16 50.25 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -61.89 155.71 60.99 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 122.662 0.385 . . . . 0.0 110.793 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -67.4 158.51 56.7 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.613 2.208 . . . . 0.0 110.622 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.1 mt -137.06 140.34 41.95 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.6 p -64.72 167.59 7.2 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.51 -48.92 79.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.68 -49.76 74.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.534 0.334 . . . . 0.0 110.924 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -52.58 -36.11 55.43 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.62 -45.29 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.2 mt -47.97 -57.84 5.21 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 117.852 0.296 . . . . 0.0 110.669 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.99 -63.86 0.88 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.934 0.494 . . . . 0.0 111.577 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -59.95 -27.17 66.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.494 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 67.4 p -93.32 -0.99 56.47 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.491 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 66.6 41.15 3.16 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.846 0.458 . . . . 0.0 109.961 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.494 ' CE1' ' O ' ' A' ' 41' ' ' THR . 7.9 m-70 -129.72 44.13 3.02 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.74 -51.28 11.71 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.07 -39.85 91.46 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.604 ' CG2' ' H ' ' A' ' 47' ' ' GLY . 18.5 tt 26.28 -105.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.866 1.266 . . . . 0.0 112.325 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.604 ' H ' ' CG2' ' A' ' 46' ' ' ILE . . . 157.34 148.84 5.24 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 108.04 -2.024 . . . . 0.0 108.04 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.4 tp -53.9 -39.97 66.23 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 117.397 0.599 . . . . 0.0 110.676 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -55.86 -58.92 5.82 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.227 0.211 . . . . 0.0 110.553 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.11 -50.14 62.53 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-O 119.513 -0.279 . . . . 0.0 110.395 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -46.01 -51.12 14.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.556 0.342 . . . . 0.0 110.47 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -64.53 -47.44 78.79 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.428 ' CH2' ' HB3' ' A' ' 9' ' ' LYS . 39.6 t90 -56.6 -41.53 77.17 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.381 0.272 . . . . 0.0 110.67 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.4 mt -61.07 -45.53 94.35 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 5.0 mmt -66.83 -47.18 72.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.729 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.3 p -110.91 33.39 4.61 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -173.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.45 -67.39 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.821 0.737 . . . . 0.0 111.092 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.58 -62.33 1.73 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -175.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.3 mt -79.71 27.93 0.28 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.88 -38.8 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -88.21 -30.54 19.64 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -60.8 120.71 55.81 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.22 -36.89 54.63 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.661 2.241 . . . . 0.0 112.183 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -66.77 -20.51 65.96 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 119.678 -0.201 . . . . 0.0 110.921 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.8 mm -92.5 117.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -106.59 122.57 46.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.7 t -83.56 121.36 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.1 mt -115.96 -98.66 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.476 ' C ' ' H ' ' A' ' 71' ' ' LYS . 21.0 t0 -82.47 52.81 2.15 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.76 -33.01 1.43 Allowed Glycine 0 CA--C 1.534 1.265 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 69' ' ' ASP . 48.1 mttp -77.8 176.51 8.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.228 0.611 . . . . 0.0 109.542 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -109.1 129.25 55.47 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.489 0.185 . . . . 0.0 110.729 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.15 172.32 8.34 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -97.11 148.14 23.33 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -104.02 106.96 55.52 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.778 0.431 . . . . 0.0 111.799 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -81.99 -52.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.75 2.3 . . . . 0.0 110.644 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -53.89 152.01 6.02 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.202 1.001 . . . . 0.0 112.726 -174.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 17.4 p90 36.15 49.22 0.61 Allowed 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.001 1.32 . . . . 0.0 111.847 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -164.6 -49.69 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.46 151.32 26.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 116.726 -1.606 . . . . 0.0 109.129 179.408 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 tt -155.68 -64.79 0.12 Allowed 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m 53.62 68.17 0.89 Allowed 'General case' 0 C--N 1.344 0.331 0 C-N-CA 122.646 0.378 . . . . 0.0 110.275 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.25 57.16 4.4 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.4 t 61.26 -173.1 0.14 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.991 0.516 . . . . 0.0 110.903 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.0 t -177.16 155.42 1.15 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.46 55.4 0.54 Allowed Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -157.54 99.5 1.74 Allowed 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HG3' ' CH2' ' A' ' 53' ' ' TRP . 1.5 ptmt 82.62 -47.36 0.16 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.689 0.796 . . . . 0.0 108.899 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -69.32 -46.34 67.33 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.73 -49.86 67.45 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.24 -45.4 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 117.015 0.407 . . . . 0.0 110.224 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.63 -37.87 76.85 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.27 74.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -61.98 -50.21 73.01 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 96.1 mt -57.76 -55.83 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.228 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 t -56.6 -44.4 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.144 0.178 . . . . 0.0 110.98 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -65.86 -52.19 52.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.57 0.168 . . . . 0.0 111.152 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -46.81 88.4 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 66.9 mmm -53.6 -48.79 68.94 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.92 -66.62 0.37 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 122.51 0.324 . . . . 0.0 110.71 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 m -52.55 -45.61 66.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.661 0.384 . . . . 0.0 111.999 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.27 -24.36 60.43 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 122.253 -0.279 . . . . 0.0 111.06 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -78.33 -39.13 40.5 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -62.04 -40.37 95.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -52.64 -54.14 37.41 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 122.497 0.319 . . . . 0.0 110.341 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.4 -22.31 0.25 Allowed Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -82.06 46.38 1.01 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 117.621 0.711 . . . . 0.0 110.006 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.74 -5.13 7.81 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.65 0.78 . . . . 0.0 111.291 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -54.88 153.42 11.41 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 122.446 0.298 . . . . 0.0 111.042 -179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.23 153.6 58.09 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.764 2.309 . . . . 0.0 111.08 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.2 mt -132.16 142.84 49.61 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.0 p -71.9 172.14 10.46 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -48.83 78.61 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.09 -52.39 61.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.89 0.476 . . . . 0.0 110.996 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -51.83 -42.32 62.46 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 122.468 0.307 . . . . 0.0 110.832 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.45 -57.75 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.5 mt -51.87 -39.95 59.79 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.255 0.222 . . . . 0.0 111.43 -177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -55.39 -52.84 62.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.722 -0.103 . . . . 0.0 110.722 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -75.44 -37.48 60.35 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.127 0.171 . . . . 0.0 110.967 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 43' ' ' HIS . 71.0 p -87.26 91.95 8.9 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -26.47 72.71 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.554 1.941 . . . . 0.0 115.592 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 41' ' ' THR . 1.3 p80 -178.58 58.12 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.89 56.68 4.08 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -162.21 -45.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.88 -89.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.597 0 C-N-CA 124.821 1.248 . . . . 0.0 112.3 177.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 140.11 168.95 11.51 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 107.166 -2.373 . . . . 0.0 107.166 -175.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.28 -49.37 77.38 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.65 0.725 . . . . 0.0 110.151 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -52.36 -55.7 19.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.312 0.245 . . . . 0.0 111.117 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -66.96 -58.58 4.68 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.282 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -48.94 -42.91 38.98 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 118.033 0.379 . . . . 0.0 110.7 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -68.15 -56.78 7.54 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.412 ' CH2' ' HG3' ' A' ' 9' ' ' LYS . 23.3 t90 -52.58 -52.6 54.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 123.151 0.282 . . . . 0.0 110.625 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.8 mt -57.07 -49.93 74.32 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.19 0.196 . . . . 0.0 110.762 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 59.2 ttm -62.09 -57.66 10.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -174.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -109.78 16.86 21.77 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -138.84 -54.21 0.59 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.432 1.015 . . . . 0.0 111.295 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -75.68 -64.76 1.01 Allowed 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.03 -29.64 70.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.3 m -67.95 -18.71 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.144 -0.455 . . . . 0.0 111.998 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.3 p30 -136.57 15.14 3.17 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 118.67 0.668 . . . . 0.0 111.783 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -69.38 132.78 89.47 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -53.37 -27.18 38.15 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.818 2.345 . . . . 0.0 113.249 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -112.36 30.25 7.24 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.242 0.474 . . . . 0.0 111.675 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.7 mm -135.3 150.51 29.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -142.69 148.3 37.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.78 110.96 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.5 mt -129.52 126.47 63.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.5 t70 58.03 27.11 14.38 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.705 0.402 . . . . 0.0 109.984 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.15 -13.38 26.61 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -91.57 174.12 7.53 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -105.26 118.28 36.16 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.43 148.64 32.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -75.32 121.56 22.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -88.02 116.39 66.05 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -65.92 -57.2 0.25 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.123 1.882 . . . . 0.0 110.094 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt 71.6 -72.25 0.12 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 123.604 0.762 . . . . 0.0 109.727 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -146.02 46.28 1.25 Allowed 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -139.51 112.44 8.01 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.65 24.67 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 116.615 -1.66 . . . . 0.0 109.529 -179.868 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.6 tp -142.64 137.05 29.71 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.2 m 53.74 54.04 10.48 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.03 -136.6 19.96 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.0 t -162.27 128.15 3.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.1 p -71.79 -66.19 0.67 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.96 55.49 0.06 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.39 50.21 0.77 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.626 0.37 . . . . 0.0 111.088 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.442 ' HB2' ' CZ3' ' A' ' 53' ' ' TRP . 20.5 ptmt -166.34 -47.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -68.58 -42.48 78.19 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.95 72.89 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.87 -45.58 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.4 tp -58.53 -46.14 87.41 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.13 99.35 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -62.55 -44.17 97.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.9 mt -60.85 -51.03 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 t -55.04 -47.74 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.2 -48.52 81.38 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 110.561 -0.162 . . . . 0.0 110.561 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -55.9 28.49 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -39.34 72.16 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -44.25 97.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.1 m -66.0 -45.49 81.37 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.135 0.174 . . . . 0.0 110.594 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -67.15 -40.59 86.72 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -61.25 -45.2 95.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -79.3 59.98 2.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.87 -51.71 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 177.48 -47.68 0.1 OUTLIER Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -76.61 73.25 3.31 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 116.97 0.385 . . . . 0.0 110.288 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.4 p -81.88 -12.18 58.57 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -63.64 154.24 80.73 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.577 0.351 . . . . 0.0 110.51 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.68 158.15 58.07 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.56 2.173 . . . . 0.0 111.386 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.4 mt -133.04 149.7 52.17 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -61.99 166.54 4.54 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tt -59.05 -52.45 65.68 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.02 -40.58 89.79 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.06 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -58.04 -43.51 86.87 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.4 mt -64.29 -43.97 97.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.36 -52.41 65.49 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -45.38 -56.89 4.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.575 0.35 . . . . 0.0 111.224 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -60.42 -34.75 74.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.549 0.34 . . . . 0.0 111.77 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.495 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 17.7 p -83.35 9.01 11.92 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 119.644 -0.217 . . . . 0.0 111.092 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 69.38 38.61 1.79 Allowed 'General case' 0 C--N 1.344 0.347 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.495 ' CE1' ' O ' ' A' ' 41' ' ' THR . 5.8 m-70 -132.37 167.05 20.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mt 166.26 -52.59 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.06 7.91 9.81 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.5 tt -48.48 147.21 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.469 0 C-N-CA 123.596 0.759 . . . . 0.0 110.237 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.35 133.43 19.9 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.3 tp -56.49 -31.05 63.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -58.02 -45.69 86.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -68.56 -47.8 65.9 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -55.69 -43.92 76.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -66.53 -50.7 62.3 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.442 ' CZ3' ' HB2' ' A' ' 9' ' ' LYS . 31.5 t90 -55.16 -45.66 75.71 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.457 0.303 . . . . 0.0 110.442 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.2 mt -56.08 -43.25 77.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.2 ttm -71.73 -50.37 30.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.5 p -104.94 23.49 13.47 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.421 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 36.0 tt0 -160.32 -68.89 0.07 Allowed 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 119.241 0.928 . . . . 0.0 111.567 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.55 -66.71 0.37 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.09 -41.52 99.41 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -65.27 -37.92 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 117.834 0.288 . . . . 0.0 110.591 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -101.78 58.35 0.84 Allowed 'General case' 0 C--N 1.342 0.279 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -148.1 112.66 3.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.29 -27.61 81.59 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.515 2.143 . . . . 0.0 111.812 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -74.92 -5.14 42.15 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.944 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.1 mm -120.5 138.21 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -126.6 119.66 27.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.29 139.06 18.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.6 mt -131.79 -96.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.316 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 71' ' ' LYS . 21.8 t0 -83.64 55.25 3.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.53 -39.05 1.47 Allowed Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 69' ' ' ASP . 8.1 mtmp? -72.27 161.42 30.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -108.52 128.55 54.9 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.866 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.2 163.01 15.81 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -92.87 125.47 37.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -78.8 122.46 84.73 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.26 50.92 2.73 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.835 2.357 . . . . 0.0 110.955 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt 55.73 -103.56 0.19 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.915 0.486 . . . . 0.0 110.046 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -115.9 28.9 8.33 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 73.99 173.76 0.28 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.133 0.573 . . . . 0.0 109.757 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -81.37 76.37 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? . . . . . 0 C--O 1.254 1.313 0 CA-C-O 115.907 -1.997 . . . . 0.0 110.284 -179.844 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -162.16 133.13 5.05 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 m -153.82 -36.58 0.1 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.87 95.25 0.47 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.9 t -57.71 -40.59 79.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -83.79 34.23 0.49 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.44 -78.95 0.96 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.405 ' CG ' ' N ' ' A' ' 9' ' ' LYS . 18.4 t80 51.95 -126.81 2.42 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.405 ' N ' ' CG ' ' A' ' 8' ' ' TYR . 39.3 mtpt -52.7 -62.6 1.54 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.577 0.751 . . . . 0.0 110.923 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -60.78 -37.05 80.56 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.979 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.15 -49.68 69.38 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.2 t -60.12 -41.99 88.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.36 -43.5 98.76 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.07 -48.8 80.28 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.021 0.128 . . . . 0.0 111.084 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.11 -30.52 67.73 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 120.643 -0.423 . . . . 0.0 109.993 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.8 mt -64.64 -46.05 93.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.89 -41.75 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.67 -47.81 77.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -44.29 95.05 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 89.2 mmm -62.51 -37.24 85.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -69.28 -53.54 19.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 m -54.1 -48.92 70.21 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.413 0.285 . . . . 0.0 111.011 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 ptm85 -64.44 -40.02 94.94 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -64.96 -19.62 66.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -88.36 -39.53 14.26 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.663 0.385 . . . . 0.0 110.68 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -69.88 -37.32 76.0 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 117.593 0.179 . . . . 0.0 110.588 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.7 48.45 0.06 OUTLIER Glycine 0 C--N 1.342 0.88 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -140.46 53.96 1.62 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.7 p -78.89 -10.09 59.7 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.679 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -61.89 147.58 89.45 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.8 151.72 68.85 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.863 2.376 . . . . 0.0 111.647 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.3 mt -131.28 142.38 50.12 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.7 p -70.53 170.85 11.26 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -46.41 90.41 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.55 -54.65 38.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.604 0.362 . . . . 0.0 110.444 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -52.28 -35.8 51.12 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.595 0.358 . . . . 0.0 111.108 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.6 mt -67.4 -48.85 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.4 mt -59.54 -43.78 93.39 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.11 -62.21 1.78 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.524 0.329 . . . . 0.0 111.164 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.07 -50.58 70.6 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.5 p -76.64 -1.29 26.97 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.588 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 56.68 60.2 3.19 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -129.35 31.37 4.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 mt -77.18 67.73 3.2 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -163.54 -40.65 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.516 ' CD1' ' H ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 18.18 -88.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.928 0 C-N-CA 125.441 1.496 . . . . 0.0 112.759 178.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.516 ' H ' ' CD1' ' A' ' 46' ' ' ILE . . . 132.77 160.48 9.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 107.351 -2.299 . . . . 0.0 107.351 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 tp -55.34 -43.81 75.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.756 0.778 . . . . 0.0 109.641 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -59.37 -53.37 58.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.522 0.329 . . . . 0.0 110.635 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -64.99 -57.66 8.12 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 119.669 -0.205 . . . . 0.0 111.083 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -48.71 -48.83 40.04 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 120.636 0.255 . . . . 0.0 110.392 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -62.5 -52.92 61.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.255 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -54.65 -49.22 71.1 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 122.286 0.235 . . . . 0.0 110.657 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 69.3 mt -56.22 -52.32 64.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 45.8 ttp -63.15 -40.78 98.55 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.2 p -114.48 27.49 9.42 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.29 -66.86 0.05 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.811 0.732 . . . . 0.0 110.749 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.35 -20.06 65.86 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.8 mt -121.23 21.84 11.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.201 0.455 . . . . 0.0 111.312 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.22 -41.78 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.22 -30.7 23.65 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -57.41 114.91 9.19 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.999 0.52 . . . . 0.0 109.962 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.83 -21.52 73.15 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.524 2.149 . . . . 0.0 111.786 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -80.96 0.68 34.42 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.543 -0.265 . . . . 0.0 110.714 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 mm -127.76 147.89 32.44 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -136.54 149.71 48.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.0 t -102.79 116.81 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.17 132.46 65.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 57.24 26.95 12.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.708 0.403 . . . . 0.0 110.136 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 -17.57 10.3 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -86.91 -179.63 6.55 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -116.05 137.6 51.98 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.657 0.265 . . . . 0.0 110.54 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.48 151.44 48.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -71.7 126.48 29.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -77.7 117.33 64.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -70.41 131.75 20.93 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 122.227 1.951 . . . . 0.0 111.426 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -74.94 -60.49 2.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -92.83 137.36 32.43 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -69.62 152.22 45.0 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.6 t -69.23 140.17 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.9 mtp85 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 116.656 -1.64 . . . . 0.0 109.455 -179.406 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.8 mp 62.08 -81.73 0.02 OUTLIER 'General case' 0 C--N 1.345 0.385 0 O-C-N 123.852 0.72 . . . . 0.0 109.776 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 p -80.46 66.21 5.89 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.48 -160.56 51.36 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.8 t 56.92 81.04 0.14 Allowed 'General case' 0 C--N 1.345 0.393 0 C-N-CA 123.044 0.538 . . . . 0.0 109.951 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.4 p -78.99 59.93 2.78 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.276 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.41 113.1 0.36 Allowed Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -61.32 141.73 57.38 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? 69.56 -67.88 0.21 Allowed 'General case' 0 C--N 1.351 0.644 0 C-N-CA 123.531 0.732 . . . . 0.0 110.728 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -55.04 -40.57 70.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.638 0.375 . . . . 0.0 110.96 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.25 -45.06 96.04 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.72 -45.1 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.26 -42.61 98.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.049 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.96 86.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -67.96 -41.56 82.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 35.2 mt -62.14 -45.83 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.54 -50.12 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -58.71 -43.54 90.12 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -58.56 8.02 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.9 mmm -54.36 -42.42 70.25 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -50.49 72.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 122.466 0.306 . . . . 0.0 110.505 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.7 m -61.83 -49.13 77.52 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -58.16 -45.13 88.01 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -62.14 -34.3 76.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -73.11 -16.98 61.45 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.506 0.322 . . . . 0.0 110.553 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.05 -52.15 4.85 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 122.49 0.316 . . . . 0.0 110.171 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.54 -30.73 0.11 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -75.35 78.28 2.43 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.2 p -93.92 -17.03 23.43 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.196 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -66.06 154.46 89.65 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 117.6 0.182 . . . . 0.0 111.012 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.8 156.6 63.3 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.075 2.517 . . . . 0.0 111.76 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -137.96 147.7 44.54 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 122.906 0.482 . . . . 0.0 109.772 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.0 p -63.64 170.99 2.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 109.923 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -55.85 29.56 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.81 -42.3 79.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.286 0.234 . . . . 0.0 111.25 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.81 -35.07 70.35 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.2 mt -69.76 -40.98 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.63 -41.92 82.32 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -50.28 -62.51 1.54 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.199 0.2 . . . . 0.0 111.011 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.4 -46.32 86.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.84 0.456 . . . . 0.0 111.671 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.42 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 48.1 p -75.65 -6.69 51.7 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 119.243 -0.408 . . . . 0.0 111.653 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 61.0 52.95 3.85 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.42 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.0 m-70 -129.16 36.32 4.18 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.387 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.0 mp -69.35 -45.84 68.45 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -83.13 62.18 6.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.8 tt -101.75 146.69 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.831 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.95 136.06 48.78 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.6 tp -52.1 -39.32 59.62 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.944 0.372 . . . . 0.0 110.64 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -62.96 -40.03 96.45 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -70.02 -50.39 41.88 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -51.39 -47.15 62.99 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -60.65 -56.52 20.27 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.669 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -50.48 -46.88 57.22 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 122.795 0.438 . . . . 0.0 111.202 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 68.3 mt -56.99 -44.92 83.2 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 21.5 ttt -76.89 -34.36 57.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.2 p -101.34 -4.47 26.94 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -138.77 -74.43 0.38 Allowed 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.028 0.831 . . . . 0.0 111.567 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.83 -63.43 1.11 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.4 mt -73.07 4.04 4.8 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.4 m -116.86 6.3 7.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 CA-C-N 118.826 0.739 . . . . 0.0 110.679 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -145.81 -15.78 0.47 Allowed 'General case' 0 C--N 1.348 0.51 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.483 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -63.9 117.88 40.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.34 -25.27 77.8 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.558 2.172 . . . . 0.0 112.346 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.66 -12.51 60.01 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 119.357 -0.354 . . . . 0.0 110.993 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mp -115.33 144.68 22.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.38 130.14 51.96 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -89.15 125.73 42.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.3 mm -116.94 -108.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -82.52 55.88 3.1 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.75 -34.47 2.09 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -77.05 166.36 23.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.87 125.17 52.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.239 0.216 . . . . 0.0 110.796 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.8 172.51 6.89 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -94.79 122.71 37.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -73.95 114.94 37.55 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.65 -81.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.309 2.006 . . . . 0.0 110.922 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -161.42 41.1 0.15 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 17.0 m-30 -97.19 66.98 2.13 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -167.52 105.39 0.53 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.1 t -131.43 140.69 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 116.736 -1.602 . . . . 0.0 109.234 179.733 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.1 tp -75.02 95.66 3.06 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 m -76.86 74.17 3.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.1 68.81 2.27 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.0 t -76.78 -28.31 55.61 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.9 t -78.03 67.85 3.96 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.83 -96.26 0.94 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.431 ' O ' ' CG ' ' A' ' 8' ' ' TYR . 2.4 t80 60.66 5.96 1.03 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.156 0.582 . . . . 0.0 110.974 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HB2' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER 175.27 -47.68 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.527 0.731 . . . . 0.0 109.565 178.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -67.35 -49.7 62.96 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.327 0.251 . . . . 0.0 110.748 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.91 -47.59 87.92 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 t -63.9 -49.53 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 tp -56.91 -47.95 79.36 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.67 99.22 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.172 0.189 . . . . 0.0 110.711 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.91 -42.12 95.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.9 mt -60.3 -50.04 81.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 t -54.56 -44.77 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 122.411 0.285 . . . . 0.0 110.269 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -70.77 -39.0 73.47 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.321 0.105 . . . . 0.0 110.859 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.429 ' CE1' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -64.05 -52.98 56.83 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 96.0 mtp -61.63 -31.55 71.65 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -55.92 14.65 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.2 m -57.44 -40.33 78.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.429 ' HG3' ' CE1' ' A' ' 19' ' ' TYR . 42.4 mmt-85 -60.87 -50.82 71.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.94 0.496 . . . . 0.0 110.29 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -62.37 -22.07 65.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.447 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -88.9 16.18 7.34 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.654 0.382 . . . . 0.0 110.489 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -136.81 -47.09 0.6 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 117.611 0.187 . . . . 0.0 110.721 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 178.21 -38.64 0.08 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -73.44 76.86 1.41 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.5 p -100.77 -30.26 11.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.141 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.6 161.97 7.27 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 123.627 0.771 . . . . 0.0 111.288 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -68.81 124.6 11.65 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.201 1.934 . . . . 0.0 110.839 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 mt -101.24 153.86 19.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 p -69.79 167.36 17.37 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.68 -56.16 25.72 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -57.64 -40.23 78.77 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.516 -0.278 . . . . 0.0 111.621 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.0 -37.61 71.9 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 118.084 0.402 . . . . 0.0 109.982 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.3 mt -71.62 -40.62 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.69 -57.24 11.7 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.454 0.115 . . . . 0.0 111.195 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -40.83 67.83 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.189 0.196 . . . . 0.0 111.349 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.9 -3.17 37.28 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.57 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 16.7 p -120.6 0.78 10.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.105 0.412 . . . . 0.0 110.289 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.434 ' N ' ' NE2' ' A' ' 42' ' ' GLN . 10.4 mm-40 73.04 26.1 2.24 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.445 0.698 . . . . 0.0 109.132 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.57 ' CE1' ' HB ' ' A' ' 41' ' ' THR . 26.6 m170 -106.56 38.45 2.06 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.62 -38.75 21.17 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.51 -44.79 95.62 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.62 ' CG2' ' H ' ' A' ' 47' ' ' GLY . 16.3 tt 22.47 -102.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.26 1.424 . . . . 0.0 112.787 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.62 ' H ' ' CG2' ' A' ' 46' ' ' ILE . . . 153.05 148.94 5.02 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.3 tt -54.95 -42.15 71.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.515 0.658 . . . . 0.0 110.253 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -59.24 -51.02 71.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.416 0.286 . . . . 0.0 110.644 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -65.77 -51.32 60.08 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.273 0.229 . . . . 0.0 110.533 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -53.33 -50.48 64.9 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -58.53 -49.15 78.45 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.401 ' CH2' ' HB2' ' A' ' 9' ' ' LYS . 22.8 t90 -54.44 -50.93 66.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.1 mt -57.46 -47.87 80.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.3 ttt -60.17 -49.75 76.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.324 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.8 t -123.69 52.19 1.45 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.31 0.505 . . . . 0.0 112.221 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -167.58 -55.16 0.02 OUTLIER 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.255 -0.278 . . . . 0.0 110.284 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.92 -62.12 1.72 Allowed 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.3 mt -71.87 2.0 6.21 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.55 0.34 . . . . 0.0 111.882 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.5 t -82.5 -49.51 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -120.15 37.43 4.24 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.738 0.415 . . . . 0.0 110.14 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -74.98 133.3 75.91 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.13 -21.39 62.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.342 2.028 . . . . 0.0 111.993 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.89 10.15 13.09 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-O 119.391 -0.338 . . . . 0.0 111.851 -177.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.2 151.34 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -141.8 152.44 43.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 t -97.37 121.2 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -138.92 136.46 42.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.1 t70 56.68 26.91 11.84 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.872 0.469 . . . . 0.0 110.477 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 -20.42 6.14 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm -86.47 -167.12 1.76 Allowed 'General case' 0 C--N 1.345 0.382 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -132.42 126.91 34.23 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-O 120.918 0.39 . . . . 0.0 110.933 -176.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.71 166.8 11.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.678 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -92.96 127.93 38.65 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -83.95 118.91 72.58 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.2 -58.9 0.62 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.282 1.988 . . . . 0.0 110.565 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -164.35 -44.47 0.03 OUTLIER 'General case' 0 C--N 1.341 0.199 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -147.08 -64.24 0.28 Allowed 'General case' 0 C--N 1.341 0.234 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 57.61 80.39 0.17 Allowed 'General case' 0 C--N 1.345 0.373 0 C-N-CA 122.836 0.454 . . . . 0.0 110.0 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 p -61.07 148.71 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.112 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.6 mtm-85 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 116.758 -1.591 . . . . 0.0 109.113 179.693 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 tp 61.56 -155.46 0.35 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 t -162.35 -176.12 4.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.32 64.94 0.2 Allowed Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.2 m -77.05 66.92 2.96 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.496 0.319 . . . . 0.0 110.22 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t -71.07 -27.02 63.32 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.81 36.03 61.7 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.13 163.51 12.43 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt 75.42 -64.89 0.35 Allowed 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 123.761 0.824 . . . . 0.0 109.121 -175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -63.29 -46.44 86.73 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.049 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.83 -49.62 76.05 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 t -59.66 -47.81 89.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.8 tp -59.39 -45.19 92.15 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.91 96.69 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -64.91 -44.03 90.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 49.2 mt -60.86 -46.94 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.13 -48.03 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 122.595 0.358 . . . . 0.0 110.048 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -61.48 -44.82 96.4 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -58.99 6.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.6 mmm -54.94 -37.69 66.76 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -45.8 92.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.2 m -60.06 -44.84 94.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -56.96 -53.18 60.9 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -61.92 -34.9 76.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.587 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -67.03 -46.78 73.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.686 -0.197 . . . . 0.0 111.05 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -71.04 -29.58 65.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 119.395 -0.335 . . . . 0.0 111.292 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.98 -20.0 0.97 Allowed Glycine 0 C--N 1.346 1.111 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.205 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -79.65 65.3 4.77 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.732 0.766 . . . . 0.0 109.747 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.0 p -78.19 -4.44 47.61 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.392 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -64.94 155.52 83.21 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 122.427 0.291 . . . . 0.0 110.725 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -69.29 155.71 66.69 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.75 2.3 . . . . 0.0 110.986 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 12.7 mt -136.6 143.45 43.58 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.4 p -70.99 167.32 19.41 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -47.8 81.3 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -55.88 -52.52 63.78 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.25 0.22 . . . . 0.0 110.466 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -55.13 -37.07 66.46 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 122.433 0.293 . . . . 0.0 110.496 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -69.42 -51.92 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.5 mt -57.4 -44.84 84.89 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -52.03 -56.81 12.02 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.465 0.306 . . . . 0.0 110.916 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.33 -41.26 88.7 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.689 -0.115 . . . . 0.0 110.689 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.416 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 40.9 p -82.36 7.29 14.45 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.121 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? 68.83 -11.95 0.4 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.358 0.663 . . . . 0.0 111.621 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.416 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.2 m-70 -77.35 35.51 0.18 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.745 -0.597 . . . . 0.0 111.701 -177.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -48.04 67.6 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.525 -0.734 . . . . 0.0 109.552 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -86.3 37.82 0.75 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.7 tt -72.77 147.3 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.09 137.54 46.75 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -55.46 -32.21 62.6 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.695 0.247 . . . . 0.0 110.471 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -54.02 -38.74 65.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -86.53 -43.83 12.41 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -51.22 -48.72 62.0 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 122.39 0.276 . . . . 0.0 110.344 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -66.22 -49.43 67.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.457 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 34.8 t90 -51.36 -44.84 62.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.547 0.339 . . . . 0.0 110.615 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.3 mt -56.95 -40.99 77.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.7 mtp -85.61 -9.36 57.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.731 -0.652 . . . . 0.0 112.643 -176.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 74.5 p -136.28 20.6 3.18 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.177 0.899 . . . . 0.0 112.931 -175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 30.7 tt0 -160.93 -49.89 0.05 OUTLIER 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.973 0.806 . . . . 0.0 111.725 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.93 -76.82 0.24 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.8 mt -56.69 -31.19 64.22 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.553 0.341 . . . . 0.0 111.694 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.7 m -58.28 -21.62 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 119.58 -0.248 . . . . 0.0 111.577 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -147.5 26.57 1.04 Allowed 'General case' 0 C--N 1.346 0.423 0 CA-C-N 118.148 0.431 . . . . 0.0 110.889 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.54 126.52 92.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.01 -24.14 78.95 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.403 2.069 . . . . 0.0 112.203 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.78 5.44 28.63 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-O 119.063 -0.494 . . . . 0.0 111.677 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.9 mt -145.2 112.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.453 0 CA-C-N 118.671 0.669 . . . . 0.0 109.573 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -96.16 156.8 16.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.257 0.623 . . . . 0.0 109.456 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -103.46 140.32 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.1 mt -127.71 -112.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 71' ' ' LYS . 25.8 t70 -80.08 61.15 3.84 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.29 -35.81 1.75 Allowed Glycine 0 CA--C 1.532 1.102 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 69' ' ' ASP . 15.4 mttp -76.38 179.17 6.0 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -123.74 134.08 53.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.13 135.8 53.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -62.4 125.4 23.79 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -86.27 128.93 55.51 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -53.21 140.73 60.96 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.201 1.934 . . . . 0.0 110.583 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -66.05 102.67 0.83 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.996 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -120.48 102.83 8.71 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -154.98 47.35 0.54 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.9 p -68.27 143.81 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 116.555 -1.688 . . . . 0.0 109.763 -179.646 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.35 29.66 0.7 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.1 p -161.33 52.29 0.26 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.12 48.91 0.28 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -165.86 162.71 18.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.1 t -91.06 -165.58 1.39 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 133.44 80.34 0.16 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -59.72 119.83 8.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 17.2 mtmm 74.2 -61.8 0.48 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.966 0.906 . . . . 0.0 110.214 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -57.31 -44.92 84.56 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.645 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.41 -49.77 73.82 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.0 -47.83 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.5 -46.19 89.54 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.502 0.321 . . . . 0.0 110.506 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.19 93.76 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.416 ' HZ1' ' CE1' ' A' ' 43' ' ' HIS . 15.6 ttpp -65.98 -39.27 90.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 mt -62.22 -46.88 95.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.38 -48.69 84.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -63.33 -38.22 90.32 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.15 -56.6 17.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.3 mtp -59.93 -35.41 74.85 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -46.14 91.86 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 m -67.59 -44.67 77.58 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 122.318 0.247 . . . . 0.0 110.397 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 47.4 ttt85 -60.02 -45.94 91.14 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -63.28 -39.66 95.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -79.42 54.8 1.79 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -165.53 -59.29 0.03 OUTLIER 'General case' 0 C--N 1.343 0.292 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.69 -44.07 0.08 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.79 74.64 2.1 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.6 p -83.71 -8.01 59.36 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -67.76 155.28 91.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -73.6 160.76 43.55 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.791 2.328 . . . . 0.0 111.617 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.5 mt -134.38 140.51 46.36 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.5 p -61.89 169.21 2.69 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.03 -50.34 74.45 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -61.6 -41.29 97.22 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.696 -0.193 . . . . 0.0 111.001 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -55.5 -34.82 64.95 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -70.15 -44.05 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 mt -52.18 -36.57 52.18 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.647 0.203 . . . . 0.0 110.531 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.86 -59.99 4.4 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.615 -0.142 . . . . 0.0 110.615 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -61.94 -66.16 0.58 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.53 80.44 4.01 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -32.6 86.41 0.0 OUTLIER 'General case' 0 C--N 1.352 0.717 0 C-N-CA 125.091 1.356 . . . . 0.0 112.555 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.416 ' CE1' ' HZ1' ' A' ' 15' ' ' LYS . 18.8 m-70 -140.6 29.27 1.95 Allowed 'General case' 0 C--O 1.213 -0.823 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.32 -38.69 80.92 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -91.04 69.18 6.23 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.443 ' CG1' ' HB2' ' A' ' 50' ' ' GLN . 1.3 tt -94.55 -46.67 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.029 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.73 131.3 6.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.859 -1.697 . . . . 0.0 108.859 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.1 tt -51.23 -40.42 58.74 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.86 0.33 . . . . 0.0 111.207 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -56.94 -33.85 67.43 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 119.828 -0.129 . . . . 0.0 111.071 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.443 ' HB2' ' CG1' ' A' ' 46' ' ' ILE . 25.6 mt-30 -89.9 -47.45 7.87 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -50.43 -52.77 34.82 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -58.87 -45.37 90.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.453 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 28.8 t90 -57.02 -54.24 48.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.7 mt -51.32 -45.89 62.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -60.75 -52.82 63.46 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.13 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 t -120.26 51.33 1.22 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.358 0.527 . . . . 0.0 112.137 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -166.95 -67.29 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -66.75 -60.48 2.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.16 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.5 mt -80.27 37.45 0.39 Allowed 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 122.367 0.267 . . . . 0.0 110.599 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.33 -45.84 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -112.23 -7.29 14.03 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.42 124.54 81.29 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.06 -34.84 99.02 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.745 2.297 . . . . 0.0 112.394 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -86.86 21.49 2.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 119.695 -0.193 . . . . 0.0 111.168 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.4 mm -135.64 144.29 34.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -145.92 141.48 27.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.56 136.0 29.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.8 mp -104.92 -59.01 3.59 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -160.32 77.6 0.63 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.29 -40.67 2.58 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.1 mtmt -83.25 145.81 28.92 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -104.62 126.57 51.84 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 122.675 0.39 . . . . 0.0 110.617 -176.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.61 150.55 29.91 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -79.23 121.56 25.21 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -74.09 121.21 84.67 Favored Pre-proline 0 N--CA 1.448 -0.574 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -63.05 132.01 34.99 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.32 2.013 . . . . 0.0 110.403 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -162.16 124.97 2.93 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 57.52 -109.65 0.49 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.224 0.61 . . . . 0.0 110.328 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 64.95 163.48 0.14 Allowed 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.356 0.662 . . . . 0.0 110.51 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 74.1 t -79.34 -56.25 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 116.326 -1.797 . . . . 0.0 108.556 179.197 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 66.4 tp -58.74 113.06 1.86 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m 55.6 34.35 23.02 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.747 0.419 . . . . 0.0 110.163 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.5 68.96 3.08 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m 71.55 135.56 0.04 OUTLIER 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.493 0.717 . . . . 0.0 110.347 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.0 t -158.28 -55.05 0.07 Allowed 'General case' 0 C--N 1.339 0.128 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.76 45.48 3.48 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -89.91 8.9 29.87 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 117.041 0.421 . . . . 0.0 110.254 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -151.44 -61.58 0.18 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -65.69 -42.78 90.81 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.106 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.74 -46.5 91.77 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -60.87 -46.03 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.75 -45.87 90.89 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.17 86.26 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -62.77 -42.57 99.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.96 -51.67 66.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.2 t -55.91 -45.35 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -64.14 -45.16 89.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -57.35 12.84 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 96.4 mtp -55.39 -39.88 70.68 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -61.09 -50.23 74.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.5 m -59.47 -46.68 88.08 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 ttm-85 -60.65 -44.31 96.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -60.8 -35.81 77.42 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -79.95 12.75 2.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.485 0.314 . . . . 0.0 110.952 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -127.86 29.95 5.35 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 117.949 0.341 . . . . 0.0 110.478 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.29 -34.53 3.61 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -74.92 77.4 2.16 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.9 p -97.2 -3.56 40.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.799 0.44 . . . . 0.0 110.993 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -70.91 156.71 91.65 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 117.739 0.245 . . . . 0.0 110.584 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.48 156.18 64.9 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.979 2.453 . . . . 0.0 111.717 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -137.69 141.88 41.09 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 122.973 0.509 . . . . 0.0 109.643 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.8 p -63.62 168.55 4.67 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.007 0.432 . . . . 0.0 110.408 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 tt -58.28 -51.83 68.12 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -54.86 -48.45 72.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.878 0.471 . . . . 0.0 111.106 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -56.25 -34.88 66.78 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.8 mt -73.5 -46.21 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 16.6 mt -46.31 -58.62 3.53 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.324 0.25 . . . . 0.0 111.048 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -46.27 -56.68 5.43 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.82 0.448 . . . . 0.0 111.913 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.79 -26.36 68.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.165 0.186 . . . . 0.0 111.445 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 28.3 p -99.12 16.94 21.11 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? 73.68 -88.84 0.02 OUTLIER 'General case' 0 C--N 1.35 0.597 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 41' ' ' THR . 23.7 m170 31.82 -109.6 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.762 0.825 . . . . 0.0 111.649 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.5 mt 69.36 -64.71 0.33 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.901 1.28 . . . . 0.0 110.443 178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.52 -68.78 0.27 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.7 tt 47.51 137.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.143 1.777 . . . . 0.0 114.305 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.21 137.59 40.66 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.9 tp -52.16 -41.85 62.94 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.217 0.508 . . . . 0.0 109.867 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -60.06 -40.58 89.99 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -66.62 -57.99 6.08 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -49.84 -48.38 51.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.919 0.488 . . . . 0.0 110.668 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -64.25 -47.34 79.97 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.426 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 38.6 t90 -57.44 -45.94 84.13 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.7 mt -56.22 -51.49 67.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 40.6 ttm -56.86 -54.69 43.58 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.792 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.7 t -121.15 50.3 1.39 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.227 0.467 . . . . 0.0 111.937 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.426 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -170.5 -65.65 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.098 -0.376 . . . . 0.0 110.497 176.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.27 -50.02 69.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.392 0.277 . . . . 0.0 111.367 -176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.2 mt -79.29 -29.58 42.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.599 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.6 t -73.69 139.1 19.95 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 69.17 -9.34 0.61 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.328 0.651 . . . . 0.0 111.579 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.56 125.11 78.71 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.42 -12.29 30.0 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.339 2.026 . . . . 0.0 112.05 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.01 7.45 21.55 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 118.029 0.377 . . . . 0.0 111.534 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 mm -136.23 157.34 37.6 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -147.95 144.19 27.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.06 106.59 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.4 mm -121.1 126.13 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.0 t0 59.16 19.9 7.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.815 0.446 . . . . 0.0 110.462 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.41 -29.2 7.95 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 168.86 18.79 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -104.59 124.89 50.12 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.543 0.211 . . . . 0.0 110.523 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.05 137.48 52.88 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.308 0.643 . . . . 0.0 109.334 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -66.99 126.86 30.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.44 117.91 69.63 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.72 -47.83 2.51 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.201 1.934 . . . . 0.0 109.731 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -157.5 -51.95 0.07 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -171.82 -52.4 0.02 OUTLIER 'General case' 0 C--N 1.343 0.308 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 51.52 63.78 2.1 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 122.999 0.519 . . . . 0.0 110.674 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 99.5 t -120.29 143.47 32.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.708 -1.615 . . . . 0.0 109.208 -179.416 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.92 28.29 0.77 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.8 p -79.39 69.11 5.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.35 172.24 14.89 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.9 t -75.99 77.92 2.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.9 m 57.69 67.73 0.93 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 122.794 0.437 . . . . 0.0 109.843 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.07 -172.38 30.35 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.7 t80 66.25 124.31 0.02 OUTLIER 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.796 0.838 . . . . 0.0 109.594 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt 65.1 -74.66 0.05 Allowed 'General case' 0 C--N 1.347 0.482 0 C-N-CA 123.195 0.598 . . . . 0.0 109.745 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -60.27 -45.41 93.41 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 122.901 0.48 . . . . 0.0 110.205 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.44 -47.52 90.7 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.02 -45.91 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.27 -44.64 96.91 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.24 99.4 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -61.86 -48.38 80.81 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 52.2 mt -58.26 -52.16 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.293 0.371 . . . . 0.0 110.114 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -55.73 -50.8 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.72 -43.29 94.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.249 0.22 . . . . 0.0 110.751 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -59.67 4.66 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -33.43 69.45 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -60.57 -46.65 89.44 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 m -73.23 -40.26 64.83 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.543 0.337 . . . . 0.0 110.164 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.434 HH21 ' CD ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -64.41 -33.71 76.49 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.576 0.75 . . . . 0.0 109.168 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -72.71 -49.77 29.09 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -38.14 65.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.897 0.479 . . . . 0.0 110.24 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -54.13 -42.51 69.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.139 0.576 . . . . 0.0 110.884 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.72 -27.73 1.77 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.75 59.68 2.59 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.7 p -66.63 -9.09 32.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.143 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -57.43 152.04 35.38 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 122.467 0.307 . . . . 0.0 110.839 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.89 155.53 54.32 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.719 2.279 . . . . 0.0 111.331 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.2 mt -135.19 144.01 46.75 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.4 p -73.38 175.25 7.11 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -54.0 50.77 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.6 -48.25 72.4 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.292 0.237 . . . . 0.0 110.584 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -54.34 -44.0 71.74 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.9 mt -63.61 -47.32 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.8 mt -56.99 -48.99 77.12 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -51.52 -56.93 10.68 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 123.187 0.304 . . . . 0.0 111.1 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.434 ' CD ' HH21 ' A' ' 23' ' ' ARG . 3.0 mt-10 -58.94 -37.19 76.17 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.047 0.139 . . . . 0.0 111.144 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.425 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 47.7 p -86.37 6.22 31.12 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.122 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? 69.04 -10.52 0.51 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.313 0.645 . . . . 0.0 111.34 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.425 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.0 m-70 -78.06 39.15 0.3 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.65 -0.656 . . . . 0.0 111.395 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.81 -45.48 61.36 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -84.23 51.71 2.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.9 tt -90.81 148.84 4.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.22 137.16 50.45 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.7 tp -54.72 -35.76 64.01 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.322 0.249 . . . . 0.0 110.631 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -58.11 -48.88 78.85 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -68.34 -44.26 75.69 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -52.54 -49.99 63.79 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.0 -52.17 66.91 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -53.74 -50.04 66.85 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.3 mt -57.33 -43.25 83.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.4 ttt -66.91 -53.03 36.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -120.41 47.14 1.83 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -167.75 -56.19 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.67 -60.18 2.46 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.179 -0.325 . . . . 0.0 111.569 -177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -80.61 27.74 0.35 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.9 m -124.73 -17.28 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 117.782 0.264 . . . . 0.0 110.36 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -130.12 6.6 4.98 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 117.718 0.235 . . . . 0.0 110.692 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -70.11 127.57 92.22 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.83 -29.96 87.8 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.443 2.095 . . . . 0.0 112.224 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -94.23 21.13 7.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 119.707 -0.187 . . . . 0.0 111.484 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.81 156.48 12.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -154.2 148.76 26.29 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.19 130.76 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.9 mt -120.87 -95.9 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 71' ' ' LYS . 30.4 t70 -83.72 51.59 2.06 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.65 -36.27 1.84 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 69' ' ' ASP . 28.9 mttp -74.07 179.13 4.56 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -114.14 126.36 54.99 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.2 138.82 50.95 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -70.06 127.32 32.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.02 120.51 81.51 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -67.02 -172.5 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.521 2.147 . . . . 0.0 110.775 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -52.34 -53.88 38.78 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -163.02 -49.31 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -90.39 157.92 17.36 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.2 t -54.21 -45.7 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 116.697 -1.62 . . . . 0.0 109.349 179.479 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.8 tp -64.35 -51.8 61.53 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.8 t -152.51 60.04 0.82 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.66 67.03 3.61 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.2 p -150.42 113.03 4.72 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.8 p -140.48 54.32 1.61 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.96 -24.03 67.7 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 39.4 p90 50.71 15.82 0.26 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.242 1.017 . . . . 0.0 112.32 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.402 ' HB2' ' CZ3' ' A' ' 53' ' ' TRP . 19.9 ptmt -169.34 -42.75 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -68.89 -43.35 75.45 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.45 93.83 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.0 -47.92 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 43.1 tp -59.27 -43.92 92.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.9 97.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -59.43 -46.53 88.47 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.8 mt -61.48 -49.11 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -57.61 -46.85 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -65.68 -42.22 91.53 Favored 'General case' 0 CA--C 1.527 0.063 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -60.22 -58.41 8.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtp -55.67 -44.51 77.36 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -55.34 -45.17 76.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.534 0.334 . . . . 0.0 110.308 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.7 m -62.98 -53.93 46.32 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 119.541 -0.266 . . . . 0.0 111.134 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -64.62 -30.87 71.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.61 0.641 . . . . 0.0 109.984 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -66.41 -40.34 89.54 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -65.35 -41.97 93.33 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.63 -55.51 29.81 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 122.179 0.192 . . . . 0.0 110.507 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.3 -30.35 0.12 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -75.89 71.31 2.7 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 117.338 0.569 . . . . 0.0 109.669 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.6 p -76.51 -9.6 58.78 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -62.98 156.32 67.9 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -77.85 161.88 29.95 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.682 2.255 . . . . 0.0 111.019 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.3 mt -132.74 144.86 50.56 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.9 p -60.75 167.19 2.87 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.98 -50.03 71.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.64 -49.08 79.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.863 0.465 . . . . 0.0 110.861 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -55.32 -34.08 63.88 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 58.5 mt -75.64 -50.53 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.417 ' CD1' HD13 ' A' ' 46' ' ' ILE . 8.8 mt -45.29 -54.16 7.47 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 122.691 0.397 . . . . 0.0 111.104 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -47.87 -59.34 3.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.699 0.399 . . . . 0.0 111.311 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -60.0 -37.7 80.48 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.221 0.208 . . . . 0.0 111.009 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.7 p -81.7 10.53 5.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.042 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 75.63 -61.0 0.48 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.74 0.816 . . . . 0.0 111.001 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 113.1 1.19 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.0 -34.09 3.8 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 122.45 0.3 . . . . 0.0 110.964 -178.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -94.54 -40.88 9.63 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 38' ' ' LEU . 3.1 mt 55.63 -134.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.934 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -136.19 143.57 15.06 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 105.275 -3.13 . . . . 0.0 105.275 172.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -49.74 -45.36 49.26 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.23 1.015 . . . . 0.0 110.527 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -58.24 -46.57 85.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -64.3 -63.07 1.24 Allowed 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -42.77 -49.63 5.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.012 0.525 . . . . 0.0 110.966 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -65.31 -52.24 55.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.425 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 37.1 t90 -52.77 -46.03 67.38 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.822 0.449 . . . . 0.0 110.81 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.0 mt -57.1 -47.23 81.58 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.2 ttt -65.31 -47.2 77.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t -120.81 40.48 3.53 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.425 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 34.4 tt0 -165.72 -66.77 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.937 -0.477 . . . . 0.0 110.115 174.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.47 -61.07 2.86 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 -177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.1 mt -81.46 31.7 0.34 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.338 0.255 . . . . 0.0 110.373 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.41 -40.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.41 -30.48 16.48 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.386 0.274 . . . . 0.0 110.423 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -56.1 118.98 23.64 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.88 -30.99 91.14 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.534 2.156 . . . . 0.0 112.075 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -82.22 10.77 6.23 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.234 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 mm -129.65 143.65 40.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -146.67 135.68 22.47 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 t -89.52 131.92 35.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.1 mm -104.06 -60.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -152.45 76.23 1.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.8 -40.01 2.44 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -85.71 154.31 21.72 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -107.73 132.17 53.65 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.913 0.485 . . . . 0.0 109.997 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -121.32 151.82 39.66 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 122.54 0.336 . . . . 0.0 110.196 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -75.27 120.64 21.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -80.39 123.26 83.08 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -62.95 120.73 8.33 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.342 2.028 . . . . 0.0 110.512 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -78.52 121.17 24.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -71.89 75.08 0.89 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -165.79 -49.26 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.0 29.23 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.834 -1.555 . . . . 0.0 108.802 -179.454 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.1 tp -155.1 118.74 4.52 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.1 m -153.22 -62.24 0.15 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.0 72.77 0.03 OUTLIER Glycine 0 C--N 1.338 0.692 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.5 p -161.72 158.46 25.9 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 m -150.35 56.3 0.93 Allowed 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.06 167.58 33.53 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -114.38 -122.43 0.29 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.453 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 7.7 mtmm -53.9 -44.37 70.45 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -62.06 -42.57 99.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.622 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.91 -51.93 53.79 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.6 t -60.64 -45.89 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.63 -51.54 69.37 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.235 0.214 . . . . 0.0 110.43 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.69 -43.9 85.44 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -50.34 74.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.1 mt -59.33 -47.8 89.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 122.544 0.338 . . . . 0.0 110.285 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.5 t -58.42 -50.11 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -59.34 -47.16 86.44 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.81 -57.32 13.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 87.9 mtp -52.93 -41.21 64.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -60.66 -63.19 1.38 Allowed 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -45.95 -45.89 15.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 122.432 0.293 . . . . 0.0 110.793 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -63.45 -41.37 98.64 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -66.81 -34.12 77.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.236 0.614 . . . . 0.0 110.094 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -69.01 -36.47 77.83 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -62.78 -56.71 15.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.169 0.188 . . . . 0.0 110.725 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.35 -35.52 0.14 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -71.11 79.73 0.68 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.0 p -91.26 -19.07 23.39 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.443 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -61.78 151.71 78.25 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 117.936 0.335 . . . . 0.0 110.21 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -71.86 157.11 55.75 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.771 2.314 . . . . 0.0 111.589 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.9 mt -125.19 148.32 48.67 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.5 p -59.75 168.42 1.73 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -57.7 11.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.2 -43.3 70.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.481 0.312 . . . . 0.0 111.205 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -53.02 -49.94 65.24 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.6 mt -58.34 -40.17 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 122.127 0.171 . . . . 0.0 110.666 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.52 -28.97 69.7 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 117.82 0.282 . . . . 0.0 110.434 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.48 -59.32 4.11 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -55.86 -68.57 0.19 Allowed 'General case' 0 C--N 1.347 0.47 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -78.65 85.39 4.69 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -36.92 84.4 0.0 OUTLIER 'General case' 0 C--N 1.351 0.669 0 C-N-CA 125.003 1.321 . . . . 0.0 112.735 -176.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -140.04 45.1 1.89 Allowed 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 10.0 mt -79.77 -37.59 35.05 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.76 -43.22 99.37 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.588 ' CG2' ' H ' ' A' ' 47' ' ' GLY . 13.5 tt 22.85 -98.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.232 1.413 . . . . 0.0 113.022 177.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.588 ' H ' ' CG2' ' A' ' 46' ' ' ILE . . . 150.59 148.24 4.74 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.1 tp -54.43 -47.56 72.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.462 0.631 . . . . 0.0 110.712 -177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -57.35 -50.95 71.32 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.166 0.186 . . . . 0.0 110.742 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -62.79 -56.51 16.85 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -48.88 -50.04 36.83 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 122.577 0.351 . . . . 0.0 110.763 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -61.77 -45.23 94.78 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.453 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 49.7 t90 -61.29 -38.05 85.38 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.6 mt -62.57 -46.44 88.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.4 -50.64 69.07 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.898 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.2 p -89.1 -42.14 11.88 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -102.0 -72.68 0.68 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.42 -64.52 0.74 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -173.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.6 mt -80.39 31.9 0.29 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.128 0.171 . . . . 0.0 111.37 -175.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.47 -47.68 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -81.42 -28.17 34.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.603 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -57.47 121.67 49.84 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.46 -18.41 62.87 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.726 2.284 . . . . 0.0 112.557 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -97.98 20.0 12.98 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.049 0.386 . . . . 0.0 110.907 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 mm -131.05 146.89 33.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 117.936 0.334 . . . . 0.0 110.115 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -137.86 136.06 36.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.14 130.47 49.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.4 mt -142.94 123.45 10.43 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.3 t70 53.79 34.54 19.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.92 0.488 . . . . 0.0 111.073 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.09 -36.31 3.32 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -72.0 163.27 28.16 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -119.25 134.01 55.44 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.375 0.27 . . . . 0.0 110.455 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -125.03 152.17 44.62 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -76.17 121.84 23.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -69.19 119.34 69.51 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -63.1 105.26 0.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.122 1.881 . . . . 0.0 109.695 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -166.22 141.02 4.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 52.21 44.16 29.97 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -83.98 60.21 5.71 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.5 t -57.84 144.9 9.71 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.928 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 . . . . . 0 C--O 1.254 1.31 0 CA-C-O 116.584 -1.674 . . . . 0.0 109.387 -179.457 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.4 154.22 39.03 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t 75.01 -57.44 0.6 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 123.605 0.762 . . . . 0.0 110.364 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.96 31.07 62.42 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 64.7 m -72.37 166.29 22.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.9 t -63.26 148.42 48.27 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 157.7 -169.43 34.53 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -62.16 141.93 57.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.4 mttm 69.12 -69.97 0.15 Allowed 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.24 0.616 . . . . 0.0 110.488 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -57.99 -47.6 82.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.759 0.823 . . . . 0.0 111.821 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.21 -45.25 94.11 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.9 t -59.74 -46.57 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.17 -42.82 99.47 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.14 89.59 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -66.23 -41.56 89.86 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 50.7 mt -62.68 -47.82 91.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.25 -47.82 89.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -59.63 -47.21 86.47 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -48.22 80.88 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.634 0.373 . . . . 0.0 110.387 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 80.8 mmm -57.22 -33.12 67.21 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 122.498 0.319 . . . . 0.0 110.256 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . 20.6 ttpp -73.66 -62.58 1.44 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -44.98 -50.22 10.75 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.087 0.555 . . . . 0.0 111.546 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -63.13 -42.39 99.51 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.26 0.482 . . . . 0.0 109.872 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -64.55 -27.28 68.85 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.778 0.431 . . . . 0.0 109.956 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -74.44 -34.7 63.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.652 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -95.17 38.99 1.12 Allowed 'General case' 0 C--N 1.35 0.623 0 CA-C-N 118.13 0.423 . . . . 0.0 111.59 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.46 -16.5 48.99 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.185 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.3 41.76 0.71 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.489 1.145 . . . . 0.0 109.889 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.58 66.65 6.17 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -142.53 152.27 59.66 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.05 151.0 84.32 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.053 2.502 . . . . 0.0 111.91 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.3 mt -140.42 143.15 35.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.4 p -62.47 171.28 2.01 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -55.29 34.05 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -58.16 -41.88 84.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.242 0.217 . . . . 0.0 111.31 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.57 -40.78 75.79 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.0 mt -64.82 -45.73 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.5 mt -55.38 -49.04 73.34 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -49.2 -58.79 4.4 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.199 0.2 . . . . 0.0 111.081 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -61.25 -42.51 98.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.24 0.216 . . . . 0.0 111.56 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.47 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 35.5 p -75.7 -8.06 55.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 119.344 -0.36 . . . . 0.0 111.228 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 64.96 49.24 2.14 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.47 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 6.5 m-70 -130.46 39.2 3.66 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.462 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mt -73.82 -44.36 55.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.9 41.22 0.79 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 tt -79.32 -31.38 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 122.793 0.437 . . . . 0.0 110.297 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.16 138.43 10.28 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.25 -25.74 65.91 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 117.079 0.44 . . . . 0.0 111.2 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -61.11 -34.08 74.39 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -89.51 -43.85 10.54 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.693 0.397 . . . . 0.0 109.947 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -55.58 -47.74 75.95 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -57.24 -48.34 79.07 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -57.16 -54.83 42.28 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.0 mt -53.46 -43.13 67.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.3 ttt -70.85 -38.88 73.2 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.0 p -118.11 36.46 4.34 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -168.38 -70.33 0.02 OUTLIER 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.291 0.496 . . . . 0.0 110.539 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.76 -63.97 1.12 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -175.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.6 mt -79.1 28.59 0.22 Allowed 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.516 -0.115 . . . . 0.0 111.192 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.49 -40.75 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -116.16 4.86 13.65 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.37 0.268 . . . . 0.0 111.403 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.42 127.5 91.3 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.78 -30.05 91.54 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.593 2.195 . . . . 0.0 112.107 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.0 36.52 1.68 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.594 0.179 . . . . 0.0 110.733 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 tp -150.85 156.99 5.89 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -157.75 138.8 13.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 39.9 t -87.81 108.3 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.7 mp -114.96 122.53 69.26 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 53.08 36.93 23.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.693 0.397 . . . . 0.0 110.489 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.71 -32.91 3.34 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -78.61 162.01 26.56 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 117.804 0.802 . . . . 0.0 108.98 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.63 123.24 44.56 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.4 153.42 28.62 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.407 ' CE1' ' HB2' ' A' ' 21' ' ' LYS . 76.2 t80 -80.35 114.49 19.29 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.182 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -73.95 122.52 87.76 Favored Pre-proline 0 N--CA 1.446 -0.646 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -51.05 128.07 23.77 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.246 1.964 . . . . 0.0 111.643 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.16 159.86 22.57 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.996 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -115.05 126.63 54.93 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.4 m120 70.22 143.78 0.05 Allowed 'General case' 0 C--N 1.346 0.443 0 C-N-CA 123.532 0.733 . . . . 0.0 110.118 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.15 -28.39 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 116.821 -1.561 . . . . 0.0 109.124 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.5 tp -79.11 91.25 4.9 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 p -153.05 35.91 0.48 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.79 -149.81 46.25 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.6 p -80.02 137.34 36.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 t -70.56 -64.59 0.87 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.37 -47.62 3.24 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -48.54 113.71 0.82 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.157 0.583 . . . . 0.0 110.262 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HB3' ' CH2' ' A' ' 53' ' ' TRP . 13.7 mttp 74.19 -65.82 0.33 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.161 0.985 . . . . 0.0 111.13 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -53.88 -39.4 65.69 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.804 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.45 -50.23 60.64 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.7 t -64.21 -46.63 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.9 tp -61.18 -46.26 91.22 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.77 -42.45 93.33 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -58.72 -51.65 69.05 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.2 mt -55.42 -49.24 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 t -58.02 -46.14 87.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.17 -50.56 69.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.559 0.344 . . . . 0.0 110.747 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CE1' ' CD ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -60.81 -46.16 91.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.725 0.41 . . . . 0.0 110.323 -177.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.3 mmm -63.04 -47.37 83.3 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -56.73 -52.07 66.42 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.758 0.423 . . . . 0.0 110.906 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.5 m -57.5 -42.13 82.11 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.449 ' CD ' ' CE1' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -68.15 -40.51 82.37 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -62.2 -34.55 76.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -67.44 -47.18 70.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.443 0.297 . . . . 0.0 111.406 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -70.37 -35.44 73.54 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 119.143 -0.456 . . . . 0.0 111.756 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.74 -30.14 0.34 Allowed Glycine 0 C--N 1.345 1.04 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.195 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -74.52 77.58 1.95 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p -93.23 -14.23 27.33 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.826 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -61.94 149.71 85.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 117.447 0.112 . . . . 0.0 110.729 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -62.98 158.42 43.47 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.932 2.421 . . . . 0.0 111.225 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.4 mt -138.04 142.33 40.34 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.8 p -62.11 167.83 3.71 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -50.29 74.08 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.56 -51.9 63.8 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.785 0.434 . . . . 0.0 110.826 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.09 -45.52 79.38 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.3 mt -59.39 -46.95 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.41 ' CD2' HD13 ' A' ' 46' ' ' ILE . 24.2 mt -59.62 -63.75 1.19 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -40.19 -58.15 1.54 Allowed 'General case' 0 C--N 1.343 0.301 0 C-N-CA 123.674 0.79 . . . . 0.0 112.452 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -57.23 -34.56 68.7 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 117.411 0.096 . . . . 0.0 111.063 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.505 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -99.3 28.77 4.3 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 67.54 -111.27 0.14 Allowed 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.505 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 3.6 m-70 46.71 -116.3 0.66 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.513 0.325 . . . . 0.0 110.536 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 78.44 -55.4 0.48 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.582 1.153 . . . . 0.0 111.029 175.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.57 -62.04 1.6 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.41 HD13 ' CD2' ' A' ' 38' ' ' LEU . 30.3 mt 66.39 -74.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 O-C-N 124.592 1.183 . . . . 0.0 111.594 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.52 124.77 1.42 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 105.166 -3.174 . . . . 0.0 105.166 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.3 tp -43.84 -42.39 5.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.536 0.668 . . . . 0.0 111.798 -175.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -51.37 -52.61 44.23 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.372 0.269 . . . . 0.0 110.333 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -69.08 -61.69 1.69 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 122.519 0.328 . . . . 0.0 110.628 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -42.13 -42.89 3.11 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.757 0.423 . . . . 0.0 110.895 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -69.45 -53.81 17.41 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' A' ' 9' ' ' LYS . 34.1 t90 -51.94 -44.78 64.06 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 122.507 0.323 . . . . 0.0 110.712 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.3 mt -57.07 -45.75 83.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 47.8 ttm -74.68 -37.45 62.66 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -176.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 t -106.56 6.73 30.3 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -173.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -152.46 -67.91 0.16 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.282 0.946 . . . . 0.0 111.917 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.01 -65.4 0.57 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.63 -48.77 71.06 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.4 m -55.74 -35.37 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 119.534 -0.27 . . . . 0.0 110.883 -177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -109.76 36.23 3.06 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -94.15 127.64 44.01 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.86 -22.86 62.9 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.32 2.013 . . . . 0.0 112.021 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -111.75 6.06 19.53 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -176.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 mt -140.81 129.21 24.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -122.98 168.96 11.66 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.4 t -98.68 131.86 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.9 mt -139.21 121.07 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.8 t70 58.46 29.94 19.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.625 0.37 . . . . 0.0 110.252 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.47 -36.54 3.22 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 168.79 15.01 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -109.12 141.98 40.53 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.5 137.51 38.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.545 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -71.59 125.96 28.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -80.17 122.07 82.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -66.41 163.5 32.07 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.435 2.09 . . . . 0.0 110.766 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -160.68 52.21 0.29 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -139.01 86.02 2.11 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 40.78 44.53 1.91 Allowed 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.402 0.681 . . . . 0.0 110.86 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 69.49 135.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 123.694 0.798 . . . . 0.0 109.831 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? . . . . . 0 C--O 1.254 1.332 0 CA-C-O 116.478 -1.725 . . . . 0.0 109.253 -178.193 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 tt 52.99 63.68 2.15 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.4 m -153.16 76.78 1.13 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.13 -122.03 28.59 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.3 p -78.77 67.37 4.49 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 t -85.65 28.44 0.77 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.484 0.314 . . . . 0.0 110.549 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.39 61.73 4.72 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -131.3 23.78 4.82 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.403 ' HB2' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -154.9 -47.4 0.09 Allowed 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 -178.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -59.62 -48.99 79.5 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.258 0.223 . . . . 0.0 110.696 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.7 -50.22 69.49 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.5 t -59.69 -49.7 82.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.53 -46.35 86.96 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.46 98.18 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -63.63 -45.68 89.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.08 -48.1 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 t -57.5 -42.81 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -73.24 -42.7 62.25 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.484 -0.135 . . . . 0.0 111.087 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -49.0 77.52 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.1 mmm -55.88 -48.49 75.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -52.39 -61.1 2.49 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 123.349 0.405 . . . . 0.0 110.6 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -54.99 -51.59 65.74 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -62.1 -38.72 89.94 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.182 0.447 . . . . 0.0 110.251 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -64.46 -37.02 86.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -82.41 43.37 0.81 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.559 0.744 . . . . 0.0 109.012 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 ttp-105 -158.6 -51.43 0.06 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.22 -38.17 0.07 OUTLIER Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.8 59.66 3.77 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.315 0.557 . . . . 0.0 110.012 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.62 -3.53 59.05 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.15 154.37 92.8 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 122.651 0.38 . . . . 0.0 110.635 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.99 120.67 7.95 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.104 1.869 . . . . 0.0 110.121 176.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.4 mt -100.76 149.44 23.81 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.0 p -76.59 170.87 15.62 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -53.32 59.63 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -58.14 -43.56 87.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.22 0.208 . . . . 0.0 111.057 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -56.62 -41.77 77.68 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.2 mt -63.97 -49.68 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.9 mt -53.76 -55.73 23.7 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -45.79 -59.11 2.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.787 0.435 . . . . 0.0 111.442 -177.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.38 -38.74 84.86 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.3 p -81.41 -1.33 45.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.072 0.396 . . . . 0.0 111.159 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 65.54 44.91 2.89 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -127.6 28.8 5.59 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.22 -44.33 75.98 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.93 55.88 2.91 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.0 tt -99.89 148.17 6.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 122.711 0.404 . . . . 0.0 110.001 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.62 141.99 41.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -57.29 -24.95 58.23 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 117.064 0.432 . . . . 0.0 111.289 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -64.87 -50.97 64.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -69.49 -43.68 72.64 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -53.68 -50.57 65.54 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 -62.45 -48.13 81.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.98 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.403 ' CH2' ' HB2' ' A' ' 9' ' ' LYS . 28.8 t90 -54.38 -50.89 66.44 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 52.1 mt -55.16 -49.34 72.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.7 ttt -63.69 -48.07 78.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -124.96 50.24 1.77 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.726 0.694 . . . . 0.0 112.554 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -172.77 -61.88 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.61 -67.02 0.47 Allowed 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.463 -0.148 . . . . 0.0 111.155 -177.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.85 -48.35 82.21 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.351 0.26 . . . . 0.0 111.523 -175.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 m -53.74 -38.75 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -89.12 -25.11 22.04 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 117.797 0.271 . . . . 0.0 110.916 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.45 117.58 28.81 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -63.81 -35.4 56.91 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.633 2.222 . . . . 0.0 111.882 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.83 -26.61 64.31 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.902 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.09 95.2 3.62 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -91.97 157.95 16.53 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.7 t -96.21 136.53 26.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.1 mm -115.8 -114.07 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.19 62.47 6.66 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.87 1.96 60.24 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -117.72 -179.98 3.9 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -114.67 129.58 56.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.654 0.264 . . . . 0.0 110.51 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.5 146.09 48.34 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.45 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -87.66 125.23 34.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -81.3 121.32 80.14 Favored Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -62.66 -39.47 43.51 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.398 2.065 . . . . 0.0 111.124 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? 70.76 128.26 0.03 OUTLIER 'General case' 0 C--N 1.348 0.524 0 C-N-CA 123.585 0.754 . . . . 0.0 109.873 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -61.5 107.07 0.73 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -144.46 152.39 40.55 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.39 147.51 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.145 -1.407 . . . . 0.0 108.758 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.6 108.52 0.84 Allowed 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 p -162.43 75.26 0.43 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.84 53.78 0.5 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 t 64.17 -168.76 0.2 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.732 0.413 . . . . 0.0 110.387 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.2 m -79.42 176.62 9.52 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.08 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.21 101.37 2.76 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -153.31 38.01 0.49 Allowed 'General case' 0 C--N 1.341 0.235 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.448 ' HB2' ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -173.5 -51.04 0.01 OUTLIER 'General case' 0 C--N 1.341 0.201 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -178.18 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.73 -39.92 95.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.353 0.261 . . . . 0.0 110.505 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.23 -50.42 65.23 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.9 t -62.78 -44.09 99.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.67 -49.42 77.63 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.95 86.09 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.34 -44.53 96.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.21 -49.29 84.71 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.1 t -53.45 -45.47 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.63 -45.63 82.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.232 0.213 . . . . 0.0 111.228 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -40.26 94.17 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -41.74 87.58 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -58.31 8.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -63.4 -48.44 77.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.847 0.459 . . . . 0.0 112.029 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.47 -35.04 79.3 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.309 0.504 . . . . 0.0 110.272 -177.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -66.29 -39.3 89.27 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -78.52 53.19 1.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.45 -50.13 0.09 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.76 -29.59 0.17 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -75.39 60.2 1.13 Allowed 'General case' 0 C--N 1.343 0.314 0 C-N-CA 122.966 0.506 . . . . 0.0 110.125 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.5 p -87.87 57.5 4.37 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -137.58 154.77 75.3 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.56 150.76 83.87 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.927 2.418 . . . . 0.0 112.32 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 16.1 mt -138.37 142.92 39.64 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.3 p -63.25 169.44 3.58 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.2 tt -60.88 -51.88 67.43 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -59.92 -41.34 91.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 119.675 -0.202 . . . . 0.0 110.655 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -56.93 -39.3 74.25 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 mt -67.0 -47.69 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.8 mt -52.0 -47.41 64.93 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -50.58 -56.77 10.22 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.33 0.252 . . . . 0.0 111.331 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -66.71 -45.06 79.97 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.13 -4.82 40.93 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.93 0.332 . . . . 0.0 110.934 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 63.2 50.22 3.08 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -130.9 45.77 2.77 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -77.59 -42.35 35.41 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -84.74 27.72 0.72 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 tt -63.26 -32.88 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 122.766 0.427 . . . . 0.0 110.456 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.76 137.73 9.93 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -59.11 -26.4 64.65 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.996 0.398 . . . . 0.0 110.99 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -61.17 -34.11 74.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -89.41 -47.42 8.03 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -57.41 -45.03 85.0 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.77 -49.17 76.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.448 ' CZ3' ' HB2' ' A' ' 9' ' ' LYS . 27.6 t90 -58.92 -50.84 72.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 66.8 mt -54.29 -42.25 69.82 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 122.104 -0.373 . . . . 0.0 110.237 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 21.7 ttt -64.12 -60.46 3.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -174.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.7 t -105.55 -3.34 22.49 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -117.74 -67.46 0.99 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.051 0.841 . . . . 0.0 111.214 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.01 -69.08 0.25 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.3 mt -57.94 -33.64 69.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.45 0.3 . . . . 0.0 111.077 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.0 t -63.58 -36.55 76.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -111.75 46.85 1.08 Allowed 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -118.23 115.91 35.91 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -66.78 -4.75 11.73 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.734 2.289 . . . . 0.0 112.853 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 4.51 17.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.404 0.547 . . . . 0.0 111.182 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.23 142.16 39.42 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.87 137.58 48.1 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.91 125.96 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.6 mt -137.54 116.6 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t0 54.31 45.49 27.13 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.687 0.395 . . . . 0.0 110.082 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.03 -41.72 2.24 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -69.5 169.99 11.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.106 0.453 . . . . 0.0 109.989 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.85 125.54 54.12 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 122.524 0.33 . . . . 0.0 110.129 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.84 127.93 56.2 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.061 0.545 . . . . 0.0 110.208 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -63.4 121.02 12.77 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -77.65 115.69 51.93 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -64.93 146.0 86.87 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.264 1.976 . . . . 0.0 110.956 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -82.13 -39.38 23.38 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.27 -61.13 0.1 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.4 t30 70.25 -67.68 0.23 Allowed 'General case' 0 C--N 1.348 0.5 0 C-N-CA 123.742 0.817 . . . . 0.0 110.571 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.12 131.86 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 116.652 -1.642 . . . . 0.0 109.113 179.665 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.41 164.05 39.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t 55.82 43.25 27.99 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.56 113.06 4.85 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.3 m -158.59 165.41 34.55 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.1 t -83.52 -128.78 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.18 -166.45 10.74 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 69.02 142.0 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.256 0.622 . . . . 0.0 110.267 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.47 -45.69 0.59 Allowed 'General case' 0 C--N 1.349 0.567 0 C-N-CA 123.219 0.608 . . . . 0.0 110.53 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -75.52 -47.8 25.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 119.015 0.825 . . . . 0.0 109.637 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.93 -44.46 97.79 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.3 -43.92 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.1 tp -59.07 -47.22 86.01 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.31 -43.19 92.68 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -61.31 -43.48 98.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.7 mt -61.3 -45.65 98.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 t -58.15 -48.09 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -61.79 -42.44 99.0 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -58.32 9.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.8 ttm -55.61 -37.68 68.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 122.615 0.366 . . . . 0.0 110.442 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -60.99 -48.77 80.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.2 m -62.39 -44.68 95.86 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.425 ' HE ' ' CB ' ' A' ' 28' ' ' ASP . 3.1 ttt85 -61.48 -47.49 85.42 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.784 0.326 . . . . 0.0 110.273 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -63.18 -54.29 39.88 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.044 0.538 . . . . 0.0 109.834 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -58.63 -32.98 69.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.979 0.512 . . . . 0.0 110.447 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -66.63 -52.55 43.9 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.75 -34.31 0.1 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.775 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.425 ' CB ' ' HE ' ' A' ' 23' ' ' ARG . 5.4 m-20 -76.14 69.67 2.72 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 117.583 0.692 . . . . 0.0 109.825 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.1 p -77.32 -14.89 59.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.644 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -61.62 154.34 66.11 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 122.402 0.281 . . . . 0.0 110.711 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.24 157.62 52.99 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.598 2.198 . . . . 0.0 110.84 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.2 mt -135.91 147.63 48.21 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.0 p -70.77 171.23 10.9 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.2 -54.93 39.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.69 -52.07 57.58 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.354 0.262 . . . . 0.0 110.641 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -51.68 -37.49 50.86 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 122.165 0.186 . . . . 0.0 110.545 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.0 mt -69.41 -48.51 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.5 mt -53.62 -52.03 61.18 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 117.537 0.153 . . . . 0.0 110.798 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.64 -65.12 0.51 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 122.934 0.494 . . . . 0.0 111.679 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.64 -46.15 81.16 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.34 0.256 . . . . 0.0 111.426 -177.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.408 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -71.98 -6.19 40.34 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.002 -178.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 67.94 41.55 2.07 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 122.899 0.48 . . . . 0.0 109.99 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.408 ' CE1' ' O ' ' A' ' 41' ' ' THR . 7.2 m-70 -127.68 33.87 4.74 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -49.18 73.65 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.22 38.72 0.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 tt -72.1 149.62 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.11 133.41 37.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.7 tp -54.29 -35.3 62.45 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.363 0.265 . . . . 0.0 110.409 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -54.56 -46.29 73.63 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -70.2 -48.66 56.15 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -49.99 -44.13 50.8 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -69.24 -54.59 13.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 15.1 t90 -50.85 -40.14 55.34 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.709 0.404 . . . . 0.0 110.881 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.3 -39.8 88.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 73.0 mtm -89.96 -0.87 57.82 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.239 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.5 p -132.4 17.23 4.44 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.765 0.711 . . . . 0.0 111.888 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -166.79 -70.77 0.03 OUTLIER 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.447 0.567 . . . . 0.0 111.038 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.45 -80.09 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -174.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 mt -59.29 -20.99 58.96 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 122.564 -0.085 . . . . 0.0 111.001 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 96.8 t -68.0 -40.74 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.575 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.66 54.57 1.18 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 117.844 0.293 . . . . 0.0 111.607 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -101.9 135.18 19.76 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -51.2 -44.99 39.53 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.655 2.237 . . . . 0.0 112.682 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -83.3 8.81 12.37 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -176.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.4 mm -123.88 150.85 28.45 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 118.091 0.405 . . . . 0.0 109.926 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -134.69 138.55 44.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.2 t -96.93 121.25 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -134.39 130.67 54.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 52.43 31.82 10.31 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 123.464 0.478 . . . . 0.0 111.196 176.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.42 -17.25 20.08 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -87.66 -173.25 4.24 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -127.49 137.36 52.64 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.19 154.18 51.4 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -77.3 125.68 29.71 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -73.94 116.97 57.36 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -74.54 168.39 24.92 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.427 2.085 . . . . 0.0 110.94 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -86.41 -12.01 50.33 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.95 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 73.56 6.33 5.02 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.579 0.751 . . . . 0.0 110.908 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.75 63.54 7.52 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.0 p -72.53 -34.22 47.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.183 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.489 -1.243 . . . . 0.0 109.392 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 61.3 tp -57.89 -34.45 69.82 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.439 0.296 . . . . 0.0 110.335 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -76.88 62.41 2.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.485 0.314 . . . . 0.0 110.767 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 36.84 63.82 0.7 Allowed Glycine 0 C--N 1.346 1.116 0 C-N-CA 123.641 0.639 . . . . 0.0 112.153 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.6 p -163.1 138.82 6.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.2 m -78.22 60.62 2.53 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.77 150.03 2.1 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -67.2 161.38 24.88 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.1 tttp 72.99 -67.2 0.28 Allowed 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.33 0.394 . . . . 0.0 110.051 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.8 -48.73 65.48 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.033 0.533 . . . . 0.0 110.68 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.63 -43.28 99.16 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.84 -50.35 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.51 -45.29 94.36 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.59 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.68 96.29 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -57.43 -48.82 78.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 62.8 mt -59.7 -50.24 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.392 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 t -55.9 -48.69 78.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -62.15 -45.17 94.6 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.074 0.15 . . . . 0.0 110.66 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -59.04 -55.27 37.22 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 ttt -62.86 -35.83 81.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -60.86 -55.14 36.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 m -62.02 -43.01 99.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.423 ' HG3' ' CE1' ' A' ' 19' ' ' TYR . 14.3 mmt180 -56.26 -50.2 72.01 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.824 0.45 . . . . 0.0 109.905 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -63.81 -38.76 92.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -83.82 48.74 1.49 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -162.79 -50.14 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.1 -31.95 0.12 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -81.19 60.29 4.25 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.069 0.434 . . . . 0.0 110.175 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -6.32 59.13 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -70.12 155.13 93.96 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -70.02 147.11 60.46 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.73 2.287 . . . . 0.0 111.957 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.3 mt -134.55 144.91 48.26 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.477 0.711 . . . . 0.0 109.447 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -64.52 173.65 2.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.013 0.435 . . . . 0.0 110.027 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -58.3 9.15 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.644 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -59.06 -38.5 79.55 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 119.599 -0.238 . . . . 0.0 111.411 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.25 -39.53 79.41 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.2 mt -68.43 -42.58 84.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.423 ' CD1' ' HZ1' ' A' ' 51' ' ' LYS . 66.3 mt -59.8 -46.66 88.5 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.676 -0.12 . . . . 0.0 110.676 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -48.52 -59.48 3.46 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.645 0.378 . . . . 0.0 111.059 -177.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -56.84 -42.37 79.52 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.386 0.274 . . . . 0.0 111.077 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 47.0 p -80.19 4.69 16.69 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.876 -0.583 . . . . 0.0 111.213 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? 72.45 -15.37 0.49 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.846 0.858 . . . . 0.0 111.618 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -78.18 42.73 0.42 Allowed 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 118.409 0.55 . . . . 0.0 111.285 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.38 -45.59 54.0 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.67 -0.644 . . . . 0.0 109.421 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.11 -55.14 31.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.45 HG23 ' H ' ' A' ' 47' ' ' GLY . 4.0 tt 34.74 -132.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.095 0.958 . . . . 0.0 110.533 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.45 ' H ' HG23 ' A' ' 46' ' ' ILE . . . -154.35 151.21 22.92 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tt -56.17 -44.55 79.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.542 0.671 . . . . 0.0 110.493 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -59.73 -45.77 91.17 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.163 0.185 . . . . 0.0 110.628 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.1 -48.8 61.6 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HZ1' ' CD1' ' A' ' 38' ' ' LEU . 20.7 ttmm -52.37 -48.51 65.55 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -63.19 -48.03 80.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.407 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 26.5 t90 -53.78 -46.03 70.89 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.459 0.304 . . . . 0.0 110.405 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 62.8 mt -61.86 -40.72 96.35 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 40.0 ttm -76.13 -26.86 56.74 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.2 t -118.81 -8.05 10.38 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -174.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 26.8 tt0 -132.9 -49.09 0.87 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.152 0.887 . . . . 0.0 112.404 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.2 -63.52 1.4 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.0 mt -80.36 2.49 24.65 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -173.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -73.83 -93.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.773 0.715 . . . . 0.0 109.422 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -83.96 51.61 2.09 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -80.85 135.01 52.43 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.113 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -64.82 -25.02 60.75 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.112 1.875 . . . . 0.0 111.266 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -108.8 1.34 20.91 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 119.011 -0.518 . . . . 0.0 112.037 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.36 134.5 22.93 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 118.776 0.716 . . . . 0.0 110.014 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -115.89 157.38 24.57 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.7 t -100.62 126.79 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.5 mp -135.42 121.43 31.52 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t0 51.53 46.96 25.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.823 0.449 . . . . 0.0 110.455 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.81 -39.49 2.0 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -73.16 176.29 6.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -117.49 153.0 33.9 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.19 139.07 28.53 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -64.82 133.86 52.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -90.14 115.92 65.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.112 0.565 . . . . 0.0 110.187 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.25 107.8 2.35 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.338 2.025 . . . . 0.0 110.135 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.41 -46.78 84.82 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -137.7 15.77 2.91 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 61.42 -155.31 0.35 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.79 150.12 34.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.0 ttm105 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 116.663 -1.637 . . . . 0.0 109.435 179.89 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tt 73.32 -68.06 0.24 Allowed 'General case' 0 C--N 1.346 0.451 0 C-N-CA 123.074 0.549 . . . . 0.0 109.816 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 t -76.18 74.36 3.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.34 -92.44 0.09 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.6 p -163.99 52.14 0.14 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -75.38 84.34 2.5 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.65 -166.77 54.68 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 66.48 145.13 0.03 OUTLIER 'General case' 0 C--N 1.348 0.515 0 C-N-CA 123.263 0.625 . . . . 0.0 110.134 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.449 ' HG3' ' CH2' ' A' ' 53' ' ' TRP . 5.6 pttt 77.68 -48.71 0.5 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.268 0.627 . . . . 0.0 110.622 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -68.59 -47.4 66.84 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.103 0.41 . . . . 0.0 110.543 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.73 -36.11 88.63 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.1 t -72.69 -49.81 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.3 tp -57.69 -40.91 80.52 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.77 0.428 . . . . 0.0 110.775 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.14 -49.49 77.66 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -62.55 -38.94 92.0 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.1 mt -60.84 -49.0 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.53 -47.92 86.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -65.77 -40.32 91.91 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.434 ' CE1' ' HG2' ' A' ' 40' ' ' GLU . 1.8 t80 -60.17 -56.65 18.96 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.524 0.33 . . . . 0.0 110.27 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -40.66 86.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -55.84 -47.39 77.33 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -63.37 -47.61 81.39 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.395 0.278 . . . . 0.0 110.921 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.402 HH21 ' CG ' ' A' ' 28' ' ' ASP . 2.2 mtp180 -58.55 -48.72 79.95 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -60.2 -40.26 89.48 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -61.85 -42.74 99.42 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -65.82 -45.65 81.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.461 0.304 . . . . 0.0 110.311 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.91 -20.83 0.3 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.402 ' CG ' HH21 ' A' ' 23' ' ' ARG . 14.9 t70 -79.83 68.78 6.02 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.53 -5.69 58.67 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.979 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -64.22 148.46 95.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 O-C-N 122.329 -0.232 . . . . 0.0 110.436 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.08 146.67 86.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.038 2.492 . . . . 0.0 112.251 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.2 mt -134.78 136.53 42.65 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.6 p -63.12 169.91 3.16 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.059 0.457 . . . . 0.0 110.049 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tt -58.35 -51.44 69.79 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -58.14 -44.75 87.99 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.59 0.356 . . . . 0.0 110.99 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -56.59 -30.43 63.19 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 49.4 mt -78.3 -42.99 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.3 mt -55.26 -43.58 74.78 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -49.47 -50.08 42.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.381 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.434 ' HG2' ' CE1' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -77.28 -49.8 14.25 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.204 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.5 p -69.08 -3.49 13.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.251 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 65.47 45.95 2.65 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -125.57 42.29 3.32 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -74.57 -49.7 20.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.59 42.53 0.91 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.4 tt -72.82 -36.13 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 122.816 0.446 . . . . 0.0 110.309 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.69 132.19 6.78 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.9 -36.21 62.45 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.821 0.311 . . . . 0.0 110.368 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -50.13 -44.09 52.16 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -78.25 -46.9 19.11 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.484 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -50.61 -49.67 55.99 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -48.95 78.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.449 ' CH2' ' HG3' ' A' ' 9' ' ' LYS . 12.8 t90 -55.76 -53.27 58.74 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.0 mt -54.95 -44.02 73.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -178.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -53.09 61.82 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.303 -175.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.1 t -120.15 48.18 1.62 Allowed 'General case' 0 C--N 1.348 0.541 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -175.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -165.75 -66.11 0.03 OUTLIER 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -64.5 -69.39 0.29 Allowed 'General case' 0 C--O 1.224 -0.267 0 O-C-N 122.904 0.127 . . . . 0.0 111.168 -176.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.7 mt -59.72 -25.28 64.7 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.416 0.286 . . . . 0.0 111.088 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 46.5 t -75.2 -47.89 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -102.26 66.02 0.98 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -143.89 118.55 6.07 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.36 -23.3 74.25 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.602 2.202 . . . . 0.0 112.285 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -93.87 12.35 26.22 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 117.793 0.27 . . . . 0.0 110.95 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mm -135.68 152.02 30.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -144.8 142.37 29.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.7 t -96.06 127.5 48.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.049 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.7 mm -112.59 -120.97 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -81.02 67.51 6.95 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.19 -36.86 1.96 Allowed Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -75.25 169.25 18.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 117.111 0.455 . . . . 0.0 109.999 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -112.47 120.81 42.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.48 134.59 51.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -64.47 135.03 55.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -97.23 118.27 64.77 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -66.34 120.95 8.15 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.311 2.007 . . . . 0.0 110.24 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -166.36 -80.35 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -89.53 67.16 7.51 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -89.25 28.87 1.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.291 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.54 -32.55 58.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.387 0 CA-C-O 117.048 -1.453 . . . . 0.0 108.906 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.6 tp -76.62 86.77 3.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.0 p -80.21 63.46 4.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.97 -71.97 1.06 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.1 p 46.15 -131.95 1.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.27 0.628 . . . . 0.0 110.605 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.9 p -92.94 28.54 2.07 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.538 0.335 . . . . 0.0 110.404 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.78 -24.2 67.76 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -56.94 114.04 1.93 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.433 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER 72.51 -65.18 0.36 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.95 0.9 . . . . 0.0 110.502 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -58.11 -37.45 74.58 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 122.868 0.467 . . . . 0.0 111.383 -175.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.48 -48.17 76.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.06 -41.97 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.82 -47.55 85.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.91 -44.14 91.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -60.7 -47.33 86.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.32 -49.66 82.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.8 t -55.68 -43.8 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 122.663 0.385 . . . . 0.0 110.152 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -65.11 -48.22 74.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -50.25 73.03 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.3 mmm -55.73 -45.54 77.94 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -43.02 87.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.6 m -61.27 -51.36 69.24 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 119.422 -0.323 . . . . 0.0 111.285 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.65 -34.4 78.13 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.857 0.753 . . . . 0.0 109.691 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -65.37 -35.37 80.75 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -69.74 -42.35 74.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.078 0.551 . . . . 0.0 110.436 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -65.75 -36.19 82.85 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.69 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.99 -23.37 0.6 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-O 119.695 -0.503 . . . . 0.0 111.935 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.74 66.68 2.71 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.651 0.726 . . . . 0.0 109.658 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.2 p -76.42 -4.16 40.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.079 0.152 . . . . 0.0 110.676 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -66.03 156.14 85.06 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -70.32 162.46 42.26 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.708 2.272 . . . . 0.0 110.881 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.2 mt -138.65 150.28 46.06 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 177.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.3 p -77.88 167.94 20.71 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -44.83 92.5 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.0 -54.45 46.63 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -54.58 -43.03 71.74 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 122.582 0.353 . . . . 0.0 110.339 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.2 mt -59.13 -62.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.2 mt -54.81 -42.34 71.72 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.162 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -52.1 -54.91 24.63 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -64.05 -31.99 73.38 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.02 13.79 5.68 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 74.44 -58.51 0.58 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 124.312 1.045 . . . . 0.0 112.592 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.76 77.75 0.45 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.615 0.366 . . . . 0.0 111.944 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.94 -33.98 51.37 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 47' ' ' GLY . 19.4 t70 -68.98 -55.37 11.1 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 tt 50.26 -70.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.675 1.59 . . . . 0.0 112.693 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 45' ' ' ASP . . . 142.46 126.34 2.09 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.5 tp -46.81 -44.96 19.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.261 0.53 . . . . 0.0 111.238 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.6 -39.21 61.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.196 0.198 . . . . 0.0 111.244 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -87.97 -48.05 8.08 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -48.11 -48.84 33.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.118 0.567 . . . . 0.0 110.495 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.39 -47.43 76.33 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.433 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 31.2 t90 -55.8 -40.27 72.46 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 122.376 0.27 . . . . 0.0 110.425 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.5 mt -58.66 -49.0 79.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 83.1 mtp -64.84 -47.98 75.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.279 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.5 p -110.32 34.35 3.97 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -173.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.17 -75.17 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.738 0.699 . . . . 0.0 110.681 177.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -52.49 -53.78 41.24 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.7 mt -79.92 -20.1 46.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.756 -0.164 . . . . 0.0 111.041 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.89 -69.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.95 60.13 5.7 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -107.44 122.81 40.05 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.128 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -63.48 -19.6 68.15 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.247 1.964 . . . . 0.0 111.845 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -125.86 19.69 7.8 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.1 mt -146.0 129.69 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -111.46 154.12 25.15 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.3 t -105.93 144.29 15.58 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.0 mt -126.52 -125.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.51 65.04 3.71 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.29 -37.34 2.57 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 171.31 14.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -122.99 147.69 46.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.94 136.51 33.9 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -66.71 130.23 42.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -77.42 129.84 76.23 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.5 157.09 9.99 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.651 2.234 . . . . 0.0 112.188 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm 71.22 -173.41 0.17 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 123.848 0.859 . . . . 0.0 110.131 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.2 32.73 0.08 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.845 -178.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -153.44 101.05 2.48 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.45 150.48 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 116.815 -1.565 . . . . 0.0 109.15 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.44 ' HB3' ' CH2' ' A' ' 53' ' ' TRP . 17.7 mtmt . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 120.486 0.184 . . . . 0.0 110.716 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -56.38 -51.85 66.77 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.775 -173.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.38 -49.77 74.92 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.646 HG13 ' CD2' ' A' ' 43' ' ' HIS . 3.3 t -58.81 -45.73 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.463 HD13 ' HB1' ' A' ' 58' ' ' ALA . 55.9 tp -61.28 -45.5 94.23 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -38.0 82.58 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -69.4 -38.34 77.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.21 -48.85 85.62 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.59 -48.35 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -60.66 -43.71 97.3 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -60.73 -57.48 12.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 95.4 mtp -55.86 -40.84 73.48 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -59.35 -48.3 82.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.6 m -66.45 -51.18 59.61 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.124 0.17 . . . . 0.0 110.771 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -59.18 -36.7 75.78 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -68.56 -41.81 79.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -58.26 -48.34 80.73 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.871 0.468 . . . . 0.0 111.386 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -65.25 -33.38 75.84 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.73 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.25 -31.05 0.48 Allowed Glycine 0 C--N 1.346 1.085 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.627 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.95 70.2 2.65 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 117.95 0.875 . . . . 0.0 109.956 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.2 p -79.58 -4.16 50.25 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -61.89 155.71 60.99 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 122.662 0.385 . . . . 0.0 110.793 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -67.4 158.51 56.7 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.613 2.208 . . . . 0.0 110.622 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 32' ' ' LEU . 12.1 mt -137.06 140.34 41.95 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.6 p -64.72 167.59 7.2 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.51 -48.92 79.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.68 -49.76 74.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.534 0.334 . . . . 0.0 110.924 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -52.58 -36.11 55.43 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.62 -45.29 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.2 mt -47.97 -57.84 5.21 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 117.852 0.296 . . . . 0.0 110.669 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.99 -63.86 0.88 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.934 0.494 . . . . 0.0 111.577 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -59.95 -27.17 66.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.494 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 67.4 p -93.32 -0.99 56.47 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.491 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 66.6 41.15 3.16 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.846 0.458 . . . . 0.0 109.961 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.646 ' CD2' HG13 ' A' ' 12' ' ' VAL . 7.9 m-70 -129.72 44.13 3.02 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.414 ' O ' HG22 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -76.74 -51.28 11.71 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.07 -39.85 91.46 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.894 HG23 ' H ' ' A' ' 47' ' ' GLY . 18.5 tt 26.28 -105.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.866 1.266 . . . . 0.0 112.325 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.894 ' H ' HG23 ' A' ' 46' ' ' ILE . . . 157.34 148.84 5.24 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 108.04 -2.024 . . . . 0.0 108.04 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.4 tp -53.9 -39.97 66.23 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 117.397 0.599 . . . . 0.0 110.676 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -55.86 -58.92 5.82 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.227 0.211 . . . . 0.0 110.553 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.11 -50.14 62.53 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-O 119.513 -0.279 . . . . 0.0 110.395 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -46.01 -51.12 14.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.556 0.342 . . . . 0.0 110.47 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -64.53 -47.44 78.79 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.44 ' CH2' ' HB3' ' A' ' 9' ' ' LYS . 39.6 t90 -56.6 -41.53 77.17 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.381 0.272 . . . . 0.0 110.67 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 80.4 mt -61.07 -45.53 94.35 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 5.0 mmt -66.83 -47.18 72.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.729 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.3 p -110.91 33.39 4.61 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -173.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.45 -67.39 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.821 0.737 . . . . 0.0 111.092 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -63.58 -62.33 1.73 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.3 mt -79.71 27.93 0.28 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.88 -38.8 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -88.21 -30.54 19.64 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -60.8 120.71 55.81 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.22 -36.89 54.63 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.661 2.241 . . . . 0.0 112.183 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -66.77 -20.51 65.96 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 119.678 -0.201 . . . . 0.0 110.921 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.8 mm -92.5 117.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -106.59 122.57 46.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.7 t -83.56 121.36 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.1 mt -115.96 -98.66 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 71' ' ' LYS . 21.0 t0 -82.47 52.81 2.15 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.76 -33.01 1.43 Allowed Glycine 0 CA--C 1.534 1.265 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 69' ' ' ASP . 48.1 mttp -77.8 176.51 8.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.228 0.611 . . . . 0.0 109.542 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -109.1 129.25 55.47 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.489 0.185 . . . . 0.0 110.729 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.15 172.32 8.34 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -97.11 148.14 23.33 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -104.02 106.96 55.52 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.778 0.431 . . . . 0.0 111.799 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 N--CA 1.449 -1.144 0 C-N-CA 122.75 2.3 . . . . 0.0 110.644 177.674 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HG3' ' CH2' ' A' ' 53' ' ' TRP . 1.5 ptmt . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -69.32 -46.34 67.33 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.73 -49.86 67.45 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.24 -45.4 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 117.015 0.407 . . . . 0.0 110.224 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.63 -37.87 76.85 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.27 74.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -61.98 -50.21 73.01 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.504 ' HA ' HG21 ' A' ' 41' ' ' THR . 96.1 mt -57.76 -55.83 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.228 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 t -56.6 -44.4 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.144 0.178 . . . . 0.0 110.98 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -65.86 -52.19 52.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.57 0.168 . . . . 0.0 111.152 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -46.81 88.4 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 66.9 mmm -53.6 -48.79 68.94 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.92 -66.62 0.37 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 122.51 0.324 . . . . 0.0 110.71 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 m -52.55 -45.61 66.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.661 0.384 . . . . 0.0 111.999 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.513 HH21 HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -73.27 -24.36 60.43 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 122.253 -0.279 . . . . 0.0 111.06 -176.501 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -78.33 -39.13 40.5 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -62.04 -40.37 95.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -52.64 -54.14 37.41 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 122.497 0.319 . . . . 0.0 110.341 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.4 -22.31 0.25 Allowed Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -82.06 46.38 1.01 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 117.621 0.711 . . . . 0.0 110.006 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.74 -5.13 7.81 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.65 0.78 . . . . 0.0 111.291 -179.045 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.446 ' CE1' HD21 ' A' ' 32' ' ' LEU . 2.3 p-80 -54.88 153.42 11.41 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 122.446 0.298 . . . . 0.0 111.042 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.23 153.6 58.09 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.764 2.309 . . . . 0.0 111.08 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.513 HD11 HH21 ' A' ' 23' ' ' ARG . 16.2 mt -132.16 142.84 49.61 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.0 p -71.9 172.14 10.46 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -48.83 78.61 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.09 -52.39 61.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.89 0.476 . . . . 0.0 110.996 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -51.83 -42.32 62.46 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 122.468 0.307 . . . . 0.0 110.832 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.45 -57.75 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.582 ' CD1' HD11 ' A' ' 46' ' ' ILE . 89.5 mt -51.87 -39.95 59.79 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.255 0.222 . . . . 0.0 111.43 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -55.39 -52.84 62.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.722 -0.103 . . . . 0.0 110.722 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -75.44 -37.48 60.35 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.127 0.171 . . . . 0.0 110.967 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 16' ' ' ILE . 71.0 p -87.26 91.95 8.9 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -26.47 72.71 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.554 1.941 . . . . 0.0 115.592 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 41' ' ' THR . 1.3 p80 -178.58 58.12 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.89 56.68 4.08 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -162.21 -45.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER 40.88 -89.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.597 0 C-N-CA 124.821 1.248 . . . . 0.0 112.3 177.599 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 140.11 168.95 11.51 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 107.166 -2.373 . . . . 0.0 107.166 -175.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.28 -49.37 77.38 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.65 0.725 . . . . 0.0 110.151 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -52.36 -55.7 19.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.312 0.245 . . . . 0.0 111.117 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -66.96 -58.58 4.68 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.282 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.606 ' HB2' HD12 ' A' ' 46' ' ' ILE . 24.6 ttpp -48.94 -42.91 38.98 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 118.033 0.379 . . . . 0.0 110.7 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -68.15 -56.78 7.54 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.412 ' CH2' ' HG3' ' A' ' 9' ' ' LYS . 23.3 t90 -52.58 -52.6 54.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 123.151 0.282 . . . . 0.0 110.625 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 76.8 mt -57.07 -49.93 74.32 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.19 0.196 . . . . 0.0 110.762 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 59.2 ttm -62.09 -57.66 10.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -174.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -109.78 16.86 21.77 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -138.84 -54.21 0.59 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.432 1.015 . . . . 0.0 111.295 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.54 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -75.68 -64.76 1.01 Allowed 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -173.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.03 -29.64 70.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.3 m -67.95 -18.71 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.144 -0.455 . . . . 0.0 111.998 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.3 p30 -136.57 15.14 3.17 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 118.67 0.668 . . . . 0.0 111.783 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -69.38 132.78 89.47 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -53.37 -27.18 38.15 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.818 2.345 . . . . 0.0 113.249 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -112.36 30.25 7.24 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.242 0.474 . . . . 0.0 111.675 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.7 mm -135.3 150.51 29.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -142.69 148.3 37.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.78 110.96 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.5 mt -129.52 126.47 63.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.5 t70 58.03 27.11 14.38 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.705 0.402 . . . . 0.0 109.984 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.15 -13.38 26.61 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -91.57 174.12 7.53 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -105.26 118.28 36.16 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.43 148.64 32.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -75.32 121.56 22.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -88.02 116.39 66.05 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo . . . . . 0 N--CA 1.447 -1.213 0 C-N-CA 122.123 1.882 . . . . 0.0 110.094 -179.936 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.448 ' HB2' ' CZ3' ' A' ' 53' ' ' TRP . 20.5 ptmt . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -68.58 -42.48 78.19 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.95 72.89 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.87 -45.58 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.4 tp -58.53 -46.14 87.41 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.13 99.35 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -62.55 -44.17 97.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.509 ' HA ' HG21 ' A' ' 41' ' ' THR . 45.9 mt -60.85 -51.03 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 t -55.04 -47.74 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.2 -48.52 81.38 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 110.561 -0.162 . . . . 0.0 110.561 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -55.9 28.49 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -39.34 72.16 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -44.25 97.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.1 m -66.0 -45.49 81.37 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.135 0.174 . . . . 0.0 110.594 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -67.15 -40.59 86.72 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -61.25 -45.2 95.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -79.3 59.98 2.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.87 -51.71 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 177.48 -47.68 0.1 OUTLIER Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -76.61 73.25 3.31 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 116.97 0.385 . . . . 0.0 110.288 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.4 p -81.88 -12.18 58.57 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -63.64 154.24 80.73 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.577 0.351 . . . . 0.0 110.51 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.68 158.15 58.07 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.56 2.173 . . . . 0.0 111.386 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 32' ' ' LEU . 22.4 mt -133.04 149.7 52.17 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -61.99 166.54 4.54 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tt -59.05 -52.45 65.68 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.02 -40.58 89.79 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.06 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -58.04 -43.51 86.87 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.4 mt -64.29 -43.97 97.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.36 -52.41 65.49 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -45.38 -56.89 4.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.575 0.35 . . . . 0.0 111.224 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -60.42 -34.75 74.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.549 0.34 . . . . 0.0 111.77 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 16' ' ' ILE . 17.7 p -83.35 9.01 11.92 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 119.644 -0.217 . . . . 0.0 111.092 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 69.38 38.61 1.79 Allowed 'General case' 0 C--N 1.344 0.347 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.495 ' CE1' ' O ' ' A' ' 41' ' ' THR . 5.8 m-70 -132.37 167.05 20.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mt 166.26 -52.59 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.06 7.91 9.81 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 50' ' ' GLN . 3.5 tt -48.48 147.21 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.469 0 C-N-CA 123.596 0.759 . . . . 0.0 110.237 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.35 133.43 19.9 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.3 tp -56.49 -31.05 63.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -58.02 -45.69 86.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.48 ' HB3' HD11 ' A' ' 46' ' ' ILE . 18.2 mp0 -68.56 -47.8 65.9 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -55.69 -43.92 76.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -66.53 -50.7 62.3 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.448 ' CZ3' ' HB2' ' A' ' 9' ' ' LYS . 31.5 t90 -55.16 -45.66 75.71 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.457 0.303 . . . . 0.0 110.442 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.694 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 37.2 mt -56.08 -43.25 77.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.2 ttm -71.73 -50.37 30.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.5 p -104.94 23.49 13.47 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 36.0 tt0 -160.32 -68.89 0.07 Allowed 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 119.241 0.928 . . . . 0.0 111.567 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.694 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -55.55 -66.71 0.37 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.09 -41.52 99.41 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -65.27 -37.92 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 117.834 0.288 . . . . 0.0 110.591 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -101.78 58.35 0.84 Allowed 'General case' 0 C--N 1.342 0.279 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -148.1 112.66 3.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.29 -27.61 81.59 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.515 2.143 . . . . 0.0 111.812 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -74.92 -5.14 42.15 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.944 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.1 mm -120.5 138.21 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -126.6 119.66 27.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.29 139.06 18.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.6 mt -131.79 -96.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.316 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.64 55.25 3.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.53 -39.05 1.47 Allowed Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -72.27 161.42 30.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -108.52 128.55 54.9 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.866 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.2 163.01 15.81 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -92.87 125.47 37.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -78.8 122.46 84.73 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 C--N 1.357 0.974 0 C-N-CA 122.835 2.357 . . . . 0.0 110.955 179.573 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt . . . . . 0 CA--C 1.515 -0.392 0 CA-C-O 121.051 0.453 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -60.78 -37.05 80.56 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.979 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.15 -49.68 69.38 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.503 HG13 ' CD2' ' A' ' 43' ' ' HIS . 6.2 t -60.12 -41.99 88.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.62 HD13 ' HB1' ' A' ' 58' ' ' ALA . 59.8 tp -61.36 -43.5 98.76 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.07 -48.8 80.28 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.021 0.128 . . . . 0.0 111.084 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.11 -30.52 67.73 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 120.643 -0.423 . . . . 0.0 109.993 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.8 mt -64.64 -46.05 93.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.89 -41.75 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.67 -47.81 77.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -44.29 95.05 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 89.2 mmm -62.51 -37.24 85.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -69.28 -53.54 19.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 m -54.1 -48.92 70.21 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.413 0.285 . . . . 0.0 111.011 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 ptm85 -64.44 -40.02 94.94 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -64.96 -19.62 66.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -88.36 -39.53 14.26 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.663 0.385 . . . . 0.0 110.68 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -69.88 -37.32 76.0 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 117.593 0.179 . . . . 0.0 110.588 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.7 48.45 0.06 OUTLIER Glycine 0 C--N 1.342 0.88 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -140.46 53.96 1.62 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.7 p -78.89 -10.09 59.7 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.679 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -61.89 147.58 89.45 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.8 151.72 68.85 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.863 2.376 . . . . 0.0 111.647 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.3 mt -131.28 142.38 50.12 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.7 p -70.53 170.85 11.26 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -46.41 90.41 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.55 -54.65 38.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.604 0.362 . . . . 0.0 110.444 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -52.28 -35.8 51.12 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.595 0.358 . . . . 0.0 111.108 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.6 mt -67.4 -48.85 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.4 mt -59.54 -43.78 93.39 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.11 -62.21 1.78 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.524 0.329 . . . . 0.0 111.164 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.07 -50.58 70.6 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.5 p -76.64 -1.29 26.97 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.588 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 56.68 60.2 3.19 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.503 ' CD2' HG13 ' A' ' 12' ' ' VAL . 9.4 m-70 -129.35 31.37 4.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 mt -77.18 67.73 3.2 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -163.54 -40.65 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.51 ' CD1' ' H ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 18.18 -88.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.928 0 C-N-CA 125.441 1.496 . . . . 0.0 112.759 178.235 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' H ' ' CD1' ' A' ' 46' ' ' ILE . . . 132.77 160.48 9.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 107.351 -2.299 . . . . 0.0 107.351 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 tp -55.34 -43.81 75.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.756 0.778 . . . . 0.0 109.641 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -59.37 -53.37 58.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.522 0.329 . . . . 0.0 110.635 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -64.99 -57.66 8.12 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 119.669 -0.205 . . . . 0.0 111.083 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HB2' HD13 ' A' ' 46' ' ' ILE . 27.4 ttpp -48.71 -48.83 40.04 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 120.636 0.255 . . . . 0.0 110.392 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -62.5 -52.92 61.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.255 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -54.65 -49.22 71.1 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 122.286 0.235 . . . . 0.0 110.657 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 69.3 mt -56.22 -52.32 64.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 45.8 ttp -63.15 -40.78 98.55 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.2 p -114.48 27.49 9.42 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.29 -66.86 0.05 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.811 0.732 . . . . 0.0 110.749 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.743 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -64.35 -20.06 65.86 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.8 mt -121.23 21.84 11.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.201 0.455 . . . . 0.0 111.312 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.22 -41.78 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.22 -30.7 23.65 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -57.41 114.91 9.19 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.999 0.52 . . . . 0.0 109.962 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.83 -21.52 73.15 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.524 2.149 . . . . 0.0 111.786 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -80.96 0.68 34.42 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.543 -0.265 . . . . 0.0 110.714 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 mm -127.76 147.89 32.44 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -136.54 149.71 48.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.0 t -102.79 116.81 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.17 132.46 65.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 57.24 26.95 12.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.708 0.403 . . . . 0.0 110.136 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 -17.57 10.3 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -86.91 -179.63 6.55 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -116.05 137.6 51.98 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.657 0.265 . . . . 0.0 110.54 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.48 151.44 48.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -71.7 126.48 29.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -77.7 117.33 64.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.447 -1.223 0 C-N-CA 122.227 1.951 . . . . 0.0 111.426 -178.6 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -55.04 -40.57 70.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.638 0.375 . . . . 0.0 110.96 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.25 -45.06 96.04 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.72 -45.1 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.26 -42.61 98.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.049 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.96 86.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -67.96 -41.56 82.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.449 ' HA ' HG21 ' A' ' 41' ' ' THR . 35.2 mt -62.14 -45.83 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.54 -50.12 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -58.71 -43.54 90.12 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -58.56 8.02 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.9 mmm -54.36 -42.42 70.25 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -50.49 72.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 122.466 0.306 . . . . 0.0 110.505 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.7 m -61.83 -49.13 77.52 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -58.16 -45.13 88.01 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -62.14 -34.3 76.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -73.11 -16.98 61.45 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.506 0.322 . . . . 0.0 110.553 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.05 -52.15 4.85 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 122.49 0.316 . . . . 0.0 110.171 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.54 -30.73 0.11 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -75.35 78.28 2.43 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.2 p -93.92 -17.03 23.43 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.196 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -66.06 154.46 89.65 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 117.6 0.182 . . . . 0.0 111.012 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.8 156.6 63.3 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.075 2.517 . . . . 0.0 111.76 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -137.96 147.7 44.54 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 122.906 0.482 . . . . 0.0 109.772 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.0 p -63.64 170.99 2.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 109.923 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -55.85 29.56 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.81 -42.3 79.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.286 0.234 . . . . 0.0 111.25 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.81 -35.07 70.35 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.2 mt -69.76 -40.98 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.63 -41.92 82.32 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.435 ' HA ' HD11 ' A' ' 44' ' ' LEU . 31.8 t70 -50.28 -62.51 1.54 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.199 0.2 . . . . 0.0 111.011 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.4 -46.32 86.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.84 0.456 . . . . 0.0 111.671 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.449 HG21 ' HA ' ' A' ' 16' ' ' ILE . 48.1 p -75.65 -6.69 51.7 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 119.243 -0.408 . . . . 0.0 111.653 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 61.0 52.95 3.85 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.429 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.0 m-70 -129.16 36.32 4.18 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.387 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 44' ' ' LEU . 4.0 mp -69.35 -45.84 68.45 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -83.13 62.18 6.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.8 tt -101.75 146.69 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.831 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.95 136.06 48.78 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.6 tp -52.1 -39.32 59.62 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.944 0.372 . . . . 0.0 110.64 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -62.96 -40.03 96.45 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -70.02 -50.39 41.88 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -51.39 -47.15 62.99 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -60.65 -56.52 20.27 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.669 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -50.48 -46.88 57.22 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 122.795 0.438 . . . . 0.0 111.202 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 68.3 mt -56.99 -44.92 83.2 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 21.5 ttt -76.89 -34.36 57.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.2 p -101.34 -4.47 26.94 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -138.77 -74.43 0.38 Allowed 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.028 0.831 . . . . 0.0 111.567 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.83 -63.43 1.11 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.4 mt -73.07 4.04 4.8 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.4 m -116.86 6.3 7.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 CA-C-N 118.826 0.739 . . . . 0.0 110.679 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -145.81 -15.78 0.47 Allowed 'General case' 0 C--N 1.348 0.51 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.483 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -63.9 117.88 40.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.34 -25.27 77.8 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.558 2.172 . . . . 0.0 112.346 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' C ' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -76.66 -12.51 60.01 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 119.357 -0.354 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.405 HD12 ' C ' ' A' ' 64' ' ' LYS . 1.5 mp -115.33 144.68 22.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.38 130.14 51.96 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -89.15 125.73 42.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.3 mm -116.94 -108.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -82.52 55.88 3.1 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.75 -34.47 2.09 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -77.05 166.36 23.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.87 125.17 52.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.239 0.216 . . . . 0.0 110.796 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.8 172.51 6.89 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -94.79 122.71 37.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -73.95 114.94 37.55 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.447 -1.239 0 C-N-CA 122.309 2.006 . . . . 0.0 110.922 -178.191 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HB2' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -67.35 -49.7 62.96 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.327 0.251 . . . . 0.0 110.748 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.91 -47.59 87.92 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.537 HG13 ' ND1' ' A' ' 43' ' ' HIS . 2.4 t -63.9 -49.53 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 tp -56.91 -47.95 79.36 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.67 99.22 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.172 0.189 . . . . 0.0 110.711 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.91 -42.12 95.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.9 mt -60.3 -50.04 81.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 t -54.56 -44.77 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 122.411 0.285 . . . . 0.0 110.269 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -70.77 -39.0 73.47 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.321 0.105 . . . . 0.0 110.859 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -64.05 -52.98 56.83 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 96.0 mtp -61.63 -31.55 71.65 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -55.92 14.65 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.2 m -57.44 -40.33 78.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.447 ' HG3' ' CE1' ' A' ' 19' ' ' TYR . 42.4 mmt-85 -60.87 -50.82 71.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.94 0.496 . . . . 0.0 110.29 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -62.37 -22.07 65.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.447 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -88.9 16.18 7.34 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.654 0.382 . . . . 0.0 110.489 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -136.81 -47.09 0.6 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 117.611 0.187 . . . . 0.0 110.721 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 178.21 -38.64 0.08 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -73.44 76.86 1.41 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.5 p -100.77 -30.26 11.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.141 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.6 161.97 7.27 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 123.627 0.771 . . . . 0.0 111.288 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -68.81 124.6 11.65 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.201 1.934 . . . . 0.0 110.839 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.4 mt -101.24 153.86 19.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 p -69.79 167.36 17.37 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.68 -56.16 25.72 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -57.64 -40.23 78.77 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.516 -0.278 . . . . 0.0 111.621 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.0 -37.61 71.9 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 118.084 0.402 . . . . 0.0 109.982 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.3 mt -71.62 -40.62 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.69 -57.24 11.7 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.454 0.115 . . . . 0.0 111.195 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -40.83 67.83 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.189 0.196 . . . . 0.0 111.349 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.9 -3.17 37.28 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.585 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 16.7 p -120.6 0.78 10.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.105 0.412 . . . . 0.0 110.289 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 73.04 26.1 2.24 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.445 0.698 . . . . 0.0 109.132 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.585 ' CE1' ' HB ' ' A' ' 41' ' ' THR . 26.6 m170 -106.56 38.45 2.06 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' O ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -83.62 -38.75 21.17 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.51 -44.79 95.62 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.931 HG23 ' H ' ' A' ' 47' ' ' GLY . 16.3 tt 22.47 -102.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.26 1.424 . . . . 0.0 112.787 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.931 ' H ' HG23 ' A' ' 46' ' ' ILE . . . 153.05 148.94 5.02 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.3 tt -54.95 -42.15 71.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.515 0.658 . . . . 0.0 110.253 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -59.24 -51.02 71.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.416 0.286 . . . . 0.0 110.644 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -65.77 -51.32 60.08 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.273 0.229 . . . . 0.0 110.533 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -53.33 -50.48 64.9 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -58.53 -49.15 78.45 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' A' ' 9' ' ' LYS . 22.8 t90 -54.44 -50.93 66.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 79.1 mt -57.46 -47.87 80.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.3 ttt -60.17 -49.75 76.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.324 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.8 t -123.69 52.19 1.45 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.31 0.505 . . . . 0.0 112.221 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -167.58 -55.16 0.02 OUTLIER 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.255 -0.278 . . . . 0.0 110.284 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -81.92 -62.12 1.72 Allowed 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.3 mt -71.87 2.0 6.21 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.55 0.34 . . . . 0.0 111.882 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.5 t -82.5 -49.51 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -120.15 37.43 4.24 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.738 0.415 . . . . 0.0 110.14 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -74.98 133.3 75.91 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.13 -21.39 62.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.342 2.028 . . . . 0.0 111.993 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.89 10.15 13.09 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-O 119.391 -0.338 . . . . 0.0 111.851 -177.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.2 151.34 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -141.8 152.44 43.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 t -97.37 121.2 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -138.92 136.46 42.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.1 t70 56.68 26.91 11.84 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.872 0.469 . . . . 0.0 110.477 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 -20.42 6.14 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm -86.47 -167.12 1.76 Allowed 'General case' 0 C--N 1.345 0.382 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -132.42 126.91 34.23 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-O 120.918 0.39 . . . . 0.0 110.933 -176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.71 166.8 11.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.678 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -92.96 127.93 38.65 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -83.95 118.91 72.58 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.449 -1.106 0 C-N-CA 122.282 1.988 . . . . 0.0 110.565 -179.487 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt . . . . . 0 CA--C 1.505 -0.781 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -63.29 -46.44 86.73 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.049 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.83 -49.62 76.05 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 t -59.66 -47.81 89.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.8 tp -59.39 -45.19 92.15 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.91 96.69 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -64.91 -44.03 90.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.489 ' HA ' HG21 ' A' ' 41' ' ' THR . 49.2 mt -60.86 -46.94 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.13 -48.03 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 122.595 0.358 . . . . 0.0 110.048 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -61.48 -44.82 96.4 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -58.99 6.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.6 mmm -54.94 -37.69 66.76 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -45.8 92.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.2 m -60.06 -44.84 94.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -56.96 -53.18 60.9 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -61.92 -34.9 76.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.587 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -67.03 -46.78 73.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.686 -0.197 . . . . 0.0 111.05 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -71.04 -29.58 65.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 119.395 -0.335 . . . . 0.0 111.292 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.98 -20.0 0.97 Allowed Glycine 0 C--N 1.346 1.111 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.205 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -79.65 65.3 4.77 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.732 0.766 . . . . 0.0 109.747 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.0 p -78.19 -4.44 47.61 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.392 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -64.94 155.52 83.21 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 122.427 0.291 . . . . 0.0 110.725 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -69.29 155.71 66.69 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.75 2.3 . . . . 0.0 110.986 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 32' ' ' LEU . 12.7 mt -136.6 143.45 43.58 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.4 p -70.99 167.32 19.41 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -47.8 81.3 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -55.88 -52.52 63.78 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.25 0.22 . . . . 0.0 110.466 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -55.13 -37.07 66.46 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 122.433 0.293 . . . . 0.0 110.496 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -69.42 -51.92 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.5 mt -57.4 -44.84 84.89 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -52.03 -56.81 12.02 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.465 0.306 . . . . 0.0 110.916 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.33 -41.26 88.7 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.689 -0.115 . . . . 0.0 110.689 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 16' ' ' ILE . 40.9 p -82.36 7.29 14.45 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.121 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? 68.83 -11.95 0.4 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.358 0.663 . . . . 0.0 111.621 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.422 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.2 m-70 -77.35 35.51 0.18 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.745 -0.597 . . . . 0.0 111.701 -177.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -48.04 67.6 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.525 -0.734 . . . . 0.0 109.552 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -86.3 37.82 0.75 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 46' ' ' ILE . 6.7 tt -72.77 147.3 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.09 137.54 46.75 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -55.46 -32.21 62.6 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.695 0.247 . . . . 0.0 110.471 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -54.02 -38.74 65.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -86.53 -43.83 12.41 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -51.22 -48.72 62.0 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 122.39 0.276 . . . . 0.0 110.344 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -66.22 -49.43 67.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 34.8 t90 -51.36 -44.84 62.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.547 0.339 . . . . 0.0 110.615 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.3 mt -56.95 -40.99 77.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.7 mtp -85.61 -9.36 57.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.731 -0.652 . . . . 0.0 112.643 -176.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 74.5 p -136.28 20.6 3.18 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.177 0.899 . . . . 0.0 112.931 -175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 30.7 tt0 -160.93 -49.89 0.05 OUTLIER 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.973 0.806 . . . . 0.0 111.725 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.93 -76.82 0.24 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.8 mt -56.69 -31.19 64.22 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.553 0.341 . . . . 0.0 111.694 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.7 m -58.28 -21.62 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 119.58 -0.248 . . . . 0.0 111.577 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -147.5 26.57 1.04 Allowed 'General case' 0 C--N 1.346 0.423 0 CA-C-N 118.148 0.431 . . . . 0.0 110.889 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.54 126.52 92.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.01 -24.14 78.95 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.403 2.069 . . . . 0.0 112.203 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.78 5.44 28.63 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-O 119.063 -0.494 . . . . 0.0 111.677 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.9 mt -145.2 112.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.453 0 CA-C-N 118.671 0.669 . . . . 0.0 109.573 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -96.16 156.8 16.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.257 0.623 . . . . 0.0 109.456 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -103.46 140.32 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.1 mt -127.71 -112.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -80.08 61.15 3.84 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.29 -35.81 1.75 Allowed Glycine 0 CA--C 1.532 1.102 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.4 mttp -76.38 179.17 6.0 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -123.74 134.08 53.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.13 135.8 53.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -62.4 125.4 23.79 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -86.27 128.93 55.51 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 N--CA 1.449 -1.128 0 C-N-CA 122.201 1.934 . . . . 0.0 110.583 179.608 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.455 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 17.2 mtmm . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 120.754 0.311 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -57.31 -44.92 84.56 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.645 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.41 -49.77 73.82 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.0 -47.83 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.5 -46.19 89.54 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.502 0.321 . . . . 0.0 110.506 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.19 93.76 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -65.98 -39.27 90.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 mt -62.22 -46.88 95.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.38 -48.69 84.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -63.33 -38.22 90.32 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.15 -56.6 17.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.3 mtp -59.93 -35.41 74.85 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -46.14 91.86 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 m -67.59 -44.67 77.58 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 122.318 0.247 . . . . 0.0 110.397 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 47.4 ttt85 -60.02 -45.94 91.14 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -63.28 -39.66 95.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -79.42 54.8 1.79 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -165.53 -59.29 0.03 OUTLIER 'General case' 0 C--N 1.343 0.292 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.69 -44.07 0.08 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.79 74.64 2.1 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.6 p -83.71 -8.01 59.36 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -67.76 155.28 91.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.49 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 13.7 Cg_endo -73.6 160.76 43.55 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.791 2.328 . . . . 0.0 111.617 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 32' ' ' LEU . 29.5 mt -134.38 140.51 46.36 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.454 HG23 ' HD2' ' A' ' 71' ' ' LYS . 45.5 p -61.89 169.21 2.69 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.504 ' C ' HD13 ' A' ' 34' ' ' LEU . 3.4 tm? -59.03 -50.34 74.45 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -61.6 -41.29 97.22 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.696 -0.193 . . . . 0.0 111.001 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -55.5 -34.82 64.95 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -70.15 -44.05 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 mt -52.18 -36.57 52.18 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.647 0.203 . . . . 0.0 110.531 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.86 -59.99 4.4 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.615 -0.142 . . . . 0.0 110.615 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -61.94 -66.16 0.58 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.53 80.44 4.01 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -32.6 86.41 0.0 OUTLIER 'General case' 0 C--N 1.352 0.717 0 C-N-CA 125.091 1.356 . . . . 0.0 112.555 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -140.6 29.27 1.95 Allowed 'General case' 0 C--O 1.213 -0.823 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.32 -38.69 80.92 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -91.04 69.18 6.23 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.476 ' CG1' ' HB2' ' A' ' 50' ' ' GLN . 1.3 tt -94.55 -46.67 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.029 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.73 131.3 6.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.859 -1.697 . . . . 0.0 108.859 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.1 tt -51.23 -40.42 58.74 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.86 0.33 . . . . 0.0 111.207 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -56.94 -33.85 67.43 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 119.828 -0.129 . . . . 0.0 111.071 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.476 ' HB2' ' CG1' ' A' ' 46' ' ' ILE . 25.6 mt-30 -89.9 -47.45 7.87 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.435 ' HD2' HD12 ' A' ' 34' ' ' LEU . 2.6 tppt? -50.43 -52.77 34.82 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -58.87 -45.37 90.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.455 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 28.8 t90 -57.02 -54.24 48.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 88.7 mt -51.32 -45.89 62.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -60.75 -52.82 63.46 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.13 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 t -120.26 51.33 1.22 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.358 0.527 . . . . 0.0 112.137 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -166.95 -67.29 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -66.75 -60.48 2.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.16 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.5 mt -80.27 37.45 0.39 Allowed 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 122.367 0.267 . . . . 0.0 110.599 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.33 -45.84 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -112.23 -7.29 14.03 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.42 124.54 81.29 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.06 -34.84 99.02 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.745 2.297 . . . . 0.0 112.394 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -86.86 21.49 2.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 119.695 -0.193 . . . . 0.0 111.168 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.4 mm -135.64 144.29 34.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -145.92 141.48 27.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.56 136.0 29.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.8 mp -104.92 -59.01 3.59 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -160.32 77.6 0.63 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.29 -40.67 2.58 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.454 ' HD2' HG23 ' A' ' 33' ' ' THR . 3.1 mtmt -83.25 145.81 28.92 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -104.62 126.57 51.84 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 122.675 0.39 . . . . 0.0 110.617 -176.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -111.61 150.55 29.91 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -79.23 121.56 25.21 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -74.09 121.21 84.67 Favored Pre-proline 0 N--CA 1.448 -0.574 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.448 -1.154 0 C-N-CA 122.32 2.013 . . . . 0.0 110.403 -179.37 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -65.69 -42.78 90.81 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.106 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.74 -46.5 91.77 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -60.87 -46.03 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.636 HD13 ' HB1' ' A' ' 58' ' ' ALA . 61.2 tp -59.75 -45.87 90.89 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.17 86.26 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -62.77 -42.57 99.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.96 -51.67 66.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.2 t -55.91 -45.35 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -64.14 -45.16 89.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -57.35 12.84 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 96.4 mtp -55.39 -39.88 70.68 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -61.09 -50.23 74.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.5 m -59.47 -46.68 88.08 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 ttm-85 -60.65 -44.31 96.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -60.8 -35.81 77.42 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -79.95 12.75 2.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.485 0.314 . . . . 0.0 110.952 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -127.86 29.95 5.35 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 117.949 0.341 . . . . 0.0 110.478 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.29 -34.53 3.61 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -74.92 77.4 2.16 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.9 p -97.2 -3.56 40.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.799 0.44 . . . . 0.0 110.993 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -70.91 156.71 91.65 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 117.739 0.245 . . . . 0.0 110.584 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.48 156.18 64.9 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.979 2.453 . . . . 0.0 111.717 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -137.69 141.88 41.09 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 122.973 0.509 . . . . 0.0 109.643 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.8 p -63.62 168.55 4.67 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.007 0.432 . . . . 0.0 110.408 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 tt -58.28 -51.83 68.12 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -54.86 -48.45 72.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.878 0.471 . . . . 0.0 111.106 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -56.25 -34.88 66.78 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.8 mt -73.5 -46.21 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.428 ' HB3' ' H ' ' A' ' 44' ' ' LEU . 16.6 mt -46.31 -58.62 3.53 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.324 0.25 . . . . 0.0 111.048 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -46.27 -56.68 5.43 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.82 0.448 . . . . 0.0 111.913 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.79 -26.36 68.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.165 0.186 . . . . 0.0 111.445 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 28.3 p -99.12 16.94 21.11 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? 73.68 -88.84 0.02 OUTLIER 'General case' 0 C--N 1.35 0.597 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 41' ' ' THR . 23.7 m170 31.82 -109.6 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.762 0.825 . . . . 0.0 111.649 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.428 ' H ' ' HB3' ' A' ' 38' ' ' LEU . 4.5 mt 69.36 -64.71 0.33 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.901 1.28 . . . . 0.0 110.443 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.52 -68.78 0.27 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.7 tt 47.51 137.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.143 1.777 . . . . 0.0 114.305 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.21 137.59 40.66 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.9 tp -52.16 -41.85 62.94 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.217 0.508 . . . . 0.0 109.867 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -60.06 -40.58 89.99 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -66.62 -57.99 6.08 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -49.84 -48.38 51.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.919 0.488 . . . . 0.0 110.668 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -64.25 -47.34 79.97 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 38.6 t90 -57.44 -45.94 84.13 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.708 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 79.7 mt -56.22 -51.49 67.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 40.6 ttm -56.86 -54.69 43.58 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.792 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.402 ' HA ' HG21 ' A' ' 60' ' ' VAL . 6.7 t -121.15 50.3 1.39 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.227 0.467 . . . . 0.0 111.937 -174.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -170.5 -65.65 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.098 -0.376 . . . . 0.0 110.497 176.575 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.708 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -64.27 -50.02 69.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.392 0.277 . . . . 0.0 111.367 -176.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.2 mt -79.29 -29.58 42.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.599 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 56' ' ' THR . 54.6 t -73.69 139.1 19.95 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 69.17 -9.34 0.61 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.328 0.651 . . . . 0.0 111.579 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.56 125.11 78.71 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.42 -12.29 30.0 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.339 2.026 . . . . 0.0 112.05 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.01 7.45 21.55 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 118.029 0.377 . . . . 0.0 111.534 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 mm -136.23 157.34 37.6 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -147.95 144.19 27.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.06 106.59 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.4 mm -121.1 126.13 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.0 t0 59.16 19.9 7.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.815 0.446 . . . . 0.0 110.462 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.41 -29.2 7.95 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 168.86 18.79 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -104.59 124.89 50.12 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.543 0.211 . . . . 0.0 110.523 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.05 137.48 52.88 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.308 0.643 . . . . 0.0 109.334 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -66.99 126.86 30.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.44 117.91 69.63 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo . . . . . 0 N--CA 1.447 -1.225 0 C-N-CA 122.201 1.934 . . . . 0.0 109.731 178.935 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -60.27 -45.41 93.41 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 122.901 0.48 . . . . 0.0 110.205 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.44 -47.52 90.7 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.02 -45.91 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.27 -44.64 96.91 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.24 99.4 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -61.86 -48.38 80.81 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.518 ' HA ' HG21 ' A' ' 41' ' ' THR . 52.2 mt -58.26 -52.16 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.293 0.371 . . . . 0.0 110.114 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -55.73 -50.8 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.72 -43.29 94.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.249 0.22 . . . . 0.0 110.751 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -59.67 4.66 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -33.43 69.45 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -60.57 -46.65 89.44 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 m -73.23 -40.26 64.83 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.543 0.337 . . . . 0.0 110.164 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -64.41 -33.71 76.49 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.576 0.75 . . . . 0.0 109.168 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -72.71 -49.77 29.09 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -38.14 65.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.897 0.479 . . . . 0.0 110.24 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -54.13 -42.51 69.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.139 0.576 . . . . 0.0 110.884 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.72 -27.73 1.77 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.75 59.68 2.59 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.7 p -66.63 -9.09 32.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.143 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -57.43 152.04 35.38 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 122.467 0.307 . . . . 0.0 110.839 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.89 155.53 54.32 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.719 2.279 . . . . 0.0 111.331 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 32' ' ' LEU . 15.2 mt -135.19 144.01 46.75 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.4 p -73.38 175.25 7.11 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -54.0 50.77 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.6 -48.25 72.4 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.292 0.237 . . . . 0.0 110.584 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -54.34 -44.0 71.74 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.9 mt -63.61 -47.32 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.8 mt -56.99 -48.99 77.12 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -51.52 -56.93 10.68 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 123.187 0.304 . . . . 0.0 111.1 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 23' ' ' ARG . 3.0 mt-10 -58.94 -37.19 76.17 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.047 0.139 . . . . 0.0 111.144 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.518 HG21 ' HA ' ' A' ' 16' ' ' ILE . 47.7 p -86.37 6.22 31.12 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.122 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? 69.04 -10.52 0.51 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.313 0.645 . . . . 0.0 111.34 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.431 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.0 m-70 -78.06 39.15 0.3 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.65 -0.656 . . . . 0.0 111.395 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.81 -45.48 61.36 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -84.23 51.71 2.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.9 tt -90.81 148.84 4.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.22 137.16 50.45 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.7 tp -54.72 -35.76 64.01 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.322 0.249 . . . . 0.0 110.631 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -58.11 -48.88 78.85 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -68.34 -44.26 75.69 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -52.54 -49.99 63.79 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.0 -52.17 66.91 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -53.74 -50.04 66.85 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.652 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 48.3 mt -57.33 -43.25 83.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.4 ttt -66.91 -53.03 36.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -120.41 47.14 1.83 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -167.75 -56.19 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.652 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -76.67 -60.18 2.46 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.179 -0.325 . . . . 0.0 111.569 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -80.61 27.74 0.35 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.9 m -124.73 -17.28 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 117.782 0.264 . . . . 0.0 110.36 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -130.12 6.6 4.98 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 117.718 0.235 . . . . 0.0 110.692 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -70.11 127.57 92.22 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.83 -29.96 87.8 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.443 2.095 . . . . 0.0 112.224 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -94.23 21.13 7.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 119.707 -0.187 . . . . 0.0 111.484 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.81 156.48 12.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -154.2 148.76 26.29 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.19 130.76 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.9 mt -120.87 -95.9 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -83.72 51.59 2.06 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.65 -36.27 1.84 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mttp -74.07 179.13 4.56 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -114.14 126.36 54.99 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.2 138.82 50.95 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -70.06 127.32 32.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.02 120.51 81.51 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 N--CA 1.452 -0.959 0 C-N-CA 122.521 2.147 . . . . 0.0 110.775 179.226 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -68.89 -43.35 75.45 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.45 93.83 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.0 -47.92 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.614 HD13 ' HB1' ' A' ' 58' ' ' ALA . 43.1 tp -59.27 -43.92 92.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.9 97.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -59.43 -46.53 88.47 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.8 mt -61.48 -49.11 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -57.61 -46.85 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -65.68 -42.22 91.53 Favored 'General case' 0 CA--C 1.527 0.063 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -60.22 -58.41 8.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtp -55.67 -44.51 77.36 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -55.34 -45.17 76.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.534 0.334 . . . . 0.0 110.308 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.7 m -62.98 -53.93 46.32 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 119.541 -0.266 . . . . 0.0 111.134 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -64.62 -30.87 71.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.61 0.641 . . . . 0.0 109.984 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -66.41 -40.34 89.54 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -65.35 -41.97 93.33 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.63 -55.51 29.81 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 122.179 0.192 . . . . 0.0 110.507 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.3 -30.35 0.12 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -75.89 71.31 2.7 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 117.338 0.569 . . . . 0.0 109.669 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.6 p -76.51 -9.6 58.78 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -62.98 156.32 67.9 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.58 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 30.0 Cg_endo -77.85 161.88 29.95 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.682 2.255 . . . . 0.0 111.019 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.3 mt -132.74 144.86 50.56 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.9 p -60.75 167.19 2.87 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.98 -50.03 71.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.64 -49.08 79.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.863 0.465 . . . . 0.0 110.861 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -55.32 -34.08 63.88 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 58.5 mt -75.64 -50.53 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.644 ' CD2' HD11 ' A' ' 46' ' ' ILE . 8.8 mt -45.29 -54.16 7.47 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 122.691 0.397 . . . . 0.0 111.104 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -47.87 -59.34 3.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.699 0.399 . . . . 0.0 111.311 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -60.0 -37.7 80.48 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.221 0.208 . . . . 0.0 111.009 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.7 p -81.7 10.53 5.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.042 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 75.63 -61.0 0.48 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.74 0.816 . . . . 0.0 111.001 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 113.1 1.19 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -120.0 -34.09 3.8 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 122.45 0.3 . . . . 0.0 110.964 -178.678 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -94.54 -40.88 9.63 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.644 HD11 ' CD2' ' A' ' 38' ' ' LEU . 3.1 mt 55.63 -134.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.934 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.429 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -136.19 143.57 15.06 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 105.275 -3.13 . . . . 0.0 105.275 172.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -49.74 -45.36 49.26 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.23 1.015 . . . . 0.0 110.527 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -58.24 -46.57 85.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -64.3 -63.07 1.24 Allowed 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -42.77 -49.63 5.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.012 0.525 . . . . 0.0 110.966 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -65.31 -52.24 55.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.434 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 37.1 t90 -52.77 -46.03 67.38 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.822 0.449 . . . . 0.0 110.81 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.725 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 65.0 mt -57.1 -47.23 81.58 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.2 ttt -65.31 -47.2 77.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t -120.81 40.48 3.53 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 34.4 tt0 -165.72 -66.77 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.937 -0.477 . . . . 0.0 110.115 174.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.725 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -58.47 -61.07 2.86 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 -177.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.1 mt -81.46 31.7 0.34 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.338 0.255 . . . . 0.0 110.373 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.41 -40.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.41 -30.48 16.48 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.386 0.274 . . . . 0.0 110.423 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -56.1 118.98 23.64 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.88 -30.99 91.14 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.534 2.156 . . . . 0.0 112.075 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -82.22 10.77 6.23 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.234 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 mm -129.65 143.65 40.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -146.67 135.68 22.47 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 t -89.52 131.92 35.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.1 mm -104.06 -60.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -152.45 76.23 1.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.8 -40.01 2.44 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -85.71 154.31 21.72 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -107.73 132.17 53.65 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.913 0.485 . . . . 0.0 109.997 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -121.32 151.82 39.66 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 122.54 0.336 . . . . 0.0 110.196 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -75.27 120.64 21.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -80.39 123.26 83.08 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 N--CA 1.447 -1.232 0 C-N-CA 122.342 2.028 . . . . 0.0 110.512 -179.412 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 7.7 mtmm . . . . . 0 N--CA 1.461 0.115 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -62.06 -42.57 99.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.622 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.91 -51.93 53.79 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.6 t -60.64 -45.89 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.709 HD13 ' HB1' ' A' ' 58' ' ' ALA . 51.9 tp -59.63 -51.54 69.37 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.235 0.214 . . . . 0.0 110.43 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.69 -43.9 85.44 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -50.34 74.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.1 mt -59.33 -47.8 89.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 122.544 0.338 . . . . 0.0 110.285 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.5 t -58.42 -50.11 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -59.34 -47.16 86.44 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.81 -57.32 13.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 87.9 mtp -52.93 -41.21 64.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -60.66 -63.19 1.38 Allowed 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -45.95 -45.89 15.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 122.432 0.293 . . . . 0.0 110.793 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -63.45 -41.37 98.64 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -66.81 -34.12 77.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.236 0.614 . . . . 0.0 110.094 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -69.01 -36.47 77.83 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -62.78 -56.71 15.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.169 0.188 . . . . 0.0 110.725 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.35 -35.52 0.14 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -71.11 79.73 0.68 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.0 p -91.26 -19.07 23.39 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.443 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -61.78 151.71 78.25 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 117.936 0.335 . . . . 0.0 110.21 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.459 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 9.4 Cg_endo -71.86 157.11 55.75 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.771 2.314 . . . . 0.0 111.589 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.9 mt -125.19 148.32 48.67 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.5 p -59.75 168.42 1.73 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -57.7 11.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.2 -43.3 70.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.481 0.312 . . . . 0.0 111.205 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -53.02 -49.94 65.24 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.6 mt -58.34 -40.17 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 122.127 0.171 . . . . 0.0 110.666 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.52 -28.97 69.7 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 117.82 0.282 . . . . 0.0 110.434 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.48 -59.32 4.11 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -55.86 -68.57 0.19 Allowed 'General case' 0 C--N 1.347 0.47 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -78.65 85.39 4.69 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -36.92 84.4 0.0 OUTLIER 'General case' 0 C--N 1.351 0.669 0 C-N-CA 125.003 1.321 . . . . 0.0 112.735 -176.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -140.04 45.1 1.89 Allowed 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.423 ' O ' HG22 ' A' ' 46' ' ' ILE . 10.0 mt -79.77 -37.59 35.05 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.76 -43.22 99.37 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.886 HG23 ' H ' ' A' ' 47' ' ' GLY . 13.5 tt 22.85 -98.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.232 1.413 . . . . 0.0 113.022 177.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.886 ' H ' HG23 ' A' ' 46' ' ' ILE . . . 150.59 148.24 4.74 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.1 tp -54.43 -47.56 72.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.462 0.631 . . . . 0.0 110.712 -177.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -57.35 -50.95 71.32 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.166 0.186 . . . . 0.0 110.742 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -62.79 -56.51 16.85 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -48.88 -50.04 36.83 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 122.577 0.351 . . . . 0.0 110.763 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -61.77 -45.23 94.78 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.463 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 49.7 t90 -61.29 -38.05 85.38 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.762 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 71.6 mt -62.57 -46.44 88.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.4 -50.64 69.07 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.898 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.2 p -89.1 -42.14 11.88 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -102.0 -72.68 0.68 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.762 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -46.42 -64.52 0.74 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -173.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.6 mt -80.39 31.9 0.29 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.128 0.171 . . . . 0.0 111.37 -175.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.47 -47.68 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -81.42 -28.17 34.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.603 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -57.47 121.67 49.84 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.46 -18.41 62.87 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.726 2.284 . . . . 0.0 112.557 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -97.98 20.0 12.98 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.049 0.386 . . . . 0.0 110.907 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 mm -131.05 146.89 33.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 117.936 0.334 . . . . 0.0 110.115 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -137.86 136.06 36.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.14 130.47 49.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.4 mt -142.94 123.45 10.43 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.3 t70 53.79 34.54 19.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.92 0.488 . . . . 0.0 111.073 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.09 -36.31 3.32 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -72.0 163.27 28.16 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -119.25 134.01 55.44 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.375 0.27 . . . . 0.0 110.455 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -125.03 152.17 44.62 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -76.17 121.84 23.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -69.19 119.34 69.51 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo . . . . . 0 N--CA 1.448 -1.181 0 C-N-CA 122.122 1.881 . . . . 0.0 109.695 -179.708 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.4 mttm . . . . . 0 N--CA 1.472 0.662 0 CA-C-O 120.58 0.229 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -57.99 -47.6 82.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.759 0.823 . . . . 0.0 111.821 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.21 -45.25 94.11 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.9 t -59.74 -46.57 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.17 -42.82 99.47 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.14 89.59 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -66.23 -41.56 89.86 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.413 ' HA ' HG21 ' A' ' 41' ' ' THR . 50.7 mt -62.68 -47.82 91.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.25 -47.82 89.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -59.63 -47.21 86.47 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -48.22 80.88 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.634 0.373 . . . . 0.0 110.387 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 80.8 mmm -57.22 -33.12 67.21 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 122.498 0.319 . . . . 0.0 110.256 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -73.66 -62.58 1.44 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -44.98 -50.22 10.75 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.087 0.555 . . . . 0.0 111.546 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -63.13 -42.39 99.51 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.26 0.482 . . . . 0.0 109.872 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -64.55 -27.28 68.85 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.778 0.431 . . . . 0.0 109.956 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -74.44 -34.7 63.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.652 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -95.17 38.99 1.12 Allowed 'General case' 0 C--N 1.35 0.623 0 CA-C-N 118.13 0.423 . . . . 0.0 111.59 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.46 -16.5 48.99 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.185 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.3 41.76 0.71 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.489 1.145 . . . . 0.0 109.889 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.58 66.65 6.17 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -142.53 152.27 59.66 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.05 151.0 84.32 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.053 2.502 . . . . 0.0 111.91 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.3 mt -140.42 143.15 35.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.4 p -62.47 171.28 2.01 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -55.29 34.05 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -58.16 -41.88 84.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.242 0.217 . . . . 0.0 111.31 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.57 -40.78 75.79 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.0 mt -64.82 -45.73 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.5 mt -55.38 -49.04 73.34 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -49.2 -58.79 4.4 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.199 0.2 . . . . 0.0 111.081 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -61.25 -42.51 98.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.24 0.216 . . . . 0.0 111.56 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.478 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 35.5 p -75.7 -8.06 55.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 119.344 -0.36 . . . . 0.0 111.228 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 64.96 49.24 2.14 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.478 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 6.5 m-70 -130.46 39.2 3.66 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.462 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mt -73.82 -44.36 55.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.9 41.22 0.79 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 tt -79.32 -31.38 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 122.793 0.437 . . . . 0.0 110.297 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.16 138.43 10.28 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.25 -25.74 65.91 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 117.079 0.44 . . . . 0.0 111.2 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -61.11 -34.08 74.39 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -89.51 -43.85 10.54 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.693 0.397 . . . . 0.0 109.947 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -55.58 -47.74 75.95 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -57.24 -48.34 79.07 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -57.16 -54.83 42.28 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.553 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 81.0 mt -53.46 -43.13 67.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.3 ttt -70.85 -38.88 73.2 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.0 p -118.11 36.46 4.34 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -168.38 -70.33 0.02 OUTLIER 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.291 0.496 . . . . 0.0 110.539 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -60.76 -63.97 1.12 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -175.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.6 mt -79.1 28.59 0.22 Allowed 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.516 -0.115 . . . . 0.0 111.192 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.49 -40.75 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -116.16 4.86 13.65 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.37 0.268 . . . . 0.0 111.403 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.42 127.5 91.3 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.78 -30.05 91.54 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.593 2.195 . . . . 0.0 112.107 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.0 36.52 1.68 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.594 0.179 . . . . 0.0 110.733 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 tp -150.85 156.99 5.89 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.419 ' HG3' HD13 ' A' ' 68' ' ' ILE . 13.6 pt-20 -157.75 138.8 13.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.473 ' C ' HD12 ' A' ' 68' ' ' ILE . 39.9 t -87.81 108.3 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.473 HD12 ' C ' ' A' ' 67' ' ' VAL . 1.7 mp -114.96 122.53 69.26 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 53.08 36.93 23.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.693 0.397 . . . . 0.0 110.489 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.71 -32.91 3.34 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -78.61 162.01 26.56 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 117.804 0.802 . . . . 0.0 108.98 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.63 123.24 44.56 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.4 153.42 28.62 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -80.35 114.49 19.29 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.182 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -73.95 122.52 87.76 Favored Pre-proline 0 N--CA 1.446 -0.646 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo . . . . . 0 N--CA 1.446 -1.304 0 C-N-CA 122.246 1.964 . . . . 0.0 111.643 -177.372 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.469 ' HB3' ' CH2' ' A' ' 53' ' ' TRP . 13.7 mttp . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 120.649 0.262 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -53.88 -39.4 65.69 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.804 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.45 -50.23 60.64 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.7 t -64.21 -46.63 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.41 HD13 ' HB1' ' A' ' 58' ' ' ALA . 55.9 tp -61.18 -46.26 91.22 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.77 -42.45 93.33 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -58.72 -51.65 69.05 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.2 mt -55.42 -49.24 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 t -58.02 -46.14 87.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.17 -50.56 69.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.559 0.344 . . . . 0.0 110.747 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CE1' ' CD ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -60.81 -46.16 91.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.725 0.41 . . . . 0.0 110.323 -177.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.3 mmm -63.04 -47.37 83.3 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -56.73 -52.07 66.42 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.758 0.423 . . . . 0.0 110.906 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.5 m -57.5 -42.13 82.11 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.449 ' CD ' ' CE1' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -68.15 -40.51 82.37 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -62.2 -34.55 76.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -67.44 -47.18 70.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.443 0.297 . . . . 0.0 111.406 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -70.37 -35.44 73.54 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 119.143 -0.456 . . . . 0.0 111.756 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.74 -30.14 0.34 Allowed Glycine 0 C--N 1.345 1.04 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.195 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -74.52 77.58 1.95 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p -93.23 -14.23 27.33 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.826 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -61.94 149.71 85.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 117.447 0.112 . . . . 0.0 110.729 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -62.98 158.42 43.47 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.932 2.421 . . . . 0.0 111.225 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 32' ' ' LEU . 18.4 mt -138.04 142.33 40.34 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.8 p -62.11 167.83 3.71 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -50.29 74.08 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.56 -51.9 63.8 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.785 0.434 . . . . 0.0 110.826 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.09 -45.52 79.38 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.3 mt -59.39 -46.95 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.654 HD22 HD11 ' A' ' 46' ' ' ILE . 24.2 mt -59.62 -63.75 1.19 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -40.19 -58.15 1.54 Allowed 'General case' 0 C--N 1.343 0.301 0 C-N-CA 123.674 0.79 . . . . 0.0 112.452 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -57.23 -34.56 68.7 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 117.411 0.096 . . . . 0.0 111.063 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.514 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -99.3 28.77 4.3 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 67.54 -111.27 0.14 Allowed 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.514 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 3.6 m-70 46.71 -116.3 0.66 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.513 0.325 . . . . 0.0 110.536 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.4 ' H ' ' HB3' ' A' ' 38' ' ' LEU . 0.4 OUTLIER 78.44 -55.4 0.48 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.582 1.153 . . . . 0.0 111.029 175.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.57 -62.04 1.6 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.654 HD11 HD22 ' A' ' 38' ' ' LEU . 30.3 mt 66.39 -74.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 O-C-N 124.592 1.183 . . . . 0.0 111.594 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.52 124.77 1.42 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 105.166 -3.174 . . . . 0.0 105.166 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.3 tp -43.84 -42.39 5.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.536 0.668 . . . . 0.0 111.798 -175.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -51.37 -52.61 44.23 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.372 0.269 . . . . 0.0 110.333 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -69.08 -61.69 1.69 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 122.519 0.328 . . . . 0.0 110.628 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -42.13 -42.89 3.11 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.757 0.423 . . . . 0.0 110.895 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -69.45 -53.81 17.41 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.469 ' CH2' ' HB3' ' A' ' 9' ' ' LYS . 34.1 t90 -51.94 -44.78 64.06 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 122.507 0.323 . . . . 0.0 110.712 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.698 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 66.3 mt -57.07 -45.75 83.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 47.8 ttm -74.68 -37.45 62.66 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -176.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 t -106.56 6.73 30.3 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -173.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -152.46 -67.91 0.16 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.282 0.946 . . . . 0.0 111.917 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.698 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -53.01 -65.4 0.57 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -174.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.63 -48.77 71.06 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.4 m -55.74 -35.37 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 119.534 -0.27 . . . . 0.0 110.883 -177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -109.76 36.23 3.06 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -94.15 127.64 44.01 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.86 -22.86 62.9 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.32 2.013 . . . . 0.0 112.021 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -111.75 6.06 19.53 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -176.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 mt -140.81 129.21 24.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -122.98 168.96 11.66 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.4 t -98.68 131.86 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.9 mt -139.21 121.07 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.8 t70 58.46 29.94 19.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.625 0.37 . . . . 0.0 110.252 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.47 -36.54 3.22 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 168.79 15.01 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -109.12 141.98 40.53 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.5 137.51 38.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.545 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -71.59 125.96 28.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -80.17 122.07 82.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 N--CA 1.451 -1.023 0 C-N-CA 122.435 2.09 . . . . 0.0 110.766 179.501 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.417 ' HB2' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -59.62 -48.99 79.5 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.258 0.223 . . . . 0.0 110.696 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.7 -50.22 69.49 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.455 HG13 ' CD2' ' A' ' 43' ' ' HIS . 23.5 t -59.69 -49.7 82.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.53 -46.35 86.96 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.46 98.18 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -63.63 -45.68 89.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.08 -48.1 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 t -57.5 -42.81 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -73.24 -42.7 62.25 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.484 -0.135 . . . . 0.0 111.087 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -49.0 77.52 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.1 mmm -55.88 -48.49 75.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -52.39 -61.1 2.49 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 123.349 0.405 . . . . 0.0 110.6 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -54.99 -51.59 65.74 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -62.1 -38.72 89.94 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.182 0.447 . . . . 0.0 110.251 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -64.46 -37.02 86.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -82.41 43.37 0.81 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.559 0.744 . . . . 0.0 109.012 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 ttp-105 -158.6 -51.43 0.06 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.22 -38.17 0.07 OUTLIER Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.8 59.66 3.77 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.315 0.557 . . . . 0.0 110.012 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.62 -3.53 59.05 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.456 ' NE2' HD21 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -67.15 154.37 92.8 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 122.651 0.38 . . . . 0.0 110.635 -179.664 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.99 120.67 7.95 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.104 1.869 . . . . 0.0 110.121 176.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.4 mt -100.76 149.44 23.81 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.0 p -76.59 170.87 15.62 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -53.32 59.63 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -58.14 -43.56 87.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.22 0.208 . . . . 0.0 111.057 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -56.62 -41.77 77.68 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.2 mt -63.97 -49.68 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.9 mt -53.76 -55.73 23.7 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -45.79 -59.11 2.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.787 0.435 . . . . 0.0 111.442 -177.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.38 -38.74 84.86 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.404 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 33.3 p -81.41 -1.33 45.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.072 0.396 . . . . 0.0 111.159 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 65.54 44.91 2.89 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.455 ' CD2' HG13 ' A' ' 12' ' ' VAL . 8.2 m-70 -127.6 28.8 5.59 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.22 -44.33 75.98 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.93 55.88 2.91 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.0 tt -99.89 148.17 6.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 122.711 0.404 . . . . 0.0 110.001 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.62 141.99 41.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -57.29 -24.95 58.23 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 117.064 0.432 . . . . 0.0 111.289 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -64.87 -50.97 64.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -69.49 -43.68 72.64 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -53.68 -50.57 65.54 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 -62.45 -48.13 81.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.98 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.468 ' CE2' ' HB2' ' A' ' 58' ' ' ALA . 28.8 t90 -54.38 -50.89 66.44 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.685 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 52.1 mt -55.16 -49.34 72.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.7 ttt -63.69 -48.07 78.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -124.96 50.24 1.77 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.726 0.694 . . . . 0.0 112.554 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -172.77 -61.88 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -65.61 -67.02 0.47 Allowed 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.463 -0.148 . . . . 0.0 111.155 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.85 -48.35 82.21 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.351 0.26 . . . . 0.0 111.523 -175.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 m -53.74 -38.75 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -89.12 -25.11 22.04 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 117.797 0.271 . . . . 0.0 110.916 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.45 117.58 28.81 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -63.81 -35.4 56.91 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.633 2.222 . . . . 0.0 111.882 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.83 -26.61 64.31 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.902 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.09 95.2 3.62 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -91.97 157.95 16.53 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.7 t -96.21 136.53 26.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.1 mm -115.8 -114.07 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.19 62.47 6.66 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.87 1.96 60.24 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -117.72 -179.98 3.9 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -114.67 129.58 56.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.654 0.264 . . . . 0.0 110.51 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.5 146.09 48.34 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.45 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -87.66 125.23 34.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -81.3 121.32 80.14 Favored Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo . . . . . 0 N--CA 1.449 -1.101 0 C-N-CA 122.398 2.065 . . . . 0.0 111.124 -179.056 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.73 -39.92 95.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.353 0.261 . . . . 0.0 110.505 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.23 -50.42 65.23 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.9 t -62.78 -44.09 99.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.67 -49.42 77.63 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.95 86.09 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.34 -44.53 96.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.21 -49.29 84.71 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.1 t -53.45 -45.47 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.63 -45.63 82.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.232 0.213 . . . . 0.0 111.228 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -40.26 94.17 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -41.74 87.58 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -58.31 8.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -63.4 -48.44 77.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.847 0.459 . . . . 0.0 112.029 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HE ' ' CB ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -66.47 -35.04 79.3 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.309 0.504 . . . . 0.0 110.272 -177.395 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -66.29 -39.3 89.27 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -78.52 53.19 1.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.45 -50.13 0.09 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.76 -29.59 0.17 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.402 ' CB ' ' HE ' ' A' ' 23' ' ' ARG . 62.6 m-20 -75.39 60.2 1.13 Allowed 'General case' 0 C--N 1.343 0.314 0 C-N-CA 122.966 0.506 . . . . 0.0 110.125 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.5 p -87.87 57.5 4.37 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -137.58 154.77 75.3 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.56 150.76 83.87 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.927 2.418 . . . . 0.0 112.32 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 32' ' ' LEU . 16.1 mt -138.37 142.92 39.64 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.3 p -63.25 169.44 3.58 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 34' ' ' LEU . 3.2 tt -60.88 -51.88 67.43 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -59.92 -41.34 91.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 119.675 -0.202 . . . . 0.0 110.655 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -56.93 -39.3 74.25 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 mt -67.0 -47.69 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.8 mt -52.0 -47.41 64.93 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HA ' HD11 ' A' ' 44' ' ' LEU . 27.1 t70 -50.58 -56.77 10.22 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.33 0.252 . . . . 0.0 111.331 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -66.71 -45.06 79.97 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.416 HG22 ' NE2' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -75.13 -4.82 40.93 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.93 0.332 . . . . 0.0 110.934 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 63.2 50.22 3.08 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.416 ' NE2' HG22 ' A' ' 41' ' ' THR . 6.8 m-70 -130.9 45.77 2.77 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' H ' HD12 ' A' ' 44' ' ' LEU . 5.1 mp -77.59 -42.35 35.41 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -84.74 27.72 0.72 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 tt -63.26 -32.88 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 122.766 0.427 . . . . 0.0 110.456 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.76 137.73 9.93 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -59.11 -26.4 64.65 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.996 0.398 . . . . 0.0 110.99 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -61.17 -34.11 74.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -89.41 -47.42 8.03 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -57.41 -45.03 85.0 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.77 -49.17 76.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.458 ' CZ3' ' HB2' ' A' ' 9' ' ' LYS . 27.6 t90 -58.92 -50.84 72.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.72 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 66.8 mt -54.29 -42.25 69.82 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 122.104 -0.373 . . . . 0.0 110.237 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 21.7 ttt -64.12 -60.46 3.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -174.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.504 ' HA ' HG21 ' A' ' 60' ' ' VAL . 5.7 t -105.55 -3.34 22.49 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -117.74 -67.46 0.99 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.051 0.841 . . . . 0.0 111.214 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.72 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -61.01 -69.08 0.25 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.3 mt -57.94 -33.64 69.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.45 0.3 . . . . 0.0 111.077 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' A' ' 56' ' ' THR . 48.0 t -63.58 -36.55 76.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -111.75 46.85 1.08 Allowed 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -118.23 115.91 35.91 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -66.78 -4.75 11.73 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.734 2.289 . . . . 0.0 112.853 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 4.51 17.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.404 0.547 . . . . 0.0 111.182 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.23 142.16 39.42 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.87 137.58 48.1 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.91 125.96 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.6 mt -137.54 116.6 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t0 54.31 45.49 27.13 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.687 0.395 . . . . 0.0 110.082 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.03 -41.72 2.24 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -69.5 169.99 11.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.106 0.453 . . . . 0.0 109.989 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.85 125.54 54.12 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 122.524 0.33 . . . . 0.0 110.129 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.84 127.93 56.2 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.061 0.545 . . . . 0.0 110.208 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -63.4 121.02 12.77 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -77.65 115.69 51.93 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 N--CA 1.449 -1.143 0 C-N-CA 122.264 1.976 . . . . 0.0 110.956 -178.066 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -75.52 -47.8 25.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 119.015 0.825 . . . . 0.0 109.637 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.93 -44.46 97.79 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.3 -43.92 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.1 tp -59.07 -47.22 86.01 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.31 -43.19 92.68 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -61.31 -43.48 98.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.7 mt -61.3 -45.65 98.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 t -58.15 -48.09 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -61.79 -42.44 99.0 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -58.32 9.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.8 ttm -55.61 -37.68 68.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 122.615 0.366 . . . . 0.0 110.442 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -60.99 -48.77 80.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.2 m -62.39 -44.68 95.86 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.425 ' HE ' ' CB ' ' A' ' 28' ' ' ASP . 3.1 ttt85 -61.48 -47.49 85.42 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.784 0.326 . . . . 0.0 110.273 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -63.18 -54.29 39.88 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.044 0.538 . . . . 0.0 109.834 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -58.63 -32.98 69.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.979 0.512 . . . . 0.0 110.447 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -66.63 -52.55 43.9 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.75 -34.31 0.1 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.775 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.425 ' CB ' ' HE ' ' A' ' 23' ' ' ARG . 5.4 m-20 -76.14 69.67 2.72 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 117.583 0.692 . . . . 0.0 109.825 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.1 p -77.32 -14.89 59.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.644 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -61.62 154.34 66.11 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 122.402 0.281 . . . . 0.0 110.711 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.24 157.62 52.99 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.598 2.198 . . . . 0.0 110.84 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 32' ' ' LEU . 17.2 mt -135.91 147.63 48.21 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.0 p -70.77 171.23 10.9 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.455 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -60.2 -54.93 39.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.69 -52.07 57.58 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.354 0.262 . . . . 0.0 110.641 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -51.68 -37.49 50.86 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 122.165 0.186 . . . . 0.0 110.545 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.0 mt -69.41 -48.51 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.5 mt -53.62 -52.03 61.18 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 117.537 0.153 . . . . 0.0 110.798 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.64 -65.12 0.51 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 122.934 0.494 . . . . 0.0 111.679 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.64 -46.15 81.16 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.34 0.256 . . . . 0.0 111.426 -177.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.453 HG22 ' NE2' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -71.98 -6.19 40.34 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.002 -178.872 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 67.94 41.55 2.07 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 122.899 0.48 . . . . 0.0 109.99 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.453 ' NE2' HG22 ' A' ' 41' ' ' THR . 7.2 m-70 -127.68 33.87 4.74 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -49.18 73.65 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.22 38.72 0.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 tt -72.1 149.62 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.11 133.41 37.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.7 tp -54.29 -35.3 62.45 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.363 0.265 . . . . 0.0 110.409 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -54.56 -46.29 73.63 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -70.2 -48.66 56.15 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -49.99 -44.13 50.8 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -69.24 -54.59 13.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.405 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 15.1 t90 -50.85 -40.14 55.34 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.709 0.404 . . . . 0.0 110.881 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.3 -39.8 88.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 73.0 mtm -89.96 -0.87 57.82 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.239 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.5 p -132.4 17.23 4.44 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.765 0.711 . . . . 0.0 111.888 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 16.1 tp10 -166.79 -70.77 0.03 OUTLIER 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.447 0.567 . . . . 0.0 111.038 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.45 -80.09 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -174.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 mt -59.29 -20.99 58.96 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 122.564 -0.085 . . . . 0.0 111.001 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 96.8 t -68.0 -40.74 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.575 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.66 54.57 1.18 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 117.844 0.293 . . . . 0.0 111.607 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -101.9 135.18 19.76 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -51.2 -44.99 39.53 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.655 2.237 . . . . 0.0 112.682 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -83.3 8.81 12.37 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -176.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.4 mm -123.88 150.85 28.45 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 118.091 0.405 . . . . 0.0 109.926 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -134.69 138.55 44.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.2 t -96.93 121.25 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -134.39 130.67 54.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 52.43 31.82 10.31 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 123.464 0.478 . . . . 0.0 111.196 176.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.42 -17.25 20.08 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -87.66 -173.25 4.24 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -127.49 137.36 52.64 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.19 154.18 51.4 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -77.3 125.68 29.71 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -73.94 116.97 57.36 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 N--CA 1.448 -1.198 0 C-N-CA 122.427 2.085 . . . . 0.0 110.94 179.821 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.1 tttp . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.8 -48.73 65.48 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.033 0.533 . . . . 0.0 110.68 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.63 -43.28 99.16 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.84 -50.35 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.51 -45.29 94.36 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.59 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.68 96.29 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -57.43 -48.82 78.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.529 ' HA ' HG21 ' A' ' 41' ' ' THR . 62.8 mt -59.7 -50.24 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.392 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 t -55.9 -48.69 78.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -62.15 -45.17 94.6 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.074 0.15 . . . . 0.0 110.66 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.432 ' CE1' ' HG3' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -59.04 -55.27 37.22 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 ttt -62.86 -35.83 81.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -60.86 -55.14 36.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 m -62.02 -43.01 99.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.432 ' HG3' ' CE1' ' A' ' 19' ' ' TYR . 14.3 mmt180 -56.26 -50.2 72.01 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.824 0.45 . . . . 0.0 109.905 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -63.81 -38.76 92.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -83.82 48.74 1.49 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -162.79 -50.14 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.1 -31.95 0.12 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -81.19 60.29 4.25 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.069 0.434 . . . . 0.0 110.175 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -6.32 59.13 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -70.12 155.13 93.96 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -70.02 147.11 60.46 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.73 2.287 . . . . 0.0 111.957 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 32' ' ' LEU . 19.3 mt -134.55 144.91 48.26 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.477 0.711 . . . . 0.0 109.447 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -64.52 173.65 2.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.013 0.435 . . . . 0.0 110.027 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -58.3 9.15 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.644 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -59.06 -38.5 79.55 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 119.599 -0.238 . . . . 0.0 111.411 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.25 -39.53 79.41 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.419 ' CG2' HG23 ' A' ' 16' ' ' ILE . 51.2 mt -68.43 -42.58 84.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 mt -59.8 -46.66 88.5 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.676 -0.12 . . . . 0.0 110.676 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -48.52 -59.48 3.46 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.645 0.378 . . . . 0.0 111.059 -177.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -56.84 -42.37 79.52 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.386 0.274 . . . . 0.0 111.077 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 16' ' ' ILE . 47.0 p -80.19 4.69 16.69 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.876 -0.583 . . . . 0.0 111.213 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? 72.45 -15.37 0.49 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.846 0.858 . . . . 0.0 111.618 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -78.18 42.73 0.42 Allowed 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 118.409 0.55 . . . . 0.0 111.285 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.38 -45.59 54.0 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.67 -0.644 . . . . 0.0 109.421 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.11 -55.14 31.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 47' ' ' GLY . 4.0 tt 34.74 -132.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.095 0.958 . . . . 0.0 110.533 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 46' ' ' ILE . . . -154.35 151.21 22.92 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tt -56.17 -44.55 79.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.542 0.671 . . . . 0.0 110.493 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -59.73 -45.77 91.17 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.163 0.185 . . . . 0.0 110.628 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.1 -48.8 61.6 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -52.37 -48.51 65.55 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -63.19 -48.03 80.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.421 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 26.5 t90 -53.78 -46.03 70.89 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.459 0.304 . . . . 0.0 110.405 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 62.8 mt -61.86 -40.72 96.35 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 40.0 ttm -76.13 -26.86 56.74 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.2 t -118.81 -8.05 10.38 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -174.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.421 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 26.8 tt0 -132.9 -49.09 0.87 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.152 0.887 . . . . 0.0 112.404 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -79.2 -63.52 1.4 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -174.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.0 mt -80.36 2.49 24.65 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -173.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -73.83 -93.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.773 0.715 . . . . 0.0 109.422 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -83.96 51.61 2.09 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -80.85 135.01 52.43 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.113 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -64.82 -25.02 60.75 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.112 1.875 . . . . 0.0 111.266 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -108.8 1.34 20.91 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 119.011 -0.518 . . . . 0.0 112.037 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.36 134.5 22.93 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 118.776 0.716 . . . . 0.0 110.014 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -115.89 157.38 24.57 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 68' ' ' ILE . 17.7 t -100.62 126.79 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.592 HD12 ' C ' ' A' ' 67' ' ' VAL . 3.5 mp -135.42 121.43 31.52 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t0 51.53 46.96 25.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.823 0.449 . . . . 0.0 110.455 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.81 -39.49 2.0 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -73.16 176.29 6.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -117.49 153.0 33.9 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB3' HD13 ' A' ' 68' ' ' ILE . . . -144.19 139.07 28.53 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -64.82 133.86 52.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -90.14 115.92 65.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.112 0.565 . . . . 0.0 110.187 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.447 -1.226 0 C-N-CA 122.338 2.025 . . . . 0.0 110.135 179.26 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.436 ' HG3' ' CH2' ' A' ' 53' ' ' TRP . 5.6 pttt . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 119.744 -0.169 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -68.59 -47.4 66.84 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.103 0.41 . . . . 0.0 110.543 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.73 -36.11 88.63 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.467 HG13 ' CD2' ' A' ' 43' ' ' HIS . 14.1 t -72.69 -49.81 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.3 tp -57.69 -40.91 80.52 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.77 0.428 . . . . 0.0 110.775 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.14 -49.49 77.66 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -62.55 -38.94 92.0 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.46 HG23 HG21 ' A' ' 37' ' ' ILE . 41.1 mt -60.84 -49.0 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.53 -47.92 86.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -65.77 -40.32 91.91 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.424 ' CE1' ' HG2' ' A' ' 40' ' ' GLU . 1.8 t80 -60.17 -56.65 18.96 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.524 0.33 . . . . 0.0 110.27 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -40.66 86.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -55.84 -47.39 77.33 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -63.37 -47.61 81.39 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.395 0.278 . . . . 0.0 110.921 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' A' ' 28' ' ' ASP . 2.2 mtp180 -58.55 -48.72 79.95 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -60.2 -40.26 89.48 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -61.85 -42.74 99.42 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -65.82 -45.65 81.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.461 0.304 . . . . 0.0 110.311 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.91 -20.83 0.3 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.407 ' CG ' HH21 ' A' ' 23' ' ' ARG . 14.9 t70 -79.83 68.78 6.02 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -87.53 -5.69 58.67 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.979 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -64.22 148.46 95.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 O-C-N 122.329 -0.232 . . . . 0.0 110.436 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.08 146.67 86.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.038 2.492 . . . . 0.0 112.251 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.2 mt -134.78 136.53 42.65 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.6 p -63.12 169.91 3.16 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.059 0.457 . . . . 0.0 110.049 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tt -58.35 -51.44 69.79 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -58.14 -44.75 87.99 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.59 0.356 . . . . 0.0 110.99 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -56.59 -30.43 63.19 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.46 HG21 HG23 ' A' ' 16' ' ' ILE . 49.4 mt -78.3 -42.99 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.3 mt -55.26 -43.58 74.78 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -49.47 -50.08 42.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.381 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG2' ' CE1' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -77.28 -49.8 14.25 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.204 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 16' ' ' ILE . 54.5 p -69.08 -3.49 13.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.251 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 65.47 45.95 2.65 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.467 ' CD2' HG13 ' A' ' 12' ' ' VAL . 7.1 m-70 -125.57 42.29 3.32 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.413 ' H ' HD12 ' A' ' 44' ' ' LEU . 4.6 mp -74.57 -49.7 20.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.59 42.53 0.91 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.4 tt -72.82 -36.13 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 122.816 0.446 . . . . 0.0 110.309 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.69 132.19 6.78 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.9 -36.21 62.45 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.821 0.311 . . . . 0.0 110.368 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -50.13 -44.09 52.16 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -78.25 -46.9 19.11 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.484 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -50.61 -49.67 55.99 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -48.95 78.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.436 ' CH2' ' HG3' ' A' ' 9' ' ' LYS . 12.8 t90 -55.76 -53.27 58.74 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 78.0 mt -54.95 -44.02 73.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -53.09 61.82 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.303 -175.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' HG21 ' A' ' 60' ' ' VAL . 7.1 t -120.15 48.18 1.62 Allowed 'General case' 0 C--N 1.348 0.541 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -175.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -165.75 -66.11 0.03 OUTLIER 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -64.5 -69.39 0.29 Allowed 'General case' 0 C--O 1.224 -0.267 0 O-C-N 122.904 0.127 . . . . 0.0 111.168 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.7 mt -59.72 -25.28 64.7 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.416 0.286 . . . . 0.0 111.088 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.439 HG21 ' HA ' ' A' ' 56' ' ' THR . 46.5 t -75.2 -47.89 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -102.26 66.02 0.98 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -143.89 118.55 6.07 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.36 -23.3 74.25 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.602 2.202 . . . . 0.0 112.285 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -93.87 12.35 26.22 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 117.793 0.27 . . . . 0.0 110.95 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mm -135.68 152.02 30.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -144.8 142.37 29.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.7 t -96.06 127.5 48.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.049 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.7 mm -112.59 -120.97 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -81.02 67.51 6.95 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.19 -36.86 1.96 Allowed Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -75.25 169.25 18.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 117.111 0.455 . . . . 0.0 109.999 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -112.47 120.81 42.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.48 134.59 51.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -64.47 135.03 55.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -97.23 118.27 64.77 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo . . . . . 0 N--CA 1.448 -1.203 0 C-N-CA 122.311 2.007 . . . . 0.0 110.24 179.619 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.44 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 120.597 0.236 . . . . 0.0 110.502 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -58.11 -37.45 74.58 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 122.868 0.467 . . . . 0.0 111.383 -175.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.48 -48.17 76.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.06 -41.97 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.728 HD13 ' HB1' ' A' ' 58' ' ' ALA . 62.6 tp -60.82 -47.55 85.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.91 -44.14 91.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -60.7 -47.33 86.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.32 -49.66 82.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.8 t -55.68 -43.8 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 122.663 0.385 . . . . 0.0 110.152 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -65.11 -48.22 74.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -50.25 73.03 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.3 mmm -55.73 -45.54 77.94 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -43.02 87.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.6 m -61.27 -51.36 69.24 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 119.422 -0.323 . . . . 0.0 111.285 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.65 -34.4 78.13 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.857 0.753 . . . . 0.0 109.691 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -65.37 -35.37 80.75 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -69.74 -42.35 74.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.078 0.551 . . . . 0.0 110.436 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -65.75 -36.19 82.85 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.69 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.99 -23.37 0.6 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-O 119.695 -0.503 . . . . 0.0 111.935 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.74 66.68 2.71 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.651 0.726 . . . . 0.0 109.658 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.2 p -76.42 -4.16 40.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.079 0.152 . . . . 0.0 110.676 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -66.03 156.14 85.06 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -70.32 162.46 42.26 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.708 2.272 . . . . 0.0 110.881 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.2 mt -138.65 150.28 46.06 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 177.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.3 p -77.88 167.94 20.71 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -44.83 92.5 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.0 -54.45 46.63 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -54.58 -43.03 71.74 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 122.582 0.353 . . . . 0.0 110.339 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.2 mt -59.13 -62.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.2 mt -54.81 -42.34 71.72 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.162 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -52.1 -54.91 24.63 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -64.05 -31.99 73.38 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.02 13.79 5.68 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 74.44 -58.51 0.58 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 124.312 1.045 . . . . 0.0 112.592 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.76 77.75 0.45 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.615 0.366 . . . . 0.0 111.944 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.94 -33.98 51.37 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 47' ' ' GLY . 19.4 t70 -68.98 -55.37 11.1 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 tt 50.26 -70.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.675 1.59 . . . . 0.0 112.693 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 45' ' ' ASP . . . 142.46 126.34 2.09 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.5 tp -46.81 -44.96 19.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.261 0.53 . . . . 0.0 111.238 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.6 -39.21 61.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.196 0.198 . . . . 0.0 111.244 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -87.97 -48.05 8.08 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -48.11 -48.84 33.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.118 0.567 . . . . 0.0 110.495 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.39 -47.43 76.33 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.44 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 31.2 t90 -55.8 -40.27 72.46 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 122.376 0.27 . . . . 0.0 110.425 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.731 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 77.5 mt -58.66 -49.0 79.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 83.1 mtp -64.84 -47.98 75.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.279 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.5 p -110.32 34.35 3.97 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -173.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -168.17 -75.17 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.738 0.699 . . . . 0.0 110.681 177.951 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.731 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -52.49 -53.78 41.24 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.7 mt -79.92 -20.1 46.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.756 -0.164 . . . . 0.0 111.041 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.89 -69.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.95 60.13 5.7 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -107.44 122.81 40.05 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.128 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -63.48 -19.6 68.15 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.247 1.964 . . . . 0.0 111.845 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -125.86 19.69 7.8 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.1 mt -146.0 129.69 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -111.46 154.12 25.15 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.3 t -105.93 144.29 15.58 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.0 mt -126.52 -125.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.51 65.04 3.71 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.29 -37.34 2.57 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 171.31 14.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -122.99 147.69 46.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.94 136.51 33.9 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -66.71 130.23 42.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -77.42 129.84 76.23 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.452 -0.937 0 C-N-CA 122.651 2.234 . . . . 0.0 112.188 -177.644 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.18 57.71 3.69 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.3 p -81.08 -35.87 31.16 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.118 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.58 -62.09 5.37 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.5 t -165.18 -170.18 1.84 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.7 m -152.77 97.0 2.18 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.05 -47.68 0.02 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -53.8 123.62 12.92 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.44 ' HB3' ' CH2' ' A' ' 53' ' ' TRP . 17.7 mtmt 74.93 -59.9 0.53 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.066 0.947 . . . . 0.0 110.716 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -56.38 -51.85 66.77 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.775 -173.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.38 -49.77 74.92 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.646 HG13 ' CD2' ' A' ' 43' ' ' HIS . 3.3 t -58.81 -45.73 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.463 HD13 ' HB1' ' A' ' 58' ' ' ALA . 55.9 tp -61.28 -45.5 94.23 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -38.0 82.58 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -69.4 -38.34 77.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.21 -48.85 85.62 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.59 -48.35 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -60.66 -43.71 97.3 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -60.73 -57.48 12.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 95.4 mtp -55.86 -40.84 73.48 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -59.35 -48.3 82.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.6 m -66.45 -51.18 59.61 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.124 0.17 . . . . 0.0 110.771 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -59.18 -36.7 75.78 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -68.56 -41.81 79.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -58.26 -48.34 80.73 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.871 0.468 . . . . 0.0 111.386 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -65.25 -33.38 75.84 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.73 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.25 -31.05 0.48 Allowed Glycine 0 C--N 1.346 1.085 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.627 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.95 70.2 2.65 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 117.95 0.875 . . . . 0.0 109.956 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.2 p -79.58 -4.16 50.25 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -61.89 155.71 60.99 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 122.662 0.385 . . . . 0.0 110.793 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -67.4 158.51 56.7 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.613 2.208 . . . . 0.0 110.622 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 32' ' ' LEU . 12.1 mt -137.06 140.34 41.95 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.6 p -64.72 167.59 7.2 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.51 -48.92 79.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.68 -49.76 74.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.534 0.334 . . . . 0.0 110.924 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -52.58 -36.11 55.43 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.62 -45.29 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.2 mt -47.97 -57.84 5.21 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 117.852 0.296 . . . . 0.0 110.669 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.99 -63.86 0.88 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.934 0.494 . . . . 0.0 111.577 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -59.95 -27.17 66.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.494 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 67.4 p -93.32 -0.99 56.47 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.491 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 66.6 41.15 3.16 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.846 0.458 . . . . 0.0 109.961 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.646 ' CD2' HG13 ' A' ' 12' ' ' VAL . 7.9 m-70 -129.72 44.13 3.02 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.414 ' O ' HG22 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -76.74 -51.28 11.71 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.07 -39.85 91.46 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.894 HG23 ' H ' ' A' ' 47' ' ' GLY . 18.5 tt 26.28 -105.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.866 1.266 . . . . 0.0 112.325 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.894 ' H ' HG23 ' A' ' 46' ' ' ILE . . . 157.34 148.84 5.24 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 108.04 -2.024 . . . . 0.0 108.04 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.4 tp -53.9 -39.97 66.23 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 117.397 0.599 . . . . 0.0 110.676 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -55.86 -58.92 5.82 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.227 0.211 . . . . 0.0 110.553 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.11 -50.14 62.53 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-O 119.513 -0.279 . . . . 0.0 110.395 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -46.01 -51.12 14.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.556 0.342 . . . . 0.0 110.47 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -64.53 -47.44 78.79 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.44 ' CH2' ' HB3' ' A' ' 9' ' ' LYS . 39.6 t90 -56.6 -41.53 77.17 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.381 0.272 . . . . 0.0 110.67 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 80.4 mt -61.07 -45.53 94.35 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 5.0 mmt -66.83 -47.18 72.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.729 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.3 p -110.91 33.39 4.61 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -173.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.45 -67.39 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.821 0.737 . . . . 0.0 111.092 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -63.58 -62.33 1.73 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.3 mt -79.71 27.93 0.28 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.88 -38.8 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -88.21 -30.54 19.64 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -60.8 120.71 55.81 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.22 -36.89 54.63 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.661 2.241 . . . . 0.0 112.183 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -66.77 -20.51 65.96 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 119.678 -0.201 . . . . 0.0 110.921 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.8 mm -92.5 117.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -106.59 122.57 46.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.7 t -83.56 121.36 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.1 mt -115.96 -98.66 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 71' ' ' LYS . 21.0 t0 -82.47 52.81 2.15 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.76 -33.01 1.43 Allowed Glycine 0 CA--C 1.534 1.265 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 69' ' ' ASP . 48.1 mttp -77.8 176.51 8.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.228 0.611 . . . . 0.0 109.542 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -109.1 129.25 55.47 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.489 0.185 . . . . 0.0 110.729 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.15 172.32 8.34 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -97.11 148.14 23.33 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -104.02 106.96 55.52 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.778 0.431 . . . . 0.0 111.799 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -81.99 -52.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.75 2.3 . . . . 0.0 110.644 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -53.89 152.01 6.02 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.202 1.001 . . . . 0.0 112.726 -174.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 17.4 p90 36.15 49.22 0.61 Allowed 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.001 1.32 . . . . 0.0 111.847 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -164.6 -49.69 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.46 151.32 26.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 116.726 -1.606 . . . . 0.0 109.129 179.408 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 tt -155.68 -64.79 0.12 Allowed 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m 53.62 68.17 0.89 Allowed 'General case' 0 C--N 1.344 0.331 0 C-N-CA 122.646 0.378 . . . . 0.0 110.275 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.25 57.16 4.4 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.4 t 61.26 -173.1 0.14 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.991 0.516 . . . . 0.0 110.903 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.0 t -177.16 155.42 1.15 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.46 55.4 0.54 Allowed Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -157.54 99.5 1.74 Allowed 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HG3' ' CH2' ' A' ' 53' ' ' TRP . 1.5 ptmt 82.62 -47.36 0.16 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.689 0.796 . . . . 0.0 108.899 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -69.32 -46.34 67.33 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.73 -49.86 67.45 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.24 -45.4 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 117.015 0.407 . . . . 0.0 110.224 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.63 -37.87 76.85 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.27 74.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -61.98 -50.21 73.01 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.504 ' HA ' HG21 ' A' ' 41' ' ' THR . 96.1 mt -57.76 -55.83 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.228 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 t -56.6 -44.4 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.144 0.178 . . . . 0.0 110.98 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -65.86 -52.19 52.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.57 0.168 . . . . 0.0 111.152 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -46.81 88.4 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 66.9 mmm -53.6 -48.79 68.94 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.92 -66.62 0.37 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 122.51 0.324 . . . . 0.0 110.71 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 m -52.55 -45.61 66.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.661 0.384 . . . . 0.0 111.999 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.513 HH21 HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -73.27 -24.36 60.43 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 122.253 -0.279 . . . . 0.0 111.06 -176.501 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -78.33 -39.13 40.5 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -62.04 -40.37 95.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -52.64 -54.14 37.41 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 122.497 0.319 . . . . 0.0 110.341 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.4 -22.31 0.25 Allowed Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -82.06 46.38 1.01 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 117.621 0.711 . . . . 0.0 110.006 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.74 -5.13 7.81 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.65 0.78 . . . . 0.0 111.291 -179.045 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.446 ' CE1' HD21 ' A' ' 32' ' ' LEU . 2.3 p-80 -54.88 153.42 11.41 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 122.446 0.298 . . . . 0.0 111.042 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.23 153.6 58.09 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.764 2.309 . . . . 0.0 111.08 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.513 HD11 HH21 ' A' ' 23' ' ' ARG . 16.2 mt -132.16 142.84 49.61 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.0 p -71.9 172.14 10.46 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -48.83 78.61 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.09 -52.39 61.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.89 0.476 . . . . 0.0 110.996 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -51.83 -42.32 62.46 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 122.468 0.307 . . . . 0.0 110.832 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.45 -57.75 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.582 ' CD1' HD11 ' A' ' 46' ' ' ILE . 89.5 mt -51.87 -39.95 59.79 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.255 0.222 . . . . 0.0 111.43 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -55.39 -52.84 62.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.722 -0.103 . . . . 0.0 110.722 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -75.44 -37.48 60.35 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.127 0.171 . . . . 0.0 110.967 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 16' ' ' ILE . 71.0 p -87.26 91.95 8.9 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -26.47 72.71 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.554 1.941 . . . . 0.0 115.592 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 41' ' ' THR . 1.3 p80 -178.58 58.12 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.89 56.68 4.08 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -162.21 -45.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER 40.88 -89.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.597 0 C-N-CA 124.821 1.248 . . . . 0.0 112.3 177.599 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 140.11 168.95 11.51 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 107.166 -2.373 . . . . 0.0 107.166 -175.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.28 -49.37 77.38 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.65 0.725 . . . . 0.0 110.151 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -52.36 -55.7 19.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.312 0.245 . . . . 0.0 111.117 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -66.96 -58.58 4.68 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.282 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.606 ' HB2' HD12 ' A' ' 46' ' ' ILE . 24.6 ttpp -48.94 -42.91 38.98 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 118.033 0.379 . . . . 0.0 110.7 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -68.15 -56.78 7.54 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.412 ' CH2' ' HG3' ' A' ' 9' ' ' LYS . 23.3 t90 -52.58 -52.6 54.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 123.151 0.282 . . . . 0.0 110.625 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 76.8 mt -57.07 -49.93 74.32 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.19 0.196 . . . . 0.0 110.762 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 59.2 ttm -62.09 -57.66 10.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -174.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -109.78 16.86 21.77 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -138.84 -54.21 0.59 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.432 1.015 . . . . 0.0 111.295 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.54 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -75.68 -64.76 1.01 Allowed 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -173.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.03 -29.64 70.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.3 m -67.95 -18.71 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.144 -0.455 . . . . 0.0 111.998 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.3 p30 -136.57 15.14 3.17 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 118.67 0.668 . . . . 0.0 111.783 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -69.38 132.78 89.47 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -53.37 -27.18 38.15 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.818 2.345 . . . . 0.0 113.249 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -112.36 30.25 7.24 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.242 0.474 . . . . 0.0 111.675 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.7 mm -135.3 150.51 29.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -142.69 148.3 37.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.78 110.96 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.5 mt -129.52 126.47 63.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.5 t70 58.03 27.11 14.38 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.705 0.402 . . . . 0.0 109.984 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.15 -13.38 26.61 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -91.57 174.12 7.53 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -105.26 118.28 36.16 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.43 148.64 32.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -75.32 121.56 22.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -88.02 116.39 66.05 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -65.92 -57.2 0.25 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.123 1.882 . . . . 0.0 110.094 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt 71.6 -72.25 0.12 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 123.604 0.762 . . . . 0.0 109.727 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -146.02 46.28 1.25 Allowed 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -139.51 112.44 8.01 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.65 24.67 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 116.615 -1.66 . . . . 0.0 109.529 -179.868 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.6 tp -142.64 137.05 29.71 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.2 m 53.74 54.04 10.48 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.03 -136.6 19.96 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.0 t -162.27 128.15 3.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.1 p -71.79 -66.19 0.67 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.96 55.49 0.06 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.39 50.21 0.77 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.626 0.37 . . . . 0.0 111.088 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.448 ' HB2' ' CZ3' ' A' ' 53' ' ' TRP . 20.5 ptmt -166.34 -47.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -68.58 -42.48 78.19 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.95 72.89 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.87 -45.58 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.4 tp -58.53 -46.14 87.41 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.13 99.35 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -62.55 -44.17 97.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.509 ' HA ' HG21 ' A' ' 41' ' ' THR . 45.9 mt -60.85 -51.03 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 t -55.04 -47.74 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.2 -48.52 81.38 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 110.561 -0.162 . . . . 0.0 110.561 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -55.9 28.49 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -39.34 72.16 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -44.25 97.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.1 m -66.0 -45.49 81.37 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.135 0.174 . . . . 0.0 110.594 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -67.15 -40.59 86.72 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -61.25 -45.2 95.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -79.3 59.98 2.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.87 -51.71 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 177.48 -47.68 0.1 OUTLIER Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -76.61 73.25 3.31 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 116.97 0.385 . . . . 0.0 110.288 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.4 p -81.88 -12.18 58.57 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -63.64 154.24 80.73 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.577 0.351 . . . . 0.0 110.51 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.68 158.15 58.07 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.56 2.173 . . . . 0.0 111.386 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 32' ' ' LEU . 22.4 mt -133.04 149.7 52.17 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -61.99 166.54 4.54 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tt -59.05 -52.45 65.68 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.02 -40.58 89.79 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.06 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -58.04 -43.51 86.87 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.4 mt -64.29 -43.97 97.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.36 -52.41 65.49 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -45.38 -56.89 4.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.575 0.35 . . . . 0.0 111.224 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -60.42 -34.75 74.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.549 0.34 . . . . 0.0 111.77 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 16' ' ' ILE . 17.7 p -83.35 9.01 11.92 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 119.644 -0.217 . . . . 0.0 111.092 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 69.38 38.61 1.79 Allowed 'General case' 0 C--N 1.344 0.347 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.495 ' CE1' ' O ' ' A' ' 41' ' ' THR . 5.8 m-70 -132.37 167.05 20.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mt 166.26 -52.59 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.06 7.91 9.81 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 50' ' ' GLN . 3.5 tt -48.48 147.21 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.469 0 C-N-CA 123.596 0.759 . . . . 0.0 110.237 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.35 133.43 19.9 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.3 tp -56.49 -31.05 63.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -58.02 -45.69 86.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.48 ' HB3' HD11 ' A' ' 46' ' ' ILE . 18.2 mp0 -68.56 -47.8 65.9 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -55.69 -43.92 76.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -66.53 -50.7 62.3 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.448 ' CZ3' ' HB2' ' A' ' 9' ' ' LYS . 31.5 t90 -55.16 -45.66 75.71 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.457 0.303 . . . . 0.0 110.442 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.694 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 37.2 mt -56.08 -43.25 77.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.2 ttm -71.73 -50.37 30.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.5 p -104.94 23.49 13.47 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 36.0 tt0 -160.32 -68.89 0.07 Allowed 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 119.241 0.928 . . . . 0.0 111.567 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.694 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -55.55 -66.71 0.37 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.09 -41.52 99.41 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -65.27 -37.92 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 117.834 0.288 . . . . 0.0 110.591 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -101.78 58.35 0.84 Allowed 'General case' 0 C--N 1.342 0.279 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -148.1 112.66 3.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.29 -27.61 81.59 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.515 2.143 . . . . 0.0 111.812 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -74.92 -5.14 42.15 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.944 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.1 mm -120.5 138.21 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -126.6 119.66 27.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.29 139.06 18.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.6 mt -131.79 -96.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.316 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.64 55.25 3.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.53 -39.05 1.47 Allowed Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -72.27 161.42 30.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -108.52 128.55 54.9 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.866 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.2 163.01 15.81 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -92.87 125.47 37.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -78.8 122.46 84.73 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.26 50.92 2.73 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.835 2.357 . . . . 0.0 110.955 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt 55.73 -103.56 0.19 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.915 0.486 . . . . 0.0 110.046 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -115.9 28.9 8.33 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 73.99 173.76 0.28 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.133 0.573 . . . . 0.0 109.757 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -81.37 76.37 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? . . . . . 0 C--O 1.254 1.313 0 CA-C-O 115.907 -1.997 . . . . 0.0 110.284 -179.844 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -162.16 133.13 5.05 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 m -153.82 -36.58 0.1 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.87 95.25 0.47 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.9 t -57.71 -40.59 79.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -83.79 34.23 0.49 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.44 -78.95 0.96 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.405 ' CG ' ' N ' ' A' ' 9' ' ' LYS . 18.4 t80 51.95 -126.81 2.42 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.405 ' N ' ' CG ' ' A' ' 8' ' ' TYR . 39.3 mtpt -52.7 -62.6 1.54 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.577 0.751 . . . . 0.0 110.923 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -60.78 -37.05 80.56 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.979 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.15 -49.68 69.38 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.503 HG13 ' CD2' ' A' ' 43' ' ' HIS . 6.2 t -60.12 -41.99 88.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.62 HD13 ' HB1' ' A' ' 58' ' ' ALA . 59.8 tp -61.36 -43.5 98.76 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.07 -48.8 80.28 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.021 0.128 . . . . 0.0 111.084 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.11 -30.52 67.73 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 120.643 -0.423 . . . . 0.0 109.993 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.8 mt -64.64 -46.05 93.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.89 -41.75 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.67 -47.81 77.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -44.29 95.05 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 89.2 mmm -62.51 -37.24 85.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -69.28 -53.54 19.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 m -54.1 -48.92 70.21 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.413 0.285 . . . . 0.0 111.011 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 ptm85 -64.44 -40.02 94.94 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -64.96 -19.62 66.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -88.36 -39.53 14.26 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.663 0.385 . . . . 0.0 110.68 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -69.88 -37.32 76.0 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 117.593 0.179 . . . . 0.0 110.588 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.7 48.45 0.06 OUTLIER Glycine 0 C--N 1.342 0.88 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -140.46 53.96 1.62 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.7 p -78.89 -10.09 59.7 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.679 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -61.89 147.58 89.45 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.8 151.72 68.85 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.863 2.376 . . . . 0.0 111.647 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.3 mt -131.28 142.38 50.12 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.7 p -70.53 170.85 11.26 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -46.41 90.41 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.55 -54.65 38.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.604 0.362 . . . . 0.0 110.444 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -52.28 -35.8 51.12 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.595 0.358 . . . . 0.0 111.108 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.6 mt -67.4 -48.85 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.4 mt -59.54 -43.78 93.39 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.11 -62.21 1.78 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.524 0.329 . . . . 0.0 111.164 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.07 -50.58 70.6 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.5 p -76.64 -1.29 26.97 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.588 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 56.68 60.2 3.19 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.503 ' CD2' HG13 ' A' ' 12' ' ' VAL . 9.4 m-70 -129.35 31.37 4.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 mt -77.18 67.73 3.2 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -163.54 -40.65 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.51 ' CD1' ' H ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 18.18 -88.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.928 0 C-N-CA 125.441 1.496 . . . . 0.0 112.759 178.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' H ' ' CD1' ' A' ' 46' ' ' ILE . . . 132.77 160.48 9.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 107.351 -2.299 . . . . 0.0 107.351 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 tp -55.34 -43.81 75.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.756 0.778 . . . . 0.0 109.641 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -59.37 -53.37 58.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.522 0.329 . . . . 0.0 110.635 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -64.99 -57.66 8.12 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 119.669 -0.205 . . . . 0.0 111.083 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HB2' HD13 ' A' ' 46' ' ' ILE . 27.4 ttpp -48.71 -48.83 40.04 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 120.636 0.255 . . . . 0.0 110.392 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -62.5 -52.92 61.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.255 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -54.65 -49.22 71.1 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 122.286 0.235 . . . . 0.0 110.657 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 69.3 mt -56.22 -52.32 64.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 45.8 ttp -63.15 -40.78 98.55 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.2 p -114.48 27.49 9.42 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.29 -66.86 0.05 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.811 0.732 . . . . 0.0 110.749 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.743 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -64.35 -20.06 65.86 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.8 mt -121.23 21.84 11.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.201 0.455 . . . . 0.0 111.312 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.22 -41.78 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.22 -30.7 23.65 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -57.41 114.91 9.19 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.999 0.52 . . . . 0.0 109.962 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.83 -21.52 73.15 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.524 2.149 . . . . 0.0 111.786 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -80.96 0.68 34.42 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.543 -0.265 . . . . 0.0 110.714 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 mm -127.76 147.89 32.44 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -136.54 149.71 48.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.0 t -102.79 116.81 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.17 132.46 65.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 57.24 26.95 12.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.708 0.403 . . . . 0.0 110.136 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 -17.57 10.3 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -86.91 -179.63 6.55 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -116.05 137.6 51.98 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.657 0.265 . . . . 0.0 110.54 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.48 151.44 48.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -71.7 126.48 29.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -77.7 117.33 64.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -70.41 131.75 20.93 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 122.227 1.951 . . . . 0.0 111.426 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -74.94 -60.49 2.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -92.83 137.36 32.43 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -69.62 152.22 45.0 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.6 t -69.23 140.17 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.9 mtp85 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 116.656 -1.64 . . . . 0.0 109.455 -179.406 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.8 mp 62.08 -81.73 0.02 OUTLIER 'General case' 0 C--N 1.345 0.385 0 O-C-N 123.852 0.72 . . . . 0.0 109.776 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 p -80.46 66.21 5.89 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.48 -160.56 51.36 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.8 t 56.92 81.04 0.14 Allowed 'General case' 0 C--N 1.345 0.393 0 C-N-CA 123.044 0.538 . . . . 0.0 109.951 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.4 p -78.99 59.93 2.78 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.276 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.41 113.1 0.36 Allowed Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -61.32 141.73 57.38 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? 69.56 -67.88 0.21 Allowed 'General case' 0 C--N 1.351 0.644 0 C-N-CA 123.531 0.732 . . . . 0.0 110.728 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -55.04 -40.57 70.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.638 0.375 . . . . 0.0 110.96 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.25 -45.06 96.04 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.72 -45.1 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.26 -42.61 98.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.049 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.96 86.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -67.96 -41.56 82.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.449 ' HA ' HG21 ' A' ' 41' ' ' THR . 35.2 mt -62.14 -45.83 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.54 -50.12 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -58.71 -43.54 90.12 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -58.56 8.02 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.9 mmm -54.36 -42.42 70.25 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -50.49 72.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 122.466 0.306 . . . . 0.0 110.505 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.7 m -61.83 -49.13 77.52 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -58.16 -45.13 88.01 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -62.14 -34.3 76.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -73.11 -16.98 61.45 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.506 0.322 . . . . 0.0 110.553 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.05 -52.15 4.85 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 122.49 0.316 . . . . 0.0 110.171 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.54 -30.73 0.11 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -75.35 78.28 2.43 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.2 p -93.92 -17.03 23.43 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.196 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -66.06 154.46 89.65 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 117.6 0.182 . . . . 0.0 111.012 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.8 156.6 63.3 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.075 2.517 . . . . 0.0 111.76 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -137.96 147.7 44.54 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 122.906 0.482 . . . . 0.0 109.772 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.0 p -63.64 170.99 2.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 109.923 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -55.85 29.56 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.81 -42.3 79.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.286 0.234 . . . . 0.0 111.25 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.81 -35.07 70.35 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.2 mt -69.76 -40.98 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.63 -41.92 82.32 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.435 ' HA ' HD11 ' A' ' 44' ' ' LEU . 31.8 t70 -50.28 -62.51 1.54 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.199 0.2 . . . . 0.0 111.011 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.4 -46.32 86.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.84 0.456 . . . . 0.0 111.671 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.449 HG21 ' HA ' ' A' ' 16' ' ' ILE . 48.1 p -75.65 -6.69 51.7 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 119.243 -0.408 . . . . 0.0 111.653 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 61.0 52.95 3.85 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.429 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.0 m-70 -129.16 36.32 4.18 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.387 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 44' ' ' LEU . 4.0 mp -69.35 -45.84 68.45 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -83.13 62.18 6.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.8 tt -101.75 146.69 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.831 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.95 136.06 48.78 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.6 tp -52.1 -39.32 59.62 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.944 0.372 . . . . 0.0 110.64 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -62.96 -40.03 96.45 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -70.02 -50.39 41.88 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -51.39 -47.15 62.99 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -60.65 -56.52 20.27 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.669 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -50.48 -46.88 57.22 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 122.795 0.438 . . . . 0.0 111.202 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 68.3 mt -56.99 -44.92 83.2 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 21.5 ttt -76.89 -34.36 57.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.2 p -101.34 -4.47 26.94 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -138.77 -74.43 0.38 Allowed 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.028 0.831 . . . . 0.0 111.567 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.83 -63.43 1.11 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.4 mt -73.07 4.04 4.8 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.4 m -116.86 6.3 7.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 CA-C-N 118.826 0.739 . . . . 0.0 110.679 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -145.81 -15.78 0.47 Allowed 'General case' 0 C--N 1.348 0.51 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.483 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -63.9 117.88 40.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.34 -25.27 77.8 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.558 2.172 . . . . 0.0 112.346 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' C ' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -76.66 -12.51 60.01 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 119.357 -0.354 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.405 HD12 ' C ' ' A' ' 64' ' ' LYS . 1.5 mp -115.33 144.68 22.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.38 130.14 51.96 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -89.15 125.73 42.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.3 mm -116.94 -108.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -82.52 55.88 3.1 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.75 -34.47 2.09 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -77.05 166.36 23.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.87 125.17 52.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.239 0.216 . . . . 0.0 110.796 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.8 172.51 6.89 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -94.79 122.71 37.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -73.95 114.94 37.55 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.65 -81.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.309 2.006 . . . . 0.0 110.922 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -161.42 41.1 0.15 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 17.0 m-30 -97.19 66.98 2.13 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -167.52 105.39 0.53 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.1 t -131.43 140.69 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 116.736 -1.602 . . . . 0.0 109.234 179.733 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.1 tp -75.02 95.66 3.06 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 m -76.86 74.17 3.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.1 68.81 2.27 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.0 t -76.78 -28.31 55.61 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.9 t -78.03 67.85 3.96 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.83 -96.26 0.94 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.431 ' O ' ' CG ' ' A' ' 8' ' ' TYR . 2.4 t80 60.66 5.96 1.03 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.156 0.582 . . . . 0.0 110.974 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HB2' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER 175.27 -47.68 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.527 0.731 . . . . 0.0 109.565 178.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -67.35 -49.7 62.96 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.327 0.251 . . . . 0.0 110.748 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.91 -47.59 87.92 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.537 HG13 ' ND1' ' A' ' 43' ' ' HIS . 2.4 t -63.9 -49.53 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 tp -56.91 -47.95 79.36 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.67 99.22 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.172 0.189 . . . . 0.0 110.711 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.91 -42.12 95.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.9 mt -60.3 -50.04 81.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 t -54.56 -44.77 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 122.411 0.285 . . . . 0.0 110.269 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -70.77 -39.0 73.47 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.321 0.105 . . . . 0.0 110.859 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -64.05 -52.98 56.83 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 96.0 mtp -61.63 -31.55 71.65 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -55.92 14.65 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.2 m -57.44 -40.33 78.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.447 ' HG3' ' CE1' ' A' ' 19' ' ' TYR . 42.4 mmt-85 -60.87 -50.82 71.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.94 0.496 . . . . 0.0 110.29 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -62.37 -22.07 65.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.447 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -88.9 16.18 7.34 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.654 0.382 . . . . 0.0 110.489 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -136.81 -47.09 0.6 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 117.611 0.187 . . . . 0.0 110.721 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 178.21 -38.64 0.08 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -73.44 76.86 1.41 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.5 p -100.77 -30.26 11.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.141 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -58.6 161.97 7.27 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 123.627 0.771 . . . . 0.0 111.288 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -68.81 124.6 11.65 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.201 1.934 . . . . 0.0 110.839 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.4 mt -101.24 153.86 19.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 p -69.79 167.36 17.37 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.68 -56.16 25.72 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -57.64 -40.23 78.77 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.516 -0.278 . . . . 0.0 111.621 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.0 -37.61 71.9 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 118.084 0.402 . . . . 0.0 109.982 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.3 mt -71.62 -40.62 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.69 -57.24 11.7 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.454 0.115 . . . . 0.0 111.195 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -40.83 67.83 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.189 0.196 . . . . 0.0 111.349 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.9 -3.17 37.28 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.585 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 16.7 p -120.6 0.78 10.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.105 0.412 . . . . 0.0 110.289 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 73.04 26.1 2.24 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.445 0.698 . . . . 0.0 109.132 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.585 ' CE1' ' HB ' ' A' ' 41' ' ' THR . 26.6 m170 -106.56 38.45 2.06 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.477 ' O ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -83.62 -38.75 21.17 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.51 -44.79 95.62 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.931 HG23 ' H ' ' A' ' 47' ' ' GLY . 16.3 tt 22.47 -102.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.26 1.424 . . . . 0.0 112.787 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.931 ' H ' HG23 ' A' ' 46' ' ' ILE . . . 153.05 148.94 5.02 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.3 tt -54.95 -42.15 71.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.515 0.658 . . . . 0.0 110.253 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -59.24 -51.02 71.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.416 0.286 . . . . 0.0 110.644 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -65.77 -51.32 60.08 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.273 0.229 . . . . 0.0 110.533 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -53.33 -50.48 64.9 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -58.53 -49.15 78.45 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' A' ' 9' ' ' LYS . 22.8 t90 -54.44 -50.93 66.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 79.1 mt -57.46 -47.87 80.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.3 ttt -60.17 -49.75 76.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.324 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.8 t -123.69 52.19 1.45 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.31 0.505 . . . . 0.0 112.221 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -167.58 -55.16 0.02 OUTLIER 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.255 -0.278 . . . . 0.0 110.284 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -81.92 -62.12 1.72 Allowed 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.3 mt -71.87 2.0 6.21 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.55 0.34 . . . . 0.0 111.882 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.5 t -82.5 -49.51 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -120.15 37.43 4.24 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.738 0.415 . . . . 0.0 110.14 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -74.98 133.3 75.91 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.13 -21.39 62.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.342 2.028 . . . . 0.0 111.993 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.89 10.15 13.09 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-O 119.391 -0.338 . . . . 0.0 111.851 -177.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.2 151.34 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -141.8 152.44 43.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 t -97.37 121.2 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -138.92 136.46 42.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.1 t70 56.68 26.91 11.84 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.872 0.469 . . . . 0.0 110.477 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 -20.42 6.14 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm -86.47 -167.12 1.76 Allowed 'General case' 0 C--N 1.345 0.382 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -132.42 126.91 34.23 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-O 120.918 0.39 . . . . 0.0 110.933 -176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.71 166.8 11.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.678 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -92.96 127.93 38.65 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -83.95 118.91 72.58 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.2 -58.9 0.62 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.282 1.988 . . . . 0.0 110.565 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -164.35 -44.47 0.03 OUTLIER 'General case' 0 C--N 1.341 0.199 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -147.08 -64.24 0.28 Allowed 'General case' 0 C--N 1.341 0.234 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 57.61 80.39 0.17 Allowed 'General case' 0 C--N 1.345 0.373 0 C-N-CA 122.836 0.454 . . . . 0.0 110.0 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 p -61.07 148.71 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.112 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.6 mtm-85 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 116.758 -1.591 . . . . 0.0 109.113 179.693 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 tp 61.56 -155.46 0.35 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 t -162.35 -176.12 4.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.32 64.94 0.2 Allowed Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.2 m -77.05 66.92 2.96 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.496 0.319 . . . . 0.0 110.22 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t -71.07 -27.02 63.32 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.81 36.03 61.7 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.13 163.51 12.43 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt 75.42 -64.89 0.35 Allowed 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 123.761 0.824 . . . . 0.0 109.121 -175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -63.29 -46.44 86.73 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.049 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.83 -49.62 76.05 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 t -59.66 -47.81 89.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.8 tp -59.39 -45.19 92.15 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.91 96.69 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -64.91 -44.03 90.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.489 ' HA ' HG21 ' A' ' 41' ' ' THR . 49.2 mt -60.86 -46.94 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.13 -48.03 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 122.595 0.358 . . . . 0.0 110.048 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -61.48 -44.82 96.4 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -58.99 6.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.6 mmm -54.94 -37.69 66.76 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -45.8 92.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.2 m -60.06 -44.84 94.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -56.96 -53.18 60.9 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -61.92 -34.9 76.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.587 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -67.03 -46.78 73.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.686 -0.197 . . . . 0.0 111.05 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -71.04 -29.58 65.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 119.395 -0.335 . . . . 0.0 111.292 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.98 -20.0 0.97 Allowed Glycine 0 C--N 1.346 1.111 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.205 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -79.65 65.3 4.77 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.732 0.766 . . . . 0.0 109.747 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.0 p -78.19 -4.44 47.61 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.392 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -64.94 155.52 83.21 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 122.427 0.291 . . . . 0.0 110.725 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -69.29 155.71 66.69 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.75 2.3 . . . . 0.0 110.986 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 32' ' ' LEU . 12.7 mt -136.6 143.45 43.58 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.4 p -70.99 167.32 19.41 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -47.8 81.3 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -55.88 -52.52 63.78 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.25 0.22 . . . . 0.0 110.466 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -55.13 -37.07 66.46 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 122.433 0.293 . . . . 0.0 110.496 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -69.42 -51.92 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.5 mt -57.4 -44.84 84.89 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -52.03 -56.81 12.02 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.465 0.306 . . . . 0.0 110.916 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.33 -41.26 88.7 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.689 -0.115 . . . . 0.0 110.689 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 16' ' ' ILE . 40.9 p -82.36 7.29 14.45 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.121 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? 68.83 -11.95 0.4 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.358 0.663 . . . . 0.0 111.621 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.422 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.2 m-70 -77.35 35.51 0.18 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.745 -0.597 . . . . 0.0 111.701 -177.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -48.04 67.6 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.525 -0.734 . . . . 0.0 109.552 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -86.3 37.82 0.75 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 46' ' ' ILE . 6.7 tt -72.77 147.3 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.09 137.54 46.75 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -55.46 -32.21 62.6 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.695 0.247 . . . . 0.0 110.471 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -54.02 -38.74 65.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -86.53 -43.83 12.41 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -51.22 -48.72 62.0 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 122.39 0.276 . . . . 0.0 110.344 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -66.22 -49.43 67.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 34.8 t90 -51.36 -44.84 62.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.547 0.339 . . . . 0.0 110.615 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.3 mt -56.95 -40.99 77.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.7 mtp -85.61 -9.36 57.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.731 -0.652 . . . . 0.0 112.643 -176.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 74.5 p -136.28 20.6 3.18 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.177 0.899 . . . . 0.0 112.931 -175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 30.7 tt0 -160.93 -49.89 0.05 OUTLIER 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.973 0.806 . . . . 0.0 111.725 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.93 -76.82 0.24 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.8 mt -56.69 -31.19 64.22 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.553 0.341 . . . . 0.0 111.694 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.7 m -58.28 -21.62 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 119.58 -0.248 . . . . 0.0 111.577 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -147.5 26.57 1.04 Allowed 'General case' 0 C--N 1.346 0.423 0 CA-C-N 118.148 0.431 . . . . 0.0 110.889 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.54 126.52 92.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.01 -24.14 78.95 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.403 2.069 . . . . 0.0 112.203 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.78 5.44 28.63 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-O 119.063 -0.494 . . . . 0.0 111.677 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.9 mt -145.2 112.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.453 0 CA-C-N 118.671 0.669 . . . . 0.0 109.573 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -96.16 156.8 16.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.257 0.623 . . . . 0.0 109.456 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -103.46 140.32 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.1 mt -127.71 -112.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -80.08 61.15 3.84 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.29 -35.81 1.75 Allowed Glycine 0 CA--C 1.532 1.102 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.4 mttp -76.38 179.17 6.0 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -123.74 134.08 53.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.13 135.8 53.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -62.4 125.4 23.79 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -86.27 128.93 55.51 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -53.21 140.73 60.96 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.201 1.934 . . . . 0.0 110.583 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -66.05 102.67 0.83 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.996 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -120.48 102.83 8.71 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -154.98 47.35 0.54 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.9 p -68.27 143.81 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 116.555 -1.688 . . . . 0.0 109.763 -179.646 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.35 29.66 0.7 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.1 p -161.33 52.29 0.26 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.12 48.91 0.28 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -165.86 162.71 18.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.1 t -91.06 -165.58 1.39 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 133.44 80.34 0.16 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -59.72 119.83 8.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.455 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 17.2 mtmm 74.2 -61.8 0.48 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.966 0.906 . . . . 0.0 110.214 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -57.31 -44.92 84.56 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.645 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.41 -49.77 73.82 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.0 -47.83 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.5 -46.19 89.54 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.502 0.321 . . . . 0.0 110.506 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.19 93.76 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -65.98 -39.27 90.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 mt -62.22 -46.88 95.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.38 -48.69 84.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -63.33 -38.22 90.32 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.15 -56.6 17.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.3 mtp -59.93 -35.41 74.85 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -46.14 91.86 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 m -67.59 -44.67 77.58 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 122.318 0.247 . . . . 0.0 110.397 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 47.4 ttt85 -60.02 -45.94 91.14 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -63.28 -39.66 95.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -79.42 54.8 1.79 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -165.53 -59.29 0.03 OUTLIER 'General case' 0 C--N 1.343 0.292 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.69 -44.07 0.08 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.79 74.64 2.1 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.6 p -83.71 -8.01 59.36 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -67.76 155.28 91.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.49 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 13.7 Cg_endo -73.6 160.76 43.55 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.791 2.328 . . . . 0.0 111.617 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 32' ' ' LEU . 29.5 mt -134.38 140.51 46.36 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.454 HG23 ' HD2' ' A' ' 71' ' ' LYS . 45.5 p -61.89 169.21 2.69 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.504 ' C ' HD13 ' A' ' 34' ' ' LEU . 3.4 tm? -59.03 -50.34 74.45 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -61.6 -41.29 97.22 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.696 -0.193 . . . . 0.0 111.001 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -55.5 -34.82 64.95 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -70.15 -44.05 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 mt -52.18 -36.57 52.18 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.647 0.203 . . . . 0.0 110.531 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.86 -59.99 4.4 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.615 -0.142 . . . . 0.0 110.615 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -61.94 -66.16 0.58 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.53 80.44 4.01 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -32.6 86.41 0.0 OUTLIER 'General case' 0 C--N 1.352 0.717 0 C-N-CA 125.091 1.356 . . . . 0.0 112.555 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -140.6 29.27 1.95 Allowed 'General case' 0 C--O 1.213 -0.823 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.32 -38.69 80.92 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -91.04 69.18 6.23 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.476 ' CG1' ' HB2' ' A' ' 50' ' ' GLN . 1.3 tt -94.55 -46.67 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.029 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.73 131.3 6.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.859 -1.697 . . . . 0.0 108.859 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.1 tt -51.23 -40.42 58.74 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.86 0.33 . . . . 0.0 111.207 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -56.94 -33.85 67.43 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 119.828 -0.129 . . . . 0.0 111.071 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.476 ' HB2' ' CG1' ' A' ' 46' ' ' ILE . 25.6 mt-30 -89.9 -47.45 7.87 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.435 ' HD2' HD12 ' A' ' 34' ' ' LEU . 2.6 tppt? -50.43 -52.77 34.82 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -58.87 -45.37 90.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.455 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 28.8 t90 -57.02 -54.24 48.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 88.7 mt -51.32 -45.89 62.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -60.75 -52.82 63.46 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.13 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 t -120.26 51.33 1.22 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.358 0.527 . . . . 0.0 112.137 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -166.95 -67.29 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -66.75 -60.48 2.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.16 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.5 mt -80.27 37.45 0.39 Allowed 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 122.367 0.267 . . . . 0.0 110.599 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.33 -45.84 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -112.23 -7.29 14.03 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.42 124.54 81.29 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.06 -34.84 99.02 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.745 2.297 . . . . 0.0 112.394 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -86.86 21.49 2.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 119.695 -0.193 . . . . 0.0 111.168 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.4 mm -135.64 144.29 34.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -145.92 141.48 27.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.56 136.0 29.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.8 mp -104.92 -59.01 3.59 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -160.32 77.6 0.63 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.29 -40.67 2.58 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.454 ' HD2' HG23 ' A' ' 33' ' ' THR . 3.1 mtmt -83.25 145.81 28.92 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -104.62 126.57 51.84 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 122.675 0.39 . . . . 0.0 110.617 -176.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -111.61 150.55 29.91 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -79.23 121.56 25.21 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -74.09 121.21 84.67 Favored Pre-proline 0 N--CA 1.448 -0.574 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -63.05 132.01 34.99 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.32 2.013 . . . . 0.0 110.403 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -162.16 124.97 2.93 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 57.52 -109.65 0.49 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.224 0.61 . . . . 0.0 110.328 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 64.95 163.48 0.14 Allowed 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.356 0.662 . . . . 0.0 110.51 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 74.1 t -79.34 -56.25 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 116.326 -1.797 . . . . 0.0 108.556 179.197 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 66.4 tp -58.74 113.06 1.86 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m 55.6 34.35 23.02 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.747 0.419 . . . . 0.0 110.163 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.5 68.96 3.08 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m 71.55 135.56 0.04 OUTLIER 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.493 0.717 . . . . 0.0 110.347 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.0 t -158.28 -55.05 0.07 Allowed 'General case' 0 C--N 1.339 0.128 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.76 45.48 3.48 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -89.91 8.9 29.87 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 117.041 0.421 . . . . 0.0 110.254 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -151.44 -61.58 0.18 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -65.69 -42.78 90.81 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.106 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.74 -46.5 91.77 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -60.87 -46.03 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.636 HD13 ' HB1' ' A' ' 58' ' ' ALA . 61.2 tp -59.75 -45.87 90.89 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.17 86.26 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -62.77 -42.57 99.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.96 -51.67 66.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.2 t -55.91 -45.35 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -64.14 -45.16 89.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -57.35 12.84 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 96.4 mtp -55.39 -39.88 70.68 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -61.09 -50.23 74.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.5 m -59.47 -46.68 88.08 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 ttm-85 -60.65 -44.31 96.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -60.8 -35.81 77.42 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -79.95 12.75 2.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.485 0.314 . . . . 0.0 110.952 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -127.86 29.95 5.35 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 117.949 0.341 . . . . 0.0 110.478 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.29 -34.53 3.61 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -74.92 77.4 2.16 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.9 p -97.2 -3.56 40.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.799 0.44 . . . . 0.0 110.993 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -70.91 156.71 91.65 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 117.739 0.245 . . . . 0.0 110.584 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.48 156.18 64.9 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.979 2.453 . . . . 0.0 111.717 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -137.69 141.88 41.09 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 122.973 0.509 . . . . 0.0 109.643 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.8 p -63.62 168.55 4.67 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.007 0.432 . . . . 0.0 110.408 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 tt -58.28 -51.83 68.12 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -54.86 -48.45 72.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.878 0.471 . . . . 0.0 111.106 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -56.25 -34.88 66.78 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.8 mt -73.5 -46.21 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.428 ' HB3' ' H ' ' A' ' 44' ' ' LEU . 16.6 mt -46.31 -58.62 3.53 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.324 0.25 . . . . 0.0 111.048 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -46.27 -56.68 5.43 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.82 0.448 . . . . 0.0 111.913 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.79 -26.36 68.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.165 0.186 . . . . 0.0 111.445 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 28.3 p -99.12 16.94 21.11 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? 73.68 -88.84 0.02 OUTLIER 'General case' 0 C--N 1.35 0.597 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 41' ' ' THR . 23.7 m170 31.82 -109.6 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.762 0.825 . . . . 0.0 111.649 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.428 ' H ' ' HB3' ' A' ' 38' ' ' LEU . 4.5 mt 69.36 -64.71 0.33 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.901 1.28 . . . . 0.0 110.443 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.52 -68.78 0.27 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.7 tt 47.51 137.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.143 1.777 . . . . 0.0 114.305 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.21 137.59 40.66 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.9 tp -52.16 -41.85 62.94 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.217 0.508 . . . . 0.0 109.867 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -60.06 -40.58 89.99 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -66.62 -57.99 6.08 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -49.84 -48.38 51.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.919 0.488 . . . . 0.0 110.668 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -64.25 -47.34 79.97 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 38.6 t90 -57.44 -45.94 84.13 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.708 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 79.7 mt -56.22 -51.49 67.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 40.6 ttm -56.86 -54.69 43.58 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.792 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.402 ' HA ' HG21 ' A' ' 60' ' ' VAL . 6.7 t -121.15 50.3 1.39 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.227 0.467 . . . . 0.0 111.937 -174.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -170.5 -65.65 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.098 -0.376 . . . . 0.0 110.497 176.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.708 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -64.27 -50.02 69.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.392 0.277 . . . . 0.0 111.367 -176.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.2 mt -79.29 -29.58 42.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.599 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 56' ' ' THR . 54.6 t -73.69 139.1 19.95 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 69.17 -9.34 0.61 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.328 0.651 . . . . 0.0 111.579 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.56 125.11 78.71 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.42 -12.29 30.0 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.339 2.026 . . . . 0.0 112.05 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.01 7.45 21.55 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 118.029 0.377 . . . . 0.0 111.534 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 mm -136.23 157.34 37.6 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -147.95 144.19 27.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.06 106.59 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.4 mm -121.1 126.13 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.0 t0 59.16 19.9 7.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.815 0.446 . . . . 0.0 110.462 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.41 -29.2 7.95 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 168.86 18.79 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -104.59 124.89 50.12 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.543 0.211 . . . . 0.0 110.523 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.05 137.48 52.88 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.308 0.643 . . . . 0.0 109.334 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -66.99 126.86 30.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.44 117.91 69.63 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.72 -47.83 2.51 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.201 1.934 . . . . 0.0 109.731 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -157.5 -51.95 0.07 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -171.82 -52.4 0.02 OUTLIER 'General case' 0 C--N 1.343 0.308 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 51.52 63.78 2.1 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 122.999 0.519 . . . . 0.0 110.674 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 99.5 t -120.29 143.47 32.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.708 -1.615 . . . . 0.0 109.208 -179.416 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.92 28.29 0.77 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.8 p -79.39 69.11 5.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.35 172.24 14.89 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.9 t -75.99 77.92 2.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.9 m 57.69 67.73 0.93 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 122.794 0.437 . . . . 0.0 109.843 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.07 -172.38 30.35 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.7 t80 66.25 124.31 0.02 OUTLIER 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.796 0.838 . . . . 0.0 109.594 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt 65.1 -74.66 0.05 Allowed 'General case' 0 C--N 1.347 0.482 0 C-N-CA 123.195 0.598 . . . . 0.0 109.745 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -60.27 -45.41 93.41 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 122.901 0.48 . . . . 0.0 110.205 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.44 -47.52 90.7 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.02 -45.91 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.27 -44.64 96.91 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.24 99.4 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -61.86 -48.38 80.81 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.518 ' HA ' HG21 ' A' ' 41' ' ' THR . 52.2 mt -58.26 -52.16 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.293 0.371 . . . . 0.0 110.114 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -55.73 -50.8 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.72 -43.29 94.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.249 0.22 . . . . 0.0 110.751 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -59.67 4.66 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -33.43 69.45 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -60.57 -46.65 89.44 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 m -73.23 -40.26 64.83 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.543 0.337 . . . . 0.0 110.164 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -64.41 -33.71 76.49 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.576 0.75 . . . . 0.0 109.168 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -72.71 -49.77 29.09 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -38.14 65.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.897 0.479 . . . . 0.0 110.24 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -54.13 -42.51 69.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.139 0.576 . . . . 0.0 110.884 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.72 -27.73 1.77 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.75 59.68 2.59 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.7 p -66.63 -9.09 32.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.143 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -57.43 152.04 35.38 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 122.467 0.307 . . . . 0.0 110.839 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.89 155.53 54.32 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.719 2.279 . . . . 0.0 111.331 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 32' ' ' LEU . 15.2 mt -135.19 144.01 46.75 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.4 p -73.38 175.25 7.11 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -54.0 50.77 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.6 -48.25 72.4 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.292 0.237 . . . . 0.0 110.584 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -54.34 -44.0 71.74 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.9 mt -63.61 -47.32 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.8 mt -56.99 -48.99 77.12 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -51.52 -56.93 10.68 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 123.187 0.304 . . . . 0.0 111.1 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 23' ' ' ARG . 3.0 mt-10 -58.94 -37.19 76.17 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.047 0.139 . . . . 0.0 111.144 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.518 HG21 ' HA ' ' A' ' 16' ' ' ILE . 47.7 p -86.37 6.22 31.12 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.122 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? 69.04 -10.52 0.51 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.313 0.645 . . . . 0.0 111.34 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.431 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.0 m-70 -78.06 39.15 0.3 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.65 -0.656 . . . . 0.0 111.395 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.81 -45.48 61.36 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -84.23 51.71 2.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.9 tt -90.81 148.84 4.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.22 137.16 50.45 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.7 tp -54.72 -35.76 64.01 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.322 0.249 . . . . 0.0 110.631 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -58.11 -48.88 78.85 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -68.34 -44.26 75.69 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -52.54 -49.99 63.79 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.0 -52.17 66.91 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -53.74 -50.04 66.85 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.652 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 48.3 mt -57.33 -43.25 83.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.4 ttt -66.91 -53.03 36.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -120.41 47.14 1.83 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -167.75 -56.19 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.652 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -76.67 -60.18 2.46 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.179 -0.325 . . . . 0.0 111.569 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -80.61 27.74 0.35 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.9 m -124.73 -17.28 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 117.782 0.264 . . . . 0.0 110.36 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -130.12 6.6 4.98 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 117.718 0.235 . . . . 0.0 110.692 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -70.11 127.57 92.22 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.83 -29.96 87.8 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.443 2.095 . . . . 0.0 112.224 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -94.23 21.13 7.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 119.707 -0.187 . . . . 0.0 111.484 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.81 156.48 12.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -154.2 148.76 26.29 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.19 130.76 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.9 mt -120.87 -95.9 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -83.72 51.59 2.06 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.65 -36.27 1.84 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mttp -74.07 179.13 4.56 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -114.14 126.36 54.99 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.2 138.82 50.95 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -70.06 127.32 32.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.02 120.51 81.51 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -67.02 -172.5 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.521 2.147 . . . . 0.0 110.775 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -52.34 -53.88 38.78 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -163.02 -49.31 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -90.39 157.92 17.36 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.2 t -54.21 -45.7 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 116.697 -1.62 . . . . 0.0 109.349 179.479 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.8 tp -64.35 -51.8 61.53 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.8 t -152.51 60.04 0.82 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.66 67.03 3.61 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.2 p -150.42 113.03 4.72 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.8 p -140.48 54.32 1.61 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.96 -24.03 67.7 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 39.4 p90 50.71 15.82 0.26 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.242 1.017 . . . . 0.0 112.32 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -169.34 -42.75 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -68.89 -43.35 75.45 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.45 93.83 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.0 -47.92 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.614 HD13 ' HB1' ' A' ' 58' ' ' ALA . 43.1 tp -59.27 -43.92 92.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.9 97.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -59.43 -46.53 88.47 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.8 mt -61.48 -49.11 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -57.61 -46.85 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -65.68 -42.22 91.53 Favored 'General case' 0 CA--C 1.527 0.063 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -60.22 -58.41 8.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtp -55.67 -44.51 77.36 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -55.34 -45.17 76.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.534 0.334 . . . . 0.0 110.308 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.7 m -62.98 -53.93 46.32 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 119.541 -0.266 . . . . 0.0 111.134 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -64.62 -30.87 71.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.61 0.641 . . . . 0.0 109.984 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -66.41 -40.34 89.54 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -65.35 -41.97 93.33 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.63 -55.51 29.81 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 122.179 0.192 . . . . 0.0 110.507 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.3 -30.35 0.12 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -75.89 71.31 2.7 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 117.338 0.569 . . . . 0.0 109.669 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.6 p -76.51 -9.6 58.78 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -62.98 156.32 67.9 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.58 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 30.0 Cg_endo -77.85 161.88 29.95 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.682 2.255 . . . . 0.0 111.019 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.3 mt -132.74 144.86 50.56 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.9 p -60.75 167.19 2.87 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.98 -50.03 71.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.64 -49.08 79.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.863 0.465 . . . . 0.0 110.861 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -55.32 -34.08 63.88 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 58.5 mt -75.64 -50.53 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.644 ' CD2' HD11 ' A' ' 46' ' ' ILE . 8.8 mt -45.29 -54.16 7.47 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 122.691 0.397 . . . . 0.0 111.104 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -47.87 -59.34 3.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.699 0.399 . . . . 0.0 111.311 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -60.0 -37.7 80.48 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.221 0.208 . . . . 0.0 111.009 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.7 p -81.7 10.53 5.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.042 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 75.63 -61.0 0.48 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.74 0.816 . . . . 0.0 111.001 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 113.1 1.19 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -120.0 -34.09 3.8 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 122.45 0.3 . . . . 0.0 110.964 -178.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -94.54 -40.88 9.63 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.644 HD11 ' CD2' ' A' ' 38' ' ' LEU . 3.1 mt 55.63 -134.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.934 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.429 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -136.19 143.57 15.06 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 105.275 -3.13 . . . . 0.0 105.275 172.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -49.74 -45.36 49.26 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.23 1.015 . . . . 0.0 110.527 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -58.24 -46.57 85.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -64.3 -63.07 1.24 Allowed 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -42.77 -49.63 5.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.012 0.525 . . . . 0.0 110.966 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -65.31 -52.24 55.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.434 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 37.1 t90 -52.77 -46.03 67.38 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.822 0.449 . . . . 0.0 110.81 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.725 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 65.0 mt -57.1 -47.23 81.58 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.2 ttt -65.31 -47.2 77.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t -120.81 40.48 3.53 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 34.4 tt0 -165.72 -66.77 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.937 -0.477 . . . . 0.0 110.115 174.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.725 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -58.47 -61.07 2.86 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 -177.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.1 mt -81.46 31.7 0.34 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.338 0.255 . . . . 0.0 110.373 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.41 -40.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.41 -30.48 16.48 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.386 0.274 . . . . 0.0 110.423 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -56.1 118.98 23.64 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.88 -30.99 91.14 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.534 2.156 . . . . 0.0 112.075 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -82.22 10.77 6.23 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.234 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 mm -129.65 143.65 40.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -146.67 135.68 22.47 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 t -89.52 131.92 35.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.1 mm -104.06 -60.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -152.45 76.23 1.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.8 -40.01 2.44 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -85.71 154.31 21.72 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -107.73 132.17 53.65 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.913 0.485 . . . . 0.0 109.997 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -121.32 151.82 39.66 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 122.54 0.336 . . . . 0.0 110.196 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -75.27 120.64 21.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -80.39 123.26 83.08 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -62.95 120.73 8.33 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.342 2.028 . . . . 0.0 110.512 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -78.52 121.17 24.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -71.89 75.08 0.89 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -165.79 -49.26 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.0 29.23 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.834 -1.555 . . . . 0.0 108.802 -179.454 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.1 tp -155.1 118.74 4.52 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.1 m -153.22 -62.24 0.15 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.0 72.77 0.03 OUTLIER Glycine 0 C--N 1.338 0.692 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.5 p -161.72 158.46 25.9 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 m -150.35 56.3 0.93 Allowed 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.06 167.58 33.53 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -114.38 -122.43 0.29 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 7.7 mtmm -53.9 -44.37 70.45 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -62.06 -42.57 99.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.622 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.91 -51.93 53.79 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.6 t -60.64 -45.89 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.709 HD13 ' HB1' ' A' ' 58' ' ' ALA . 51.9 tp -59.63 -51.54 69.37 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.235 0.214 . . . . 0.0 110.43 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.69 -43.9 85.44 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -50.34 74.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.1 mt -59.33 -47.8 89.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 122.544 0.338 . . . . 0.0 110.285 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.5 t -58.42 -50.11 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -59.34 -47.16 86.44 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.81 -57.32 13.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 87.9 mtp -52.93 -41.21 64.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -60.66 -63.19 1.38 Allowed 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -45.95 -45.89 15.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 122.432 0.293 . . . . 0.0 110.793 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -63.45 -41.37 98.64 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -66.81 -34.12 77.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.236 0.614 . . . . 0.0 110.094 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -69.01 -36.47 77.83 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -62.78 -56.71 15.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.169 0.188 . . . . 0.0 110.725 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.35 -35.52 0.14 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -71.11 79.73 0.68 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.0 p -91.26 -19.07 23.39 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.443 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -61.78 151.71 78.25 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 117.936 0.335 . . . . 0.0 110.21 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.459 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 9.4 Cg_endo -71.86 157.11 55.75 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.771 2.314 . . . . 0.0 111.589 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.9 mt -125.19 148.32 48.67 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.5 p -59.75 168.42 1.73 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -57.7 11.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.2 -43.3 70.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.481 0.312 . . . . 0.0 111.205 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -53.02 -49.94 65.24 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.6 mt -58.34 -40.17 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 122.127 0.171 . . . . 0.0 110.666 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.52 -28.97 69.7 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 117.82 0.282 . . . . 0.0 110.434 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.48 -59.32 4.11 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -55.86 -68.57 0.19 Allowed 'General case' 0 C--N 1.347 0.47 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -78.65 85.39 4.69 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -36.92 84.4 0.0 OUTLIER 'General case' 0 C--N 1.351 0.669 0 C-N-CA 125.003 1.321 . . . . 0.0 112.735 -176.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -140.04 45.1 1.89 Allowed 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.423 ' O ' HG22 ' A' ' 46' ' ' ILE . 10.0 mt -79.77 -37.59 35.05 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.76 -43.22 99.37 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.886 HG23 ' H ' ' A' ' 47' ' ' GLY . 13.5 tt 22.85 -98.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.232 1.413 . . . . 0.0 113.022 177.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.886 ' H ' HG23 ' A' ' 46' ' ' ILE . . . 150.59 148.24 4.74 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.1 tp -54.43 -47.56 72.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.462 0.631 . . . . 0.0 110.712 -177.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -57.35 -50.95 71.32 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.166 0.186 . . . . 0.0 110.742 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -62.79 -56.51 16.85 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -48.88 -50.04 36.83 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 122.577 0.351 . . . . 0.0 110.763 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -61.77 -45.23 94.78 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.463 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 49.7 t90 -61.29 -38.05 85.38 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.762 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 71.6 mt -62.57 -46.44 88.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.4 -50.64 69.07 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.898 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.2 p -89.1 -42.14 11.88 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -102.0 -72.68 0.68 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.762 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -46.42 -64.52 0.74 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -173.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.6 mt -80.39 31.9 0.29 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.128 0.171 . . . . 0.0 111.37 -175.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.47 -47.68 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -81.42 -28.17 34.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.603 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -57.47 121.67 49.84 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.46 -18.41 62.87 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.726 2.284 . . . . 0.0 112.557 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -97.98 20.0 12.98 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.049 0.386 . . . . 0.0 110.907 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 mm -131.05 146.89 33.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 117.936 0.334 . . . . 0.0 110.115 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -137.86 136.06 36.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.14 130.47 49.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.4 mt -142.94 123.45 10.43 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.3 t70 53.79 34.54 19.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.92 0.488 . . . . 0.0 111.073 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.09 -36.31 3.32 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -72.0 163.27 28.16 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -119.25 134.01 55.44 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.375 0.27 . . . . 0.0 110.455 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -125.03 152.17 44.62 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -76.17 121.84 23.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -69.19 119.34 69.51 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -63.1 105.26 0.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.122 1.881 . . . . 0.0 109.695 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -166.22 141.02 4.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 52.21 44.16 29.97 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -83.98 60.21 5.71 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.5 t -57.84 144.9 9.71 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.928 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 . . . . . 0 C--O 1.254 1.31 0 CA-C-O 116.584 -1.674 . . . . 0.0 109.387 -179.457 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.4 154.22 39.03 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t 75.01 -57.44 0.6 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 123.605 0.762 . . . . 0.0 110.364 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.96 31.07 62.42 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 64.7 m -72.37 166.29 22.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.9 t -63.26 148.42 48.27 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 157.7 -169.43 34.53 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -62.16 141.93 57.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.4 mttm 69.12 -69.97 0.15 Allowed 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.24 0.616 . . . . 0.0 110.488 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -57.99 -47.6 82.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.759 0.823 . . . . 0.0 111.821 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.21 -45.25 94.11 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.9 t -59.74 -46.57 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.17 -42.82 99.47 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.14 89.59 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -66.23 -41.56 89.86 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.413 ' HA ' HG21 ' A' ' 41' ' ' THR . 50.7 mt -62.68 -47.82 91.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.25 -47.82 89.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -59.63 -47.21 86.47 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -48.22 80.88 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.634 0.373 . . . . 0.0 110.387 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 80.8 mmm -57.22 -33.12 67.21 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 122.498 0.319 . . . . 0.0 110.256 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -73.66 -62.58 1.44 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -44.98 -50.22 10.75 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.087 0.555 . . . . 0.0 111.546 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -63.13 -42.39 99.51 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.26 0.482 . . . . 0.0 109.872 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -64.55 -27.28 68.85 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.778 0.431 . . . . 0.0 109.956 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -74.44 -34.7 63.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.652 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -95.17 38.99 1.12 Allowed 'General case' 0 C--N 1.35 0.623 0 CA-C-N 118.13 0.423 . . . . 0.0 111.59 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.46 -16.5 48.99 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.185 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.3 41.76 0.71 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.489 1.145 . . . . 0.0 109.889 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.58 66.65 6.17 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -142.53 152.27 59.66 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.05 151.0 84.32 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.053 2.502 . . . . 0.0 111.91 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.3 mt -140.42 143.15 35.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.4 p -62.47 171.28 2.01 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -55.29 34.05 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -58.16 -41.88 84.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.242 0.217 . . . . 0.0 111.31 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.57 -40.78 75.79 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.0 mt -64.82 -45.73 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.5 mt -55.38 -49.04 73.34 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -49.2 -58.79 4.4 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.199 0.2 . . . . 0.0 111.081 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -61.25 -42.51 98.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.24 0.216 . . . . 0.0 111.56 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.478 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 35.5 p -75.7 -8.06 55.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 119.344 -0.36 . . . . 0.0 111.228 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 64.96 49.24 2.14 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.478 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 6.5 m-70 -130.46 39.2 3.66 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.462 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mt -73.82 -44.36 55.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.9 41.22 0.79 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 tt -79.32 -31.38 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 122.793 0.437 . . . . 0.0 110.297 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.16 138.43 10.28 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.25 -25.74 65.91 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 117.079 0.44 . . . . 0.0 111.2 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -61.11 -34.08 74.39 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -89.51 -43.85 10.54 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.693 0.397 . . . . 0.0 109.947 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -55.58 -47.74 75.95 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -57.24 -48.34 79.07 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -57.16 -54.83 42.28 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.553 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 81.0 mt -53.46 -43.13 67.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.3 ttt -70.85 -38.88 73.2 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.0 p -118.11 36.46 4.34 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -168.38 -70.33 0.02 OUTLIER 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.291 0.496 . . . . 0.0 110.539 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -60.76 -63.97 1.12 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -175.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.6 mt -79.1 28.59 0.22 Allowed 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.516 -0.115 . . . . 0.0 111.192 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.49 -40.75 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -116.16 4.86 13.65 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.37 0.268 . . . . 0.0 111.403 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.42 127.5 91.3 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.78 -30.05 91.54 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.593 2.195 . . . . 0.0 112.107 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.0 36.52 1.68 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.594 0.179 . . . . 0.0 110.733 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 tp -150.85 156.99 5.89 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.419 ' HG3' HD13 ' A' ' 68' ' ' ILE . 13.6 pt-20 -157.75 138.8 13.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.473 ' C ' HD12 ' A' ' 68' ' ' ILE . 39.9 t -87.81 108.3 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.473 HD12 ' C ' ' A' ' 67' ' ' VAL . 1.7 mp -114.96 122.53 69.26 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 53.08 36.93 23.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.693 0.397 . . . . 0.0 110.489 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.71 -32.91 3.34 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -78.61 162.01 26.56 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 117.804 0.802 . . . . 0.0 108.98 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.63 123.24 44.56 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.4 153.42 28.62 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -80.35 114.49 19.29 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.182 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -73.95 122.52 87.76 Favored Pre-proline 0 N--CA 1.446 -0.646 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -51.05 128.07 23.77 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.246 1.964 . . . . 0.0 111.643 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.16 159.86 22.57 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.996 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -115.05 126.63 54.93 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.4 m120 70.22 143.78 0.05 Allowed 'General case' 0 C--N 1.346 0.443 0 C-N-CA 123.532 0.733 . . . . 0.0 110.118 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.15 -28.39 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 116.821 -1.561 . . . . 0.0 109.124 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.5 tp -79.11 91.25 4.9 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 p -153.05 35.91 0.48 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.79 -149.81 46.25 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.6 p -80.02 137.34 36.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 t -70.56 -64.59 0.87 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.37 -47.62 3.24 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -48.54 113.71 0.82 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.157 0.583 . . . . 0.0 110.262 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.469 ' HB3' ' CH2' ' A' ' 53' ' ' TRP . 13.7 mttp 74.19 -65.82 0.33 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.161 0.985 . . . . 0.0 111.13 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -53.88 -39.4 65.69 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.804 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.45 -50.23 60.64 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.7 t -64.21 -46.63 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.41 HD13 ' HB1' ' A' ' 58' ' ' ALA . 55.9 tp -61.18 -46.26 91.22 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.77 -42.45 93.33 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -58.72 -51.65 69.05 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.2 mt -55.42 -49.24 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 t -58.02 -46.14 87.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.17 -50.56 69.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.559 0.344 . . . . 0.0 110.747 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CE1' ' CD ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -60.81 -46.16 91.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.725 0.41 . . . . 0.0 110.323 -177.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.3 mmm -63.04 -47.37 83.3 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -56.73 -52.07 66.42 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.758 0.423 . . . . 0.0 110.906 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.5 m -57.5 -42.13 82.11 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.449 ' CD ' ' CE1' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -68.15 -40.51 82.37 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -62.2 -34.55 76.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -67.44 -47.18 70.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.443 0.297 . . . . 0.0 111.406 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -70.37 -35.44 73.54 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 119.143 -0.456 . . . . 0.0 111.756 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.74 -30.14 0.34 Allowed Glycine 0 C--N 1.345 1.04 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.195 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -74.52 77.58 1.95 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p -93.23 -14.23 27.33 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.826 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -61.94 149.71 85.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 117.447 0.112 . . . . 0.0 110.729 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -62.98 158.42 43.47 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.932 2.421 . . . . 0.0 111.225 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 32' ' ' LEU . 18.4 mt -138.04 142.33 40.34 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.8 p -62.11 167.83 3.71 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -50.29 74.08 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.56 -51.9 63.8 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.785 0.434 . . . . 0.0 110.826 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.09 -45.52 79.38 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.3 mt -59.39 -46.95 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.654 HD22 HD11 ' A' ' 46' ' ' ILE . 24.2 mt -59.62 -63.75 1.19 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -40.19 -58.15 1.54 Allowed 'General case' 0 C--N 1.343 0.301 0 C-N-CA 123.674 0.79 . . . . 0.0 112.452 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -57.23 -34.56 68.7 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 117.411 0.096 . . . . 0.0 111.063 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.514 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -99.3 28.77 4.3 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 67.54 -111.27 0.14 Allowed 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.514 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 3.6 m-70 46.71 -116.3 0.66 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.513 0.325 . . . . 0.0 110.536 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.4 ' H ' ' HB3' ' A' ' 38' ' ' LEU . 0.4 OUTLIER 78.44 -55.4 0.48 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.582 1.153 . . . . 0.0 111.029 175.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.57 -62.04 1.6 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.654 HD11 HD22 ' A' ' 38' ' ' LEU . 30.3 mt 66.39 -74.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 O-C-N 124.592 1.183 . . . . 0.0 111.594 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.52 124.77 1.42 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 105.166 -3.174 . . . . 0.0 105.166 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.3 tp -43.84 -42.39 5.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.536 0.668 . . . . 0.0 111.798 -175.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -51.37 -52.61 44.23 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.372 0.269 . . . . 0.0 110.333 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -69.08 -61.69 1.69 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 122.519 0.328 . . . . 0.0 110.628 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -42.13 -42.89 3.11 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.757 0.423 . . . . 0.0 110.895 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -69.45 -53.81 17.41 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.469 ' CH2' ' HB3' ' A' ' 9' ' ' LYS . 34.1 t90 -51.94 -44.78 64.06 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 122.507 0.323 . . . . 0.0 110.712 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.698 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 66.3 mt -57.07 -45.75 83.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 47.8 ttm -74.68 -37.45 62.66 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -176.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 t -106.56 6.73 30.3 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -173.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -152.46 -67.91 0.16 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.282 0.946 . . . . 0.0 111.917 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.698 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -53.01 -65.4 0.57 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -174.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.63 -48.77 71.06 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.4 m -55.74 -35.37 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 119.534 -0.27 . . . . 0.0 110.883 -177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -109.76 36.23 3.06 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -94.15 127.64 44.01 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.86 -22.86 62.9 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.32 2.013 . . . . 0.0 112.021 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -111.75 6.06 19.53 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -176.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 mt -140.81 129.21 24.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -122.98 168.96 11.66 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.4 t -98.68 131.86 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.9 mt -139.21 121.07 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.8 t70 58.46 29.94 19.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.625 0.37 . . . . 0.0 110.252 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.47 -36.54 3.22 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 168.79 15.01 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -109.12 141.98 40.53 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.5 137.51 38.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.545 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -71.59 125.96 28.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -80.17 122.07 82.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -66.41 163.5 32.07 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.435 2.09 . . . . 0.0 110.766 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -160.68 52.21 0.29 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -139.01 86.02 2.11 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 40.78 44.53 1.91 Allowed 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.402 0.681 . . . . 0.0 110.86 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 69.49 135.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 123.694 0.798 . . . . 0.0 109.831 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? . . . . . 0 C--O 1.254 1.332 0 CA-C-O 116.478 -1.725 . . . . 0.0 109.253 -178.193 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 tt 52.99 63.68 2.15 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.4 m -153.16 76.78 1.13 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.13 -122.03 28.59 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.3 p -78.77 67.37 4.49 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 t -85.65 28.44 0.77 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.484 0.314 . . . . 0.0 110.549 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.39 61.73 4.72 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -131.3 23.78 4.82 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.417 ' HB2' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -154.9 -47.4 0.09 Allowed 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 -178.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -59.62 -48.99 79.5 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.258 0.223 . . . . 0.0 110.696 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.7 -50.22 69.49 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.455 HG13 ' CD2' ' A' ' 43' ' ' HIS . 23.5 t -59.69 -49.7 82.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.53 -46.35 86.96 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.46 98.18 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -63.63 -45.68 89.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.08 -48.1 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 t -57.5 -42.81 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -73.24 -42.7 62.25 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.484 -0.135 . . . . 0.0 111.087 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -49.0 77.52 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.1 mmm -55.88 -48.49 75.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -52.39 -61.1 2.49 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 123.349 0.405 . . . . 0.0 110.6 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -54.99 -51.59 65.74 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -62.1 -38.72 89.94 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.182 0.447 . . . . 0.0 110.251 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -64.46 -37.02 86.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -82.41 43.37 0.81 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.559 0.744 . . . . 0.0 109.012 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 ttp-105 -158.6 -51.43 0.06 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.22 -38.17 0.07 OUTLIER Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.8 59.66 3.77 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.315 0.557 . . . . 0.0 110.012 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.62 -3.53 59.05 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.456 ' NE2' HD21 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -67.15 154.37 92.8 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 122.651 0.38 . . . . 0.0 110.635 -179.664 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.99 120.67 7.95 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.104 1.869 . . . . 0.0 110.121 176.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.4 mt -100.76 149.44 23.81 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.0 p -76.59 170.87 15.62 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -53.32 59.63 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -58.14 -43.56 87.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.22 0.208 . . . . 0.0 111.057 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -56.62 -41.77 77.68 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.2 mt -63.97 -49.68 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.9 mt -53.76 -55.73 23.7 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -45.79 -59.11 2.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.787 0.435 . . . . 0.0 111.442 -177.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.38 -38.74 84.86 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.404 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 33.3 p -81.41 -1.33 45.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.072 0.396 . . . . 0.0 111.159 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 65.54 44.91 2.89 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.455 ' CD2' HG13 ' A' ' 12' ' ' VAL . 8.2 m-70 -127.6 28.8 5.59 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.22 -44.33 75.98 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.93 55.88 2.91 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.0 tt -99.89 148.17 6.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 122.711 0.404 . . . . 0.0 110.001 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.62 141.99 41.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -57.29 -24.95 58.23 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 117.064 0.432 . . . . 0.0 111.289 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -64.87 -50.97 64.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -69.49 -43.68 72.64 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -53.68 -50.57 65.54 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 -62.45 -48.13 81.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.98 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.468 ' CE2' ' HB2' ' A' ' 58' ' ' ALA . 28.8 t90 -54.38 -50.89 66.44 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.685 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 52.1 mt -55.16 -49.34 72.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.7 ttt -63.69 -48.07 78.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -124.96 50.24 1.77 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.726 0.694 . . . . 0.0 112.554 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -172.77 -61.88 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -65.61 -67.02 0.47 Allowed 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.463 -0.148 . . . . 0.0 111.155 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.85 -48.35 82.21 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.351 0.26 . . . . 0.0 111.523 -175.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 m -53.74 -38.75 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -89.12 -25.11 22.04 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 117.797 0.271 . . . . 0.0 110.916 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.45 117.58 28.81 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -63.81 -35.4 56.91 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.633 2.222 . . . . 0.0 111.882 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.83 -26.61 64.31 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.902 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.09 95.2 3.62 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -91.97 157.95 16.53 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.7 t -96.21 136.53 26.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.1 mm -115.8 -114.07 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.19 62.47 6.66 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.87 1.96 60.24 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -117.72 -179.98 3.9 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -114.67 129.58 56.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.654 0.264 . . . . 0.0 110.51 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.5 146.09 48.34 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.45 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -87.66 125.23 34.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -81.3 121.32 80.14 Favored Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -62.66 -39.47 43.51 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.398 2.065 . . . . 0.0 111.124 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? 70.76 128.26 0.03 OUTLIER 'General case' 0 C--N 1.348 0.524 0 C-N-CA 123.585 0.754 . . . . 0.0 109.873 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -61.5 107.07 0.73 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -144.46 152.39 40.55 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.39 147.51 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.145 -1.407 . . . . 0.0 108.758 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.6 108.52 0.84 Allowed 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 p -162.43 75.26 0.43 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.84 53.78 0.5 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 t 64.17 -168.76 0.2 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.732 0.413 . . . . 0.0 110.387 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.2 m -79.42 176.62 9.52 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.08 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.21 101.37 2.76 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -153.31 38.01 0.49 Allowed 'General case' 0 C--N 1.341 0.235 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -173.5 -51.04 0.01 OUTLIER 'General case' 0 C--N 1.341 0.201 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -178.18 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.73 -39.92 95.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.353 0.261 . . . . 0.0 110.505 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.23 -50.42 65.23 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.9 t -62.78 -44.09 99.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.67 -49.42 77.63 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.95 86.09 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.34 -44.53 96.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.21 -49.29 84.71 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.1 t -53.45 -45.47 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.63 -45.63 82.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.232 0.213 . . . . 0.0 111.228 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -40.26 94.17 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -41.74 87.58 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -58.31 8.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -63.4 -48.44 77.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.847 0.459 . . . . 0.0 112.029 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HE ' ' CB ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -66.47 -35.04 79.3 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.309 0.504 . . . . 0.0 110.272 -177.395 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -66.29 -39.3 89.27 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -78.52 53.19 1.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.45 -50.13 0.09 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.76 -29.59 0.17 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.402 ' CB ' ' HE ' ' A' ' 23' ' ' ARG . 62.6 m-20 -75.39 60.2 1.13 Allowed 'General case' 0 C--N 1.343 0.314 0 C-N-CA 122.966 0.506 . . . . 0.0 110.125 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.5 p -87.87 57.5 4.37 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -137.58 154.77 75.3 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.56 150.76 83.87 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.927 2.418 . . . . 0.0 112.32 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 32' ' ' LEU . 16.1 mt -138.37 142.92 39.64 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.3 p -63.25 169.44 3.58 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 34' ' ' LEU . 3.2 tt -60.88 -51.88 67.43 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -59.92 -41.34 91.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 119.675 -0.202 . . . . 0.0 110.655 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -56.93 -39.3 74.25 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 mt -67.0 -47.69 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.8 mt -52.0 -47.41 64.93 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HA ' HD11 ' A' ' 44' ' ' LEU . 27.1 t70 -50.58 -56.77 10.22 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.33 0.252 . . . . 0.0 111.331 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -66.71 -45.06 79.97 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.416 HG22 ' NE2' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -75.13 -4.82 40.93 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.93 0.332 . . . . 0.0 110.934 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 63.2 50.22 3.08 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.416 ' NE2' HG22 ' A' ' 41' ' ' THR . 6.8 m-70 -130.9 45.77 2.77 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' H ' HD12 ' A' ' 44' ' ' LEU . 5.1 mp -77.59 -42.35 35.41 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -84.74 27.72 0.72 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 tt -63.26 -32.88 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 122.766 0.427 . . . . 0.0 110.456 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.76 137.73 9.93 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -59.11 -26.4 64.65 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.996 0.398 . . . . 0.0 110.99 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -61.17 -34.11 74.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -89.41 -47.42 8.03 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -57.41 -45.03 85.0 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.77 -49.17 76.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.458 ' CZ3' ' HB2' ' A' ' 9' ' ' LYS . 27.6 t90 -58.92 -50.84 72.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.72 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 66.8 mt -54.29 -42.25 69.82 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 122.104 -0.373 . . . . 0.0 110.237 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 21.7 ttt -64.12 -60.46 3.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -174.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.504 ' HA ' HG21 ' A' ' 60' ' ' VAL . 5.7 t -105.55 -3.34 22.49 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -117.74 -67.46 0.99 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.051 0.841 . . . . 0.0 111.214 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.72 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -61.01 -69.08 0.25 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.3 mt -57.94 -33.64 69.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.45 0.3 . . . . 0.0 111.077 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' A' ' 56' ' ' THR . 48.0 t -63.58 -36.55 76.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -111.75 46.85 1.08 Allowed 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -118.23 115.91 35.91 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -66.78 -4.75 11.73 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.734 2.289 . . . . 0.0 112.853 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 4.51 17.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.404 0.547 . . . . 0.0 111.182 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.23 142.16 39.42 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.87 137.58 48.1 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.91 125.96 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.6 mt -137.54 116.6 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t0 54.31 45.49 27.13 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.687 0.395 . . . . 0.0 110.082 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.03 -41.72 2.24 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -69.5 169.99 11.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.106 0.453 . . . . 0.0 109.989 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.85 125.54 54.12 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 122.524 0.33 . . . . 0.0 110.129 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.84 127.93 56.2 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.061 0.545 . . . . 0.0 110.208 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -63.4 121.02 12.77 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -77.65 115.69 51.93 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -64.93 146.0 86.87 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.264 1.976 . . . . 0.0 110.956 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -82.13 -39.38 23.38 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.27 -61.13 0.1 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.4 t30 70.25 -67.68 0.23 Allowed 'General case' 0 C--N 1.348 0.5 0 C-N-CA 123.742 0.817 . . . . 0.0 110.571 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.12 131.86 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 116.652 -1.642 . . . . 0.0 109.113 179.665 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.41 164.05 39.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t 55.82 43.25 27.99 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.56 113.06 4.85 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.3 m -158.59 165.41 34.55 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.1 t -83.52 -128.78 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.18 -166.45 10.74 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 69.02 142.0 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.256 0.622 . . . . 0.0 110.267 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.47 -45.69 0.59 Allowed 'General case' 0 C--N 1.349 0.567 0 C-N-CA 123.219 0.608 . . . . 0.0 110.53 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -75.52 -47.8 25.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 119.015 0.825 . . . . 0.0 109.637 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.93 -44.46 97.79 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.3 -43.92 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.1 tp -59.07 -47.22 86.01 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.31 -43.19 92.68 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -61.31 -43.48 98.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.7 mt -61.3 -45.65 98.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 t -58.15 -48.09 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -61.79 -42.44 99.0 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -58.32 9.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.8 ttm -55.61 -37.68 68.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 122.615 0.366 . . . . 0.0 110.442 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -60.99 -48.77 80.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.2 m -62.39 -44.68 95.86 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.425 ' HE ' ' CB ' ' A' ' 28' ' ' ASP . 3.1 ttt85 -61.48 -47.49 85.42 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.784 0.326 . . . . 0.0 110.273 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -63.18 -54.29 39.88 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.044 0.538 . . . . 0.0 109.834 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -58.63 -32.98 69.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.979 0.512 . . . . 0.0 110.447 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -66.63 -52.55 43.9 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.75 -34.31 0.1 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.775 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.425 ' CB ' ' HE ' ' A' ' 23' ' ' ARG . 5.4 m-20 -76.14 69.67 2.72 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 117.583 0.692 . . . . 0.0 109.825 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.1 p -77.32 -14.89 59.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.644 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -61.62 154.34 66.11 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 122.402 0.281 . . . . 0.0 110.711 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.24 157.62 52.99 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.598 2.198 . . . . 0.0 110.84 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 32' ' ' LEU . 17.2 mt -135.91 147.63 48.21 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.0 p -70.77 171.23 10.9 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.455 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -60.2 -54.93 39.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.69 -52.07 57.58 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.354 0.262 . . . . 0.0 110.641 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -51.68 -37.49 50.86 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 122.165 0.186 . . . . 0.0 110.545 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.0 mt -69.41 -48.51 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.5 mt -53.62 -52.03 61.18 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 117.537 0.153 . . . . 0.0 110.798 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.64 -65.12 0.51 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 122.934 0.494 . . . . 0.0 111.679 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.64 -46.15 81.16 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.34 0.256 . . . . 0.0 111.426 -177.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.453 HG22 ' NE2' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -71.98 -6.19 40.34 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.002 -178.872 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 67.94 41.55 2.07 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 122.899 0.48 . . . . 0.0 109.99 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.453 ' NE2' HG22 ' A' ' 41' ' ' THR . 7.2 m-70 -127.68 33.87 4.74 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -49.18 73.65 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.22 38.72 0.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 tt -72.1 149.62 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.11 133.41 37.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.7 tp -54.29 -35.3 62.45 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.363 0.265 . . . . 0.0 110.409 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -54.56 -46.29 73.63 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -70.2 -48.66 56.15 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -49.99 -44.13 50.8 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -69.24 -54.59 13.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.405 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 15.1 t90 -50.85 -40.14 55.34 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.709 0.404 . . . . 0.0 110.881 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.3 -39.8 88.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 73.0 mtm -89.96 -0.87 57.82 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.239 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.5 p -132.4 17.23 4.44 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.765 0.711 . . . . 0.0 111.888 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 16.1 tp10 -166.79 -70.77 0.03 OUTLIER 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.447 0.567 . . . . 0.0 111.038 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.45 -80.09 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -174.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 mt -59.29 -20.99 58.96 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 122.564 -0.085 . . . . 0.0 111.001 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 96.8 t -68.0 -40.74 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.575 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.66 54.57 1.18 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 117.844 0.293 . . . . 0.0 111.607 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -101.9 135.18 19.76 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -51.2 -44.99 39.53 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.655 2.237 . . . . 0.0 112.682 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -83.3 8.81 12.37 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -176.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.4 mm -123.88 150.85 28.45 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 118.091 0.405 . . . . 0.0 109.926 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -134.69 138.55 44.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.2 t -96.93 121.25 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -134.39 130.67 54.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 52.43 31.82 10.31 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 123.464 0.478 . . . . 0.0 111.196 176.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.42 -17.25 20.08 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -87.66 -173.25 4.24 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -127.49 137.36 52.64 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.19 154.18 51.4 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -77.3 125.68 29.71 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -73.94 116.97 57.36 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -74.54 168.39 24.92 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.427 2.085 . . . . 0.0 110.94 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -86.41 -12.01 50.33 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.95 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 73.56 6.33 5.02 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.579 0.751 . . . . 0.0 110.908 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.75 63.54 7.52 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.0 p -72.53 -34.22 47.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.183 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.489 -1.243 . . . . 0.0 109.392 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 61.3 tp -57.89 -34.45 69.82 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.439 0.296 . . . . 0.0 110.335 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -76.88 62.41 2.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.485 0.314 . . . . 0.0 110.767 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 36.84 63.82 0.7 Allowed Glycine 0 C--N 1.346 1.116 0 C-N-CA 123.641 0.639 . . . . 0.0 112.153 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.6 p -163.1 138.82 6.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.2 m -78.22 60.62 2.53 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.77 150.03 2.1 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -67.2 161.38 24.88 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.1 tttp 72.99 -67.2 0.28 Allowed 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.33 0.394 . . . . 0.0 110.051 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.8 -48.73 65.48 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.033 0.533 . . . . 0.0 110.68 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.63 -43.28 99.16 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.84 -50.35 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.51 -45.29 94.36 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.59 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.68 96.29 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -57.43 -48.82 78.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.529 ' HA ' HG21 ' A' ' 41' ' ' THR . 62.8 mt -59.7 -50.24 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.392 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 t -55.9 -48.69 78.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -62.15 -45.17 94.6 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.074 0.15 . . . . 0.0 110.66 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.432 ' CE1' ' HG3' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -59.04 -55.27 37.22 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 ttt -62.86 -35.83 81.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -60.86 -55.14 36.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 m -62.02 -43.01 99.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.432 ' HG3' ' CE1' ' A' ' 19' ' ' TYR . 14.3 mmt180 -56.26 -50.2 72.01 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.824 0.45 . . . . 0.0 109.905 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -63.81 -38.76 92.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -83.82 48.74 1.49 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -162.79 -50.14 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.1 -31.95 0.12 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -81.19 60.29 4.25 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.069 0.434 . . . . 0.0 110.175 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -6.32 59.13 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -70.12 155.13 93.96 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -70.02 147.11 60.46 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.73 2.287 . . . . 0.0 111.957 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 32' ' ' LEU . 19.3 mt -134.55 144.91 48.26 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.477 0.711 . . . . 0.0 109.447 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -64.52 173.65 2.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.013 0.435 . . . . 0.0 110.027 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -58.3 9.15 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.644 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -59.06 -38.5 79.55 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 119.599 -0.238 . . . . 0.0 111.411 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.25 -39.53 79.41 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.419 ' CG2' HG23 ' A' ' 16' ' ' ILE . 51.2 mt -68.43 -42.58 84.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 mt -59.8 -46.66 88.5 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.676 -0.12 . . . . 0.0 110.676 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -48.52 -59.48 3.46 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.645 0.378 . . . . 0.0 111.059 -177.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -56.84 -42.37 79.52 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.386 0.274 . . . . 0.0 111.077 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 16' ' ' ILE . 47.0 p -80.19 4.69 16.69 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.876 -0.583 . . . . 0.0 111.213 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? 72.45 -15.37 0.49 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.846 0.858 . . . . 0.0 111.618 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -78.18 42.73 0.42 Allowed 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 118.409 0.55 . . . . 0.0 111.285 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.38 -45.59 54.0 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.67 -0.644 . . . . 0.0 109.421 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.11 -55.14 31.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 47' ' ' GLY . 4.0 tt 34.74 -132.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.095 0.958 . . . . 0.0 110.533 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 46' ' ' ILE . . . -154.35 151.21 22.92 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tt -56.17 -44.55 79.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.542 0.671 . . . . 0.0 110.493 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -59.73 -45.77 91.17 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.163 0.185 . . . . 0.0 110.628 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.1 -48.8 61.6 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -52.37 -48.51 65.55 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -63.19 -48.03 80.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.421 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 26.5 t90 -53.78 -46.03 70.89 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.459 0.304 . . . . 0.0 110.405 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 62.8 mt -61.86 -40.72 96.35 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 40.0 ttm -76.13 -26.86 56.74 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.2 t -118.81 -8.05 10.38 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -174.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.421 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 26.8 tt0 -132.9 -49.09 0.87 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.152 0.887 . . . . 0.0 112.404 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -79.2 -63.52 1.4 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -174.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.0 mt -80.36 2.49 24.65 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -173.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -73.83 -93.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.773 0.715 . . . . 0.0 109.422 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -83.96 51.61 2.09 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -80.85 135.01 52.43 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.113 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -64.82 -25.02 60.75 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.112 1.875 . . . . 0.0 111.266 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -108.8 1.34 20.91 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 119.011 -0.518 . . . . 0.0 112.037 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.36 134.5 22.93 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 118.776 0.716 . . . . 0.0 110.014 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -115.89 157.38 24.57 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 68' ' ' ILE . 17.7 t -100.62 126.79 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.592 HD12 ' C ' ' A' ' 67' ' ' VAL . 3.5 mp -135.42 121.43 31.52 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t0 51.53 46.96 25.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.823 0.449 . . . . 0.0 110.455 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.81 -39.49 2.0 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -73.16 176.29 6.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -117.49 153.0 33.9 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB3' HD13 ' A' ' 68' ' ' ILE . . . -144.19 139.07 28.53 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -64.82 133.86 52.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -90.14 115.92 65.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.112 0.565 . . . . 0.0 110.187 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.25 107.8 2.35 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.338 2.025 . . . . 0.0 110.135 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.41 -46.78 84.82 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -137.7 15.77 2.91 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 61.42 -155.31 0.35 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.79 150.12 34.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.0 ttm105 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 116.663 -1.637 . . . . 0.0 109.435 179.89 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tt 73.32 -68.06 0.24 Allowed 'General case' 0 C--N 1.346 0.451 0 C-N-CA 123.074 0.549 . . . . 0.0 109.816 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 t -76.18 74.36 3.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.34 -92.44 0.09 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.6 p -163.99 52.14 0.14 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -75.38 84.34 2.5 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.65 -166.77 54.68 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 66.48 145.13 0.03 OUTLIER 'General case' 0 C--N 1.348 0.515 0 C-N-CA 123.263 0.625 . . . . 0.0 110.134 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.436 ' HG3' ' CH2' ' A' ' 53' ' ' TRP . 5.6 pttt 77.68 -48.71 0.5 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.268 0.627 . . . . 0.0 110.622 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -68.59 -47.4 66.84 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.103 0.41 . . . . 0.0 110.543 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.73 -36.11 88.63 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.467 HG13 ' CD2' ' A' ' 43' ' ' HIS . 14.1 t -72.69 -49.81 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.3 tp -57.69 -40.91 80.52 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.77 0.428 . . . . 0.0 110.775 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.14 -49.49 77.66 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -62.55 -38.94 92.0 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.46 HG23 HG21 ' A' ' 37' ' ' ILE . 41.1 mt -60.84 -49.0 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.53 -47.92 86.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -65.77 -40.32 91.91 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.424 ' CE1' ' HG2' ' A' ' 40' ' ' GLU . 1.8 t80 -60.17 -56.65 18.96 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.524 0.33 . . . . 0.0 110.27 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -40.66 86.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -55.84 -47.39 77.33 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -63.37 -47.61 81.39 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.395 0.278 . . . . 0.0 110.921 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' A' ' 28' ' ' ASP . 2.2 mtp180 -58.55 -48.72 79.95 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -60.2 -40.26 89.48 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -61.85 -42.74 99.42 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -65.82 -45.65 81.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.461 0.304 . . . . 0.0 110.311 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.91 -20.83 0.3 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.407 ' CG ' HH21 ' A' ' 23' ' ' ARG . 14.9 t70 -79.83 68.78 6.02 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -87.53 -5.69 58.67 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.979 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -64.22 148.46 95.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 O-C-N 122.329 -0.232 . . . . 0.0 110.436 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.08 146.67 86.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.038 2.492 . . . . 0.0 112.251 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.2 mt -134.78 136.53 42.65 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.6 p -63.12 169.91 3.16 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.059 0.457 . . . . 0.0 110.049 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tt -58.35 -51.44 69.79 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -58.14 -44.75 87.99 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.59 0.356 . . . . 0.0 110.99 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -56.59 -30.43 63.19 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.46 HG21 HG23 ' A' ' 16' ' ' ILE . 49.4 mt -78.3 -42.99 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.3 mt -55.26 -43.58 74.78 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -49.47 -50.08 42.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.381 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG2' ' CE1' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -77.28 -49.8 14.25 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.204 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 16' ' ' ILE . 54.5 p -69.08 -3.49 13.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.251 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 65.47 45.95 2.65 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.467 ' CD2' HG13 ' A' ' 12' ' ' VAL . 7.1 m-70 -125.57 42.29 3.32 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.413 ' H ' HD12 ' A' ' 44' ' ' LEU . 4.6 mp -74.57 -49.7 20.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.59 42.53 0.91 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.4 tt -72.82 -36.13 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 122.816 0.446 . . . . 0.0 110.309 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.69 132.19 6.78 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.9 -36.21 62.45 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.821 0.311 . . . . 0.0 110.368 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -50.13 -44.09 52.16 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -78.25 -46.9 19.11 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.484 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -50.61 -49.67 55.99 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -48.95 78.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.436 ' CH2' ' HG3' ' A' ' 9' ' ' LYS . 12.8 t90 -55.76 -53.27 58.74 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 78.0 mt -54.95 -44.02 73.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -53.09 61.82 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.303 -175.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' HG21 ' A' ' 60' ' ' VAL . 7.1 t -120.15 48.18 1.62 Allowed 'General case' 0 C--N 1.348 0.541 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -175.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -165.75 -66.11 0.03 OUTLIER 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -64.5 -69.39 0.29 Allowed 'General case' 0 C--O 1.224 -0.267 0 O-C-N 122.904 0.127 . . . . 0.0 111.168 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.7 mt -59.72 -25.28 64.7 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.416 0.286 . . . . 0.0 111.088 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.439 HG21 ' HA ' ' A' ' 56' ' ' THR . 46.5 t -75.2 -47.89 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -102.26 66.02 0.98 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -143.89 118.55 6.07 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.36 -23.3 74.25 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.602 2.202 . . . . 0.0 112.285 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -93.87 12.35 26.22 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 117.793 0.27 . . . . 0.0 110.95 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mm -135.68 152.02 30.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -144.8 142.37 29.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.7 t -96.06 127.5 48.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.049 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.7 mm -112.59 -120.97 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -81.02 67.51 6.95 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.19 -36.86 1.96 Allowed Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -75.25 169.25 18.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 117.111 0.455 . . . . 0.0 109.999 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -112.47 120.81 42.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.48 134.59 51.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -64.47 135.03 55.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -97.23 118.27 64.77 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -66.34 120.95 8.15 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.311 2.007 . . . . 0.0 110.24 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -166.36 -80.35 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -89.53 67.16 7.51 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -89.25 28.87 1.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.291 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.54 -32.55 58.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.387 0 CA-C-O 117.048 -1.453 . . . . 0.0 108.906 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.6 tp -76.62 86.77 3.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.0 p -80.21 63.46 4.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.97 -71.97 1.06 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.1 p 46.15 -131.95 1.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.27 0.628 . . . . 0.0 110.605 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.9 p -92.94 28.54 2.07 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.538 0.335 . . . . 0.0 110.404 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.78 -24.2 67.76 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -56.94 114.04 1.93 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.44 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER 72.51 -65.18 0.36 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.95 0.9 . . . . 0.0 110.502 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -58.11 -37.45 74.58 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 122.868 0.467 . . . . 0.0 111.383 -175.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.48 -48.17 76.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.06 -41.97 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.728 HD13 ' HB1' ' A' ' 58' ' ' ALA . 62.6 tp -60.82 -47.55 85.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.91 -44.14 91.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -60.7 -47.33 86.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.32 -49.66 82.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.8 t -55.68 -43.8 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 122.663 0.385 . . . . 0.0 110.152 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -65.11 -48.22 74.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -50.25 73.03 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.3 mmm -55.73 -45.54 77.94 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -43.02 87.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.6 m -61.27 -51.36 69.24 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 119.422 -0.323 . . . . 0.0 111.285 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.65 -34.4 78.13 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.857 0.753 . . . . 0.0 109.691 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -65.37 -35.37 80.75 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -69.74 -42.35 74.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.078 0.551 . . . . 0.0 110.436 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -65.75 -36.19 82.85 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.69 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.99 -23.37 0.6 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-O 119.695 -0.503 . . . . 0.0 111.935 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.74 66.68 2.71 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.651 0.726 . . . . 0.0 109.658 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.2 p -76.42 -4.16 40.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.079 0.152 . . . . 0.0 110.676 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -66.03 156.14 85.06 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -70.32 162.46 42.26 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.708 2.272 . . . . 0.0 110.881 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.2 mt -138.65 150.28 46.06 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 177.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.3 p -77.88 167.94 20.71 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -44.83 92.5 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.0 -54.45 46.63 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -54.58 -43.03 71.74 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 122.582 0.353 . . . . 0.0 110.339 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.2 mt -59.13 -62.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.2 mt -54.81 -42.34 71.72 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.162 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -52.1 -54.91 24.63 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -64.05 -31.99 73.38 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.02 13.79 5.68 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 74.44 -58.51 0.58 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 124.312 1.045 . . . . 0.0 112.592 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.76 77.75 0.45 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.615 0.366 . . . . 0.0 111.944 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.94 -33.98 51.37 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 47' ' ' GLY . 19.4 t70 -68.98 -55.37 11.1 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 tt 50.26 -70.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.675 1.59 . . . . 0.0 112.693 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 45' ' ' ASP . . . 142.46 126.34 2.09 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.5 tp -46.81 -44.96 19.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.261 0.53 . . . . 0.0 111.238 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.6 -39.21 61.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.196 0.198 . . . . 0.0 111.244 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -87.97 -48.05 8.08 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -48.11 -48.84 33.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.118 0.567 . . . . 0.0 110.495 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.39 -47.43 76.33 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.44 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 31.2 t90 -55.8 -40.27 72.46 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 122.376 0.27 . . . . 0.0 110.425 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.731 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 77.5 mt -58.66 -49.0 79.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 83.1 mtp -64.84 -47.98 75.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.279 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.5 p -110.32 34.35 3.97 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -173.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -168.17 -75.17 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.738 0.699 . . . . 0.0 110.681 177.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.731 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -52.49 -53.78 41.24 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.7 mt -79.92 -20.1 46.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.756 -0.164 . . . . 0.0 111.041 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.89 -69.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.95 60.13 5.7 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -107.44 122.81 40.05 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.128 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -63.48 -19.6 68.15 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.247 1.964 . . . . 0.0 111.845 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -125.86 19.69 7.8 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.1 mt -146.0 129.69 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -111.46 154.12 25.15 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.3 t -105.93 144.29 15.58 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.0 mt -126.52 -125.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.51 65.04 3.71 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.29 -37.34 2.57 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 171.31 14.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -122.99 147.69 46.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.94 136.51 33.9 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -66.71 130.23 42.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -77.42 129.84 76.23 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.5 157.09 9.99 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.651 2.234 . . . . 0.0 112.188 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm 71.22 -173.41 0.17 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 123.848 0.859 . . . . 0.0 110.131 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.2 32.73 0.08 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.845 -178.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -153.44 101.05 2.48 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.45 150.48 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 116.815 -1.565 . . . . 0.0 109.15 179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.44 ' HB3' ' CH2' ' A' ' 53' ' ' TRP . 17.7 mtmt . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 120.486 0.184 . . . . 0.0 110.716 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -56.38 -51.85 66.77 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.775 -173.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.38 -49.77 74.92 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.646 HG13 ' CD2' ' A' ' 43' ' ' HIS . 3.3 t -58.81 -45.73 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.463 HD13 ' HB1' ' A' ' 58' ' ' ALA . 55.9 tp -61.28 -45.5 94.23 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -38.0 82.58 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -69.4 -38.34 77.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.21 -48.85 85.62 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.59 -48.35 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -60.66 -43.71 97.3 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -60.73 -57.48 12.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 95.4 mtp -55.86 -40.84 73.48 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -59.35 -48.3 82.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.6 m -66.45 -51.18 59.61 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.124 0.17 . . . . 0.0 110.771 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -59.18 -36.7 75.78 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -68.56 -41.81 79.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -58.26 -48.34 80.73 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.871 0.468 . . . . 0.0 111.386 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -65.25 -33.38 75.84 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.73 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.25 -31.05 0.48 Allowed Glycine 0 C--N 1.346 1.085 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.627 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.95 70.2 2.65 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 117.95 0.875 . . . . 0.0 109.956 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.2 p -79.58 -4.16 50.25 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -61.89 155.71 60.99 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 122.662 0.385 . . . . 0.0 110.793 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -67.4 158.51 56.7 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.613 2.208 . . . . 0.0 110.622 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 32' ' ' LEU . 12.1 mt -137.06 140.34 41.95 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.6 p -64.72 167.59 7.2 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.51 -48.92 79.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.68 -49.76 74.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.534 0.334 . . . . 0.0 110.924 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -52.58 -36.11 55.43 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.62 -45.29 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.2 mt -47.97 -57.84 5.21 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 117.852 0.296 . . . . 0.0 110.669 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.99 -63.86 0.88 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.934 0.494 . . . . 0.0 111.577 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -59.95 -27.17 66.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.494 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 67.4 p -93.32 -0.99 56.47 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.491 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 66.6 41.15 3.16 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.846 0.458 . . . . 0.0 109.961 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.646 ' CD2' HG13 ' A' ' 12' ' ' VAL . 7.9 m-70 -129.72 44.13 3.02 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.414 ' O ' HG22 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -76.74 -51.28 11.71 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.07 -39.85 91.46 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.894 HG23 ' H ' ' A' ' 47' ' ' GLY . 18.5 tt 26.28 -105.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.866 1.266 . . . . 0.0 112.325 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.894 ' H ' HG23 ' A' ' 46' ' ' ILE . . . 157.34 148.84 5.24 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 108.04 -2.024 . . . . 0.0 108.04 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.4 tp -53.9 -39.97 66.23 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 117.397 0.599 . . . . 0.0 110.676 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -55.86 -58.92 5.82 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.227 0.211 . . . . 0.0 110.553 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.11 -50.14 62.53 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-O 119.513 -0.279 . . . . 0.0 110.395 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -46.01 -51.12 14.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.556 0.342 . . . . 0.0 110.47 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -64.53 -47.44 78.79 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.44 ' CH2' ' HB3' ' A' ' 9' ' ' LYS . 39.6 t90 -56.6 -41.53 77.17 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.381 0.272 . . . . 0.0 110.67 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 80.4 mt -61.07 -45.53 94.35 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 5.0 mmt -66.83 -47.18 72.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.729 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.3 p -110.91 33.39 4.61 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -173.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.45 -67.39 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.821 0.737 . . . . 0.0 111.092 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -63.58 -62.33 1.73 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.3 mt -79.71 27.93 0.28 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.88 -38.8 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -88.21 -30.54 19.64 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -60.8 120.71 55.81 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.22 -36.89 54.63 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.661 2.241 . . . . 0.0 112.183 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -66.77 -20.51 65.96 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 119.678 -0.201 . . . . 0.0 110.921 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.8 mm -92.5 117.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -106.59 122.57 46.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.7 t -83.56 121.36 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.1 mt -115.96 -98.66 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 71' ' ' LYS . 21.0 t0 -82.47 52.81 2.15 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.76 -33.01 1.43 Allowed Glycine 0 CA--C 1.534 1.265 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 69' ' ' ASP . 48.1 mttp -77.8 176.51 8.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.228 0.611 . . . . 0.0 109.542 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -109.1 129.25 55.47 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.489 0.185 . . . . 0.0 110.729 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.15 172.32 8.34 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -97.11 148.14 23.33 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -104.02 106.96 55.52 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.778 0.431 . . . . 0.0 111.799 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 N--CA 1.449 -1.144 0 C-N-CA 122.75 2.3 . . . . 0.0 110.644 177.674 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HG3' ' CH2' ' A' ' 53' ' ' TRP . 1.5 ptmt . . . . . 0 N--CA 1.47 0.569 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -69.32 -46.34 67.33 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.73 -49.86 67.45 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.24 -45.4 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 117.015 0.407 . . . . 0.0 110.224 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.63 -37.87 76.85 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.27 74.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -61.98 -50.21 73.01 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.504 ' HA ' HG21 ' A' ' 41' ' ' THR . 96.1 mt -57.76 -55.83 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.228 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 t -56.6 -44.4 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.144 0.178 . . . . 0.0 110.98 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -65.86 -52.19 52.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.57 0.168 . . . . 0.0 111.152 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -46.81 88.4 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 66.9 mmm -53.6 -48.79 68.94 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.92 -66.62 0.37 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 122.51 0.324 . . . . 0.0 110.71 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 m -52.55 -45.61 66.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.661 0.384 . . . . 0.0 111.999 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.513 HH21 HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -73.27 -24.36 60.43 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 122.253 -0.279 . . . . 0.0 111.06 -176.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -78.33 -39.13 40.5 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -62.04 -40.37 95.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -52.64 -54.14 37.41 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 122.497 0.319 . . . . 0.0 110.341 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.4 -22.31 0.25 Allowed Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -82.06 46.38 1.01 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 117.621 0.711 . . . . 0.0 110.006 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.74 -5.13 7.81 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.65 0.78 . . . . 0.0 111.291 -179.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.446 ' CE1' HD21 ' A' ' 32' ' ' LEU . 2.3 p-80 -54.88 153.42 11.41 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 122.446 0.298 . . . . 0.0 111.042 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.23 153.6 58.09 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.764 2.309 . . . . 0.0 111.08 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.513 HD11 HH21 ' A' ' 23' ' ' ARG . 16.2 mt -132.16 142.84 49.61 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.0 p -71.9 172.14 10.46 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -48.83 78.61 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.09 -52.39 61.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.89 0.476 . . . . 0.0 110.996 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -51.83 -42.32 62.46 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 122.468 0.307 . . . . 0.0 110.832 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.45 -57.75 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.582 ' CD1' HD11 ' A' ' 46' ' ' ILE . 89.5 mt -51.87 -39.95 59.79 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.255 0.222 . . . . 0.0 111.43 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -55.39 -52.84 62.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.722 -0.103 . . . . 0.0 110.722 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -75.44 -37.48 60.35 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.127 0.171 . . . . 0.0 110.967 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 16' ' ' ILE . 71.0 p -87.26 91.95 8.9 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -26.47 72.71 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.554 1.941 . . . . 0.0 115.592 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 41' ' ' THR . 1.3 p80 -178.58 58.12 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.89 56.68 4.08 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -162.21 -45.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER 40.88 -89.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.597 0 C-N-CA 124.821 1.248 . . . . 0.0 112.3 177.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 140.11 168.95 11.51 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 107.166 -2.373 . . . . 0.0 107.166 -175.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.28 -49.37 77.38 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.65 0.725 . . . . 0.0 110.151 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -52.36 -55.7 19.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.312 0.245 . . . . 0.0 111.117 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -66.96 -58.58 4.68 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.282 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.606 ' HB2' HD12 ' A' ' 46' ' ' ILE . 24.6 ttpp -48.94 -42.91 38.98 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 118.033 0.379 . . . . 0.0 110.7 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -68.15 -56.78 7.54 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.412 ' CH2' ' HG3' ' A' ' 9' ' ' LYS . 23.3 t90 -52.58 -52.6 54.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 123.151 0.282 . . . . 0.0 110.625 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 76.8 mt -57.07 -49.93 74.32 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.19 0.196 . . . . 0.0 110.762 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 59.2 ttm -62.09 -57.66 10.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -174.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -109.78 16.86 21.77 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -138.84 -54.21 0.59 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.432 1.015 . . . . 0.0 111.295 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.54 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -75.68 -64.76 1.01 Allowed 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -173.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.03 -29.64 70.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.3 m -67.95 -18.71 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.144 -0.455 . . . . 0.0 111.998 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.3 p30 -136.57 15.14 3.17 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 118.67 0.668 . . . . 0.0 111.783 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -69.38 132.78 89.47 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -53.37 -27.18 38.15 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.818 2.345 . . . . 0.0 113.249 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -112.36 30.25 7.24 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.242 0.474 . . . . 0.0 111.675 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.7 mm -135.3 150.51 29.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -142.69 148.3 37.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.78 110.96 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.5 mt -129.52 126.47 63.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.5 t70 58.03 27.11 14.38 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.705 0.402 . . . . 0.0 109.984 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.15 -13.38 26.61 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -91.57 174.12 7.53 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -105.26 118.28 36.16 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.43 148.64 32.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -75.32 121.56 22.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -88.02 116.39 66.05 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo . . . . . 0 N--CA 1.447 -1.213 0 C-N-CA 122.123 1.882 . . . . 0.0 110.094 -179.936 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.448 ' HB2' ' CZ3' ' A' ' 53' ' ' TRP . 20.5 ptmt . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -68.58 -42.48 78.19 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.95 72.89 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.87 -45.58 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.4 tp -58.53 -46.14 87.41 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.13 99.35 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -62.55 -44.17 97.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.509 ' HA ' HG21 ' A' ' 41' ' ' THR . 45.9 mt -60.85 -51.03 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 t -55.04 -47.74 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.2 -48.52 81.38 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 110.561 -0.162 . . . . 0.0 110.561 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -55.9 28.49 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -39.34 72.16 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -44.25 97.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.1 m -66.0 -45.49 81.37 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.135 0.174 . . . . 0.0 110.594 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -67.15 -40.59 86.72 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -61.25 -45.2 95.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -79.3 59.98 2.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.87 -51.71 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 177.48 -47.68 0.1 OUTLIER Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -76.61 73.25 3.31 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 116.97 0.385 . . . . 0.0 110.288 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.4 p -81.88 -12.18 58.57 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -63.64 154.24 80.73 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.577 0.351 . . . . 0.0 110.51 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.68 158.15 58.07 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.56 2.173 . . . . 0.0 111.386 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 32' ' ' LEU . 22.4 mt -133.04 149.7 52.17 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -61.99 166.54 4.54 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tt -59.05 -52.45 65.68 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.02 -40.58 89.79 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.06 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -58.04 -43.51 86.87 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.4 mt -64.29 -43.97 97.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.36 -52.41 65.49 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -45.38 -56.89 4.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.575 0.35 . . . . 0.0 111.224 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -60.42 -34.75 74.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.549 0.34 . . . . 0.0 111.77 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 16' ' ' ILE . 17.7 p -83.35 9.01 11.92 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 119.644 -0.217 . . . . 0.0 111.092 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 69.38 38.61 1.79 Allowed 'General case' 0 C--N 1.344 0.347 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.495 ' CE1' ' O ' ' A' ' 41' ' ' THR . 5.8 m-70 -132.37 167.05 20.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mt 166.26 -52.59 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.06 7.91 9.81 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 50' ' ' GLN . 3.5 tt -48.48 147.21 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.469 0 C-N-CA 123.596 0.759 . . . . 0.0 110.237 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.35 133.43 19.9 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.3 tp -56.49 -31.05 63.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -58.02 -45.69 86.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.48 ' HB3' HD11 ' A' ' 46' ' ' ILE . 18.2 mp0 -68.56 -47.8 65.9 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -55.69 -43.92 76.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -66.53 -50.7 62.3 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.448 ' CZ3' ' HB2' ' A' ' 9' ' ' LYS . 31.5 t90 -55.16 -45.66 75.71 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.457 0.303 . . . . 0.0 110.442 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.694 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 37.2 mt -56.08 -43.25 77.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.2 ttm -71.73 -50.37 30.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.5 p -104.94 23.49 13.47 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 36.0 tt0 -160.32 -68.89 0.07 Allowed 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 119.241 0.928 . . . . 0.0 111.567 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.694 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -55.55 -66.71 0.37 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.09 -41.52 99.41 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -65.27 -37.92 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 117.834 0.288 . . . . 0.0 110.591 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -101.78 58.35 0.84 Allowed 'General case' 0 C--N 1.342 0.279 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -148.1 112.66 3.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.29 -27.61 81.59 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.515 2.143 . . . . 0.0 111.812 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -74.92 -5.14 42.15 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.944 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.1 mm -120.5 138.21 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -126.6 119.66 27.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.29 139.06 18.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.6 mt -131.79 -96.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.316 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.64 55.25 3.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.53 -39.05 1.47 Allowed Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -72.27 161.42 30.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -108.52 128.55 54.9 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.866 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.2 163.01 15.81 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -92.87 125.47 37.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -78.8 122.46 84.73 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 C--N 1.357 0.974 0 C-N-CA 122.835 2.357 . . . . 0.0 110.955 179.573 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt . . . . . 0 CA--C 1.515 -0.392 0 CA-C-O 121.051 0.453 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -60.78 -37.05 80.56 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.979 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.15 -49.68 69.38 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.503 HG13 ' CD2' ' A' ' 43' ' ' HIS . 6.2 t -60.12 -41.99 88.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.62 HD13 ' HB1' ' A' ' 58' ' ' ALA . 59.8 tp -61.36 -43.5 98.76 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.07 -48.8 80.28 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.021 0.128 . . . . 0.0 111.084 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.11 -30.52 67.73 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 120.643 -0.423 . . . . 0.0 109.993 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.8 mt -64.64 -46.05 93.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.89 -41.75 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.67 -47.81 77.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -44.29 95.05 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 89.2 mmm -62.51 -37.24 85.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -69.28 -53.54 19.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 m -54.1 -48.92 70.21 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.413 0.285 . . . . 0.0 111.011 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 ptm85 -64.44 -40.02 94.94 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -64.96 -19.62 66.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -88.36 -39.53 14.26 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.663 0.385 . . . . 0.0 110.68 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -69.88 -37.32 76.0 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 117.593 0.179 . . . . 0.0 110.588 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.7 48.45 0.06 OUTLIER Glycine 0 C--N 1.342 0.88 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -140.46 53.96 1.62 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.7 p -78.89 -10.09 59.7 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.679 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -61.89 147.58 89.45 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.8 151.72 68.85 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.863 2.376 . . . . 0.0 111.647 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.3 mt -131.28 142.38 50.12 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.7 p -70.53 170.85 11.26 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -46.41 90.41 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.55 -54.65 38.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.604 0.362 . . . . 0.0 110.444 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -52.28 -35.8 51.12 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.595 0.358 . . . . 0.0 111.108 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.6 mt -67.4 -48.85 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.4 mt -59.54 -43.78 93.39 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.11 -62.21 1.78 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.524 0.329 . . . . 0.0 111.164 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.07 -50.58 70.6 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.5 p -76.64 -1.29 26.97 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.588 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 56.68 60.2 3.19 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.503 ' CD2' HG13 ' A' ' 12' ' ' VAL . 9.4 m-70 -129.35 31.37 4.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 mt -77.18 67.73 3.2 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -163.54 -40.65 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.51 ' CD1' ' H ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 18.18 -88.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.928 0 C-N-CA 125.441 1.496 . . . . 0.0 112.759 178.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.51 ' H ' ' CD1' ' A' ' 46' ' ' ILE . . . 132.77 160.48 9.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 107.351 -2.299 . . . . 0.0 107.351 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 tp -55.34 -43.81 75.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.756 0.778 . . . . 0.0 109.641 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -59.37 -53.37 58.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.522 0.329 . . . . 0.0 110.635 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -64.99 -57.66 8.12 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 119.669 -0.205 . . . . 0.0 111.083 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HB2' HD13 ' A' ' 46' ' ' ILE . 27.4 ttpp -48.71 -48.83 40.04 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 120.636 0.255 . . . . 0.0 110.392 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -62.5 -52.92 61.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.255 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -54.65 -49.22 71.1 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 122.286 0.235 . . . . 0.0 110.657 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 69.3 mt -56.22 -52.32 64.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 45.8 ttp -63.15 -40.78 98.55 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.2 p -114.48 27.49 9.42 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.29 -66.86 0.05 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.811 0.732 . . . . 0.0 110.749 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.743 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -64.35 -20.06 65.86 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.8 mt -121.23 21.84 11.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.201 0.455 . . . . 0.0 111.312 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.22 -41.78 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.22 -30.7 23.65 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -57.41 114.91 9.19 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.999 0.52 . . . . 0.0 109.962 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.83 -21.52 73.15 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.524 2.149 . . . . 0.0 111.786 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -80.96 0.68 34.42 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.543 -0.265 . . . . 0.0 110.714 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 mm -127.76 147.89 32.44 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -136.54 149.71 48.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.0 t -102.79 116.81 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.17 132.46 65.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 57.24 26.95 12.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.708 0.403 . . . . 0.0 110.136 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 -17.57 10.3 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -86.91 -179.63 6.55 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -116.05 137.6 51.98 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.657 0.265 . . . . 0.0 110.54 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.48 151.44 48.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -71.7 126.48 29.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -77.7 117.33 64.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.447 -1.223 0 C-N-CA 122.227 1.951 . . . . 0.0 111.426 -178.6 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 110.728 -0.101 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -55.04 -40.57 70.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.638 0.375 . . . . 0.0 110.96 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.25 -45.06 96.04 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.72 -45.1 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.26 -42.61 98.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.049 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.96 86.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -67.96 -41.56 82.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.449 ' HA ' HG21 ' A' ' 41' ' ' THR . 35.2 mt -62.14 -45.83 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.54 -50.12 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -58.71 -43.54 90.12 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -58.56 8.02 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.9 mmm -54.36 -42.42 70.25 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -50.49 72.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 122.466 0.306 . . . . 0.0 110.505 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.7 m -61.83 -49.13 77.52 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -58.16 -45.13 88.01 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -62.14 -34.3 76.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -73.11 -16.98 61.45 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.506 0.322 . . . . 0.0 110.553 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.05 -52.15 4.85 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 122.49 0.316 . . . . 0.0 110.171 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.54 -30.73 0.11 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -75.35 78.28 2.43 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.2 p -93.92 -17.03 23.43 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.196 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -66.06 154.46 89.65 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 117.6 0.182 . . . . 0.0 111.012 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.8 156.6 63.3 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.075 2.517 . . . . 0.0 111.76 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -137.96 147.7 44.54 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 122.906 0.482 . . . . 0.0 109.772 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.0 p -63.64 170.99 2.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 109.923 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -55.85 29.56 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.81 -42.3 79.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.286 0.234 . . . . 0.0 111.25 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.81 -35.07 70.35 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.2 mt -69.76 -40.98 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.63 -41.92 82.32 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.435 ' HA ' HD11 ' A' ' 44' ' ' LEU . 31.8 t70 -50.28 -62.51 1.54 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.199 0.2 . . . . 0.0 111.011 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.4 -46.32 86.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.84 0.456 . . . . 0.0 111.671 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.449 HG21 ' HA ' ' A' ' 16' ' ' ILE . 48.1 p -75.65 -6.69 51.7 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 119.243 -0.408 . . . . 0.0 111.653 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 61.0 52.95 3.85 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.429 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.0 m-70 -129.16 36.32 4.18 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.387 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 44' ' ' LEU . 4.0 mp -69.35 -45.84 68.45 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -83.13 62.18 6.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.8 tt -101.75 146.69 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.831 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.95 136.06 48.78 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.6 tp -52.1 -39.32 59.62 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.944 0.372 . . . . 0.0 110.64 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -62.96 -40.03 96.45 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -70.02 -50.39 41.88 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -51.39 -47.15 62.99 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -60.65 -56.52 20.27 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.669 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -50.48 -46.88 57.22 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 122.795 0.438 . . . . 0.0 111.202 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 68.3 mt -56.99 -44.92 83.2 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 21.5 ttt -76.89 -34.36 57.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.2 p -101.34 -4.47 26.94 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -138.77 -74.43 0.38 Allowed 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.028 0.831 . . . . 0.0 111.567 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.83 -63.43 1.11 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.4 mt -73.07 4.04 4.8 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.4 m -116.86 6.3 7.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 CA-C-N 118.826 0.739 . . . . 0.0 110.679 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -145.81 -15.78 0.47 Allowed 'General case' 0 C--N 1.348 0.51 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.483 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -63.9 117.88 40.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.34 -25.27 77.8 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.558 2.172 . . . . 0.0 112.346 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.405 ' C ' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -76.66 -12.51 60.01 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 119.357 -0.354 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.405 HD12 ' C ' ' A' ' 64' ' ' LYS . 1.5 mp -115.33 144.68 22.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.38 130.14 51.96 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -89.15 125.73 42.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.3 mm -116.94 -108.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -82.52 55.88 3.1 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.75 -34.47 2.09 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -77.05 166.36 23.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.87 125.17 52.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.239 0.216 . . . . 0.0 110.796 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.8 172.51 6.89 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -94.79 122.71 37.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -73.95 114.94 37.55 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo . . . . . 0 N--CA 1.447 -1.239 0 C-N-CA 122.309 2.006 . . . . 0.0 110.922 -178.191 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HB2' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -67.35 -49.7 62.96 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.327 0.251 . . . . 0.0 110.748 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.91 -47.59 87.92 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.537 HG13 ' ND1' ' A' ' 43' ' ' HIS . 2.4 t -63.9 -49.53 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 tp -56.91 -47.95 79.36 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.67 99.22 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.172 0.189 . . . . 0.0 110.711 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.91 -42.12 95.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.9 mt -60.3 -50.04 81.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 t -54.56 -44.77 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 122.411 0.285 . . . . 0.0 110.269 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -70.77 -39.0 73.47 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.321 0.105 . . . . 0.0 110.859 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -64.05 -52.98 56.83 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 96.0 mtp -61.63 -31.55 71.65 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -55.92 14.65 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.2 m -57.44 -40.33 78.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.447 ' HG3' ' CE1' ' A' ' 19' ' ' TYR . 42.4 mmt-85 -60.87 -50.82 71.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.94 0.496 . . . . 0.0 110.29 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -62.37 -22.07 65.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.447 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -88.9 16.18 7.34 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.654 0.382 . . . . 0.0 110.489 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -136.81 -47.09 0.6 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 117.611 0.187 . . . . 0.0 110.721 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 178.21 -38.64 0.08 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -73.44 76.86 1.41 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.5 p -100.77 -30.26 11.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.141 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.6 161.97 7.27 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 123.627 0.771 . . . . 0.0 111.288 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -68.81 124.6 11.65 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.201 1.934 . . . . 0.0 110.839 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.4 mt -101.24 153.86 19.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 p -69.79 167.36 17.37 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.68 -56.16 25.72 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -57.64 -40.23 78.77 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.516 -0.278 . . . . 0.0 111.621 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.0 -37.61 71.9 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 118.084 0.402 . . . . 0.0 109.982 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.3 mt -71.62 -40.62 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.69 -57.24 11.7 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.454 0.115 . . . . 0.0 111.195 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -40.83 67.83 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.189 0.196 . . . . 0.0 111.349 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.9 -3.17 37.28 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.585 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 16.7 p -120.6 0.78 10.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.105 0.412 . . . . 0.0 110.289 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.434 ' N ' ' NE2' ' A' ' 42' ' ' GLN . 10.4 mm-40 73.04 26.1 2.24 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.445 0.698 . . . . 0.0 109.132 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.585 ' CE1' ' HB ' ' A' ' 41' ' ' THR . 26.6 m170 -106.56 38.45 2.06 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' O ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -83.62 -38.75 21.17 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.51 -44.79 95.62 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.931 HG23 ' H ' ' A' ' 47' ' ' GLY . 16.3 tt 22.47 -102.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.26 1.424 . . . . 0.0 112.787 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.931 ' H ' HG23 ' A' ' 46' ' ' ILE . . . 153.05 148.94 5.02 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.3 tt -54.95 -42.15 71.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.515 0.658 . . . . 0.0 110.253 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -59.24 -51.02 71.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.416 0.286 . . . . 0.0 110.644 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -65.77 -51.32 60.08 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.273 0.229 . . . . 0.0 110.533 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -53.33 -50.48 64.9 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -58.53 -49.15 78.45 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' A' ' 9' ' ' LYS . 22.8 t90 -54.44 -50.93 66.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 79.1 mt -57.46 -47.87 80.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.3 ttt -60.17 -49.75 76.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.324 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.8 t -123.69 52.19 1.45 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.31 0.505 . . . . 0.0 112.221 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -167.58 -55.16 0.02 OUTLIER 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.255 -0.278 . . . . 0.0 110.284 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -81.92 -62.12 1.72 Allowed 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.3 mt -71.87 2.0 6.21 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.55 0.34 . . . . 0.0 111.882 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.5 t -82.5 -49.51 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -120.15 37.43 4.24 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.738 0.415 . . . . 0.0 110.14 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -74.98 133.3 75.91 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.13 -21.39 62.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.342 2.028 . . . . 0.0 111.993 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.89 10.15 13.09 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-O 119.391 -0.338 . . . . 0.0 111.851 -177.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.2 151.34 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -141.8 152.44 43.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 t -97.37 121.2 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -138.92 136.46 42.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.1 t70 56.68 26.91 11.84 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.872 0.469 . . . . 0.0 110.477 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 -20.42 6.14 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm -86.47 -167.12 1.76 Allowed 'General case' 0 C--N 1.345 0.382 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -132.42 126.91 34.23 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-O 120.918 0.39 . . . . 0.0 110.933 -176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.71 166.8 11.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.678 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -92.96 127.93 38.65 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -83.95 118.91 72.58 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.449 -1.106 0 C-N-CA 122.282 1.988 . . . . 0.0 110.565 -179.487 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt . . . . . 0 CA--C 1.505 -0.781 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -63.29 -46.44 86.73 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.049 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.83 -49.62 76.05 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 t -59.66 -47.81 89.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.8 tp -59.39 -45.19 92.15 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.91 96.69 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -64.91 -44.03 90.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.489 ' HA ' HG21 ' A' ' 41' ' ' THR . 49.2 mt -60.86 -46.94 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.13 -48.03 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 122.595 0.358 . . . . 0.0 110.048 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -61.48 -44.82 96.4 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -58.99 6.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.6 mmm -54.94 -37.69 66.76 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -45.8 92.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.2 m -60.06 -44.84 94.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -56.96 -53.18 60.9 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -61.92 -34.9 76.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.587 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -67.03 -46.78 73.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.686 -0.197 . . . . 0.0 111.05 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -71.04 -29.58 65.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 119.395 -0.335 . . . . 0.0 111.292 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.98 -20.0 0.97 Allowed Glycine 0 C--N 1.346 1.111 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.205 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -79.65 65.3 4.77 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.732 0.766 . . . . 0.0 109.747 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.0 p -78.19 -4.44 47.61 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.392 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -64.94 155.52 83.21 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 122.427 0.291 . . . . 0.0 110.725 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -69.29 155.71 66.69 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.75 2.3 . . . . 0.0 110.986 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 32' ' ' LEU . 12.7 mt -136.6 143.45 43.58 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.4 p -70.99 167.32 19.41 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -47.8 81.3 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -55.88 -52.52 63.78 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.25 0.22 . . . . 0.0 110.466 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -55.13 -37.07 66.46 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 122.433 0.293 . . . . 0.0 110.496 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -69.42 -51.92 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.5 mt -57.4 -44.84 84.89 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -52.03 -56.81 12.02 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.465 0.306 . . . . 0.0 110.916 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.33 -41.26 88.7 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.689 -0.115 . . . . 0.0 110.689 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 16' ' ' ILE . 40.9 p -82.36 7.29 14.45 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.121 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? 68.83 -11.95 0.4 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.358 0.663 . . . . 0.0 111.621 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.422 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.2 m-70 -77.35 35.51 0.18 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.745 -0.597 . . . . 0.0 111.701 -177.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -48.04 67.6 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.525 -0.734 . . . . 0.0 109.552 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -86.3 37.82 0.75 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 46' ' ' ILE . 6.7 tt -72.77 147.3 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.09 137.54 46.75 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -55.46 -32.21 62.6 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.695 0.247 . . . . 0.0 110.471 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -54.02 -38.74 65.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -86.53 -43.83 12.41 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -51.22 -48.72 62.0 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 122.39 0.276 . . . . 0.0 110.344 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -66.22 -49.43 67.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 34.8 t90 -51.36 -44.84 62.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.547 0.339 . . . . 0.0 110.615 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.3 mt -56.95 -40.99 77.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.7 mtp -85.61 -9.36 57.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.731 -0.652 . . . . 0.0 112.643 -176.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 74.5 p -136.28 20.6 3.18 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.177 0.899 . . . . 0.0 112.931 -175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 30.7 tt0 -160.93 -49.89 0.05 OUTLIER 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.973 0.806 . . . . 0.0 111.725 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.93 -76.82 0.24 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.8 mt -56.69 -31.19 64.22 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.553 0.341 . . . . 0.0 111.694 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.7 m -58.28 -21.62 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 119.58 -0.248 . . . . 0.0 111.577 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -147.5 26.57 1.04 Allowed 'General case' 0 C--N 1.346 0.423 0 CA-C-N 118.148 0.431 . . . . 0.0 110.889 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.54 126.52 92.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.01 -24.14 78.95 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.403 2.069 . . . . 0.0 112.203 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.78 5.44 28.63 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-O 119.063 -0.494 . . . . 0.0 111.677 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.9 mt -145.2 112.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.453 0 CA-C-N 118.671 0.669 . . . . 0.0 109.573 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -96.16 156.8 16.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.257 0.623 . . . . 0.0 109.456 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -103.46 140.32 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.1 mt -127.71 -112.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -80.08 61.15 3.84 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.29 -35.81 1.75 Allowed Glycine 0 CA--C 1.532 1.102 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.4 mttp -76.38 179.17 6.0 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -123.74 134.08 53.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.13 135.8 53.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -62.4 125.4 23.79 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -86.27 128.93 55.51 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 N--CA 1.449 -1.128 0 C-N-CA 122.201 1.934 . . . . 0.0 110.583 179.608 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.455 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 17.2 mtmm . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 120.754 0.311 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -57.31 -44.92 84.56 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.645 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.41 -49.77 73.82 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.0 -47.83 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.5 -46.19 89.54 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.502 0.321 . . . . 0.0 110.506 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.19 93.76 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -65.98 -39.27 90.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 mt -62.22 -46.88 95.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.38 -48.69 84.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -63.33 -38.22 90.32 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.15 -56.6 17.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.3 mtp -59.93 -35.41 74.85 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -46.14 91.86 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 m -67.59 -44.67 77.58 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 122.318 0.247 . . . . 0.0 110.397 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 47.4 ttt85 -60.02 -45.94 91.14 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -63.28 -39.66 95.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -79.42 54.8 1.79 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -165.53 -59.29 0.03 OUTLIER 'General case' 0 C--N 1.343 0.292 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.69 -44.07 0.08 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.79 74.64 2.1 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.6 p -83.71 -8.01 59.36 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -67.76 155.28 91.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.49 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 13.7 Cg_endo -73.6 160.76 43.55 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.791 2.328 . . . . 0.0 111.617 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 32' ' ' LEU . 29.5 mt -134.38 140.51 46.36 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.454 HG23 ' HD2' ' A' ' 71' ' ' LYS . 45.5 p -61.89 169.21 2.69 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.504 ' C ' HD13 ' A' ' 34' ' ' LEU . 3.4 tm? -59.03 -50.34 74.45 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -61.6 -41.29 97.22 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.696 -0.193 . . . . 0.0 111.001 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -55.5 -34.82 64.95 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -70.15 -44.05 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 mt -52.18 -36.57 52.18 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.647 0.203 . . . . 0.0 110.531 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.86 -59.99 4.4 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.615 -0.142 . . . . 0.0 110.615 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -61.94 -66.16 0.58 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.53 80.44 4.01 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -32.6 86.41 0.0 OUTLIER 'General case' 0 C--N 1.352 0.717 0 C-N-CA 125.091 1.356 . . . . 0.0 112.555 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -140.6 29.27 1.95 Allowed 'General case' 0 C--O 1.213 -0.823 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.32 -38.69 80.92 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -91.04 69.18 6.23 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.476 ' CG1' ' HB2' ' A' ' 50' ' ' GLN . 1.3 tt -94.55 -46.67 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.029 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.73 131.3 6.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.859 -1.697 . . . . 0.0 108.859 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.1 tt -51.23 -40.42 58.74 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.86 0.33 . . . . 0.0 111.207 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -56.94 -33.85 67.43 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 119.828 -0.129 . . . . 0.0 111.071 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.476 ' HB2' ' CG1' ' A' ' 46' ' ' ILE . 25.6 mt-30 -89.9 -47.45 7.87 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.435 ' HD2' HD12 ' A' ' 34' ' ' LEU . 2.6 tppt? -50.43 -52.77 34.82 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -58.87 -45.37 90.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.455 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 28.8 t90 -57.02 -54.24 48.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 88.7 mt -51.32 -45.89 62.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -60.75 -52.82 63.46 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.13 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 t -120.26 51.33 1.22 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.358 0.527 . . . . 0.0 112.137 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -166.95 -67.29 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -66.75 -60.48 2.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.16 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.5 mt -80.27 37.45 0.39 Allowed 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 122.367 0.267 . . . . 0.0 110.599 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.33 -45.84 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -112.23 -7.29 14.03 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.42 124.54 81.29 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.06 -34.84 99.02 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.745 2.297 . . . . 0.0 112.394 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -86.86 21.49 2.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 119.695 -0.193 . . . . 0.0 111.168 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.4 mm -135.64 144.29 34.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -145.92 141.48 27.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.56 136.0 29.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.8 mp -104.92 -59.01 3.59 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -160.32 77.6 0.63 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.29 -40.67 2.58 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.454 ' HD2' HG23 ' A' ' 33' ' ' THR . 3.1 mtmt -83.25 145.81 28.92 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -104.62 126.57 51.84 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 122.675 0.39 . . . . 0.0 110.617 -176.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -111.61 150.55 29.91 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -79.23 121.56 25.21 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -74.09 121.21 84.67 Favored Pre-proline 0 N--CA 1.448 -0.574 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo . . . . . 0 N--CA 1.448 -1.154 0 C-N-CA 122.32 2.013 . . . . 0.0 110.403 -179.37 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -65.69 -42.78 90.81 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.106 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.74 -46.5 91.77 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -60.87 -46.03 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.636 HD13 ' HB1' ' A' ' 58' ' ' ALA . 61.2 tp -59.75 -45.87 90.89 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.17 86.26 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -62.77 -42.57 99.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.96 -51.67 66.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.2 t -55.91 -45.35 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -64.14 -45.16 89.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -57.35 12.84 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 96.4 mtp -55.39 -39.88 70.68 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -61.09 -50.23 74.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.5 m -59.47 -46.68 88.08 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 ttm-85 -60.65 -44.31 96.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -60.8 -35.81 77.42 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -79.95 12.75 2.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.485 0.314 . . . . 0.0 110.952 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -127.86 29.95 5.35 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 117.949 0.341 . . . . 0.0 110.478 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.29 -34.53 3.61 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -74.92 77.4 2.16 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.9 p -97.2 -3.56 40.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.799 0.44 . . . . 0.0 110.993 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -70.91 156.71 91.65 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 117.739 0.245 . . . . 0.0 110.584 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.48 156.18 64.9 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.979 2.453 . . . . 0.0 111.717 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -137.69 141.88 41.09 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 122.973 0.509 . . . . 0.0 109.643 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.8 p -63.62 168.55 4.67 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.007 0.432 . . . . 0.0 110.408 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 tt -58.28 -51.83 68.12 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -54.86 -48.45 72.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.878 0.471 . . . . 0.0 111.106 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -56.25 -34.88 66.78 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.8 mt -73.5 -46.21 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.428 ' HB3' ' H ' ' A' ' 44' ' ' LEU . 16.6 mt -46.31 -58.62 3.53 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.324 0.25 . . . . 0.0 111.048 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -46.27 -56.68 5.43 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.82 0.448 . . . . 0.0 111.913 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.79 -26.36 68.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.165 0.186 . . . . 0.0 111.445 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 28.3 p -99.12 16.94 21.11 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? 73.68 -88.84 0.02 OUTLIER 'General case' 0 C--N 1.35 0.597 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 41' ' ' THR . 23.7 m170 31.82 -109.6 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.762 0.825 . . . . 0.0 111.649 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.428 ' H ' ' HB3' ' A' ' 38' ' ' LEU . 4.5 mt 69.36 -64.71 0.33 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.901 1.28 . . . . 0.0 110.443 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.52 -68.78 0.27 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.7 tt 47.51 137.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.143 1.777 . . . . 0.0 114.305 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.21 137.59 40.66 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.9 tp -52.16 -41.85 62.94 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.217 0.508 . . . . 0.0 109.867 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -60.06 -40.58 89.99 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -66.62 -57.99 6.08 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -49.84 -48.38 51.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.919 0.488 . . . . 0.0 110.668 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -64.25 -47.34 79.97 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 38.6 t90 -57.44 -45.94 84.13 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.708 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 79.7 mt -56.22 -51.49 67.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 40.6 ttm -56.86 -54.69 43.58 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.792 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.402 ' HA ' HG21 ' A' ' 60' ' ' VAL . 6.7 t -121.15 50.3 1.39 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.227 0.467 . . . . 0.0 111.937 -174.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -170.5 -65.65 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.098 -0.376 . . . . 0.0 110.497 176.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.708 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -64.27 -50.02 69.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.392 0.277 . . . . 0.0 111.367 -176.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.2 mt -79.29 -29.58 42.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.599 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 56' ' ' THR . 54.6 t -73.69 139.1 19.95 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 69.17 -9.34 0.61 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.328 0.651 . . . . 0.0 111.579 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.56 125.11 78.71 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.42 -12.29 30.0 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.339 2.026 . . . . 0.0 112.05 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.01 7.45 21.55 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 118.029 0.377 . . . . 0.0 111.534 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 mm -136.23 157.34 37.6 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -147.95 144.19 27.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.06 106.59 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.4 mm -121.1 126.13 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.0 t0 59.16 19.9 7.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.815 0.446 . . . . 0.0 110.462 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.41 -29.2 7.95 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 168.86 18.79 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -104.59 124.89 50.12 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.543 0.211 . . . . 0.0 110.523 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.05 137.48 52.88 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.308 0.643 . . . . 0.0 109.334 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -66.99 126.86 30.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.44 117.91 69.63 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo . . . . . 0 N--CA 1.447 -1.225 0 C-N-CA 122.201 1.934 . . . . 0.0 109.731 178.935 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -60.27 -45.41 93.41 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 122.901 0.48 . . . . 0.0 110.205 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.44 -47.52 90.7 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.02 -45.91 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.27 -44.64 96.91 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.24 99.4 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -61.86 -48.38 80.81 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.518 ' HA ' HG21 ' A' ' 41' ' ' THR . 52.2 mt -58.26 -52.16 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.293 0.371 . . . . 0.0 110.114 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -55.73 -50.8 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.72 -43.29 94.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.249 0.22 . . . . 0.0 110.751 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -59.67 4.66 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -33.43 69.45 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -60.57 -46.65 89.44 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 m -73.23 -40.26 64.83 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.543 0.337 . . . . 0.0 110.164 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -64.41 -33.71 76.49 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.576 0.75 . . . . 0.0 109.168 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -72.71 -49.77 29.09 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -38.14 65.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.897 0.479 . . . . 0.0 110.24 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -54.13 -42.51 69.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.139 0.576 . . . . 0.0 110.884 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.72 -27.73 1.77 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.75 59.68 2.59 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.7 p -66.63 -9.09 32.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.143 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -57.43 152.04 35.38 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 122.467 0.307 . . . . 0.0 110.839 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.89 155.53 54.32 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.719 2.279 . . . . 0.0 111.331 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 32' ' ' LEU . 15.2 mt -135.19 144.01 46.75 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.4 p -73.38 175.25 7.11 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -54.0 50.77 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.6 -48.25 72.4 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.292 0.237 . . . . 0.0 110.584 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -54.34 -44.0 71.74 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.9 mt -63.61 -47.32 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.8 mt -56.99 -48.99 77.12 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -51.52 -56.93 10.68 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 123.187 0.304 . . . . 0.0 111.1 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 23' ' ' ARG . 3.0 mt-10 -58.94 -37.19 76.17 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.047 0.139 . . . . 0.0 111.144 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.518 HG21 ' HA ' ' A' ' 16' ' ' ILE . 47.7 p -86.37 6.22 31.12 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.122 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? 69.04 -10.52 0.51 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.313 0.645 . . . . 0.0 111.34 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.431 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.0 m-70 -78.06 39.15 0.3 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.65 -0.656 . . . . 0.0 111.395 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.81 -45.48 61.36 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -84.23 51.71 2.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.9 tt -90.81 148.84 4.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.22 137.16 50.45 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.7 tp -54.72 -35.76 64.01 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.322 0.249 . . . . 0.0 110.631 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -58.11 -48.88 78.85 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -68.34 -44.26 75.69 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -52.54 -49.99 63.79 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.0 -52.17 66.91 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -53.74 -50.04 66.85 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.652 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 48.3 mt -57.33 -43.25 83.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.4 ttt -66.91 -53.03 36.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -120.41 47.14 1.83 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -167.75 -56.19 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.652 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -76.67 -60.18 2.46 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.179 -0.325 . . . . 0.0 111.569 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -80.61 27.74 0.35 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.9 m -124.73 -17.28 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 117.782 0.264 . . . . 0.0 110.36 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -130.12 6.6 4.98 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 117.718 0.235 . . . . 0.0 110.692 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -70.11 127.57 92.22 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.83 -29.96 87.8 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.443 2.095 . . . . 0.0 112.224 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -94.23 21.13 7.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 119.707 -0.187 . . . . 0.0 111.484 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.81 156.48 12.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -154.2 148.76 26.29 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.19 130.76 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.9 mt -120.87 -95.9 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -83.72 51.59 2.06 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.65 -36.27 1.84 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mttp -74.07 179.13 4.56 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -114.14 126.36 54.99 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.2 138.82 50.95 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -70.06 127.32 32.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.02 120.51 81.51 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo . . . . . 0 N--CA 1.452 -0.959 0 C-N-CA 122.521 2.147 . . . . 0.0 110.775 179.226 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt . . . . . 0 CA--C 1.531 0.245 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -68.89 -43.35 75.45 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.45 93.83 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.0 -47.92 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.614 HD13 ' HB1' ' A' ' 58' ' ' ALA . 43.1 tp -59.27 -43.92 92.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.9 97.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -59.43 -46.53 88.47 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.8 mt -61.48 -49.11 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -57.61 -46.85 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -65.68 -42.22 91.53 Favored 'General case' 0 CA--C 1.527 0.063 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -60.22 -58.41 8.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtp -55.67 -44.51 77.36 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -55.34 -45.17 76.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.534 0.334 . . . . 0.0 110.308 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.7 m -62.98 -53.93 46.32 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 119.541 -0.266 . . . . 0.0 111.134 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -64.62 -30.87 71.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.61 0.641 . . . . 0.0 109.984 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -66.41 -40.34 89.54 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -65.35 -41.97 93.33 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.63 -55.51 29.81 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 122.179 0.192 . . . . 0.0 110.507 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.3 -30.35 0.12 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -75.89 71.31 2.7 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 117.338 0.569 . . . . 0.0 109.669 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.6 p -76.51 -9.6 58.78 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -62.98 156.32 67.9 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.58 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 30.0 Cg_endo -77.85 161.88 29.95 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.682 2.255 . . . . 0.0 111.019 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.3 mt -132.74 144.86 50.56 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.9 p -60.75 167.19 2.87 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.98 -50.03 71.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.64 -49.08 79.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.863 0.465 . . . . 0.0 110.861 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -55.32 -34.08 63.88 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 58.5 mt -75.64 -50.53 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.644 ' CD2' HD11 ' A' ' 46' ' ' ILE . 8.8 mt -45.29 -54.16 7.47 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 122.691 0.397 . . . . 0.0 111.104 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -47.87 -59.34 3.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.699 0.399 . . . . 0.0 111.311 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -60.0 -37.7 80.48 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.221 0.208 . . . . 0.0 111.009 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.7 p -81.7 10.53 5.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.042 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 75.63 -61.0 0.48 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.74 0.816 . . . . 0.0 111.001 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 113.1 1.19 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -120.0 -34.09 3.8 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 122.45 0.3 . . . . 0.0 110.964 -178.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -94.54 -40.88 9.63 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.644 HD11 ' CD2' ' A' ' 38' ' ' LEU . 3.1 mt 55.63 -134.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.934 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.429 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -136.19 143.57 15.06 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 105.275 -3.13 . . . . 0.0 105.275 172.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -49.74 -45.36 49.26 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.23 1.015 . . . . 0.0 110.527 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -58.24 -46.57 85.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -64.3 -63.07 1.24 Allowed 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -42.77 -49.63 5.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.012 0.525 . . . . 0.0 110.966 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -65.31 -52.24 55.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.434 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 37.1 t90 -52.77 -46.03 67.38 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.822 0.449 . . . . 0.0 110.81 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.725 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 65.0 mt -57.1 -47.23 81.58 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.2 ttt -65.31 -47.2 77.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t -120.81 40.48 3.53 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 34.4 tt0 -165.72 -66.77 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.937 -0.477 . . . . 0.0 110.115 174.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.725 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -58.47 -61.07 2.86 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 -177.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.1 mt -81.46 31.7 0.34 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.338 0.255 . . . . 0.0 110.373 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.41 -40.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.41 -30.48 16.48 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.386 0.274 . . . . 0.0 110.423 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -56.1 118.98 23.64 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.88 -30.99 91.14 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.534 2.156 . . . . 0.0 112.075 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -82.22 10.77 6.23 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.234 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 mm -129.65 143.65 40.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -146.67 135.68 22.47 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 t -89.52 131.92 35.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.1 mm -104.06 -60.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -152.45 76.23 1.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.8 -40.01 2.44 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -85.71 154.31 21.72 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -107.73 132.17 53.65 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.913 0.485 . . . . 0.0 109.997 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -121.32 151.82 39.66 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 122.54 0.336 . . . . 0.0 110.196 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -75.27 120.64 21.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -80.39 123.26 83.08 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo . . . . . 0 N--CA 1.447 -1.232 0 C-N-CA 122.342 2.028 . . . . 0.0 110.512 -179.412 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 7.7 mtmm . . . . . 0 N--CA 1.461 0.115 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -62.06 -42.57 99.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.622 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.91 -51.93 53.79 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.6 t -60.64 -45.89 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.709 HD13 ' HB1' ' A' ' 58' ' ' ALA . 51.9 tp -59.63 -51.54 69.37 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.235 0.214 . . . . 0.0 110.43 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.69 -43.9 85.44 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -50.34 74.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.1 mt -59.33 -47.8 89.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 122.544 0.338 . . . . 0.0 110.285 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.5 t -58.42 -50.11 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -59.34 -47.16 86.44 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.81 -57.32 13.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 87.9 mtp -52.93 -41.21 64.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -60.66 -63.19 1.38 Allowed 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -45.95 -45.89 15.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 122.432 0.293 . . . . 0.0 110.793 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -63.45 -41.37 98.64 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -66.81 -34.12 77.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.236 0.614 . . . . 0.0 110.094 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -69.01 -36.47 77.83 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -62.78 -56.71 15.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.169 0.188 . . . . 0.0 110.725 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.35 -35.52 0.14 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -71.11 79.73 0.68 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.0 p -91.26 -19.07 23.39 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.443 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -61.78 151.71 78.25 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 117.936 0.335 . . . . 0.0 110.21 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.459 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 9.4 Cg_endo -71.86 157.11 55.75 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.771 2.314 . . . . 0.0 111.589 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.9 mt -125.19 148.32 48.67 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.5 p -59.75 168.42 1.73 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -57.7 11.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.2 -43.3 70.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.481 0.312 . . . . 0.0 111.205 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -53.02 -49.94 65.24 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.6 mt -58.34 -40.17 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 122.127 0.171 . . . . 0.0 110.666 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.52 -28.97 69.7 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 117.82 0.282 . . . . 0.0 110.434 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.48 -59.32 4.11 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -55.86 -68.57 0.19 Allowed 'General case' 0 C--N 1.347 0.47 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -78.65 85.39 4.69 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -36.92 84.4 0.0 OUTLIER 'General case' 0 C--N 1.351 0.669 0 C-N-CA 125.003 1.321 . . . . 0.0 112.735 -176.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -140.04 45.1 1.89 Allowed 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.423 ' O ' HG22 ' A' ' 46' ' ' ILE . 10.0 mt -79.77 -37.59 35.05 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.76 -43.22 99.37 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.886 HG23 ' H ' ' A' ' 47' ' ' GLY . 13.5 tt 22.85 -98.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.232 1.413 . . . . 0.0 113.022 177.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.886 ' H ' HG23 ' A' ' 46' ' ' ILE . . . 150.59 148.24 4.74 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.1 tp -54.43 -47.56 72.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.462 0.631 . . . . 0.0 110.712 -177.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -57.35 -50.95 71.32 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.166 0.186 . . . . 0.0 110.742 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -62.79 -56.51 16.85 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -48.88 -50.04 36.83 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 122.577 0.351 . . . . 0.0 110.763 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -61.77 -45.23 94.78 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.463 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 49.7 t90 -61.29 -38.05 85.38 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.762 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 71.6 mt -62.57 -46.44 88.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.4 -50.64 69.07 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.898 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.2 p -89.1 -42.14 11.88 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -102.0 -72.68 0.68 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.762 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -46.42 -64.52 0.74 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -173.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.6 mt -80.39 31.9 0.29 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.128 0.171 . . . . 0.0 111.37 -175.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.47 -47.68 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -81.42 -28.17 34.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.603 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -57.47 121.67 49.84 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.46 -18.41 62.87 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.726 2.284 . . . . 0.0 112.557 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -97.98 20.0 12.98 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.049 0.386 . . . . 0.0 110.907 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 mm -131.05 146.89 33.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 117.936 0.334 . . . . 0.0 110.115 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -137.86 136.06 36.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.14 130.47 49.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.4 mt -142.94 123.45 10.43 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.3 t70 53.79 34.54 19.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.92 0.488 . . . . 0.0 111.073 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.09 -36.31 3.32 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -72.0 163.27 28.16 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -119.25 134.01 55.44 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.375 0.27 . . . . 0.0 110.455 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -125.03 152.17 44.62 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -76.17 121.84 23.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -69.19 119.34 69.51 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo . . . . . 0 N--CA 1.448 -1.181 0 C-N-CA 122.122 1.881 . . . . 0.0 109.695 -179.708 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.4 mttm . . . . . 0 N--CA 1.472 0.662 0 CA-C-O 120.58 0.229 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -57.99 -47.6 82.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.759 0.823 . . . . 0.0 111.821 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.21 -45.25 94.11 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.9 t -59.74 -46.57 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.17 -42.82 99.47 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.14 89.59 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -66.23 -41.56 89.86 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.413 ' HA ' HG21 ' A' ' 41' ' ' THR . 50.7 mt -62.68 -47.82 91.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.25 -47.82 89.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -59.63 -47.21 86.47 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -48.22 80.88 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.634 0.373 . . . . 0.0 110.387 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 80.8 mmm -57.22 -33.12 67.21 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 122.498 0.319 . . . . 0.0 110.256 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -73.66 -62.58 1.44 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -44.98 -50.22 10.75 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.087 0.555 . . . . 0.0 111.546 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -63.13 -42.39 99.51 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.26 0.482 . . . . 0.0 109.872 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -64.55 -27.28 68.85 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.778 0.431 . . . . 0.0 109.956 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -74.44 -34.7 63.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.652 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -95.17 38.99 1.12 Allowed 'General case' 0 C--N 1.35 0.623 0 CA-C-N 118.13 0.423 . . . . 0.0 111.59 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.46 -16.5 48.99 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.185 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.3 41.76 0.71 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.489 1.145 . . . . 0.0 109.889 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.58 66.65 6.17 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -142.53 152.27 59.66 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.05 151.0 84.32 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.053 2.502 . . . . 0.0 111.91 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.3 mt -140.42 143.15 35.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.4 p -62.47 171.28 2.01 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -55.29 34.05 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -58.16 -41.88 84.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.242 0.217 . . . . 0.0 111.31 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.57 -40.78 75.79 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.0 mt -64.82 -45.73 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.5 mt -55.38 -49.04 73.34 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -49.2 -58.79 4.4 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.199 0.2 . . . . 0.0 111.081 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -61.25 -42.51 98.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.24 0.216 . . . . 0.0 111.56 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.478 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 35.5 p -75.7 -8.06 55.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 119.344 -0.36 . . . . 0.0 111.228 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 64.96 49.24 2.14 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.478 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 6.5 m-70 -130.46 39.2 3.66 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.462 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mt -73.82 -44.36 55.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.9 41.22 0.79 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 tt -79.32 -31.38 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 122.793 0.437 . . . . 0.0 110.297 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.16 138.43 10.28 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.25 -25.74 65.91 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 117.079 0.44 . . . . 0.0 111.2 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -61.11 -34.08 74.39 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -89.51 -43.85 10.54 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.693 0.397 . . . . 0.0 109.947 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -55.58 -47.74 75.95 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -57.24 -48.34 79.07 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -57.16 -54.83 42.28 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.553 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 81.0 mt -53.46 -43.13 67.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.3 ttt -70.85 -38.88 73.2 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.0 p -118.11 36.46 4.34 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -168.38 -70.33 0.02 OUTLIER 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.291 0.496 . . . . 0.0 110.539 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -60.76 -63.97 1.12 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -175.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.6 mt -79.1 28.59 0.22 Allowed 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.516 -0.115 . . . . 0.0 111.192 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.49 -40.75 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -116.16 4.86 13.65 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.37 0.268 . . . . 0.0 111.403 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.42 127.5 91.3 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.78 -30.05 91.54 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.593 2.195 . . . . 0.0 112.107 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.0 36.52 1.68 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.594 0.179 . . . . 0.0 110.733 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 tp -150.85 156.99 5.89 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.419 ' HG3' HD13 ' A' ' 68' ' ' ILE . 13.6 pt-20 -157.75 138.8 13.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.473 ' C ' HD12 ' A' ' 68' ' ' ILE . 39.9 t -87.81 108.3 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.473 HD12 ' C ' ' A' ' 67' ' ' VAL . 1.7 mp -114.96 122.53 69.26 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 53.08 36.93 23.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.693 0.397 . . . . 0.0 110.489 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.71 -32.91 3.34 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -78.61 162.01 26.56 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 117.804 0.802 . . . . 0.0 108.98 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.63 123.24 44.56 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.4 153.42 28.62 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -80.35 114.49 19.29 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.182 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -73.95 122.52 87.76 Favored Pre-proline 0 N--CA 1.446 -0.646 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo . . . . . 0 N--CA 1.446 -1.304 0 C-N-CA 122.246 1.964 . . . . 0.0 111.643 -177.372 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.469 ' HB3' ' CH2' ' A' ' 53' ' ' TRP . 13.7 mttp . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 120.649 0.262 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -53.88 -39.4 65.69 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.804 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.45 -50.23 60.64 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.7 t -64.21 -46.63 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.41 HD13 ' HB1' ' A' ' 58' ' ' ALA . 55.9 tp -61.18 -46.26 91.22 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.77 -42.45 93.33 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -58.72 -51.65 69.05 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.2 mt -55.42 -49.24 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 t -58.02 -46.14 87.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.17 -50.56 69.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.559 0.344 . . . . 0.0 110.747 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CE1' ' CD ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -60.81 -46.16 91.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.725 0.41 . . . . 0.0 110.323 -177.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.3 mmm -63.04 -47.37 83.3 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -56.73 -52.07 66.42 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.758 0.423 . . . . 0.0 110.906 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.5 m -57.5 -42.13 82.11 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.449 ' CD ' ' CE1' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -68.15 -40.51 82.37 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -62.2 -34.55 76.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -67.44 -47.18 70.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.443 0.297 . . . . 0.0 111.406 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -70.37 -35.44 73.54 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 119.143 -0.456 . . . . 0.0 111.756 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.74 -30.14 0.34 Allowed Glycine 0 C--N 1.345 1.04 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.195 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -74.52 77.58 1.95 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p -93.23 -14.23 27.33 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.826 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -61.94 149.71 85.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 117.447 0.112 . . . . 0.0 110.729 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -62.98 158.42 43.47 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.932 2.421 . . . . 0.0 111.225 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 32' ' ' LEU . 18.4 mt -138.04 142.33 40.34 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.8 p -62.11 167.83 3.71 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -50.29 74.08 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.56 -51.9 63.8 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.785 0.434 . . . . 0.0 110.826 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.09 -45.52 79.38 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.3 mt -59.39 -46.95 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.654 HD22 HD11 ' A' ' 46' ' ' ILE . 24.2 mt -59.62 -63.75 1.19 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -40.19 -58.15 1.54 Allowed 'General case' 0 C--N 1.343 0.301 0 C-N-CA 123.674 0.79 . . . . 0.0 112.452 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -57.23 -34.56 68.7 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 117.411 0.096 . . . . 0.0 111.063 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.514 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -99.3 28.77 4.3 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 67.54 -111.27 0.14 Allowed 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.514 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 3.6 m-70 46.71 -116.3 0.66 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.513 0.325 . . . . 0.0 110.536 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.4 ' H ' ' HB3' ' A' ' 38' ' ' LEU . 0.4 OUTLIER 78.44 -55.4 0.48 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.582 1.153 . . . . 0.0 111.029 175.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.57 -62.04 1.6 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.654 HD11 HD22 ' A' ' 38' ' ' LEU . 30.3 mt 66.39 -74.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 O-C-N 124.592 1.183 . . . . 0.0 111.594 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.52 124.77 1.42 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 105.166 -3.174 . . . . 0.0 105.166 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.3 tp -43.84 -42.39 5.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.536 0.668 . . . . 0.0 111.798 -175.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -51.37 -52.61 44.23 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.372 0.269 . . . . 0.0 110.333 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -69.08 -61.69 1.69 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 122.519 0.328 . . . . 0.0 110.628 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -42.13 -42.89 3.11 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.757 0.423 . . . . 0.0 110.895 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -69.45 -53.81 17.41 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.469 ' CH2' ' HB3' ' A' ' 9' ' ' LYS . 34.1 t90 -51.94 -44.78 64.06 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 122.507 0.323 . . . . 0.0 110.712 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.698 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 66.3 mt -57.07 -45.75 83.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 47.8 ttm -74.68 -37.45 62.66 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -176.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 t -106.56 6.73 30.3 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -173.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -152.46 -67.91 0.16 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.282 0.946 . . . . 0.0 111.917 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.698 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -53.01 -65.4 0.57 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -174.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.63 -48.77 71.06 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.4 m -55.74 -35.37 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 119.534 -0.27 . . . . 0.0 110.883 -177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -109.76 36.23 3.06 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -94.15 127.64 44.01 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.86 -22.86 62.9 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.32 2.013 . . . . 0.0 112.021 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -111.75 6.06 19.53 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -176.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 mt -140.81 129.21 24.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -122.98 168.96 11.66 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.4 t -98.68 131.86 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.9 mt -139.21 121.07 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.8 t70 58.46 29.94 19.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.625 0.37 . . . . 0.0 110.252 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.47 -36.54 3.22 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 168.79 15.01 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -109.12 141.98 40.53 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.5 137.51 38.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.545 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -71.59 125.96 28.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -80.17 122.07 82.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo . . . . . 0 N--CA 1.451 -1.023 0 C-N-CA 122.435 2.09 . . . . 0.0 110.766 179.501 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.417 ' HB2' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.154 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -59.62 -48.99 79.5 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.258 0.223 . . . . 0.0 110.696 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.7 -50.22 69.49 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.455 HG13 ' CD2' ' A' ' 43' ' ' HIS . 23.5 t -59.69 -49.7 82.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.53 -46.35 86.96 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.46 98.18 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -63.63 -45.68 89.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.08 -48.1 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 t -57.5 -42.81 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -73.24 -42.7 62.25 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.484 -0.135 . . . . 0.0 111.087 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -49.0 77.52 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.1 mmm -55.88 -48.49 75.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -52.39 -61.1 2.49 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 123.349 0.405 . . . . 0.0 110.6 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -54.99 -51.59 65.74 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -62.1 -38.72 89.94 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.182 0.447 . . . . 0.0 110.251 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -64.46 -37.02 86.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -82.41 43.37 0.81 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.559 0.744 . . . . 0.0 109.012 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 ttp-105 -158.6 -51.43 0.06 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.22 -38.17 0.07 OUTLIER Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.8 59.66 3.77 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.315 0.557 . . . . 0.0 110.012 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.62 -3.53 59.05 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.456 ' NE2' HD21 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -67.15 154.37 92.8 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 122.651 0.38 . . . . 0.0 110.635 -179.664 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.99 120.67 7.95 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.104 1.869 . . . . 0.0 110.121 176.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.4 mt -100.76 149.44 23.81 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.0 p -76.59 170.87 15.62 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -53.32 59.63 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -58.14 -43.56 87.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.22 0.208 . . . . 0.0 111.057 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -56.62 -41.77 77.68 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.2 mt -63.97 -49.68 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.9 mt -53.76 -55.73 23.7 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -45.79 -59.11 2.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.787 0.435 . . . . 0.0 111.442 -177.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.38 -38.74 84.86 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.404 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 33.3 p -81.41 -1.33 45.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.072 0.396 . . . . 0.0 111.159 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 65.54 44.91 2.89 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.455 ' CD2' HG13 ' A' ' 12' ' ' VAL . 8.2 m-70 -127.6 28.8 5.59 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.22 -44.33 75.98 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.93 55.88 2.91 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.0 tt -99.89 148.17 6.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 122.711 0.404 . . . . 0.0 110.001 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.62 141.99 41.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -57.29 -24.95 58.23 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 117.064 0.432 . . . . 0.0 111.289 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -64.87 -50.97 64.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -69.49 -43.68 72.64 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -53.68 -50.57 65.54 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 -62.45 -48.13 81.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.98 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.468 ' CE2' ' HB2' ' A' ' 58' ' ' ALA . 28.8 t90 -54.38 -50.89 66.44 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.685 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 52.1 mt -55.16 -49.34 72.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.7 ttt -63.69 -48.07 78.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -124.96 50.24 1.77 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.726 0.694 . . . . 0.0 112.554 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -172.77 -61.88 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -65.61 -67.02 0.47 Allowed 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.463 -0.148 . . . . 0.0 111.155 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.85 -48.35 82.21 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.351 0.26 . . . . 0.0 111.523 -175.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 m -53.74 -38.75 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -89.12 -25.11 22.04 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 117.797 0.271 . . . . 0.0 110.916 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.45 117.58 28.81 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -63.81 -35.4 56.91 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.633 2.222 . . . . 0.0 111.882 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.83 -26.61 64.31 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.902 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.09 95.2 3.62 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -91.97 157.95 16.53 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.7 t -96.21 136.53 26.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.1 mm -115.8 -114.07 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.19 62.47 6.66 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.87 1.96 60.24 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -117.72 -179.98 3.9 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -114.67 129.58 56.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.654 0.264 . . . . 0.0 110.51 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.5 146.09 48.34 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.45 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -87.66 125.23 34.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -81.3 121.32 80.14 Favored Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo . . . . . 0 N--CA 1.449 -1.101 0 C-N-CA 122.398 2.065 . . . . 0.0 111.124 -179.056 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.73 -39.92 95.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.353 0.261 . . . . 0.0 110.505 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.23 -50.42 65.23 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.9 t -62.78 -44.09 99.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.67 -49.42 77.63 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.95 86.09 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.34 -44.53 96.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.21 -49.29 84.71 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.1 t -53.45 -45.47 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.63 -45.63 82.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.232 0.213 . . . . 0.0 111.228 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -40.26 94.17 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -41.74 87.58 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -58.31 8.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -63.4 -48.44 77.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.847 0.459 . . . . 0.0 112.029 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HE ' ' CB ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -66.47 -35.04 79.3 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.309 0.504 . . . . 0.0 110.272 -177.395 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -66.29 -39.3 89.27 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -78.52 53.19 1.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.45 -50.13 0.09 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.76 -29.59 0.17 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.402 ' CB ' ' HE ' ' A' ' 23' ' ' ARG . 62.6 m-20 -75.39 60.2 1.13 Allowed 'General case' 0 C--N 1.343 0.314 0 C-N-CA 122.966 0.506 . . . . 0.0 110.125 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.5 p -87.87 57.5 4.37 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -137.58 154.77 75.3 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.56 150.76 83.87 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.927 2.418 . . . . 0.0 112.32 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 32' ' ' LEU . 16.1 mt -138.37 142.92 39.64 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.3 p -63.25 169.44 3.58 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 34' ' ' LEU . 3.2 tt -60.88 -51.88 67.43 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -59.92 -41.34 91.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 119.675 -0.202 . . . . 0.0 110.655 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -56.93 -39.3 74.25 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 mt -67.0 -47.69 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.8 mt -52.0 -47.41 64.93 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HA ' HD11 ' A' ' 44' ' ' LEU . 27.1 t70 -50.58 -56.77 10.22 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.33 0.252 . . . . 0.0 111.331 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -66.71 -45.06 79.97 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.416 HG22 ' NE2' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -75.13 -4.82 40.93 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.93 0.332 . . . . 0.0 110.934 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 63.2 50.22 3.08 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.416 ' NE2' HG22 ' A' ' 41' ' ' THR . 6.8 m-70 -130.9 45.77 2.77 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' H ' HD12 ' A' ' 44' ' ' LEU . 5.1 mp -77.59 -42.35 35.41 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -84.74 27.72 0.72 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 tt -63.26 -32.88 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 122.766 0.427 . . . . 0.0 110.456 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.76 137.73 9.93 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -59.11 -26.4 64.65 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.996 0.398 . . . . 0.0 110.99 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -61.17 -34.11 74.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -89.41 -47.42 8.03 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -57.41 -45.03 85.0 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.77 -49.17 76.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.458 ' CZ3' ' HB2' ' A' ' 9' ' ' LYS . 27.6 t90 -58.92 -50.84 72.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.72 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 66.8 mt -54.29 -42.25 69.82 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 122.104 -0.373 . . . . 0.0 110.237 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 21.7 ttt -64.12 -60.46 3.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -174.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.504 ' HA ' HG21 ' A' ' 60' ' ' VAL . 5.7 t -105.55 -3.34 22.49 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -117.74 -67.46 0.99 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.051 0.841 . . . . 0.0 111.214 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.72 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -61.01 -69.08 0.25 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.3 mt -57.94 -33.64 69.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.45 0.3 . . . . 0.0 111.077 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' A' ' 56' ' ' THR . 48.0 t -63.58 -36.55 76.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -111.75 46.85 1.08 Allowed 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -118.23 115.91 35.91 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -66.78 -4.75 11.73 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.734 2.289 . . . . 0.0 112.853 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 4.51 17.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.404 0.547 . . . . 0.0 111.182 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.23 142.16 39.42 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.87 137.58 48.1 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.91 125.96 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.6 mt -137.54 116.6 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t0 54.31 45.49 27.13 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.687 0.395 . . . . 0.0 110.082 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.03 -41.72 2.24 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -69.5 169.99 11.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.106 0.453 . . . . 0.0 109.989 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.85 125.54 54.12 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 122.524 0.33 . . . . 0.0 110.129 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.84 127.93 56.2 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.061 0.545 . . . . 0.0 110.208 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -63.4 121.02 12.77 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -77.65 115.69 51.93 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 N--CA 1.449 -1.143 0 C-N-CA 122.264 1.976 . . . . 0.0 110.956 -178.066 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.447 0 CA-C-O 119.288 -0.387 . . . . 0.0 110.53 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -75.52 -47.8 25.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 119.015 0.825 . . . . 0.0 109.637 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.93 -44.46 97.79 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.3 -43.92 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.1 tp -59.07 -47.22 86.01 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.31 -43.19 92.68 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -61.31 -43.48 98.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.7 mt -61.3 -45.65 98.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 t -58.15 -48.09 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -61.79 -42.44 99.0 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -58.32 9.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.8 ttm -55.61 -37.68 68.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 122.615 0.366 . . . . 0.0 110.442 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -60.99 -48.77 80.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.2 m -62.39 -44.68 95.86 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.425 ' HE ' ' CB ' ' A' ' 28' ' ' ASP . 3.1 ttt85 -61.48 -47.49 85.42 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.784 0.326 . . . . 0.0 110.273 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -63.18 -54.29 39.88 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.044 0.538 . . . . 0.0 109.834 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -58.63 -32.98 69.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.979 0.512 . . . . 0.0 110.447 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -66.63 -52.55 43.9 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.75 -34.31 0.1 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.775 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.425 ' CB ' ' HE ' ' A' ' 23' ' ' ARG . 5.4 m-20 -76.14 69.67 2.72 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 117.583 0.692 . . . . 0.0 109.825 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.1 p -77.32 -14.89 59.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.644 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -61.62 154.34 66.11 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 122.402 0.281 . . . . 0.0 110.711 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.24 157.62 52.99 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.598 2.198 . . . . 0.0 110.84 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 32' ' ' LEU . 17.2 mt -135.91 147.63 48.21 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.0 p -70.77 171.23 10.9 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.455 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -60.2 -54.93 39.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.69 -52.07 57.58 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.354 0.262 . . . . 0.0 110.641 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -51.68 -37.49 50.86 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 122.165 0.186 . . . . 0.0 110.545 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.0 mt -69.41 -48.51 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.5 mt -53.62 -52.03 61.18 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 117.537 0.153 . . . . 0.0 110.798 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.64 -65.12 0.51 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 122.934 0.494 . . . . 0.0 111.679 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.64 -46.15 81.16 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.34 0.256 . . . . 0.0 111.426 -177.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.453 HG22 ' NE2' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -71.98 -6.19 40.34 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.002 -178.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 67.94 41.55 2.07 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 122.899 0.48 . . . . 0.0 109.99 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.453 ' NE2' HG22 ' A' ' 41' ' ' THR . 7.2 m-70 -127.68 33.87 4.74 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -49.18 73.65 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.22 38.72 0.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 tt -72.1 149.62 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.11 133.41 37.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.7 tp -54.29 -35.3 62.45 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.363 0.265 . . . . 0.0 110.409 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -54.56 -46.29 73.63 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -70.2 -48.66 56.15 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -49.99 -44.13 50.8 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -69.24 -54.59 13.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.405 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 15.1 t90 -50.85 -40.14 55.34 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.709 0.404 . . . . 0.0 110.881 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.3 -39.8 88.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 73.0 mtm -89.96 -0.87 57.82 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.239 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.5 p -132.4 17.23 4.44 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.765 0.711 . . . . 0.0 111.888 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 16.1 tp10 -166.79 -70.77 0.03 OUTLIER 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.447 0.567 . . . . 0.0 111.038 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.45 -80.09 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -174.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 mt -59.29 -20.99 58.96 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 122.564 -0.085 . . . . 0.0 111.001 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 96.8 t -68.0 -40.74 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.575 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.66 54.57 1.18 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 117.844 0.293 . . . . 0.0 111.607 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -101.9 135.18 19.76 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -51.2 -44.99 39.53 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.655 2.237 . . . . 0.0 112.682 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -83.3 8.81 12.37 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -176.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.4 mm -123.88 150.85 28.45 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 118.091 0.405 . . . . 0.0 109.926 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -134.69 138.55 44.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.2 t -96.93 121.25 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -134.39 130.67 54.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 52.43 31.82 10.31 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 123.464 0.478 . . . . 0.0 111.196 176.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.42 -17.25 20.08 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -87.66 -173.25 4.24 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -127.49 137.36 52.64 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.19 154.18 51.4 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -77.3 125.68 29.71 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -73.94 116.97 57.36 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 N--CA 1.448 -1.198 0 C-N-CA 122.427 2.085 . . . . 0.0 110.94 179.821 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.1 tttp . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.8 -48.73 65.48 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.033 0.533 . . . . 0.0 110.68 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.63 -43.28 99.16 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.84 -50.35 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.51 -45.29 94.36 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.59 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.68 96.29 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -57.43 -48.82 78.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.529 ' HA ' HG21 ' A' ' 41' ' ' THR . 62.8 mt -59.7 -50.24 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.392 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 t -55.9 -48.69 78.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -62.15 -45.17 94.6 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.074 0.15 . . . . 0.0 110.66 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.432 ' CE1' ' HG3' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -59.04 -55.27 37.22 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 ttt -62.86 -35.83 81.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -60.86 -55.14 36.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 m -62.02 -43.01 99.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.432 ' HG3' ' CE1' ' A' ' 19' ' ' TYR . 14.3 mmt180 -56.26 -50.2 72.01 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.824 0.45 . . . . 0.0 109.905 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -63.81 -38.76 92.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -83.82 48.74 1.49 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -162.79 -50.14 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.1 -31.95 0.12 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -81.19 60.29 4.25 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.069 0.434 . . . . 0.0 110.175 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -6.32 59.13 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -70.12 155.13 93.96 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -70.02 147.11 60.46 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.73 2.287 . . . . 0.0 111.957 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 32' ' ' LEU . 19.3 mt -134.55 144.91 48.26 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.477 0.711 . . . . 0.0 109.447 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -64.52 173.65 2.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.013 0.435 . . . . 0.0 110.027 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -58.3 9.15 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.644 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -59.06 -38.5 79.55 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 119.599 -0.238 . . . . 0.0 111.411 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.25 -39.53 79.41 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.419 ' CG2' HG23 ' A' ' 16' ' ' ILE . 51.2 mt -68.43 -42.58 84.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 mt -59.8 -46.66 88.5 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.676 -0.12 . . . . 0.0 110.676 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -48.52 -59.48 3.46 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.645 0.378 . . . . 0.0 111.059 -177.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -56.84 -42.37 79.52 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.386 0.274 . . . . 0.0 111.077 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 16' ' ' ILE . 47.0 p -80.19 4.69 16.69 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.876 -0.583 . . . . 0.0 111.213 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? 72.45 -15.37 0.49 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.846 0.858 . . . . 0.0 111.618 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -78.18 42.73 0.42 Allowed 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 118.409 0.55 . . . . 0.0 111.285 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.38 -45.59 54.0 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.67 -0.644 . . . . 0.0 109.421 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.11 -55.14 31.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 47' ' ' GLY . 4.0 tt 34.74 -132.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.095 0.958 . . . . 0.0 110.533 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 46' ' ' ILE . . . -154.35 151.21 22.92 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tt -56.17 -44.55 79.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.542 0.671 . . . . 0.0 110.493 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -59.73 -45.77 91.17 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.163 0.185 . . . . 0.0 110.628 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.1 -48.8 61.6 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -52.37 -48.51 65.55 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -63.19 -48.03 80.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.421 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 26.5 t90 -53.78 -46.03 70.89 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.459 0.304 . . . . 0.0 110.405 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 62.8 mt -61.86 -40.72 96.35 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 40.0 ttm -76.13 -26.86 56.74 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.2 t -118.81 -8.05 10.38 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -174.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.421 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 26.8 tt0 -132.9 -49.09 0.87 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.152 0.887 . . . . 0.0 112.404 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -79.2 -63.52 1.4 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -174.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.0 mt -80.36 2.49 24.65 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -173.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -73.83 -93.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.773 0.715 . . . . 0.0 109.422 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -83.96 51.61 2.09 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -80.85 135.01 52.43 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.113 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -64.82 -25.02 60.75 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.112 1.875 . . . . 0.0 111.266 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -108.8 1.34 20.91 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 119.011 -0.518 . . . . 0.0 112.037 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.36 134.5 22.93 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 118.776 0.716 . . . . 0.0 110.014 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -115.89 157.38 24.57 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 68' ' ' ILE . 17.7 t -100.62 126.79 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.592 HD12 ' C ' ' A' ' 67' ' ' VAL . 3.5 mp -135.42 121.43 31.52 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t0 51.53 46.96 25.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.823 0.449 . . . . 0.0 110.455 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.81 -39.49 2.0 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -73.16 176.29 6.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -117.49 153.0 33.9 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB3' HD13 ' A' ' 68' ' ' ILE . . . -144.19 139.07 28.53 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -64.82 133.86 52.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -90.14 115.92 65.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.112 0.565 . . . . 0.0 110.187 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo . . . . . 0 N--CA 1.447 -1.226 0 C-N-CA 122.338 2.025 . . . . 0.0 110.135 179.26 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.436 ' HG3' ' CH2' ' A' ' 53' ' ' TRP . 5.6 pttt . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 119.744 -0.169 . . . . 0.0 110.622 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -68.59 -47.4 66.84 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.103 0.41 . . . . 0.0 110.543 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.73 -36.11 88.63 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.467 HG13 ' CD2' ' A' ' 43' ' ' HIS . 14.1 t -72.69 -49.81 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.3 tp -57.69 -40.91 80.52 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.77 0.428 . . . . 0.0 110.775 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.14 -49.49 77.66 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -62.55 -38.94 92.0 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.46 HG23 HG21 ' A' ' 37' ' ' ILE . 41.1 mt -60.84 -49.0 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.53 -47.92 86.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -65.77 -40.32 91.91 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.424 ' CE1' ' HG2' ' A' ' 40' ' ' GLU . 1.8 t80 -60.17 -56.65 18.96 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.524 0.33 . . . . 0.0 110.27 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -40.66 86.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -55.84 -47.39 77.33 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -63.37 -47.61 81.39 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.395 0.278 . . . . 0.0 110.921 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' A' ' 28' ' ' ASP . 2.2 mtp180 -58.55 -48.72 79.95 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -60.2 -40.26 89.48 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -61.85 -42.74 99.42 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -65.82 -45.65 81.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.461 0.304 . . . . 0.0 110.311 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.91 -20.83 0.3 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.407 ' CG ' HH21 ' A' ' 23' ' ' ARG . 14.9 t70 -79.83 68.78 6.02 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -87.53 -5.69 58.67 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.979 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -64.22 148.46 95.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 O-C-N 122.329 -0.232 . . . . 0.0 110.436 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.08 146.67 86.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.038 2.492 . . . . 0.0 112.251 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.2 mt -134.78 136.53 42.65 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.6 p -63.12 169.91 3.16 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.059 0.457 . . . . 0.0 110.049 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tt -58.35 -51.44 69.79 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -58.14 -44.75 87.99 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.59 0.356 . . . . 0.0 110.99 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -56.59 -30.43 63.19 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.46 HG21 HG23 ' A' ' 16' ' ' ILE . 49.4 mt -78.3 -42.99 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.3 mt -55.26 -43.58 74.78 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -49.47 -50.08 42.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.381 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG2' ' CE1' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -77.28 -49.8 14.25 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.204 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 16' ' ' ILE . 54.5 p -69.08 -3.49 13.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.251 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 65.47 45.95 2.65 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.467 ' CD2' HG13 ' A' ' 12' ' ' VAL . 7.1 m-70 -125.57 42.29 3.32 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.413 ' H ' HD12 ' A' ' 44' ' ' LEU . 4.6 mp -74.57 -49.7 20.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.59 42.53 0.91 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.4 tt -72.82 -36.13 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 122.816 0.446 . . . . 0.0 110.309 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.69 132.19 6.78 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.9 -36.21 62.45 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.821 0.311 . . . . 0.0 110.368 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -50.13 -44.09 52.16 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -78.25 -46.9 19.11 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.484 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -50.61 -49.67 55.99 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -48.95 78.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.436 ' CH2' ' HG3' ' A' ' 9' ' ' LYS . 12.8 t90 -55.76 -53.27 58.74 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 78.0 mt -54.95 -44.02 73.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -53.09 61.82 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.303 -175.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' HG21 ' A' ' 60' ' ' VAL . 7.1 t -120.15 48.18 1.62 Allowed 'General case' 0 C--N 1.348 0.541 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -175.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -165.75 -66.11 0.03 OUTLIER 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -64.5 -69.39 0.29 Allowed 'General case' 0 C--O 1.224 -0.267 0 O-C-N 122.904 0.127 . . . . 0.0 111.168 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.7 mt -59.72 -25.28 64.7 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.416 0.286 . . . . 0.0 111.088 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.439 HG21 ' HA ' ' A' ' 56' ' ' THR . 46.5 t -75.2 -47.89 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -102.26 66.02 0.98 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -143.89 118.55 6.07 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.36 -23.3 74.25 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.602 2.202 . . . . 0.0 112.285 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -93.87 12.35 26.22 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 117.793 0.27 . . . . 0.0 110.95 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mm -135.68 152.02 30.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -144.8 142.37 29.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.7 t -96.06 127.5 48.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.049 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.7 mm -112.59 -120.97 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -81.02 67.51 6.95 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.19 -36.86 1.96 Allowed Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -75.25 169.25 18.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 117.111 0.455 . . . . 0.0 109.999 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -112.47 120.81 42.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.48 134.59 51.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -64.47 135.03 55.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -97.23 118.27 64.77 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo . . . . . 0 N--CA 1.448 -1.203 0 C-N-CA 122.311 2.007 . . . . 0.0 110.24 179.619 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.44 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.47 0.526 0 CA-C-O 120.597 0.236 . . . . 0.0 110.502 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -58.11 -37.45 74.58 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 122.868 0.467 . . . . 0.0 111.383 -175.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.48 -48.17 76.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.06 -41.97 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.728 HD13 ' HB1' ' A' ' 58' ' ' ALA . 62.6 tp -60.82 -47.55 85.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.91 -44.14 91.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -60.7 -47.33 86.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.32 -49.66 82.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.8 t -55.68 -43.8 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 122.663 0.385 . . . . 0.0 110.152 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -65.11 -48.22 74.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -50.25 73.03 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.3 mmm -55.73 -45.54 77.94 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -43.02 87.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.6 m -61.27 -51.36 69.24 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 119.422 -0.323 . . . . 0.0 111.285 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.65 -34.4 78.13 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.857 0.753 . . . . 0.0 109.691 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -65.37 -35.37 80.75 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -69.74 -42.35 74.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.078 0.551 . . . . 0.0 110.436 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -65.75 -36.19 82.85 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.69 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.99 -23.37 0.6 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-O 119.695 -0.503 . . . . 0.0 111.935 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.74 66.68 2.71 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.651 0.726 . . . . 0.0 109.658 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.2 p -76.42 -4.16 40.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.079 0.152 . . . . 0.0 110.676 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -66.03 156.14 85.06 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -70.32 162.46 42.26 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.708 2.272 . . . . 0.0 110.881 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.2 mt -138.65 150.28 46.06 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 177.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.3 p -77.88 167.94 20.71 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -44.83 92.5 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.0 -54.45 46.63 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -54.58 -43.03 71.74 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 122.582 0.353 . . . . 0.0 110.339 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.2 mt -59.13 -62.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.2 mt -54.81 -42.34 71.72 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.162 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -52.1 -54.91 24.63 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -64.05 -31.99 73.38 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.02 13.79 5.68 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 74.44 -58.51 0.58 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 124.312 1.045 . . . . 0.0 112.592 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.76 77.75 0.45 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.615 0.366 . . . . 0.0 111.944 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.94 -33.98 51.37 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 47' ' ' GLY . 19.4 t70 -68.98 -55.37 11.1 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 tt 50.26 -70.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.675 1.59 . . . . 0.0 112.693 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 45' ' ' ASP . . . 142.46 126.34 2.09 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.5 tp -46.81 -44.96 19.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.261 0.53 . . . . 0.0 111.238 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.6 -39.21 61.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.196 0.198 . . . . 0.0 111.244 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -87.97 -48.05 8.08 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -48.11 -48.84 33.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.118 0.567 . . . . 0.0 110.495 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.39 -47.43 76.33 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.44 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 31.2 t90 -55.8 -40.27 72.46 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 122.376 0.27 . . . . 0.0 110.425 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.731 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 77.5 mt -58.66 -49.0 79.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 83.1 mtp -64.84 -47.98 75.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.279 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.5 p -110.32 34.35 3.97 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -173.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -168.17 -75.17 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.738 0.699 . . . . 0.0 110.681 177.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.731 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -52.49 -53.78 41.24 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.7 mt -79.92 -20.1 46.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.756 -0.164 . . . . 0.0 111.041 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.89 -69.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.95 60.13 5.7 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -107.44 122.81 40.05 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.128 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -63.48 -19.6 68.15 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.247 1.964 . . . . 0.0 111.845 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -125.86 19.69 7.8 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.1 mt -146.0 129.69 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -111.46 154.12 25.15 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.3 t -105.93 144.29 15.58 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.0 mt -126.52 -125.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.51 65.04 3.71 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.29 -37.34 2.57 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 171.31 14.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -122.99 147.69 46.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.94 136.51 33.9 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -66.71 130.23 42.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -77.42 129.84 76.23 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.452 -0.937 0 C-N-CA 122.651 2.234 . . . . 0.0 112.188 -177.644 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.18 57.71 3.69 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.3 p -81.08 -35.87 31.16 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.118 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.58 -62.09 5.37 Favored Glycine 0 C--N 1.341 0.813 0 N-CA-C 110.319 -1.112 . . . . 0.0 110.319 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.5 t -165.18 -170.18 1.84 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.7 m -152.77 97.0 2.18 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.05 -47.68 0.02 OUTLIER Glycine 0 C--N 1.338 0.681 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -53.8 123.62 12.92 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.44 ' HB3' ' CH2' ' A' ' 53' ' ' TRP . 17.7 mtmt 74.93 -59.9 0.53 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.066 0.947 . . . . 0.0 110.716 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -56.38 -51.85 66.77 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.775 -173.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.38 -49.77 74.92 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.646 HG13 ' CD2' ' A' ' 43' ' ' HIS . 3.3 t -58.81 -45.73 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.463 HD13 ' HB1' ' A' ' 58' ' ' ALA . 55.9 tp -61.28 -45.5 94.23 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.39 -38.0 82.58 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -69.4 -38.34 77.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 33.5 mt -63.21 -48.85 85.62 Favored 'Isoleucine or valine' 0 C--N 1.341 0.214 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -59.59 -48.35 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -60.66 -43.71 97.3 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -60.73 -57.48 12.5 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 95.4 mtp -55.86 -40.84 73.48 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -59.35 -48.3 82.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.6 m -66.45 -51.18 59.61 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.124 0.17 . . . . 0.0 110.771 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.6 ttt180 -59.18 -36.7 75.78 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -68.56 -41.81 79.22 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -58.26 -48.34 80.73 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.871 0.468 . . . . 0.0 111.386 -178.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -65.25 -33.38 75.84 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 119.142 -0.456 . . . . 0.0 111.73 -176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.25 -31.05 0.48 Allowed Glycine 0 C--N 1.346 1.085 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.627 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.95 70.2 2.65 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 117.95 0.875 . . . . 0.0 109.956 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 71.2 p -79.58 -4.16 50.25 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -61.89 155.71 60.99 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 122.662 0.385 . . . . 0.0 110.793 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -67.4 158.51 56.7 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 122.613 2.208 . . . . 0.0 110.622 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 32' ' ' LEU . 12.1 mt -137.06 140.34 41.95 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 71.6 p -64.72 167.59 7.2 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -60.51 -48.92 79.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -56.68 -49.76 74.13 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.534 0.334 . . . . 0.0 110.924 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -52.58 -36.11 55.43 Favored 'General case' 0 C--N 1.343 0.304 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 60.3 mt -71.62 -45.29 67.85 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.2 mt -47.97 -57.84 5.21 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 117.852 0.296 . . . . 0.0 110.669 -178.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -45.99 -63.86 0.88 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.934 0.494 . . . . 0.0 111.577 -177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -59.95 -27.17 66.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.494 ' O ' ' CE1' ' A' ' 43' ' ' HIS . 67.4 p -93.32 -0.99 56.47 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 119.014 -0.517 . . . . 0.0 111.491 -178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 66.6 41.15 3.16 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 122.846 0.458 . . . . 0.0 109.961 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.646 ' CD2' HG13 ' A' ' 12' ' ' VAL . 7.9 m-70 -129.72 44.13 3.02 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.414 ' O ' HG22 ' A' ' 46' ' ' ILE . 0.5 OUTLIER -76.74 -51.28 11.71 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.07 -39.85 91.46 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.894 HG23 ' H ' ' A' ' 47' ' ' GLY . 18.5 tt 26.28 -105.72 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 124.866 1.266 . . . . 0.0 112.325 178.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.894 ' H ' HG23 ' A' ' 46' ' ' ILE . . . 157.34 148.84 5.24 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 108.04 -2.024 . . . . 0.0 108.04 -178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.4 tp -53.9 -39.97 66.23 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 117.397 0.599 . . . . 0.0 110.676 -178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -55.86 -58.92 5.82 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 122.227 0.211 . . . . 0.0 110.553 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -67.11 -50.14 62.53 Favored 'General case' 0 C--O 1.219 -0.513 0 CA-C-O 119.513 -0.279 . . . . 0.0 110.395 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.2 tppt? -46.01 -51.12 14.13 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 122.556 0.342 . . . . 0.0 110.47 178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.8 tp60 -64.53 -47.44 78.79 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.44 ' CH2' ' HB3' ' A' ' 9' ' ' LYS . 39.6 t90 -56.6 -41.53 77.17 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.381 0.272 . . . . 0.0 110.67 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.593 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 80.4 mt -61.07 -45.53 94.35 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 5.0 mmt -66.83 -47.18 72.8 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.729 -177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.3 p -110.91 33.39 4.61 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -173.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -165.45 -67.39 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 118.821 0.737 . . . . 0.0 111.092 178.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -63.58 -62.33 1.73 Allowed 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -175.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 29.3 mt -79.71 27.93 0.28 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.5 m -134.88 -38.8 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -88.21 -30.54 19.64 Favored 'General case' 0 C--N 1.342 0.27 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -60.8 120.71 55.81 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_endo -63.22 -36.89 54.63 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.661 2.241 . . . . 0.0 112.183 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -66.77 -20.51 65.96 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-O 119.678 -0.201 . . . . 0.0 110.921 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.8 mm -92.5 117.25 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -106.59 122.57 46.59 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 47.7 t -83.56 121.36 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 33.1 mt -115.96 -98.66 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 71' ' ' LYS . 21.0 t0 -82.47 52.81 2.15 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.76 -33.01 1.43 Allowed Glycine 0 CA--C 1.534 1.265 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 69' ' ' ASP . 48.1 mttp -77.8 176.51 8.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.228 0.611 . . . . 0.0 109.542 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -109.1 129.25 55.47 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.489 0.185 . . . . 0.0 110.729 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.15 172.32 8.34 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -97.11 148.14 23.33 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.6 ttmt -104.02 106.96 55.52 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.778 0.431 . . . . 0.0 111.799 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -81.99 -52.38 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.75 2.3 . . . . 0.0 110.644 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -53.89 152.01 6.02 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.202 1.001 . . . . 0.0 112.726 -174.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 17.4 p90 36.15 49.22 0.61 Allowed 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.001 1.32 . . . . 0.0 111.847 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -164.6 -49.69 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.5 t -122.46 151.32 26.33 Favored 'Isoleucine or valine' 0 C--N 1.34 0.189 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 116.726 -1.606 . . . . 0.0 109.129 179.408 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.0 tt -155.68 -64.79 0.12 Allowed 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.2 m 53.62 68.17 0.89 Allowed 'General case' 0 C--N 1.344 0.331 0 C-N-CA 122.646 0.378 . . . . 0.0 110.275 179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.25 57.16 4.4 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.4 t 61.26 -173.1 0.14 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 122.991 0.516 . . . . 0.0 110.903 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.0 t -177.16 155.42 1.15 Allowed 'General case' 0 C--O 1.232 0.169 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.46 55.4 0.54 Allowed Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -157.54 99.5 1.74 Allowed 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.412 ' HG3' ' CH2' ' A' ' 53' ' ' TRP . 1.5 ptmt 82.62 -47.36 0.16 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.689 0.796 . . . . 0.0 108.899 -176.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -69.32 -46.34 67.33 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -56.73 -49.86 67.45 Favored Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.502 -1.039 . . . . 0.0 110.502 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.6 t -64.24 -45.4 96.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 117.015 0.407 . . . . 0.0 110.224 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.8 tp -58.63 -37.87 76.85 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.85 -34.27 74.34 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -61.98 -50.21 73.01 Favored 'General case' 0 C--N 1.348 0.516 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.504 ' HA ' HG21 ' A' ' 41' ' ' THR . 96.1 mt -57.76 -55.83 19.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.228 -179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.2 t -56.6 -44.4 80.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 122.144 0.178 . . . . 0.0 110.98 -178.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -65.86 -52.19 52.44 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 117.57 0.168 . . . . 0.0 111.152 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -46.81 88.4 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 66.9 mmm -53.6 -48.79 68.94 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.92 -66.62 0.37 Allowed 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 122.51 0.324 . . . . 0.0 110.71 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 m -52.55 -45.61 66.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.661 0.384 . . . . 0.0 111.999 -177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.513 HH21 HD11 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -73.27 -24.36 60.43 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 122.253 -0.279 . . . . 0.0 111.06 -176.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -78.33 -39.13 40.5 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -62.04 -40.37 95.53 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -52.64 -54.14 37.41 Favored 'General case' 0 C--N 1.342 0.282 0 C-N-CA 122.497 0.319 . . . . 0.0 110.341 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.4 -22.31 0.25 Allowed Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -82.06 46.38 1.01 Allowed 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 117.621 0.711 . . . . 0.0 110.006 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.408 HG22 ' H ' ' A' ' 29' ' ' THR . 0.0 OUTLIER -65.74 -5.13 7.81 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.65 0.78 . . . . 0.0 111.291 -179.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.446 ' CE1' HD21 ' A' ' 32' ' ' LEU . 2.3 p-80 -54.88 153.42 11.41 Favored Pre-proline 0 CA--C 1.547 0.84 0 C-N-CA 122.446 0.298 . . . . 0.0 111.042 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -60.23 153.6 58.09 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.764 2.309 . . . . 0.0 111.08 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.513 HD11 HH21 ' A' ' 23' ' ' ARG . 16.2 mt -132.16 142.84 49.61 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.0 p -71.9 172.14 10.46 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.98 -48.83 78.61 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -54.09 -52.39 61.15 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.89 0.476 . . . . 0.0 110.996 -179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -51.83 -42.32 62.46 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 122.468 0.307 . . . . 0.0 110.832 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 62.9 mt -64.45 -57.75 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.582 ' CD1' HD11 ' A' ' 46' ' ' ILE . 89.5 mt -51.87 -39.95 59.79 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.255 0.222 . . . . 0.0 111.43 -177.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -55.39 -52.84 62.22 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 110.722 -0.103 . . . . 0.0 110.722 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -75.44 -37.48 60.35 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 122.127 0.171 . . . . 0.0 110.967 -178.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.504 HG21 ' HA ' ' A' ' 16' ' ' ILE . 71.0 p -87.26 91.95 8.9 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 mp0 -26.47 72.71 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.554 1.941 . . . . 0.0 115.592 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.438 ' N ' ' O ' ' A' ' 41' ' ' THR . 1.3 p80 -178.58 58.12 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.89 56.68 4.08 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -162.21 -45.06 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.606 HD12 ' HB2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER 40.88 -89.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.597 0 C-N-CA 124.821 1.248 . . . . 0.0 112.3 177.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 140.11 168.95 11.51 Favored Glycine 0 N--CA 1.44 -1.034 0 N-CA-C 107.166 -2.373 . . . . 0.0 107.166 -175.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 tt -58.28 -49.37 77.38 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 117.65 0.725 . . . . 0.0 110.151 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.9 mmtt -52.36 -55.7 19.83 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.312 0.245 . . . . 0.0 111.117 -178.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -66.96 -58.58 4.68 Favored 'General case' 0 C--O 1.222 -0.358 0 CA-C-O 119.488 -0.292 . . . . 0.0 111.282 -176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.606 ' HB2' HD12 ' A' ' 46' ' ' ILE . 24.6 ttpp -48.94 -42.91 38.98 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 118.033 0.379 . . . . 0.0 110.7 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -68.15 -56.78 7.54 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.412 ' CH2' ' HG3' ' A' ' 9' ' ' LYS . 23.3 t90 -52.58 -52.6 54.39 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 123.151 0.282 . . . . 0.0 110.625 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.54 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 76.8 mt -57.07 -49.93 74.32 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.19 0.196 . . . . 0.0 110.762 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 59.2 ttm -62.09 -57.66 10.76 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -174.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.4 t -109.78 16.86 21.77 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -138.84 -54.21 0.59 Allowed 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 119.432 1.015 . . . . 0.0 111.295 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.54 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -75.68 -64.76 1.01 Allowed 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -173.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.03 -29.64 70.42 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -175.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.3 m -67.95 -18.71 23.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 119.144 -0.455 . . . . 0.0 111.998 -178.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 40.3 p30 -136.57 15.14 3.17 Favored 'General case' 0 C--N 1.348 0.521 0 CA-C-N 118.67 0.668 . . . . 0.0 111.783 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -69.38 132.78 89.47 Favored Pre-proline 0 CA--C 1.539 0.523 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -53.37 -27.18 38.15 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.818 2.345 . . . . 0.0 113.249 -177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.4 mtpm? -112.36 30.25 7.24 Favored 'General case' 0 C--N 1.346 0.418 0 CA-C-N 118.242 0.474 . . . . 0.0 111.675 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 18.7 mm -135.3 150.51 29.41 Favored 'Isoleucine or valine' 0 C--N 1.346 0.433 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -142.69 148.3 37.11 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 60.5 t -92.78 110.96 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.5 mt -129.52 126.47 63.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.5 t70 58.03 27.11 14.38 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.705 0.402 . . . . 0.0 109.984 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.15 -13.38 26.61 Favored Glycine 0 CA--C 1.534 1.228 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.4 mmtm -91.57 174.12 7.53 Favored 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -105.26 118.28 36.16 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.43 148.64 32.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -75.32 121.56 22.4 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -88.02 116.39 66.05 Favored Pre-proline 0 N--CA 1.452 -0.33 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -65.92 -57.2 0.25 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 122.123 1.882 . . . . 0.0 110.094 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt 71.6 -72.25 0.12 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 123.604 0.762 . . . . 0.0 109.727 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -146.02 46.28 1.25 Allowed 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -139.51 112.44 8.01 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.65 24.67 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 116.615 -1.66 . . . . 0.0 109.529 -179.868 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 54.6 tp -142.64 137.05 29.71 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.2 m 53.74 54.04 10.48 Favored 'General case' 0 C--N 1.343 0.325 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 76.03 -136.6 19.96 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.0 t -162.27 128.15 3.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.1 p -71.79 -66.19 0.67 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.96 55.49 0.06 OUTLIER Glycine 0 CA--C 1.523 0.587 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.39 50.21 0.77 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 122.626 0.37 . . . . 0.0 111.088 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.448 ' HB2' ' CZ3' ' A' ' 53' ' ' TRP . 20.5 ptmt -166.34 -47.87 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -68.58 -42.48 78.19 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.391 -0.226 . . . . 0.0 110.391 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.01 -49.95 72.89 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 110.176 -1.17 . . . . 0.0 110.176 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.87 -45.58 98.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 67.4 tp -58.53 -46.14 87.41 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.06 -43.13 99.35 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -62.55 -44.17 97.0 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.509 ' HA ' HG21 ' A' ' 41' ' ' THR . 45.9 mt -60.85 -51.03 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 t -55.04 -47.74 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -60.2 -48.52 81.38 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 110.561 -0.162 . . . . 0.0 110.561 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.74 -55.9 28.49 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.16 -39.34 72.16 Favored 'General case' 0 C--O 1.222 -0.354 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.95 -44.25 97.15 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 178.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.1 m -66.0 -45.49 81.37 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.135 0.174 . . . . 0.0 110.594 -178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 12.9 ttt180 -67.15 -40.59 86.72 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -61.25 -45.2 95.5 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -79.3 59.98 2.98 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.87 -51.71 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 177.48 -47.68 0.1 OUTLIER Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -76.61 73.25 3.31 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 116.97 0.385 . . . . 0.0 110.288 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.4 p -81.88 -12.18 58.57 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -63.64 154.24 80.73 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 122.577 0.351 . . . . 0.0 110.51 -178.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.68 158.15 58.07 Favored 'Trans proline' 0 N--CA 1.448 -1.155 0 C-N-CA 122.56 2.173 . . . . 0.0 111.386 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 32' ' ' LEU . 22.4 mt -133.04 149.7 52.17 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -61.99 166.54 4.54 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tt -59.05 -52.45 65.68 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.02 -40.58 89.79 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 119.462 -0.304 . . . . 0.0 111.06 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -58.04 -43.51 86.87 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.4 mt -64.29 -43.97 97.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 83.9 mt -57.36 -52.41 65.49 Favored 'General case' 0 C--N 1.345 0.405 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -45.38 -56.89 4.49 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 122.575 0.35 . . . . 0.0 111.224 -177.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -60.42 -34.75 74.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 122.549 0.34 . . . . 0.0 111.77 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 16' ' ' ILE . 17.7 p -83.35 9.01 11.92 Favored 'General case' 0 C--O 1.219 -0.536 0 CA-C-O 119.644 -0.217 . . . . 0.0 111.092 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 69.38 38.61 1.79 Allowed 'General case' 0 C--N 1.344 0.347 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.495 ' CE1' ' O ' ' A' ' 41' ' ' THR . 5.8 m-70 -132.37 167.05 20.59 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 mt 166.26 -52.59 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 177.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -81.06 7.91 9.81 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.48 HD11 ' HB3' ' A' ' 50' ' ' GLN . 3.5 tt -48.48 147.21 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.469 0 C-N-CA 123.596 0.759 . . . . 0.0 110.237 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.35 133.43 19.9 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.033 -1.227 . . . . 0.0 110.033 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 64.3 tp -56.49 -31.05 63.67 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -58.02 -45.69 86.49 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.48 ' HB3' HD11 ' A' ' 46' ' ' ILE . 18.2 mp0 -68.56 -47.8 65.9 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.1 ttmt -55.69 -43.92 76.86 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -66.53 -50.7 62.3 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.448 ' CZ3' ' HB2' ' A' ' 9' ' ' LYS . 31.5 t90 -55.16 -45.66 75.71 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 122.457 0.303 . . . . 0.0 110.442 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.694 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 37.2 mt -56.08 -43.25 77.85 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 38.2 ttm -71.73 -50.37 30.81 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 -176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 80.5 p -104.94 23.49 13.47 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 36.0 tt0 -160.32 -68.89 0.07 Allowed 'General case' 0 C--O 1.225 -0.204 0 CA-C-N 119.241 0.928 . . . . 0.0 111.567 177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.694 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -55.55 -66.71 0.37 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.316 0.487 . . . . 0.0 112.316 -174.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.9 mt -63.09 -41.52 99.41 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 111.569 0.211 . . . . 0.0 111.569 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 20.3 m -65.27 -37.92 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 117.834 0.288 . . . . 0.0 110.591 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -101.78 58.35 0.84 Allowed 'General case' 0 C--N 1.342 0.279 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.3 t-20 -148.1 112.66 3.84 Favored Pre-proline 0 CA--C 1.534 0.34 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -58.29 -27.61 81.59 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.515 2.143 . . . . 0.0 111.812 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -74.92 -5.14 42.15 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.944 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 25.1 mm -120.5 138.21 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 -179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -126.6 119.66 27.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -89.29 139.06 18.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.6 mt -131.79 -96.65 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.316 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.64 55.25 3.15 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 76.53 -39.05 1.47 Allowed Glycine 0 CA--C 1.531 1.085 0 N-CA-C 110.633 -0.987 . . . . 0.0 110.633 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.1 mtmp? -72.27 161.42 30.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -108.52 128.55 54.9 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 116.693 -0.23 . . . . 0.0 110.866 -175.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.2 163.01 15.81 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -92.87 125.47 37.49 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -78.8 122.46 84.73 Favored Pre-proline 0 N--CA 1.451 -0.411 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.26 50.92 2.73 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.835 2.357 . . . . 0.0 110.955 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 61.5 mtpt 55.73 -103.56 0.19 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 122.915 0.486 . . . . 0.0 110.046 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.8 p90 -115.9 28.9 8.33 Favored 'General case' 0 C--N 1.345 0.411 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 73.99 173.76 0.28 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.133 0.573 . . . . 0.0 109.757 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.8 t -81.37 76.37 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? . . . . . 0 C--O 1.254 1.313 0 CA-C-O 115.907 -1.997 . . . . 0.0 110.284 -179.844 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.703 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -162.16 133.13 5.05 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.7 m -153.82 -36.58 0.1 Allowed 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.87 95.25 0.47 Allowed Glycine 0 C--N 1.339 0.719 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.9 t -57.71 -40.59 79.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -83.79 34.23 0.49 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.44 -78.95 0.96 Allowed Glycine 0 C--N 1.34 0.778 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.405 ' CG ' ' N ' ' A' ' 9' ' ' LYS . 18.4 t80 51.95 -126.81 2.42 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.405 ' N ' ' CG ' ' A' ' 8' ' ' TYR . 39.3 mtpt -52.7 -62.6 1.54 Allowed 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 123.577 0.751 . . . . 0.0 110.923 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -60.78 -37.05 80.56 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.979 -175.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.15 -49.68 69.38 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 178.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.503 HG13 ' CD2' ' A' ' 43' ' ' HIS . 6.2 t -60.12 -41.99 88.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.62 HD13 ' HB1' ' A' ' 58' ' ' ALA . 59.8 tp -61.36 -43.5 98.76 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.07 -48.8 80.28 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.021 0.128 . . . . 0.0 111.084 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.11 -30.52 67.73 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 120.643 -0.423 . . . . 0.0 109.993 -178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 29.8 mt -64.64 -46.05 93.56 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 176.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -58.89 -41.75 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.67 -47.81 77.06 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -44.29 95.05 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 110.073 -0.344 . . . . 0.0 110.073 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 89.2 mmm -62.51 -37.24 85.26 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -69.28 -53.54 19.26 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.9 m -54.1 -48.92 70.21 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 122.413 0.285 . . . . 0.0 111.011 -176.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.2 ptm85 -64.44 -40.02 94.94 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -64.96 -19.62 66.06 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -88.36 -39.53 14.26 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.663 0.385 . . . . 0.0 110.68 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -69.88 -37.32 76.0 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-N 117.593 0.179 . . . . 0.0 110.588 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 138.7 48.45 0.06 OUTLIER Glycine 0 C--N 1.342 0.88 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -140.46 53.96 1.62 Allowed 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.7 p -78.89 -10.09 59.7 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.679 -175.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -61.89 147.58 89.45 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -59.8 151.72 68.85 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.863 2.376 . . . . 0.0 111.647 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.3 mt -131.28 142.38 50.12 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.7 p -70.53 170.85 11.26 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.31 -46.41 90.41 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -54.55 -54.65 38.43 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 122.604 0.362 . . . . 0.0 110.444 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -52.28 -35.8 51.12 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.595 0.358 . . . . 0.0 111.108 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 27.6 mt -67.4 -48.85 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 89.4 mt -59.54 -43.78 93.39 Favored 'General case' 0 C--N 1.345 0.377 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.11 -62.21 1.78 Allowed 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.524 0.329 . . . . 0.0 111.164 -178.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.07 -50.58 70.6 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.5 p -76.64 -1.29 26.97 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 119.455 -0.307 . . . . 0.0 111.588 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 56.68 60.2 3.19 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.503 ' CD2' HG13 ' A' ' 12' ' ' VAL . 9.4 m-70 -129.35 31.37 4.84 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 19.3 mt -77.18 67.73 3.2 Favored 'General case' 0 C--N 1.343 0.315 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -163.54 -40.65 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 -178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.51 ' CD1' ' H ' ' A' ' 47' ' ' GLY . 0.6 OUTLIER 18.18 -88.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.928 0 C-N-CA 125.441 1.496 . . . . 0.0 112.759 178.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.51 ' H ' ' CD1' ' A' ' 46' ' ' ILE . . . 132.77 160.48 9.57 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 107.351 -2.299 . . . . 0.0 107.351 -176.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.4 tp -55.34 -43.81 75.35 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 117.756 0.778 . . . . 0.0 109.641 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -59.37 -53.37 58.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 122.522 0.329 . . . . 0.0 110.635 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -64.99 -57.66 8.12 Favored 'General case' 0 C--O 1.223 -0.338 0 CA-C-O 119.669 -0.205 . . . . 0.0 111.083 -176.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HB2' HD13 ' A' ' 46' ' ' ILE . 27.4 ttpp -48.71 -48.83 40.04 Favored 'General case' 0 C--N 1.344 0.343 0 CA-C-O 120.636 0.255 . . . . 0.0 110.392 -179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -62.5 -52.92 61.56 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.255 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 21.5 t90 -54.65 -49.22 71.1 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 122.286 0.235 . . . . 0.0 110.657 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 69.3 mt -56.22 -52.32 64.87 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 45.8 ttp -63.15 -40.78 98.55 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -176.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 82.2 p -114.48 27.49 9.42 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.29 -66.86 0.05 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.811 0.732 . . . . 0.0 110.749 177.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.743 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -64.35 -20.06 65.86 Favored 'General case' 0 C--O 1.226 -0.171 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.8 mt -121.23 21.84 11.04 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.201 0.455 . . . . 0.0 111.312 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.22 -41.78 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -85.22 -30.7 23.65 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 64.2 t-20 -57.41 114.91 9.19 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 122.999 0.52 . . . . 0.0 109.962 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.83 -21.52 73.15 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.524 2.149 . . . . 0.0 111.786 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -80.96 0.68 34.42 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 119.543 -0.265 . . . . 0.0 110.714 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 20.3 mm -127.76 147.89 32.44 Favored 'Isoleucine or valine' 0 C--N 1.344 0.359 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -136.54 149.71 48.25 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.0 t -102.79 116.81 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 3.1 mp -130.17 132.46 65.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.9 t70 57.24 26.95 12.9 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 122.708 0.403 . . . . 0.0 110.136 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 -17.57 10.3 Favored Glycine 0 CA--C 1.534 1.22 0 N-CA-C 110.945 -0.862 . . . . 0.0 110.945 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.0 mmtm -86.91 -179.63 6.55 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -116.05 137.6 51.98 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-O 120.657 0.265 . . . . 0.0 110.54 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.48 151.44 48.47 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -71.7 126.48 29.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -77.7 117.33 64.96 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -70.41 131.75 20.93 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 122.227 1.951 . . . . 0.0 111.426 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -74.94 -60.49 2.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -92.83 137.36 32.43 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -69.62 152.22 45.0 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.6 t -69.23 140.17 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 45.9 mtp85 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 116.656 -1.64 . . . . 0.0 109.455 -179.406 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 10.8 mp 62.08 -81.73 0.02 OUTLIER 'General case' 0 C--N 1.345 0.385 0 O-C-N 123.852 0.72 . . . . 0.0 109.776 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 p -80.46 66.21 5.89 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.48 -160.56 51.36 Favored Glycine 0 CA--C 1.53 0.999 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.8 t 56.92 81.04 0.14 Allowed 'General case' 0 C--N 1.345 0.393 0 C-N-CA 123.044 0.538 . . . . 0.0 109.951 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.4 p -78.99 59.93 2.78 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.519 -0.309 . . . . 0.0 110.276 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.41 113.1 0.36 Allowed Glycine 0 CA--C 1.528 0.906 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -61.32 141.73 57.38 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 mtmp? 69.56 -67.88 0.21 Allowed 'General case' 0 C--N 1.351 0.644 0 C-N-CA 123.531 0.732 . . . . 0.0 110.728 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -55.04 -40.57 70.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 122.638 0.375 . . . . 0.0 110.96 -176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.25 -45.06 96.04 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.72 -45.1 98.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 61.8 tp -61.26 -42.61 98.93 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.049 179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -38.96 86.6 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -67.96 -41.56 82.27 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.449 ' HA ' HG21 ' A' ' 41' ' ' THR . 35.2 mt -62.14 -45.83 97.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.54 -50.12 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -58.71 -43.54 90.12 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 110.178 -0.304 . . . . 0.0 110.178 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.03 -58.56 8.02 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 88.9 mmm -54.36 -42.42 70.25 Favored 'General case' 0 C--N 1.341 0.232 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.29 -50.49 72.79 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 122.466 0.306 . . . . 0.0 110.505 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.7 m -61.83 -49.13 77.52 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -58.16 -45.13 88.01 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.1 t60 -62.14 -34.3 76.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -73.11 -16.98 61.45 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.506 0.322 . . . . 0.0 110.553 179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.05 -52.15 4.85 Favored 'General case' 0 C--N 1.345 0.395 0 C-N-CA 122.49 0.316 . . . . 0.0 110.171 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.54 -30.73 0.11 Allowed Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -75.35 78.28 2.43 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.2 p -93.92 -17.03 23.43 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.196 -178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -66.06 154.46 89.65 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 117.6 0.182 . . . . 0.0 111.012 -176.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.8 156.6 63.3 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.075 2.517 . . . . 0.0 111.76 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 28.5 mt -137.96 147.7 44.54 Favored 'General case' 0 C--N 1.345 0.412 0 C-N-CA 122.906 0.482 . . . . 0.0 109.772 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.0 p -63.64 170.99 2.87 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.946 0.403 . . . . 0.0 109.923 177.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.38 -55.85 29.56 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -56.81 -42.3 79.31 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 122.286 0.234 . . . . 0.0 111.25 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -57.81 -35.07 70.35 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.2 mt -69.76 -40.98 79.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.4 mt -57.63 -41.92 82.32 Favored 'General case' 0 C--N 1.345 0.408 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.435 ' HA ' HD11 ' A' ' 44' ' ' LEU . 31.8 t70 -50.28 -62.51 1.54 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 122.199 0.2 . . . . 0.0 111.011 -177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -58.4 -46.32 86.65 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 122.84 0.456 . . . . 0.0 111.671 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.449 HG21 ' HA ' ' A' ' 16' ' ' ILE . 48.1 p -75.65 -6.69 51.7 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 119.243 -0.408 . . . . 0.0 111.653 -177.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 9.1 tp60 61.0 52.95 3.85 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.429 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.0 m-70 -129.16 36.32 4.18 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.387 179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' H ' HD12 ' A' ' 44' ' ' LEU . 4.0 mp -69.35 -45.84 68.45 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -83.13 62.18 6.47 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 12.8 tt -101.75 146.69 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.831 -178.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.95 136.06 48.78 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.6 tp -52.1 -39.32 59.62 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.944 0.372 . . . . 0.0 110.64 -178.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -62.96 -40.03 96.45 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.566 -0.161 . . . . 0.0 110.566 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -70.02 -50.39 41.88 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -51.39 -47.15 62.99 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -60.65 -56.52 20.27 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.669 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -50.48 -46.88 57.22 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 122.795 0.438 . . . . 0.0 111.202 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 68.3 mt -56.99 -44.92 83.2 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 21.5 ttt -76.89 -34.36 57.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.2 p -101.34 -4.47 26.94 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -174.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -138.77 -74.43 0.38 Allowed 'General case' 0 C--N 1.342 0.253 0 CA-C-N 119.028 0.831 . . . . 0.0 111.567 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -49.83 -63.43 1.11 Allowed 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.457 0.539 . . . . 0.0 112.457 -174.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.4 mt -73.07 4.04 4.8 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.4 m -116.86 6.3 7.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.415 0 CA-C-N 118.826 0.739 . . . . 0.0 110.679 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -145.81 -15.78 0.47 Allowed 'General case' 0 C--N 1.348 0.51 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.483 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -63.9 117.88 40.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.34 -25.27 77.8 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.558 2.172 . . . . 0.0 112.346 -177.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.405 ' C ' HD12 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -76.66 -12.51 60.01 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-O 119.357 -0.354 . . . . 0.0 110.993 -178.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.405 HD12 ' C ' ' A' ' 64' ' ' LYS . 1.5 mp -115.33 144.68 22.35 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -124.38 130.14 51.96 Favored 'General case' 0 C--N 1.341 0.221 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -89.15 125.73 42.18 Favored 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 30.3 mm -116.94 -108.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -82.52 55.88 3.1 Favored 'General case' 0 C--N 1.342 0.263 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.75 -34.47 2.09 Favored Glycine 0 CA--C 1.531 1.089 0 N-CA-C 110.714 -0.954 . . . . 0.0 110.714 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -77.05 166.36 23.4 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -109.87 125.17 52.5 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.239 0.216 . . . . 0.0 110.796 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -112.8 172.51 6.89 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -94.79 122.71 37.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 177.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -73.95 114.94 37.55 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.65 -81.86 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.239 0 C-N-CA 122.309 2.006 . . . . 0.0 110.922 -178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -161.42 41.1 0.15 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 17.0 m-30 -97.19 66.98 2.13 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -167.52 105.39 0.53 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.1 t -131.43 140.69 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.0 mmm180 . . . . . 0 C--O 1.252 1.194 0 CA-C-O 116.736 -1.602 . . . . 0.0 109.234 179.733 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.1 tp -75.02 95.66 3.06 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 m -76.86 74.17 3.48 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.1 68.81 2.27 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.0 t -76.78 -28.31 55.61 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.9 t -78.03 67.85 3.96 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.83 -96.26 0.94 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.431 ' O ' ' CG ' ' A' ' 8' ' ' TYR . 2.4 t80 60.66 5.96 1.03 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.156 0.582 . . . . 0.0 110.974 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.407 ' HB2' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER 175.27 -47.68 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.527 0.731 . . . . 0.0 109.565 178.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -67.35 -49.7 62.96 Favored 'General case' 0 CA--C 1.527 0.081 0 C-N-CA 122.327 0.251 . . . . 0.0 110.748 -177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.91 -47.59 87.92 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.537 HG13 ' ND1' ' A' ' 43' ' ' HIS . 2.4 t -63.9 -49.53 81.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 63.8 tp -56.91 -47.95 79.36 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.65 -42.67 99.22 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.172 0.189 . . . . 0.0 110.711 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.91 -42.12 95.0 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 40.9 mt -60.3 -50.04 81.82 Favored 'Isoleucine or valine' 0 C--N 1.341 0.234 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 t -54.56 -44.77 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 122.411 0.285 . . . . 0.0 110.269 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -70.77 -39.0 73.47 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 120.321 0.105 . . . . 0.0 110.859 -178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CE1' ' HG3' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -64.05 -52.98 56.83 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -179.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 96.0 mtp -61.63 -31.55 71.65 Favored 'General case' 0 C--O 1.224 -0.28 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -55.92 14.65 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.2 m -57.44 -40.33 78.2 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.447 ' HG3' ' CE1' ' A' ' 19' ' ' TYR . 42.4 mmt-85 -60.87 -50.82 71.88 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.94 0.496 . . . . 0.0 110.29 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 25.5 t60 -62.37 -22.07 65.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.447 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -88.9 16.18 7.34 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 122.654 0.382 . . . . 0.0 110.489 178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -136.81 -47.09 0.6 Allowed 'General case' 0 C--N 1.348 0.508 0 CA-C-N 117.611 0.187 . . . . 0.0 110.721 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 178.21 -38.64 0.08 OUTLIER Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.349 -0.7 . . . . 0.0 111.349 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -73.44 76.86 1.41 Allowed 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.5 p -100.77 -30.26 11.81 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.141 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -58.6 161.97 7.27 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 123.627 0.771 . . . . 0.0 111.288 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -68.81 124.6 11.65 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 122.201 1.934 . . . . 0.0 110.839 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.4 mt -101.24 153.86 19.25 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 177.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 p -69.79 167.36 17.37 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.68 -56.16 25.72 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -57.64 -40.23 78.77 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.516 -0.278 . . . . 0.0 111.621 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -57.0 -37.61 71.9 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 118.084 0.402 . . . . 0.0 109.982 178.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.3 mt -71.62 -40.62 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 36.5 mt -62.69 -57.24 11.7 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 117.454 0.115 . . . . 0.0 111.195 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -40.83 67.83 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 122.189 0.196 . . . . 0.0 111.349 -175.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -76.9 -3.17 37.28 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -175.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.585 ' HB ' ' CE1' ' A' ' 43' ' ' HIS . 16.7 p -120.6 0.78 10.52 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.105 0.412 . . . . 0.0 110.289 176.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.434 ' N ' ' NE2' ' A' ' 42' ' ' GLN . 10.4 mm-40 73.04 26.1 2.24 Favored 'General case' 0 C--N 1.343 0.306 0 C-N-CA 123.445 0.698 . . . . 0.0 109.132 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.585 ' CE1' ' HB ' ' A' ' 41' ' ' THR . 26.6 m170 -106.56 38.45 2.06 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.477 ' O ' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -83.62 -38.75 21.17 Favored 'General case' 0 CA--C 1.527 0.088 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -60.51 -44.79 95.62 Favored 'General case' 0 C--N 1.339 0.139 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 176.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.931 HG23 ' H ' ' A' ' 47' ' ' GLY . 16.3 tt 22.47 -102.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 125.26 1.424 . . . . 0.0 112.787 176.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.931 ' H ' HG23 ' A' ' 46' ' ' ILE . . . 153.05 148.94 5.02 Favored Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 -178.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.3 tt -54.95 -42.15 71.98 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 117.515 0.658 . . . . 0.0 110.253 -178.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -59.24 -51.02 71.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.416 0.286 . . . . 0.0 110.644 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -65.77 -51.32 60.08 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.273 0.229 . . . . 0.0 110.533 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 22.1 ttmt -53.33 -50.48 64.9 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -58.53 -49.15 78.45 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.407 ' CH2' ' HB2' ' A' ' 9' ' ' LYS . 22.8 t90 -54.44 -50.93 66.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 79.1 mt -57.46 -47.87 80.71 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.3 ttt -60.17 -49.75 76.38 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.324 -175.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.8 t -123.69 52.19 1.45 Allowed 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 118.31 0.505 . . . . 0.0 112.221 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -167.58 -55.16 0.02 OUTLIER 'General case' 0 C--N 1.339 0.139 0 O-C-N 122.255 -0.278 . . . . 0.0 110.284 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.445 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -81.92 -62.12 1.72 Allowed 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -176.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 44.3 mt -71.87 2.0 6.21 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.55 0.34 . . . . 0.0 111.882 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 36.5 t -82.5 -49.51 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -120.15 37.43 4.24 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.738 0.415 . . . . 0.0 110.14 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -74.98 133.3 75.91 Favored Pre-proline 0 CA--C 1.536 0.44 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -65.13 -21.39 62.8 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 122.342 2.028 . . . . 0.0 111.993 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.89 10.15 13.09 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-O 119.391 -0.338 . . . . 0.0 111.851 -177.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -140.2 151.34 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -141.8 152.44 43.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 t -97.37 121.2 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 -177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 mp -138.92 136.46 42.83 Favored 'Isoleucine or valine' 0 C--N 1.343 0.298 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 29.1 t70 56.68 26.91 11.84 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 122.872 0.469 . . . . 0.0 110.477 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.51 -20.42 6.14 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm -86.47 -167.12 1.76 Allowed 'General case' 0 C--N 1.345 0.382 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -132.42 126.91 34.23 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-O 120.918 0.39 . . . . 0.0 110.933 -176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.71 166.8 11.35 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.678 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -92.96 127.93 38.65 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -83.95 118.91 72.58 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.2 -58.9 0.62 Allowed 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.282 1.988 . . . . 0.0 110.565 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -164.35 -44.47 0.03 OUTLIER 'General case' 0 C--N 1.341 0.199 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -147.08 -64.24 0.28 Allowed 'General case' 0 C--N 1.341 0.234 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 57.61 80.39 0.17 Allowed 'General case' 0 C--N 1.345 0.373 0 C-N-CA 122.836 0.454 . . . . 0.0 110.0 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.8 p -61.07 148.71 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.112 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 47.6 mtm-85 . . . . . 0 C--O 1.25 1.092 0 CA-C-O 116.758 -1.591 . . . . 0.0 109.113 179.693 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 tp 61.56 -155.46 0.35 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.8 t -162.35 -176.12 4.91 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -167.32 64.94 0.2 Allowed Glycine 0 CA--C 1.523 0.56 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.2 m -77.05 66.92 2.96 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 122.496 0.319 . . . . 0.0 110.22 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.7 t -71.07 -27.02 63.32 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.81 36.03 61.7 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -64.13 163.51 12.43 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt 75.42 -64.89 0.35 Allowed 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 123.761 0.824 . . . . 0.0 109.121 -175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -63.29 -46.44 86.73 Favored 'General case' 0 N--CA 1.426 -1.663 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.049 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.83 -49.62 76.05 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 t -59.66 -47.81 89.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.8 tp -59.39 -45.19 92.15 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 110.284 -0.265 . . . . 0.0 110.284 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.35 -42.91 96.69 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 -179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -64.91 -44.03 90.92 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.489 ' HA ' HG21 ' A' ' 41' ' ' THR . 49.2 mt -60.86 -46.94 95.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.8 t -59.13 -48.03 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 122.595 0.358 . . . . 0.0 110.048 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -61.48 -44.82 96.4 Favored 'General case' 0 C--O 1.226 -0.175 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -59.79 -58.99 6.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 85.6 mmm -54.94 -37.69 66.76 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -45.8 92.42 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.2 m -60.06 -44.84 94.44 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -56.96 -53.18 60.9 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -61.92 -34.9 76.92 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.587 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.0 tp60 -67.03 -46.78 73.41 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 119.686 -0.197 . . . . 0.0 111.05 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -71.04 -29.58 65.53 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 119.395 -0.335 . . . . 0.0 111.292 -177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 150.98 -20.0 0.97 Allowed Glycine 0 C--N 1.346 1.111 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.205 178.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -79.65 65.3 4.77 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 117.732 0.766 . . . . 0.0 109.747 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 36.0 p -78.19 -4.44 47.61 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.629 -0.259 . . . . 0.0 110.392 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -64.94 155.52 83.21 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 122.427 0.291 . . . . 0.0 110.725 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -69.29 155.71 66.69 Favored 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.75 2.3 . . . . 0.0 110.986 178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.461 HD23 ' HA ' ' A' ' 32' ' ' LEU . 12.7 mt -136.6 143.45 43.58 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 176.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.4 p -70.99 167.32 19.41 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -47.8 81.3 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -55.88 -52.52 63.78 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 122.25 0.22 . . . . 0.0 110.466 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -55.13 -37.07 66.46 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 122.433 0.293 . . . . 0.0 110.496 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 21.6 mt -69.42 -51.92 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 -179.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 79.5 mt -57.4 -44.84 84.89 Favored 'General case' 0 C--N 1.341 0.235 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -52.03 -56.81 12.02 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.465 0.306 . . . . 0.0 110.916 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.33 -41.26 88.7 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.689 -0.115 . . . . 0.0 110.689 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 16' ' ' ILE . 40.9 p -82.36 7.29 14.45 Favored 'General case' 0 C--O 1.22 -0.491 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.121 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.6 tm0? 68.83 -11.95 0.4 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.358 0.663 . . . . 0.0 111.621 178.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.422 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.2 m-70 -77.35 35.51 0.18 Allowed 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.745 -0.597 . . . . 0.0 111.701 -177.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -48.04 67.6 Favored 'General case' 0 C--O 1.236 0.382 0 O-C-N 121.525 -0.734 . . . . 0.0 109.552 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -86.3 37.82 0.75 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 46' ' ' ILE . 6.7 tt -72.77 147.3 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.09 137.54 46.75 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.5 tt -55.46 -32.21 62.6 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.695 0.247 . . . . 0.0 110.471 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -54.02 -38.74 65.47 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -86.53 -43.83 12.41 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -51.22 -48.72 62.0 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 122.39 0.276 . . . . 0.0 110.344 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -66.22 -49.43 67.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.474 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 34.8 t90 -51.36 -44.84 62.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.547 0.339 . . . . 0.0 110.615 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 32.3 mt -56.95 -40.99 77.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 92.7 mtp -85.61 -9.36 57.4 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 118.731 -0.652 . . . . 0.0 112.643 -176.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 74.5 p -136.28 20.6 3.18 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 119.177 0.899 . . . . 0.0 112.931 -175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 30.7 tt0 -160.93 -49.89 0.05 OUTLIER 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.973 0.806 . . . . 0.0 111.725 178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.93 -76.82 0.24 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.8 mt -56.69 -31.19 64.22 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 122.553 0.341 . . . . 0.0 111.694 -174.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 16.7 m -58.28 -21.62 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 119.58 -0.248 . . . . 0.0 111.577 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 25.3 p30 -147.5 26.57 1.04 Allowed 'General case' 0 C--N 1.346 0.423 0 CA-C-N 118.148 0.431 . . . . 0.0 110.889 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -70.54 126.52 92.28 Favored Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.01 -24.14 78.95 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.403 2.069 . . . . 0.0 112.203 -178.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -106.78 5.44 28.63 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-O 119.063 -0.494 . . . . 0.0 111.677 -177.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 17.9 mt -145.2 112.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.453 0 CA-C-N 118.671 0.669 . . . . 0.0 109.573 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -96.16 156.8 16.18 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.257 0.623 . . . . 0.0 109.456 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 t -103.46 140.32 21.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.1 mt -127.71 -112.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -80.08 61.15 3.84 Favored 'General case' 0 C--N 1.343 0.301 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.29 -35.81 1.75 Allowed Glycine 0 CA--C 1.532 1.102 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.4 mttp -76.38 179.17 6.0 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -123.74 134.08 53.74 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -177.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -124.13 135.8 53.76 Favored 'General case' 0 CA--C 1.519 -0.222 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -62.4 125.4 23.79 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 46.0 tttm -86.27 128.93 55.51 Favored Pre-proline 0 N--CA 1.448 -0.56 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -53.21 140.73 60.96 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 C-N-CA 122.201 1.934 . . . . 0.0 110.583 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 9.1 ttpp -66.05 102.67 0.83 Allowed 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.996 -177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -120.48 102.83 8.71 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -154.98 47.35 0.54 Allowed 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.9 p -68.27 143.81 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.5 ttp180 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 116.555 -1.688 . . . . 0.0 109.763 -179.646 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -150.35 29.66 0.7 Allowed 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.1 p -161.33 52.29 0.26 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.12 48.91 0.28 Allowed Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.1 t -165.86 162.71 18.52 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.1 t -91.06 -165.58 1.39 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 133.44 80.34 0.16 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -59.72 119.83 8.36 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.455 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 17.2 mtmm 74.2 -61.8 0.48 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.966 0.906 . . . . 0.0 110.214 -178.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 8.6 m-85 -57.31 -44.92 84.56 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.645 -174.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.41 -49.77 73.82 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 54.8 t -58.0 -47.83 85.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.5 -46.19 89.54 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.502 0.321 . . . . 0.0 110.506 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.19 93.76 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.6 ttpp -65.98 -39.27 90.21 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 31.6 mt -62.22 -46.88 95.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.6 t -58.38 -48.69 84.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.336 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -63.33 -38.22 90.32 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.15 -56.6 17.19 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.3 mtp -59.93 -35.41 74.85 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -46.14 91.86 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.1 m -67.59 -44.67 77.58 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 122.318 0.247 . . . . 0.0 110.397 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 47.4 ttt85 -60.02 -45.94 91.14 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -63.28 -39.66 95.22 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -79.42 54.8 1.79 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -165.53 -59.29 0.03 OUTLIER 'General case' 0 C--N 1.343 0.292 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.69 -44.07 0.08 OUTLIER Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -74.79 74.64 2.1 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.6 p -83.71 -8.01 59.36 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -67.76 155.28 91.86 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -178.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.49 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 13.7 Cg_endo -73.6 160.76 43.55 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.791 2.328 . . . . 0.0 111.617 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 32' ' ' LEU . 29.5 mt -134.38 140.51 46.36 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.454 HG23 ' HD2' ' A' ' 71' ' ' LYS . 45.5 p -61.89 169.21 2.69 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.504 ' C ' HD13 ' A' ' 34' ' ' LEU . 3.4 tm? -59.03 -50.34 74.45 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -61.6 -41.29 97.22 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 119.696 -0.193 . . . . 0.0 111.001 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -55.5 -34.82 64.95 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 68.3 mt -70.15 -44.05 78.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 mt -52.18 -36.57 52.18 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 117.647 0.203 . . . . 0.0 110.531 -178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -57.86 -59.99 4.4 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 110.615 -0.142 . . . . 0.0 110.615 -178.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -61.94 -66.16 0.58 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.53 80.44 4.01 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -32.6 86.41 0.0 OUTLIER 'General case' 0 C--N 1.352 0.717 0 C-N-CA 125.091 1.356 . . . . 0.0 112.555 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.8 m-70 -140.6 29.27 1.95 Allowed 'General case' 0 C--O 1.213 -0.823 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.2 mt -59.32 -38.69 80.92 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -91.04 69.18 6.23 Favored 'General case' 0 C--N 1.342 0.268 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 174.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.476 ' CG1' ' HB2' ' A' ' 50' ' ' GLN . 1.3 tt -94.55 -46.67 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.029 -175.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.73 131.3 6.13 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.859 -1.697 . . . . 0.0 108.859 -178.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.1 tt -51.23 -40.42 58.74 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.86 0.33 . . . . 0.0 111.207 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -56.94 -33.85 67.43 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 119.828 -0.129 . . . . 0.0 111.071 -178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.476 ' HB2' ' CG1' ' A' ' 46' ' ' ILE . 25.6 mt-30 -89.9 -47.45 7.87 Favored 'General case' 0 C--O 1.222 -0.373 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.435 ' HD2' HD12 ' A' ' 34' ' ' LEU . 2.6 tppt? -50.43 -52.77 34.82 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 47.0 tp60 -58.87 -45.37 90.33 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.455 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 28.8 t90 -57.02 -54.24 48.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.443 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 88.7 mt -51.32 -45.89 62.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 12.2 tmm? -60.75 -52.82 63.46 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.13 -176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 5.3 t -120.26 51.33 1.22 Allowed 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 118.358 0.527 . . . . 0.0 112.137 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -166.95 -67.29 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.443 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -66.75 -60.48 2.64 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.16 -177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 36.5 mt -80.27 37.45 0.39 Allowed 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 122.367 0.267 . . . . 0.0 110.599 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.7 t -129.33 -45.84 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -112.23 -7.29 14.03 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.42 124.54 81.29 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -59.06 -34.84 99.02 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.745 2.297 . . . . 0.0 112.394 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -86.86 21.49 2.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 119.695 -0.193 . . . . 0.0 111.168 -178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 24.4 mm -135.64 144.29 34.18 Favored 'Isoleucine or valine' 0 C--N 1.345 0.393 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -145.92 141.48 27.82 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.56 136.0 29.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.157 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 68' ' ' ILE . 1.8 mp -104.92 -59.01 3.59 Favored 'Isoleucine or valine' 0 C--N 1.343 0.289 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -160.32 77.6 0.63 Allowed 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 81.29 -40.67 2.58 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 110.507 -1.037 . . . . 0.0 110.507 -178.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.454 ' HD2' HG23 ' A' ' 33' ' ' THR . 3.1 mtmt -83.25 145.81 28.92 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -104.62 126.57 51.84 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 122.675 0.39 . . . . 0.0 110.617 -176.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -111.61 150.55 29.91 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -79.23 121.56 25.21 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 176.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -74.09 121.21 84.67 Favored Pre-proline 0 N--CA 1.448 -0.574 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -63.05 132.01 34.99 Favored 'Trans proline' 0 N--CA 1.448 -1.154 0 C-N-CA 122.32 2.013 . . . . 0.0 110.403 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 33.9 tptt -162.16 124.97 2.93 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 57.52 -109.65 0.49 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.224 0.61 . . . . 0.0 110.328 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 64.95 163.48 0.14 Allowed 'General case' 0 C--N 1.35 0.63 0 C-N-CA 123.356 0.662 . . . . 0.0 110.51 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 74.1 t -79.34 -56.25 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 13.6 tpt180 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 116.326 -1.797 . . . . 0.0 108.556 179.197 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 66.4 tp -58.74 113.06 1.86 Allowed 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.4 m 55.6 34.35 23.02 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.747 0.419 . . . . 0.0 110.163 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.5 68.96 3.08 Favored Glycine 0 C--N 1.342 0.894 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 m 71.55 135.56 0.04 OUTLIER 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.493 0.717 . . . . 0.0 110.347 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 35.0 t -158.28 -55.05 0.07 Allowed 'General case' 0 C--N 1.339 0.128 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.76 45.48 3.48 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.747 -0.941 . . . . 0.0 110.747 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -89.91 8.9 29.87 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 117.041 0.421 . . . . 0.0 110.254 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -151.44 -61.58 0.18 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -65.69 -42.78 90.81 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.106 -178.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.74 -46.5 91.77 Favored Glycine 0 C--N 1.34 0.762 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.2 t -60.87 -46.03 97.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.636 HD13 ' HB1' ' A' ' 58' ' ' ALA . 61.2 tp -59.75 -45.87 90.89 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.17 86.26 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.9 ttpp -62.77 -42.57 99.75 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 93.5 mt -63.96 -51.67 66.4 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.284 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.2 t -55.91 -45.35 79.91 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -64.14 -45.16 89.75 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -57.35 12.84 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 96.4 mtp -55.39 -39.88 70.68 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.6 tttt -61.09 -50.23 74.12 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 77.5 m -59.47 -46.68 88.08 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.1 ttm-85 -60.65 -44.31 96.57 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 35.2 t60 -60.8 -35.81 77.42 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -79.95 12.75 2.55 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 122.485 0.314 . . . . 0.0 110.952 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -127.86 29.95 5.35 Favored 'General case' 0 C--N 1.349 0.56 0 CA-C-N 117.949 0.341 . . . . 0.0 110.478 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.29 -34.53 3.61 Favored Glycine 0 CA--C 1.528 0.901 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -74.92 77.4 2.16 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.9 p -97.2 -3.56 40.67 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 122.799 0.44 . . . . 0.0 110.993 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -70.91 156.71 91.65 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 117.739 0.245 . . . . 0.0 110.584 -177.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -65.48 156.18 64.9 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.979 2.453 . . . . 0.0 111.717 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.6 mt -137.69 141.88 41.09 Favored 'General case' 0 C--N 1.347 0.496 0 C-N-CA 122.973 0.509 . . . . 0.0 109.643 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 73.8 p -63.62 168.55 4.67 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.007 0.432 . . . . 0.0 110.408 176.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 tt -58.28 -51.83 68.12 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -54.86 -48.45 72.91 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.878 0.471 . . . . 0.0 111.106 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -56.25 -34.88 66.78 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 42.8 mt -73.5 -46.21 49.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.428 ' HB3' ' H ' ' A' ' 44' ' ' LEU . 16.6 mt -46.31 -58.62 3.53 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 122.324 0.25 . . . . 0.0 111.048 -178.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -46.27 -56.68 5.43 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.82 0.448 . . . . 0.0 111.913 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.79 -26.36 68.6 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.165 0.186 . . . . 0.0 111.445 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.506 ' O ' ' CD2' ' A' ' 43' ' ' HIS . 28.3 p -99.12 16.94 21.11 Favored 'General case' 0 C--O 1.216 -0.665 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? 73.68 -88.84 0.02 OUTLIER 'General case' 0 C--N 1.35 0.597 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -177.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' A' ' 41' ' ' THR . 23.7 m170 31.82 -109.6 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.762 0.825 . . . . 0.0 111.649 177.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.428 ' H ' ' HB3' ' A' ' 38' ' ' LEU . 4.5 mt 69.36 -64.71 0.33 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 124.901 1.28 . . . . 0.0 110.443 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.52 -68.78 0.27 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 18.7 tt 47.51 137.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.143 1.777 . . . . 0.0 114.305 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.21 137.59 40.66 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 108.977 -1.649 . . . . 0.0 108.977 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.9 tp -52.16 -41.85 62.94 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.217 0.508 . . . . 0.0 109.867 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -60.06 -40.58 89.99 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -66.62 -57.99 6.08 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.7 ttpt -49.84 -48.38 51.06 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.919 0.488 . . . . 0.0 110.668 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -64.25 -47.34 79.97 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.439 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 38.6 t90 -57.44 -45.94 84.13 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.708 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 79.7 mt -56.22 -51.49 67.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 40.6 ttm -56.86 -54.69 43.58 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.792 -175.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.402 ' HA ' HG21 ' A' ' 60' ' ' VAL . 6.7 t -121.15 50.3 1.39 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.227 0.467 . . . . 0.0 111.937 -174.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.439 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -170.5 -65.65 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 O-C-N 122.098 -0.376 . . . . 0.0 110.497 176.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.708 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -64.27 -50.02 69.53 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.392 0.277 . . . . 0.0 111.367 -176.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.2 mt -79.29 -29.58 42.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.599 -177.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.402 HG21 ' HA ' ' A' ' 56' ' ' THR . 54.6 t -73.69 139.1 19.95 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.155 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 69.17 -9.34 0.61 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.328 0.651 . . . . 0.0 111.579 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.6 t-20 -59.56 125.11 78.71 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -63.42 -12.29 30.0 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.339 2.026 . . . . 0.0 112.05 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -111.01 7.45 21.55 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 118.029 0.377 . . . . 0.0 111.534 -178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 9.9 mm -136.23 157.34 37.6 Favored 'Isoleucine or valine' 0 C--N 1.346 0.452 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -147.95 144.19 27.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.06 106.59 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.4 mm -121.1 126.13 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.0 t0 59.16 19.9 7.89 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.815 0.446 . . . . 0.0 110.462 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 92.41 -29.2 7.95 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.66 168.86 18.79 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -104.59 124.89 50.12 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-O 120.543 0.211 . . . . 0.0 110.523 -177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.05 137.48 52.88 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.308 0.643 . . . . 0.0 109.334 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -66.99 126.86 30.47 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.44 117.91 69.63 Favored Pre-proline 0 CA--C 1.534 0.335 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -66.72 -47.83 2.51 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.201 1.934 . . . . 0.0 109.731 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -157.5 -51.95 0.07 Allowed 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.6 p90 -171.82 -52.4 0.02 OUTLIER 'General case' 0 C--N 1.343 0.308 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 51.52 63.78 2.1 Favored 'General case' 0 C--N 1.344 0.366 0 C-N-CA 122.999 0.519 . . . . 0.0 110.674 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 99.5 t -120.29 143.47 32.04 Favored 'Isoleucine or valine' 0 C--N 1.34 0.182 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.6 mpt_? . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.708 -1.615 . . . . 0.0 109.208 -179.416 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.695 0 N-CA-C 110.143 -0.318 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -149.92 28.29 0.77 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 33.8 p -79.39 69.11 5.58 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -111.35 172.24 14.89 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.089 -1.204 . . . . 0.0 110.089 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.9 t -75.99 77.92 2.86 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.9 m 57.69 67.73 0.93 Allowed 'General case' 0 C--N 1.342 0.24 0 C-N-CA 122.794 0.437 . . . . 0.0 109.843 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.07 -172.38 30.35 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 110.639 -0.985 . . . . 0.0 110.639 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 89.7 t80 66.25 124.31 0.02 OUTLIER 'General case' 0 C--N 1.349 0.582 0 C-N-CA 123.796 0.838 . . . . 0.0 109.594 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.2 mtpt 65.1 -74.66 0.05 Allowed 'General case' 0 C--N 1.347 0.482 0 C-N-CA 123.195 0.598 . . . . 0.0 109.745 -178.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -60.27 -45.41 93.41 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 122.901 0.48 . . . . 0.0 110.205 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.44 -47.52 90.7 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.354 -1.099 . . . . 0.0 110.354 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.0 t -62.02 -45.91 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.27 -44.64 96.91 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.92 -41.24 99.4 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -61.86 -48.38 80.81 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.518 ' HA ' HG21 ' A' ' 41' ' ' THR . 52.2 mt -58.26 -52.16 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 O-C-N 123.293 0.371 . . . . 0.0 110.114 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.8 t -55.73 -50.8 65.44 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -59.72 -43.29 94.21 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.249 0.22 . . . . 0.0 110.751 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -59.67 4.66 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -33.43 69.45 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 ttpt -60.57 -46.65 89.44 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.1 m -73.23 -40.26 64.83 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.543 0.337 . . . . 0.0 110.164 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 40' ' ' GLU . 0.8 OUTLIER -64.41 -33.71 76.49 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.576 0.75 . . . . 0.0 109.168 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -72.71 -49.77 29.09 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -38.14 65.09 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.897 0.479 . . . . 0.0 110.24 178.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.7 ttt-85 -54.13 -42.51 69.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.139 0.576 . . . . 0.0 110.884 -178.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 145.72 -27.73 1.77 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.75 59.68 2.59 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.7 p -66.63 -9.09 32.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.143 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -57.43 152.04 35.38 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 122.467 0.307 . . . . 0.0 110.839 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -61.89 155.53 54.32 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.719 2.279 . . . . 0.0 111.331 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.442 HD23 ' HA ' ' A' ' 32' ' ' LEU . 15.2 mt -135.19 144.01 46.75 Favored 'General case' 0 C--N 1.344 0.342 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 32.4 p -73.38 175.25 7.11 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.54 -54.0 50.77 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -54.6 -48.25 72.4 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.292 0.237 . . . . 0.0 110.584 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -54.34 -44.0 71.74 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 33.9 mt -63.61 -47.32 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 69.8 mt -56.99 -48.99 77.12 Favored 'General case' 0 C--N 1.345 0.38 0 N-CA-C 110.356 -0.239 . . . . 0.0 110.356 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -51.52 -56.93 10.68 Favored 'General case' 0 C--N 1.339 0.135 0 O-C-N 123.187 0.304 . . . . 0.0 111.1 -177.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 23' ' ' ARG . 3.0 mt-10 -58.94 -37.19 76.17 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.047 0.139 . . . . 0.0 111.144 -178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.518 HG21 ' HA ' ' A' ' 16' ' ' ILE . 47.7 p -86.37 6.22 31.12 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-O 119.164 -0.446 . . . . 0.0 111.122 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? 69.04 -10.52 0.51 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.313 0.645 . . . . 0.0 111.34 179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.431 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 7.0 m-70 -78.06 39.15 0.3 Allowed 'General case' 0 CA--C 1.536 0.424 0 O-C-N 121.65 -0.656 . . . . 0.0 111.395 -177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.81 -45.48 61.36 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -84.23 51.71 2.15 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 10.9 tt -90.81 148.84 4.3 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.22 137.16 50.45 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.7 tp -54.72 -35.76 64.01 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 122.322 0.249 . . . . 0.0 110.631 -178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -58.11 -48.88 78.85 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.992 -0.374 . . . . 0.0 109.992 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -68.34 -44.26 75.69 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -52.54 -49.99 63.79 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.0 -52.17 66.91 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -53.74 -50.04 66.85 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.652 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 48.3 mt -57.33 -43.25 83.21 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.4 ttt -66.91 -53.03 36.09 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -120.41 47.14 1.83 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -174.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -167.75 -56.19 0.02 OUTLIER 'General case' 0 C--O 1.224 -0.255 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 174.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.652 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -76.67 -60.18 2.46 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 122.179 -0.325 . . . . 0.0 111.569 -177.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 71.6 mt -80.61 27.74 0.35 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.9 m -124.73 -17.28 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-N 117.782 0.264 . . . . 0.0 110.36 177.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -130.12 6.6 4.98 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-N 117.718 0.235 . . . . 0.0 110.692 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -70.11 127.57 92.22 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.83 -29.96 87.8 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 122.443 2.095 . . . . 0.0 112.224 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -94.23 21.13 7.25 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 119.707 -0.187 . . . . 0.0 111.484 -177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.81 156.48 12.66 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -154.2 148.76 26.29 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.19 130.76 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 39.9 mt -120.87 -95.9 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -83.72 51.59 2.06 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.65 -36.27 1.84 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 110.201 -1.159 . . . . 0.0 110.201 -178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mttp -74.07 179.13 4.56 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -114.14 126.36 54.99 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -178.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.2 138.82 50.95 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -70.06 127.32 32.44 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.02 120.51 81.51 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -67.02 -172.5 0.34 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.521 2.147 . . . . 0.0 110.775 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -52.34 -53.88 38.78 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -163.02 -49.31 0.04 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -90.39 157.92 17.36 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.2 t -54.21 -45.7 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 116.697 -1.62 . . . . 0.0 109.349 179.479 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.8 tp -64.35 -51.8 61.53 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.8 t -152.51 60.04 0.82 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.66 67.03 3.61 Favored Glycine 0 C--N 1.338 0.667 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.2 p -150.42 113.03 4.72 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.8 p -140.48 54.32 1.61 Allowed 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.96 -24.03 67.7 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 111.263 -0.735 . . . . 0.0 111.263 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 39.4 p90 50.71 15.82 0.26 Allowed 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.242 1.017 . . . . 0.0 112.32 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -169.34 -42.75 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -68.89 -43.35 75.45 Favored 'General case' 0 C--O 1.227 -0.118 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.45 93.83 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.503 -1.039 . . . . 0.0 110.503 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.0 -47.92 90.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.614 HD13 ' HB1' ' A' ' 58' ' ' ALA . 43.1 tp -59.27 -43.92 92.49 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.9 97.92 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -59.43 -46.53 88.47 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 54.8 mt -61.48 -49.11 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 t -57.61 -46.85 86.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 N-CA-C 110.272 -0.269 . . . . 0.0 110.272 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 m-20 -65.68 -42.22 91.53 Favored 'General case' 0 CA--C 1.527 0.063 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -178.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -60.22 -58.41 8.64 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 mtp -55.67 -44.51 77.36 Favored 'General case' 0 C--N 1.342 0.257 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -55.34 -45.17 76.44 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.534 0.334 . . . . 0.0 110.308 179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.7 m -62.98 -53.93 46.32 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 119.541 -0.266 . . . . 0.0 111.134 -177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.0 ptp180 -64.62 -30.87 71.9 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 118.61 0.641 . . . . 0.0 109.984 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -66.41 -40.34 89.54 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -65.35 -41.97 93.33 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -61.63 -55.51 29.81 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 122.179 0.192 . . . . 0.0 110.507 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 171.3 -30.35 0.12 Allowed Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.556 -0.618 . . . . 0.0 111.556 -179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -75.89 71.31 2.7 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 117.338 0.569 . . . . 0.0 109.669 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 82.6 p -76.51 -9.6 58.78 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -62.98 156.32 67.9 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.58 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 30.0 Cg_endo -77.85 161.88 29.95 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.682 2.255 . . . . 0.0 111.019 -179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 34.3 mt -132.74 144.86 50.56 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.9 p -60.75 167.19 2.87 Favored 'General case' 0 C--N 1.343 0.324 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.98 -50.03 71.94 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 176.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.64 -49.08 79.15 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.863 0.465 . . . . 0.0 110.861 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -55.32 -34.08 63.88 Favored 'General case' 0 C--N 1.344 0.36 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 58.5 mt -75.64 -50.53 23.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.644 ' CD2' HD11 ' A' ' 46' ' ' ILE . 8.8 mt -45.29 -54.16 7.47 Favored 'General case' 0 C--N 1.345 0.389 0 C-N-CA 122.691 0.397 . . . . 0.0 111.104 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -47.87 -59.34 3.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.699 0.399 . . . . 0.0 111.311 -177.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -60.0 -37.7 80.48 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.221 0.208 . . . . 0.0 111.009 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.7 p -81.7 10.53 5.97 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.042 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 75.63 -61.0 0.48 Allowed 'General case' 0 C--N 1.35 0.621 0 C-N-CA 123.74 0.816 . . . . 0.0 111.001 177.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -54.76 113.1 1.19 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.402 ' HA ' ' HB3' ' A' ' 38' ' ' LEU . 0.4 OUTLIER -120.0 -34.09 3.8 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 122.45 0.3 . . . . 0.0 110.964 -178.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -94.54 -40.88 9.63 Favored 'General case' 0 CA--C 1.507 -0.706 0 N-CA-C 106.333 -1.729 . . . . 0.0 106.333 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.644 HD11 ' CD2' ' A' ' 38' ' ' LEU . 3.1 mt 55.63 -134.37 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 CA-C-N 114.687 -1.142 . . . . 0.0 108.934 177.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.429 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -136.19 143.57 15.06 Favored Glycine 0 N--CA 1.437 -1.288 0 N-CA-C 105.275 -3.13 . . . . 0.0 105.275 172.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.9 tp -49.74 -45.36 49.26 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.23 1.015 . . . . 0.0 110.527 -176.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -58.24 -46.57 85.68 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -64.3 -63.07 1.24 Allowed 'General case' 0 C--O 1.217 -0.645 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? -42.77 -49.63 5.68 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.012 0.525 . . . . 0.0 110.966 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -65.31 -52.24 55.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 -179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.434 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 37.1 t90 -52.77 -46.03 67.38 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.822 0.449 . . . . 0.0 110.81 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.725 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 65.0 mt -57.1 -47.23 81.58 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 24.2 ttt -65.31 -47.2 77.41 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.1 t -120.81 40.48 3.53 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -174.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.434 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 34.4 tt0 -165.72 -66.77 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 O-C-N 121.937 -0.477 . . . . 0.0 110.115 174.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.725 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -58.47 -61.07 2.86 Favored 'General case' 0 N--CA 1.457 -0.078 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 -177.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.1 mt -81.46 31.7 0.34 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.338 0.255 . . . . 0.0 110.373 -178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.0 t -134.41 -40.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.41 -30.48 16.48 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.386 0.274 . . . . 0.0 110.423 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -56.1 118.98 23.64 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -60.88 -30.99 91.14 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.534 2.156 . . . . 0.0 112.075 -177.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -82.22 10.77 6.23 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.586 -0.245 . . . . 0.0 111.234 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 mm -129.65 143.65 40.48 Favored 'Isoleucine or valine' 0 C--N 1.344 0.34 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -146.67 135.68 22.47 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.5 t -89.52 131.92 35.58 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.1 mm -104.06 -60.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -152.45 76.23 1.15 Allowed 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 80.8 -40.01 2.44 Favored Glycine 0 CA--C 1.531 1.033 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 42.5 mttt -85.71 154.31 21.72 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -107.73 132.17 53.65 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 122.913 0.485 . . . . 0.0 109.997 -177.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -121.32 151.82 39.66 Favored 'General case' 0 C--N 1.343 0.308 0 C-N-CA 122.54 0.336 . . . . 0.0 110.196 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -75.27 120.64 21.03 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 175.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.4 ttpt -80.39 123.26 83.08 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -62.95 120.73 8.33 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.342 2.028 . . . . 0.0 110.512 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 ttmm -78.52 121.17 24.25 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -71.89 75.08 0.89 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -165.79 -49.26 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 t -124.0 29.23 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 25.5 tpt180 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.834 -1.555 . . . . 0.0 108.802 -179.454 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.1 tp -155.1 118.74 4.52 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.1 m -153.22 -62.24 0.15 Allowed 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 164.0 72.77 0.03 OUTLIER Glycine 0 C--N 1.338 0.692 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.5 p -161.72 158.46 25.9 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 32.1 m -150.35 56.3 0.93 Allowed 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.06 167.58 33.53 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -114.38 -122.43 0.29 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.463 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 7.7 mtmm -53.9 -44.37 70.45 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -62.06 -42.57 99.33 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.622 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.91 -51.93 53.79 Favored Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.6 t -60.64 -45.89 96.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.709 HD13 ' HB1' ' A' ' 58' ' ' ALA . 51.9 tp -59.63 -51.54 69.37 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 122.235 0.214 . . . . 0.0 110.43 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.69 -43.9 85.44 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.09 -50.34 74.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.1 mt -59.33 -47.8 89.24 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.276 0 C-N-CA 122.544 0.338 . . . . 0.0 110.285 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 8.5 t -58.42 -50.11 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -59.34 -47.16 86.44 Favored 'General case' 0 C--O 1.233 0.199 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 -179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.81 -57.32 13.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 -179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 87.9 mtp -52.93 -41.21 64.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -60.66 -63.19 1.38 Allowed 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -45.95 -45.89 15.87 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 122.432 0.293 . . . . 0.0 110.793 179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -63.45 -41.37 98.64 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -66.81 -34.12 77.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.236 0.614 . . . . 0.0 110.094 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -69.01 -36.47 77.83 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.3 mtp-105 -62.78 -56.71 15.05 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.169 0.188 . . . . 0.0 110.725 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.35 -35.52 0.14 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -71.11 79.73 0.68 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 42.0 p -91.26 -19.07 23.39 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.443 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -61.78 151.71 78.25 Favored Pre-proline 0 CA--C 1.542 0.661 0 CA-C-N 117.936 0.335 . . . . 0.0 110.21 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.459 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 9.4 Cg_endo -71.86 157.11 55.75 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 122.771 2.314 . . . . 0.0 111.589 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 51.9 mt -125.19 148.32 48.67 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 45.5 p -59.75 168.42 1.73 Allowed 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.42 -57.7 11.76 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -54.2 -43.3 70.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.481 0.312 . . . . 0.0 111.205 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -53.02 -49.94 65.24 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.6 mt -58.34 -40.17 77.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 122.127 0.171 . . . . 0.0 110.666 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 52.4 mt -61.52 -28.97 69.7 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 117.82 0.282 . . . . 0.0 110.434 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -65.48 -59.32 4.11 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 110.319 -0.252 . . . . 0.0 110.319 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -55.86 -68.57 0.19 Allowed 'General case' 0 C--N 1.347 0.47 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -78.65 85.39 4.69 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 175.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -36.92 84.4 0.0 OUTLIER 'General case' 0 C--N 1.351 0.669 0 C-N-CA 125.003 1.321 . . . . 0.0 112.735 -176.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 18.3 m-70 -140.04 45.1 1.89 Allowed 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.423 ' O ' HG22 ' A' ' 46' ' ' ILE . 10.0 mt -79.77 -37.59 35.05 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.76 -43.22 99.37 Favored 'General case' 0 C--N 1.34 0.181 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.886 HG23 ' H ' ' A' ' 47' ' ' GLY . 13.5 tt 22.85 -98.42 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.753 0 C-N-CA 125.232 1.413 . . . . 0.0 113.022 177.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.886 ' H ' HG23 ' A' ' 46' ' ' ILE . . . 150.59 148.24 4.74 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 67.1 tp -54.43 -47.56 72.68 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.462 0.631 . . . . 0.0 110.712 -177.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -57.35 -50.95 71.32 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.166 0.186 . . . . 0.0 110.742 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -62.79 -56.51 16.85 Favored 'General case' 0 C--O 1.22 -0.466 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.7 tttt -48.88 -50.04 36.83 Favored 'General case' 0 C--N 1.342 0.276 0 C-N-CA 122.577 0.351 . . . . 0.0 110.763 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -61.77 -45.23 94.78 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.463 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 49.7 t90 -61.29 -38.05 85.38 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.762 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 71.6 mt -62.57 -46.44 88.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 178.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -63.4 -50.64 69.07 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.898 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 38.2 p -89.1 -42.14 11.88 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -102.0 -72.68 0.68 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -174.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.762 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -46.42 -64.52 0.74 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -173.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.6 mt -80.39 31.9 0.29 Allowed 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.128 0.171 . . . . 0.0 111.37 -175.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -134.47 -47.68 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -81.42 -28.17 34.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.726 -0.216 . . . . 0.0 110.603 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -57.47 121.67 49.84 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.46 -18.41 62.87 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 C-N-CA 122.726 2.284 . . . . 0.0 112.557 -177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -97.98 20.0 12.98 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.049 0.386 . . . . 0.0 110.907 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 21.3 mm -131.05 146.89 33.21 Favored 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 117.936 0.334 . . . . 0.0 110.115 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -137.86 136.06 36.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.14 130.47 49.27 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.4 mt -142.94 123.45 10.43 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 32.3 t70 53.79 34.54 19.36 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 122.92 0.488 . . . . 0.0 111.073 178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 87.09 -36.31 3.32 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -72.0 163.27 28.16 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -119.25 134.01 55.44 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.375 0.27 . . . . 0.0 110.455 -177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 31' ' ' PRO . . . -125.03 152.17 44.62 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -76.17 121.84 23.46 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.3 tttp -69.19 119.34 69.51 Favored Pre-proline 0 N--CA 1.449 -0.518 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -63.1 105.26 0.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 C-N-CA 122.122 1.881 . . . . 0.0 109.695 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -166.22 141.02 4.49 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 52.21 44.16 29.97 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -83.98 60.21 5.71 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.5 t -57.84 144.9 9.71 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.928 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.2 ptp180 . . . . . 0 C--O 1.254 1.31 0 CA-C-O 116.584 -1.674 . . . . 0.0 109.387 -179.457 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.739 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.4 154.22 39.03 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.7 t 75.01 -57.44 0.6 Allowed 'General case' 0 C--N 1.345 0.412 0 C-N-CA 123.605 0.762 . . . . 0.0 110.364 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 72.96 31.07 62.42 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 64.7 m -72.37 166.29 22.83 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.9 t -63.26 148.42 48.27 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 157.7 -169.43 34.53 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -62.16 141.93 57.91 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 14.4 mttm 69.12 -69.97 0.15 Allowed 'General case' 0 C--N 1.354 0.792 0 C-N-CA 123.24 0.616 . . . . 0.0 110.488 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -57.99 -47.6 82.52 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.759 0.823 . . . . 0.0 111.821 -176.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.21 -45.25 94.11 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.544 -1.022 . . . . 0.0 110.544 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.9 t -59.74 -46.57 93.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 53.7 tp -63.17 -42.82 99.47 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.83 -38.14 89.59 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 110.304 -0.258 . . . . 0.0 110.304 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -66.23 -41.56 89.86 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.413 ' HA ' HG21 ' A' ' 41' ' ' THR . 50.7 mt -62.68 -47.82 91.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.25 -47.82 89.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -59.63 -47.21 86.47 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.28 -48.22 80.88 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 122.634 0.373 . . . . 0.0 110.387 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 80.8 mmm -57.22 -33.12 67.21 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 122.498 0.319 . . . . 0.0 110.256 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.6 ttpp -73.66 -62.58 1.44 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 177.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.6 m -44.98 -50.22 10.75 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.087 0.555 . . . . 0.0 111.546 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -63.13 -42.39 99.51 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.26 0.482 . . . . 0.0 109.872 -179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -64.55 -27.28 68.85 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 122.778 0.431 . . . . 0.0 109.956 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -74.44 -34.7 63.27 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.652 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -95.17 38.99 1.12 Allowed 'General case' 0 C--N 1.35 0.623 0 CA-C-N 118.13 0.423 . . . . 0.0 111.59 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.46 -16.5 48.99 Favored Glycine 0 CA--C 1.533 1.177 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.185 174.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.3 41.76 0.71 Allowed 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.489 1.145 . . . . 0.0 109.889 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.58 66.65 6.17 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.2 p-80 -142.53 152.27 59.66 Favored Pre-proline 0 CA--C 1.54 0.585 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -62.05 151.0 84.32 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.053 2.502 . . . . 0.0 111.91 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.452 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.3 mt -140.42 143.15 35.47 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 177.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 80.4 p -62.47 171.28 2.01 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -55.29 34.05 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -58.16 -41.88 84.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 122.242 0.217 . . . . 0.0 111.31 -177.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -56.57 -40.78 75.79 Favored 'General case' 0 C--N 1.343 0.307 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 46.0 mt -64.82 -45.73 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 45.5 mt -55.38 -49.04 73.34 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 110.31 -0.255 . . . . 0.0 110.31 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -49.2 -58.79 4.4 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 122.199 0.2 . . . . 0.0 111.081 -177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -61.25 -42.51 98.75 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.24 0.216 . . . . 0.0 111.56 -177.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.478 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 35.5 p -75.7 -8.06 55.88 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 119.344 -0.36 . . . . 0.0 111.228 -179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 64.96 49.24 2.14 Favored 'General case' 0 C--N 1.344 0.328 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.478 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 6.5 m-70 -130.46 39.2 3.66 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.462 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mt -73.82 -44.36 55.99 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -83.9 41.22 0.79 Allowed 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 tt -79.32 -31.38 14.35 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 122.793 0.437 . . . . 0.0 110.297 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.16 138.43 10.28 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -60.25 -25.74 65.91 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 117.079 0.44 . . . . 0.0 111.2 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -61.11 -34.08 74.39 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -89.51 -43.85 10.54 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.693 0.397 . . . . 0.0 109.947 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -55.58 -47.74 75.95 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -57.24 -48.34 79.07 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 15.4 t90 -57.16 -54.83 42.28 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.553 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 81.0 mt -53.46 -43.13 67.86 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 22.3 ttt -70.85 -38.88 73.2 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 76.0 p -118.11 36.46 4.34 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -174.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -168.38 -70.33 0.02 OUTLIER 'General case' 0 C--N 1.34 0.191 0 CA-C-N 118.291 0.496 . . . . 0.0 110.539 177.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.553 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -60.76 -63.97 1.12 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 111.403 0.149 . . . . 0.0 111.403 -175.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.6 mt -79.1 28.59 0.22 Allowed 'General case' 0 CA--C 1.532 0.271 0 O-C-N 122.516 -0.115 . . . . 0.0 111.192 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.6 t -114.49 -40.75 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -116.16 4.86 13.65 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 122.37 0.268 . . . . 0.0 111.403 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -63.42 127.5 91.3 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -58.78 -30.05 91.54 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.593 2.195 . . . . 0.0 112.107 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.0 36.52 1.68 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.594 0.179 . . . . 0.0 110.733 -178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 tp -150.85 156.99 5.89 Favored 'Isoleucine or valine' 0 C--N 1.342 0.244 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.419 ' HG3' HD13 ' A' ' 68' ' ' ILE . 13.6 pt-20 -157.75 138.8 13.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 177.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.473 ' C ' HD12 ' A' ' 68' ' ' ILE . 39.9 t -87.81 108.3 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 -177.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.473 HD12 ' C ' ' A' ' 67' ' ' VAL . 1.7 mp -114.96 122.53 69.26 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.8 t0 53.08 36.93 23.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 122.693 0.397 . . . . 0.0 110.489 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 84.71 -32.91 3.34 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -78.61 162.01 26.56 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 117.804 0.802 . . . . 0.0 108.98 -179.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -100.63 123.24 44.56 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.4 153.42 28.62 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -80.35 114.49 19.29 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.182 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.4 tttp -73.95 122.52 87.76 Favored Pre-proline 0 N--CA 1.446 -0.646 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -51.05 128.07 23.77 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 C-N-CA 122.246 1.964 . . . . 0.0 111.643 -177.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.16 159.86 22.57 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.996 179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -115.05 126.63 54.93 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 16.4 m120 70.22 143.78 0.05 Allowed 'General case' 0 C--N 1.346 0.443 0 C-N-CA 123.532 0.733 . . . . 0.0 110.118 -178.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.5 p -69.15 -28.39 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.025 0 CA-C-O 116.821 -1.561 . . . . 0.0 109.124 178.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.751 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.5 tp -79.11 91.25 4.9 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.1 p -153.05 35.91 0.48 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.79 -149.81 46.25 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.6 p -80.02 137.34 36.79 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.9 t -70.56 -64.59 0.87 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.37 -47.62 3.24 Favored Glycine 0 CA--C 1.53 1.021 0 N-CA-C 110.759 -0.937 . . . . 0.0 110.759 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -48.54 113.71 0.82 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.157 0.583 . . . . 0.0 110.262 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.469 ' HB3' ' CH2' ' A' ' 53' ' ' TRP . 13.7 mttp 74.19 -65.82 0.33 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.161 0.985 . . . . 0.0 111.13 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -53.88 -39.4 65.69 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.804 -172.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.45 -50.23 60.64 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.7 t -64.21 -46.63 92.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.41 HD13 ' HB1' ' A' ' 58' ' ' ALA . 55.9 tp -61.18 -46.26 91.22 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.77 -42.45 93.33 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -58.72 -51.65 69.05 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.2 mt -55.42 -49.24 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.0 t -58.02 -46.14 87.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -63.17 -50.56 69.87 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.559 0.344 . . . . 0.0 110.747 -178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.449 ' CE1' ' CD ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -60.81 -46.16 91.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 122.725 0.41 . . . . 0.0 110.323 -177.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 86.3 mmm -63.04 -47.37 83.3 Favored 'General case' 0 C--O 1.224 -0.277 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.3 tttp -56.73 -52.07 66.42 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.758 0.423 . . . . 0.0 110.906 -178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.5 m -57.5 -42.13 82.11 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 110.43 -0.211 . . . . 0.0 110.43 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.449 ' CD ' ' CE1' ' A' ' 19' ' ' TYR . 0.4 OUTLIER -68.15 -40.51 82.37 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.656 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -62.2 -34.55 76.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -67.44 -47.18 70.91 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.443 0.297 . . . . 0.0 111.406 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.4 ptt85 -70.37 -35.44 73.54 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 119.143 -0.456 . . . . 0.0 111.756 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 160.74 -30.14 0.34 Allowed Glycine 0 C--N 1.345 1.04 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.195 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -74.52 77.58 1.95 Allowed 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.9 p -93.23 -14.23 27.33 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.826 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -61.94 149.71 85.04 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 117.447 0.112 . . . . 0.0 110.729 -176.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -62.98 158.42 43.47 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.932 2.421 . . . . 0.0 111.225 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 32' ' ' LEU . 18.4 mt -138.04 142.33 40.34 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.8 p -62.11 167.83 3.71 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -50.29 74.08 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -54.56 -51.9 63.8 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.785 0.434 . . . . 0.0 110.826 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -56.09 -45.52 79.38 Favored 'General case' 0 C--N 1.342 0.243 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.3 mt -59.39 -46.95 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.654 HD22 HD11 ' A' ' 46' ' ' ILE . 24.2 mt -59.62 -63.75 1.19 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -40.19 -58.15 1.54 Allowed 'General case' 0 C--N 1.343 0.301 0 C-N-CA 123.674 0.79 . . . . 0.0 112.452 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -57.23 -34.56 68.7 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 117.411 0.096 . . . . 0.0 111.063 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.514 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -99.3 28.77 4.3 Favored 'General case' 0 C--O 1.211 -0.927 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 67.54 -111.27 0.14 Allowed 'General case' 0 C--N 1.347 0.462 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 -178.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.514 ' CD2' ' HB ' ' A' ' 41' ' ' THR . 3.6 m-70 46.71 -116.3 0.66 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 122.513 0.325 . . . . 0.0 110.536 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.4 ' H ' ' HB3' ' A' ' 38' ' ' LEU . 0.4 OUTLIER 78.44 -55.4 0.48 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.582 1.153 . . . . 0.0 111.029 175.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -86.57 -62.04 1.6 Allowed 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.654 HD11 HD22 ' A' ' 38' ' ' LEU . 30.3 mt 66.39 -74.11 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 O-C-N 124.592 1.183 . . . . 0.0 111.594 176.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 148.52 124.77 1.42 Allowed Glycine 0 N--CA 1.438 -1.218 0 N-CA-C 105.166 -3.174 . . . . 0.0 105.166 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.3 tp -43.84 -42.39 5.66 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 117.536 0.668 . . . . 0.0 111.798 -175.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -51.37 -52.61 44.23 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 122.372 0.269 . . . . 0.0 110.333 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -69.08 -61.69 1.69 Allowed 'General case' 0 C--O 1.219 -0.547 0 C-N-CA 122.519 0.328 . . . . 0.0 110.628 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -42.13 -42.89 3.11 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.757 0.423 . . . . 0.0 110.895 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 -69.45 -53.81 17.41 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.469 ' CH2' ' HB3' ' A' ' 9' ' ' LYS . 34.1 t90 -51.94 -44.78 64.06 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 122.507 0.323 . . . . 0.0 110.712 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.698 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 66.3 mt -57.07 -45.75 83.03 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 47.8 ttm -74.68 -37.45 62.66 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -176.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.6 t -106.56 6.73 30.3 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -173.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -152.46 -67.91 0.16 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.282 0.946 . . . . 0.0 111.917 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.698 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -53.01 -65.4 0.57 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -174.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.1 mt -65.63 -48.77 71.06 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 111.524 0.194 . . . . 0.0 111.524 -174.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.4 m -55.74 -35.37 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 119.534 -0.27 . . . . 0.0 110.883 -177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -109.76 36.23 3.06 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -94.15 127.64 44.01 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -64.86 -22.86 62.9 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.32 2.013 . . . . 0.0 112.021 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.1 mtmt -111.75 6.06 19.53 Favored 'General case' 0 C--N 1.346 0.427 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -176.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 12.4 mt -140.81 129.21 24.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.479 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -122.98 168.96 11.66 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.4 t -98.68 131.86 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 47.9 mt -139.21 121.07 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 35.8 t70 58.46 29.94 19.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 122.625 0.37 . . . . 0.0 110.252 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.47 -36.54 3.22 Favored Glycine 0 CA--C 1.53 1.003 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.22 168.79 15.01 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -109.12 141.98 40.53 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.5 137.51 38.73 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.545 -177.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -71.59 125.96 28.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 176.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -80.17 122.07 82.52 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 -177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -66.41 163.5 32.07 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.435 2.09 . . . . 0.0 110.766 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -160.68 52.21 0.29 Allowed 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -139.01 86.02 2.11 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 -178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 40.78 44.53 1.91 Allowed 'General case' 0 C--N 1.349 0.576 0 C-N-CA 123.402 0.681 . . . . 0.0 110.86 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 69.49 135.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.347 0.48 0 C-N-CA 123.694 0.798 . . . . 0.0 109.831 -178.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? . . . . . 0 C--O 1.254 1.332 0 CA-C-O 116.478 -1.725 . . . . 0.0 109.253 -178.193 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 tt 52.99 63.68 2.15 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.4 m -153.16 76.78 1.13 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 -178.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 60.13 -122.03 28.59 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.3 p -78.77 67.37 4.49 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.5 t -85.65 28.44 0.77 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 122.484 0.314 . . . . 0.0 110.549 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -83.39 61.73 4.72 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.722 -0.951 . . . . 0.0 110.722 -179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -131.3 23.78 4.82 Favored 'General case' 0 C--N 1.342 0.269 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.417 ' HB2' ' CH2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -154.9 -47.4 0.09 Allowed 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 -178.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -59.62 -48.99 79.5 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.258 0.223 . . . . 0.0 110.696 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -58.7 -50.22 69.49 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.455 HG13 ' CD2' ' A' ' 43' ' ' HIS . 23.5 t -59.69 -49.7 82.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.9 tp -58.53 -46.35 86.96 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.286 -0.265 . . . . 0.0 110.286 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.46 98.18 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 15.3 ttmm -63.63 -45.68 89.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.08 -48.1 87.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.1 t -57.5 -42.81 81.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 N-CA-C 110.533 -0.173 . . . . 0.0 110.533 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 19.4 t30 -73.24 -42.7 62.25 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.484 -0.135 . . . . 0.0 111.087 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -49.0 77.52 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.1 mmm -55.88 -48.49 75.49 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 ttpt -52.39 -61.1 2.49 Favored 'General case' 0 C--O 1.219 -0.536 0 O-C-N 123.349 0.405 . . . . 0.0 110.6 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 97.3 m -54.99 -51.59 65.74 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 111.863 0.32 . . . . 0.0 111.863 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.0 mtp180 -62.1 -38.72 89.94 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.182 0.447 . . . . 0.0 110.251 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -64.46 -37.02 86.08 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 176.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -82.41 43.37 0.81 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.559 0.744 . . . . 0.0 109.012 177.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 ttp-105 -158.6 -51.43 0.06 Allowed 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -179.22 -38.17 0.07 OUTLIER Glycine 0 CA--C 1.53 0.98 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.8 59.66 3.77 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 117.315 0.557 . . . . 0.0 110.012 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.62 -3.53 59.05 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.456 ' NE2' HD21 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -67.15 154.37 92.8 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 122.651 0.38 . . . . 0.0 110.635 -179.664 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.99 120.67 7.95 Favored 'Trans proline' 0 N--CA 1.444 -1.391 0 C-N-CA 122.104 1.869 . . . . 0.0 110.121 176.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.4 mt -100.76 149.44 23.81 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.0 p -76.59 170.87 15.62 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.51 -53.32 59.63 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -58.14 -43.56 87.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 122.22 0.208 . . . . 0.0 111.057 -178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -56.62 -41.77 77.68 Favored 'General case' 0 C--N 1.344 0.341 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 25.2 mt -63.97 -49.68 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 81.9 mt -53.76 -55.73 23.7 Favored 'General case' 0 C--N 1.347 0.461 0 N-CA-C 110.407 -0.22 . . . . 0.0 110.407 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -45.79 -59.11 2.98 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 122.787 0.435 . . . . 0.0 111.442 -177.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.38 -38.74 84.86 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.404 ' HB ' ' CD2' ' A' ' 43' ' ' HIS . 33.3 p -81.41 -1.33 45.23 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.072 0.396 . . . . 0.0 111.159 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 65.54 44.91 2.89 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.455 ' CD2' HG13 ' A' ' 12' ' ' VAL . 8.2 m-70 -127.6 28.8 5.59 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.22 -44.33 75.98 Favored 'General case' 0 CA--C 1.527 0.064 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -81.93 55.88 2.91 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 17.0 tt -99.89 148.17 6.82 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 122.711 0.404 . . . . 0.0 110.001 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.62 141.99 41.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -57.29 -24.95 58.23 Favored 'General case' 0 C--O 1.222 -0.352 0 CA-C-N 117.064 0.432 . . . . 0.0 111.289 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -64.87 -50.97 64.48 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -69.49 -43.68 72.64 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -53.68 -50.57 65.54 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 -62.45 -48.13 81.01 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.98 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.468 ' CE2' ' HB2' ' A' ' 58' ' ' ALA . 28.8 t90 -54.38 -50.89 66.44 Favored 'General case' 0 C--O 1.225 -0.211 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.685 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 52.1 mt -55.16 -49.34 72.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 23.7 ttt -63.69 -48.07 78.65 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.2 t -124.96 50.24 1.77 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 118.726 0.694 . . . . 0.0 112.554 -174.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -172.77 -61.88 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -65.61 -67.02 0.47 Allowed 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.463 -0.148 . . . . 0.0 111.155 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.85 -48.35 82.21 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.351 0.26 . . . . 0.0 111.523 -175.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 29.6 m -53.74 -38.75 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 N-CA-C 111.531 0.197 . . . . 0.0 111.531 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -89.12 -25.11 22.04 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 117.797 0.271 . . . . 0.0 110.916 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -61.45 117.58 28.81 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -63.81 -35.4 56.91 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.633 2.222 . . . . 0.0 111.882 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -69.83 -26.61 64.31 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 119.363 -0.351 . . . . 0.0 110.902 -178.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 42.9 mm -114.09 95.2 3.62 Favored 'Isoleucine or valine' 0 C--N 1.345 0.381 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -91.97 157.95 16.53 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 57.7 t -96.21 136.53 26.78 Favored 'Isoleucine or valine' 0 C--N 1.34 0.175 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -178.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 27.1 mm -115.8 -114.07 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -83.19 62.47 6.66 Favored 'General case' 0 C--N 1.346 0.443 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -178.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 73.87 1.96 60.24 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -117.72 -179.98 3.9 Favored 'General case' 0 C--N 1.344 0.367 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -114.67 129.58 56.7 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 120.654 0.264 . . . . 0.0 110.51 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.5 146.09 48.34 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.45 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -87.66 125.23 34.26 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 25.2 tttp -81.3 121.32 80.14 Favored Pre-proline 0 N--CA 1.449 -0.519 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -62.66 -39.47 43.51 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.398 2.065 . . . . 0.0 111.124 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? 70.76 128.26 0.03 OUTLIER 'General case' 0 C--N 1.348 0.524 0 C-N-CA 123.585 0.754 . . . . 0.0 109.873 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -61.5 107.07 0.73 Allowed 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -144.46 152.39 40.55 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.9 p -71.39 147.51 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.166 0 CA-C-O 117.145 -1.407 . . . . 0.0 108.758 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.6 108.52 0.84 Allowed 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.0 p -162.43 75.26 0.43 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.84 53.78 0.5 Allowed Glycine 0 C--N 1.338 0.677 0 N-CA-C 110.107 -1.197 . . . . 0.0 110.107 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 t 64.17 -168.76 0.2 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 122.732 0.413 . . . . 0.0 110.387 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 64.2 m -79.42 176.62 9.52 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.08 -179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -89.21 101.37 2.76 Favored Glycine 0 CA--C 1.528 0.903 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -153.31 38.01 0.49 Allowed 'General case' 0 C--N 1.341 0.235 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 177.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -173.5 -51.04 0.01 OUTLIER 'General case' 0 C--N 1.341 0.201 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -178.18 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -62.73 -39.92 95.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 122.353 0.261 . . . . 0.0 110.505 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -62.23 -50.42 65.23 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 85.9 t -62.78 -44.09 99.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.67 -49.42 77.63 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -57.97 -42.95 86.09 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.34 -44.53 96.26 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.4 mt -60.21 -49.29 84.71 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.1 t -53.45 -45.47 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -65.63 -45.63 82.32 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.232 0.213 . . . . 0.0 111.228 -178.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.6 -40.26 94.17 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.69 -41.74 87.58 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -58.31 8.29 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -63.4 -48.44 77.82 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.847 0.459 . . . . 0.0 112.029 -176.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HE ' ' CB ' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -66.47 -35.04 79.3 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 118.309 0.504 . . . . 0.0 110.272 -177.395 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -66.29 -39.3 89.27 Favored 'General case' 0 C--N 1.344 0.327 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 175.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -78.52 53.19 1.26 Allowed 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.45 -50.13 0.09 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 167.76 -29.59 0.17 Allowed Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.402 ' CB ' ' HE ' ' A' ' 23' ' ' ARG . 62.6 m-20 -75.39 60.2 1.13 Allowed 'General case' 0 C--N 1.343 0.314 0 C-N-CA 122.966 0.506 . . . . 0.0 110.125 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.5 p -87.87 57.5 4.37 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -137.58 154.77 75.3 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -66.56 150.76 83.87 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.927 2.418 . . . . 0.0 112.32 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 32' ' ' LEU . 16.1 mt -138.37 142.92 39.64 Favored 'General case' 0 C--N 1.344 0.361 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 69.3 p -63.25 169.44 3.58 Favored 'General case' 0 C--N 1.342 0.251 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 34' ' ' LEU . 3.2 tt -60.88 -51.88 67.43 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -59.92 -41.34 91.52 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 119.675 -0.202 . . . . 0.0 110.655 -178.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -56.93 -39.3 74.25 Favored 'General case' 0 C--N 1.345 0.396 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 mt -67.0 -47.69 81.5 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 21.8 mt -52.0 -47.41 64.93 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.502 ' HA ' HD11 ' A' ' 44' ' ' LEU . 27.1 t70 -50.58 -56.77 10.22 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.33 0.252 . . . . 0.0 111.331 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -66.71 -45.06 79.97 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -176.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.416 HG22 ' NE2' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -75.13 -4.82 40.93 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 117.93 0.332 . . . . 0.0 110.934 -179.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 63.2 50.22 3.08 Favored 'General case' 0 C--N 1.346 0.432 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.416 ' NE2' HG22 ' A' ' 41' ' ' THR . 6.8 m-70 -130.9 45.77 2.77 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' H ' HD12 ' A' ' 44' ' ' LEU . 5.1 mp -77.59 -42.35 35.41 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -84.74 27.72 0.72 Allowed 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.6 tt -63.26 -32.88 58.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 122.766 0.427 . . . . 0.0 110.456 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.76 137.73 9.93 Favored Glycine 0 C--N 1.34 0.78 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -59.11 -26.4 64.65 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.996 0.398 . . . . 0.0 110.99 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? -61.17 -34.11 74.5 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -89.41 -47.42 8.03 Favored 'General case' 0 C--O 1.219 -0.504 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.9 ttpt -57.41 -45.03 85.0 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -56.77 -49.17 76.1 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.458 ' CZ3' ' HB2' ' A' ' 9' ' ' LYS . 27.6 t90 -58.92 -50.84 72.54 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.72 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 66.8 mt -54.29 -42.25 69.82 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 122.104 -0.373 . . . . 0.0 110.237 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 21.7 ttt -64.12 -60.46 3.2 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 -174.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.504 ' HA ' HG21 ' A' ' 60' ' ' VAL . 5.7 t -105.55 -3.34 22.49 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -172.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -117.74 -67.46 0.99 Allowed 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 119.051 0.841 . . . . 0.0 111.214 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.72 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -61.01 -69.08 0.25 Allowed 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.3 mt -57.94 -33.64 69.04 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.45 0.3 . . . . 0.0 111.077 -176.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.504 HG21 ' HA ' ' A' ' 56' ' ' THR . 48.0 t -63.58 -36.55 76.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.6 m-80 -111.75 46.85 1.08 Allowed 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -118.23 115.91 35.91 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -66.78 -4.75 11.73 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.734 2.289 . . . . 0.0 112.853 -177.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.66 4.51 17.23 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.404 0.547 . . . . 0.0 111.182 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.23 142.16 39.42 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -131.87 137.58 48.1 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.6 t -79.91 125.96 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 36.6 mt -137.54 116.6 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t0 54.31 45.49 27.13 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.687 0.395 . . . . 0.0 110.082 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.03 -41.72 2.24 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -69.5 169.99 11.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.106 0.453 . . . . 0.0 109.989 -179.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.85 125.54 54.12 Favored 'General case' 0 C--N 1.341 0.209 0 C-N-CA 122.524 0.33 . . . . 0.0 110.129 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.84 127.93 56.2 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.061 0.545 . . . . 0.0 110.208 -179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -63.4 121.02 12.77 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -77.65 115.69 51.93 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -64.93 146.0 86.87 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.264 1.976 . . . . 0.0 110.956 -178.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -82.13 -39.38 23.38 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.27 -61.13 0.1 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.4 t30 70.25 -67.68 0.23 Allowed 'General case' 0 C--N 1.348 0.5 0 C-N-CA 123.742 0.817 . . . . 0.0 110.571 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.12 131.86 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.0 tpp85 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 116.652 -1.642 . . . . 0.0 109.113 179.665 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.725 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -155.41 164.05 39.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.6 t 55.82 43.25 27.99 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.56 113.06 4.85 Favored Glycine 0 C--N 1.34 0.791 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.3 m -158.59 165.41 34.55 Favored 'General case' 0 C--N 1.339 0.146 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.1 t -83.52 -128.78 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.18 -166.45 10.74 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 177.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 69.02 142.0 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.256 0.622 . . . . 0.0 110.267 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 74.47 -45.69 0.59 Allowed 'General case' 0 C--N 1.349 0.567 0 C-N-CA 123.219 0.608 . . . . 0.0 110.53 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -75.52 -47.8 25.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 119.015 0.825 . . . . 0.0 109.637 175.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.93 -44.46 97.79 Favored Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.8 t -65.3 -43.92 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.1 tp -59.07 -47.22 86.01 Favored 'General case' 0 C--N 1.342 0.265 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.31 -43.19 92.68 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.9 tttp -61.31 -43.48 98.8 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.7 mt -61.3 -45.65 98.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.9 t -58.15 -48.09 85.46 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -61.79 -42.44 99.0 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -58.32 9.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.8 ttm -55.61 -37.68 68.45 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 122.615 0.366 . . . . 0.0 110.442 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -60.99 -48.77 80.28 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 39.2 m -62.39 -44.68 95.86 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.425 ' HE ' ' CB ' ' A' ' 28' ' ' ASP . 3.1 ttt85 -61.48 -47.49 85.42 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.784 0.326 . . . . 0.0 110.273 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -63.18 -54.29 39.88 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 123.044 0.538 . . . . 0.0 109.834 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.9 tp-100 -58.63 -32.98 69.54 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 122.979 0.512 . . . . 0.0 110.447 -179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -66.63 -52.55 43.9 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.75 -34.31 0.1 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 121.122 -0.561 . . . . 0.0 111.775 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.425 ' CB ' ' HE ' ' A' ' 23' ' ' ARG . 5.4 m-20 -76.14 69.67 2.72 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 117.583 0.692 . . . . 0.0 109.825 -178.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.1 p -77.32 -14.89 59.65 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 116.672 -0.24 . . . . 0.0 110.644 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -61.62 154.34 66.11 Favored Pre-proline 0 CA--C 1.541 0.597 0 C-N-CA 122.402 0.281 . . . . 0.0 110.711 -178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.24 157.62 52.99 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.598 2.198 . . . . 0.0 110.84 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 32' ' ' LEU . 17.2 mt -135.91 147.63 48.21 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.0 p -70.77 171.23 10.9 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 176.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.455 ' HA ' HD22 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -60.2 -54.93 39.93 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -52.69 -52.07 57.58 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.354 0.262 . . . . 0.0 110.641 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -51.68 -37.49 50.86 Favored 'General case' 0 C--N 1.343 0.3 0 C-N-CA 122.165 0.186 . . . . 0.0 110.545 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 23.0 mt -69.41 -48.51 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.5 mt -53.62 -52.03 61.18 Favored 'General case' 0 C--N 1.343 0.309 0 CA-C-N 117.537 0.153 . . . . 0.0 110.798 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -42.64 -65.12 0.51 Allowed 'General case' 0 C--N 1.342 0.275 0 C-N-CA 122.934 0.494 . . . . 0.0 111.679 -177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.64 -46.15 81.16 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.34 0.256 . . . . 0.0 111.426 -177.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.453 HG22 ' NE2' ' A' ' 43' ' ' HIS . 0.2 OUTLIER -71.98 -6.19 40.34 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 119.545 -0.264 . . . . 0.0 111.002 -178.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 67.94 41.55 2.07 Favored 'General case' 0 C--N 1.344 0.361 0 C-N-CA 122.899 0.48 . . . . 0.0 109.99 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.453 ' NE2' HG22 ' A' ' 41' ' ' THR . 7.2 m-70 -127.68 33.87 4.74 Favored 'General case' 0 C--O 1.224 -0.279 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -49.18 73.65 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -87.22 38.72 0.83 Allowed 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.6 tt -72.1 149.62 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -52.11 133.41 37.31 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 178.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 52.7 tp -54.29 -35.3 62.45 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.363 0.265 . . . . 0.0 110.409 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -54.56 -46.29 73.63 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -70.2 -48.66 56.15 Favored 'General case' 0 C--O 1.222 -0.344 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.0 ttmt -49.99 -44.13 50.8 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -69.24 -54.59 13.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.405 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 15.1 t90 -50.85 -40.14 55.34 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 122.709 0.404 . . . . 0.0 110.881 -179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.3 -39.8 88.23 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 73.0 mtm -89.96 -0.87 57.82 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 119.027 -0.511 . . . . 0.0 112.239 -177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.5 p -132.4 17.23 4.44 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.765 0.711 . . . . 0.0 111.888 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.405 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 16.1 tp10 -166.79 -70.77 0.03 OUTLIER 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.447 0.567 . . . . 0.0 111.038 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.45 -80.09 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -174.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.4 mt -59.29 -20.99 58.96 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 122.564 -0.085 . . . . 0.0 111.001 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 96.8 t -68.0 -40.74 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 CA-C-O 119.604 -0.236 . . . . 0.0 110.575 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -145.66 54.57 1.18 Allowed 'General case' 0 C--N 1.344 0.363 0 CA-C-N 117.844 0.293 . . . . 0.0 111.607 -178.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -101.9 135.18 19.76 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -51.2 -44.99 39.53 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.655 2.237 . . . . 0.0 112.682 -177.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -83.3 8.81 12.37 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -176.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 27.4 mm -123.88 150.85 28.45 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 CA-C-N 118.091 0.405 . . . . 0.0 109.926 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -134.69 138.55 44.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 41.2 t -96.93 121.25 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.3 mp -134.39 130.67 54.19 Favored 'Isoleucine or valine' 0 C--N 1.343 0.296 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 52.43 31.82 10.31 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 123.464 0.478 . . . . 0.0 111.196 176.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.42 -17.25 20.08 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 14.1 mmtm -87.66 -173.25 4.24 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -127.49 137.36 52.64 Favored 'General case' 0 C--N 1.34 0.196 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -178.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -134.19 154.18 51.4 Favored 'General case' 0 C--O 1.222 -0.343 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -77.3 125.68 29.71 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -73.94 116.97 57.36 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -74.54 168.39 24.92 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.427 2.085 . . . . 0.0 110.94 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -86.41 -12.01 50.33 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.95 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 73.56 6.33 5.02 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.579 0.751 . . . . 0.0 110.908 178.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.75 63.54 7.52 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 10.0 p -72.53 -34.22 47.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.183 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.09 0 CA-C-O 117.489 -1.243 . . . . 0.0 109.392 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 109.954 -0.387 . . . . 0.0 109.954 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 61.3 tp -57.89 -34.45 69.82 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.439 0.296 . . . . 0.0 110.335 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.9 m -76.88 62.41 2.08 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 122.485 0.314 . . . . 0.0 110.767 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 36.84 63.82 0.7 Allowed Glycine 0 C--N 1.346 1.116 0 C-N-CA 123.641 0.639 . . . . 0.0 112.153 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.6 p -163.1 138.82 6.86 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.2 m -78.22 60.62 2.53 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.77 150.03 2.1 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -67.2 161.38 24.88 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 47.1 tttp 72.99 -67.2 0.28 Allowed 'General case' 0 CA--C 1.536 0.44 0 O-C-N 123.33 0.394 . . . . 0.0 110.051 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -67.8 -48.73 65.48 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.033 0.533 . . . . 0.0 110.68 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.63 -43.28 99.16 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 48.0 t -60.84 -50.35 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.7 tp -60.51 -45.29 94.36 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.669 -0.241 . . . . 0.0 110.59 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.91 -44.68 96.29 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -57.43 -48.82 78.12 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.529 ' HA ' HG21 ' A' ' 41' ' ' THR . 62.8 mt -59.7 -50.24 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.392 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.0 t -55.9 -48.69 78.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -62.15 -45.17 94.6 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 122.074 0.15 . . . . 0.0 110.66 -179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.432 ' CE1' ' HG3' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -59.04 -55.27 37.22 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.1 ttt -62.86 -35.83 81.25 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -178.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.7 tttt -60.86 -55.14 36.55 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 81.1 m -62.02 -43.01 99.75 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.432 ' HG3' ' CE1' ' A' ' 19' ' ' TYR . 14.3 mmt180 -56.26 -50.2 72.01 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 122.824 0.45 . . . . 0.0 109.905 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 22.0 t60 -63.81 -38.76 92.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -83.82 48.74 1.49 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 177.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -162.79 -50.14 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -178.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 172.1 -31.95 0.12 Allowed Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -81.19 60.29 4.25 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 117.069 0.434 . . . . 0.0 110.175 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.76 -6.32 59.13 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -70.12 155.13 93.96 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 110.29 -0.263 . . . . 0.0 110.29 -178.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -70.02 147.11 60.46 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.73 2.287 . . . . 0.0 111.957 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 32' ' ' LEU . 19.3 mt -134.55 144.91 48.26 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 123.477 0.711 . . . . 0.0 109.447 178.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 81.2 p -64.52 173.65 2.05 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.013 0.435 . . . . 0.0 110.027 177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.06 -58.3 9.15 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.644 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -59.06 -38.5 79.55 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 119.599 -0.238 . . . . 0.0 111.411 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -58.25 -39.53 79.41 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.419 ' CG2' HG23 ' A' ' 16' ' ' ILE . 51.2 mt -68.43 -42.58 84.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 66.3 mt -59.8 -46.66 88.5 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.676 -0.12 . . . . 0.0 110.676 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -48.52 -59.48 3.46 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 122.645 0.378 . . . . 0.0 111.059 -177.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -56.84 -42.37 79.52 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.386 0.274 . . . . 0.0 111.077 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.529 HG21 ' HA ' ' A' ' 16' ' ' ILE . 47.0 p -80.19 4.69 16.69 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 118.876 -0.583 . . . . 0.0 111.213 -178.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? 72.45 -15.37 0.49 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.846 0.858 . . . . 0.0 111.618 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -78.18 42.73 0.42 Allowed 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 118.409 0.55 . . . . 0.0 111.285 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.38 -45.59 54.0 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 121.67 -0.644 . . . . 0.0 109.421 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -62.11 -55.14 31.89 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.459 HG23 ' N ' ' A' ' 47' ' ' GLY . 4.0 tt 34.74 -132.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.022 0 C-N-CA 124.095 0.958 . . . . 0.0 110.533 178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.459 ' N ' HG23 ' A' ' 46' ' ' ILE . . . -154.35 151.21 22.92 Favored Glycine 0 C--O 1.224 -0.473 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.0 tt -56.17 -44.55 79.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 117.542 0.671 . . . . 0.0 110.493 -178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -59.73 -45.77 91.17 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.163 0.185 . . . . 0.0 110.628 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -69.1 -48.8 61.6 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -52.37 -48.51 65.55 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -63.19 -48.03 80.08 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.421 ' CD1' ' HB3' ' A' ' 57' ' ' GLU . 26.5 t90 -53.78 -46.03 70.89 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.459 0.304 . . . . 0.0 110.405 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.578 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 62.8 mt -61.86 -40.72 96.35 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 40.0 ttm -76.13 -26.86 56.74 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -175.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.2 t -118.81 -8.05 10.38 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.804 1.038 . . . . 0.0 113.804 -174.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.421 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 26.8 tt0 -132.9 -49.09 0.87 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.152 0.887 . . . . 0.0 112.404 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -79.2 -63.52 1.4 Allowed 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -174.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.0 mt -80.36 2.49 24.65 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -173.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER -73.83 -93.46 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 118.773 0.715 . . . . 0.0 109.422 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 34.9 p30 -83.96 51.61 2.09 Favored 'General case' 0 C--N 1.34 0.188 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -80.85 135.01 52.43 Favored Pre-proline 0 N--CA 1.45 -0.452 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.113 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -64.82 -25.02 60.75 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 122.112 1.875 . . . . 0.0 111.266 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -108.8 1.34 20.91 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-O 119.011 -0.518 . . . . 0.0 112.037 -177.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.36 134.5 22.93 Favored 'Isoleucine or valine' 0 C--N 1.346 0.435 0 CA-C-N 118.776 0.716 . . . . 0.0 110.014 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -115.89 157.38 24.57 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.592 ' C ' HD12 ' A' ' 68' ' ' ILE . 17.7 t -100.62 126.79 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.592 HD12 ' C ' ' A' ' 67' ' ' VAL . 3.5 mp -135.42 121.43 31.52 Favored 'Isoleucine or valine' 0 C--N 1.344 0.348 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t0 51.53 46.96 25.7 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.823 0.449 . . . . 0.0 110.455 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 78.81 -39.49 2.0 Allowed Glycine 0 CA--C 1.532 1.122 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 24.1 mtmt -73.16 176.29 6.0 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -117.49 153.0 33.9 Favored 'General case' 0 C--O 1.222 -0.351 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.483 ' HB3' HD13 ' A' ' 68' ' ' ILE . . . -144.19 139.07 28.53 Favored 'General case' 0 C--O 1.223 -0.312 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 -178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -64.82 133.86 52.87 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -90.14 115.92 65.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 123.112 0.565 . . . . 0.0 110.187 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -72.25 107.8 2.35 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.338 2.025 . . . . 0.0 110.135 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.41 -46.78 84.82 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -137.7 15.77 2.91 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 61.42 -155.31 0.35 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.79 150.12 34.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.0 ttm105 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 116.663 -1.637 . . . . 0.0 109.435 179.89 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tt 73.32 -68.06 0.24 Allowed 'General case' 0 C--N 1.346 0.451 0 C-N-CA 123.074 0.549 . . . . 0.0 109.816 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 t -76.18 74.36 3.01 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -159.34 -92.44 0.09 OUTLIER Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.6 p -163.99 52.14 0.14 Allowed 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.6 t -75.38 84.34 2.5 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.65 -166.77 54.68 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER 66.48 145.13 0.03 OUTLIER 'General case' 0 C--N 1.348 0.515 0 C-N-CA 123.263 0.625 . . . . 0.0 110.134 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.436 ' HG3' ' CH2' ' A' ' 53' ' ' TRP . 5.6 pttt 77.68 -48.71 0.5 Allowed 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.268 0.627 . . . . 0.0 110.622 -179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -68.59 -47.4 66.84 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 118.103 0.41 . . . . 0.0 110.543 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.73 -36.11 88.63 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.467 HG13 ' CD2' ' A' ' 43' ' ' HIS . 14.1 t -72.69 -49.81 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 62.3 tp -57.69 -40.91 80.52 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.77 0.428 . . . . 0.0 110.775 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.14 -49.49 77.66 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 110.483 -0.191 . . . . 0.0 110.483 -179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -62.55 -38.94 92.0 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.46 HG23 HG21 ' A' ' 37' ' ' ILE . 41.1 mt -60.84 -49.0 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 t -58.53 -47.92 86.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -65.77 -40.32 91.91 Favored 'General case' 0 C--N 1.339 0.147 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -178.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.424 ' CE1' ' HG2' ' A' ' 40' ' ' GLU . 1.8 t80 -60.17 -56.65 18.96 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.524 0.33 . . . . 0.0 110.27 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.28 -40.66 86.81 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -55.84 -47.39 77.33 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -63.37 -47.61 81.39 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 122.395 0.278 . . . . 0.0 110.921 -178.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.407 HH21 ' CG ' ' A' ' 28' ' ' ASP . 2.2 mtp180 -58.55 -48.72 79.95 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -60.2 -40.26 89.48 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -61.85 -42.74 99.42 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 110.008 -0.368 . . . . 0.0 110.008 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -65.82 -45.65 81.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.461 0.304 . . . . 0.0 110.311 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 158.91 -20.83 0.3 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.407 ' CG ' HH21 ' A' ' 23' ' ' ARG . 14.9 t70 -79.83 68.78 6.02 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.423 HG22 ' H ' ' A' ' 29' ' ' THR . 0.6 OUTLIER -87.53 -5.69 58.67 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.979 179.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.3 p-80 -64.22 148.46 95.7 Favored Pre-proline 0 CA--C 1.541 0.622 0 O-C-N 122.329 -0.232 . . . . 0.0 110.436 -177.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.08 146.67 86.79 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.038 2.492 . . . . 0.0 112.251 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.43 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.2 mt -134.78 136.53 42.65 Favored 'General case' 0 C--N 1.348 0.504 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 60.6 p -63.12 169.91 3.16 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-O 121.059 0.457 . . . . 0.0 110.049 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.9 tt -58.35 -51.44 69.79 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -58.14 -44.75 87.99 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 122.59 0.356 . . . . 0.0 110.99 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -56.59 -30.43 63.19 Favored 'General case' 0 C--N 1.345 0.399 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.46 HG21 HG23 ' A' ' 16' ' ' ILE . 49.4 mt -78.3 -42.99 27.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 178.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 25.3 mt -55.26 -43.58 74.78 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -49.47 -50.08 42.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.381 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG2' ' CE1' ' A' ' 19' ' ' TYR . 0.8 OUTLIER -77.28 -49.8 14.25 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.204 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 16' ' ' ILE . 54.5 p -69.08 -3.49 13.45 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.251 -177.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 65.47 45.95 2.65 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 109.522 -0.548 . . . . 0.0 109.522 179.041 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.467 ' CD2' HG13 ' A' ' 12' ' ' VAL . 7.1 m-70 -125.57 42.29 3.32 Favored 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.413 ' H ' HD12 ' A' ' 44' ' ' LEU . 4.6 mp -74.57 -49.7 20.8 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -84.59 42.53 0.91 Allowed 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.4 tt -72.82 -36.13 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 122.816 0.446 . . . . 0.0 110.309 -178.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.69 132.19 6.78 Favored Glycine 0 C--N 1.337 0.619 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 -177.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.9 -36.21 62.45 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.821 0.311 . . . . 0.0 110.368 -178.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -50.13 -44.09 52.16 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -78.25 -46.9 19.11 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.484 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 34.4 ttmt -50.61 -49.67 55.99 Favored 'General case' 0 C--N 1.344 0.331 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.41 -48.95 78.98 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.436 ' CH2' ' HG3' ' A' ' 9' ' ' LYS . 12.8 t90 -55.76 -53.27 58.74 Favored 'General case' 0 C--N 1.342 0.258 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 78.0 mt -54.95 -44.02 73.95 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.19 -53.09 61.82 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.303 -175.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.439 ' HA ' HG21 ' A' ' 60' ' ' VAL . 7.1 t -120.15 48.18 1.62 Allowed 'General case' 0 C--N 1.348 0.541 0 N-CA-C 112.439 0.533 . . . . 0.0 112.439 -175.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -165.75 -66.11 0.03 OUTLIER 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.568 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -64.5 -69.39 0.29 Allowed 'General case' 0 C--O 1.224 -0.267 0 O-C-N 122.904 0.127 . . . . 0.0 111.168 -176.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.7 mt -59.72 -25.28 64.7 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.416 0.286 . . . . 0.0 111.088 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.439 HG21 ' HA ' ' A' ' 56' ' ' THR . 46.5 t -75.2 -47.89 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -102.26 66.02 0.98 Allowed 'General case' 0 C--N 1.342 0.252 0 N-CA-C 110.103 -0.332 . . . . 0.0 110.103 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -143.89 118.55 6.07 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.36 -23.3 74.25 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.602 2.202 . . . . 0.0 112.285 -177.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -93.87 12.35 26.22 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 117.793 0.27 . . . . 0.0 110.95 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.2 mm -135.68 152.02 30.61 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -144.8 142.37 29.92 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 22.7 t -96.06 127.5 48.08 Favored 'Isoleucine or valine' 0 C--O 1.23 0.049 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.7 mm -112.59 -120.97 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -81.02 67.51 6.95 Favored 'General case' 0 C--N 1.342 0.259 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 79.19 -36.86 1.96 Allowed Glycine 0 CA--C 1.531 1.083 0 N-CA-C 110.744 -0.942 . . . . 0.0 110.744 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.9 mttt -75.25 169.25 18.42 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 117.111 0.455 . . . . 0.0 109.999 -179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -112.47 120.81 42.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.48 134.59 51.7 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -64.47 135.03 55.66 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -97.23 118.27 64.77 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -66.34 120.95 8.15 Favored 'Trans proline' 0 N--CA 1.448 -1.203 0 C-N-CA 122.311 2.007 . . . . 0.0 110.24 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -166.36 -80.35 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -89.53 67.16 7.51 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -89.25 28.87 1.16 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.291 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.54 -32.55 58.28 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.387 0 CA-C-O 117.048 -1.453 . . . . 0.0 108.906 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.728 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 21.6 tp -76.62 86.77 3.29 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.0 p -80.21 63.46 4.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.97 -71.97 1.06 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 68.1 p 46.15 -131.95 1.11 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.27 0.628 . . . . 0.0 110.605 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.9 p -92.94 28.54 2.07 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.538 0.335 . . . . 0.0 110.404 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -76.78 -24.2 67.76 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -56.94 114.04 1.93 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 -179.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.44 ' HB3' ' CZ3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER 72.51 -65.18 0.36 Allowed 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.95 0.9 . . . . 0.0 110.502 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -58.11 -37.45 74.58 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 122.868 0.467 . . . . 0.0 111.383 -175.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.48 -48.17 76.37 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.06 -41.97 91.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.728 HD13 ' HB1' ' A' ' 58' ' ' ALA . 62.6 tp -60.82 -47.55 85.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.91 -44.14 91.21 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -60.7 -47.33 86.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 61.7 mt -59.32 -49.66 82.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.222 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.8 t -55.68 -43.8 74.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 C-N-CA 122.663 0.385 . . . . 0.0 110.152 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -65.11 -48.22 74.4 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 110.367 -0.234 . . . . 0.0 110.367 -178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -61.85 -50.25 73.03 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 -179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 78.3 mmm -55.73 -45.54 77.94 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.3 -43.02 87.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 96.6 m -61.27 -51.36 69.24 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 119.422 -0.323 . . . . 0.0 111.285 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -65.65 -34.4 78.13 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 118.857 0.753 . . . . 0.0 109.691 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 27.3 t60 -65.37 -35.37 80.75 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -69.74 -42.35 74.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.078 0.551 . . . . 0.0 110.436 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.6 ptt180 -65.75 -36.19 82.85 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 119.606 -0.235 . . . . 0.0 110.69 -177.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 154.99 -23.37 0.6 Allowed Glycine 0 C--N 1.344 1.02 0 CA-C-O 119.695 -0.503 . . . . 0.0 111.935 179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -76.74 66.68 2.71 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 117.651 0.726 . . . . 0.0 109.658 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 70.2 p -76.42 -4.16 40.92 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 122.079 0.152 . . . . 0.0 110.676 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -66.03 156.14 85.06 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 110.393 -0.225 . . . . 0.0 110.393 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -70.32 162.46 42.26 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.708 2.272 . . . . 0.0 110.881 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 32' ' ' LEU . 14.2 mt -138.65 150.28 46.06 Favored 'General case' 0 C--N 1.342 0.261 0 N-CA-C 109.236 -0.654 . . . . 0.0 109.236 177.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 74.3 p -77.88 167.94 20.71 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 177.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.3 -44.83 92.5 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -57.0 -54.45 46.63 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 109.959 -0.386 . . . . 0.0 109.959 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -54.58 -43.03 71.74 Favored 'General case' 0 C--N 1.343 0.296 0 C-N-CA 122.582 0.353 . . . . 0.0 110.339 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 13.2 mt -59.13 -62.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 98.2 mt -54.81 -42.34 71.72 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.162 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -52.1 -54.91 24.63 Favored 'General case' 0 C--N 1.341 0.208 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -64.05 -31.99 73.38 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.02 13.79 5.68 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 74.44 -58.51 0.58 Allowed 'General case' 0 C--N 1.355 0.813 0 C-N-CA 124.312 1.045 . . . . 0.0 112.592 175.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -69.76 77.75 0.45 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.615 0.366 . . . . 0.0 111.944 -175.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.94 -33.98 51.37 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 47' ' ' GLY . 19.4 t70 -68.98 -55.37 11.1 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 tt 50.26 -70.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.675 1.59 . . . . 0.0 112.693 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 45' ' ' ASP . . . 142.46 126.34 2.09 Favored Glycine 0 C--O 1.223 -0.579 0 N-CA-C 108.172 -1.971 . . . . 0.0 108.172 -178.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 66.5 tp -46.81 -44.96 19.69 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.261 0.53 . . . . 0.0 111.238 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.6 -39.21 61.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 122.196 0.198 . . . . 0.0 111.244 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -87.97 -48.05 8.08 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 13.8 ttmt -48.11 -48.84 33.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.118 0.567 . . . . 0.0 110.495 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.39 -47.43 76.33 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.44 ' CZ3' ' HB3' ' A' ' 9' ' ' LYS . 31.2 t90 -55.8 -40.27 72.46 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 122.376 0.27 . . . . 0.0 110.425 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.731 ' HA ' ' HB3' ' A' ' 58' ' ' ALA . 77.5 mt -58.66 -49.0 79.16 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 83.1 mtp -64.84 -47.98 75.98 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.13 -0.486 . . . . 0.0 112.279 -176.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 67.5 p -110.32 34.35 3.97 Favored 'General case' 0 C--N 1.344 0.356 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -173.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -168.17 -75.17 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 118.738 0.699 . . . . 0.0 110.681 177.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.731 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . . . -52.49 -53.78 41.24 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -174.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 57.7 mt -79.92 -20.1 46.52 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 119.756 -0.164 . . . . 0.0 111.041 -176.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.89 -69.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.236 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.95 60.13 5.7 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -107.44 122.81 40.05 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.128 -178.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -63.48 -19.6 68.15 Favored 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 122.247 1.964 . . . . 0.0 111.845 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -125.86 19.69 7.8 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -177.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 36.1 mt -146.0 129.69 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -111.46 154.12 25.15 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.3 t -105.93 144.29 15.58 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 6.0 mt -126.52 -125.15 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 -179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -78.51 65.04 3.71 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 82.29 -37.34 2.57 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.13 171.31 14.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -122.99 147.69 46.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.94 136.51 33.9 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -66.71 130.23 42.49 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -77.42 129.84 76.23 Favored Pre-proline 0 N--CA 1.448 -0.569 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -53.5 157.09 9.99 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.651 2.234 . . . . 0.0 112.188 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 mtmm 71.22 -173.41 0.17 Allowed 'General case' 0 C--N 1.344 0.345 0 C-N-CA 123.848 0.859 . . . . 0.0 110.131 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.2 32.73 0.08 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.845 -178.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -153.44 101.05 2.48 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.45 150.48 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 27.1 tpt180 . . . . . 0 C--O 1.249 1.078 0 CA-C-O 116.815 -1.565 . . . . 0.0 109.15 179.994 . . . . . . . . 0 0 . 1 stop_ save_